Har yaushe waɗannan alamun za su kasance?
Kuma duk cututtukan kirji ya kamata a bi da su ta wannan hanyar, musamman a kan shekarunsu.
Kuma akwai zafi.
Kuma za a duba hawan jini na ku.
Kuma yanzu kana da zazzabi?
Kuma yanzu kana ciwon kirji ne?
Kuma bayan haka, kuna numfashi?
Kuma za ku iya gaya mini, wane irin alamun da kuke da shi?
Kuma yaya zafin jikinka ya taɓa ƙaruwa?
Kuma ina jin ƙishirwa.
Na yi sanyi kuma na yi tari kaɗan.
A yau, na ji ciwon kirji sosai.
Kuma wannan lokaci ne da ya dace da fushinka?
Kuma hakan yana sa na ji zafi sosai.
Kuma ina tsammanin ina da ɗan zafi.
Kuma ina so in gaya muku dalla-dalla game da wannan ciwon kirji.
Kuma suna da ƙananan zafi.
da kuma tarihin ciwon sukari.
Ka sani, na ji kamar ƙirjina na kan yi fashewa.
Kuma ka san cewa suna yi mini ba'a a kowane lokaci.
Kuma kuna ciwon kirji.
Kuma kun ce wannan shine matsin lamba a kirjinku.
Wani a cikin iyalin yana da matsaloli na zuciya, ciwon zuciya, jini mai yawa, yawan cholesterol.
Shin akwai wasu alamun cututtuka ko kuma matsaloli da ka lura da su, kamar ciwon tsoka?
Akwai wani a cikin gidanka da yake da irin wannan rashin lafiya da kuma cututtukan?
Shin kuna da wasu alamun?
Shin kuna da numfashi?
Shin har yanzu kuna ciwon kirji?
Domin wannan babban lokacin sanyi ne.
Amma ba ma bukatar mu damu da ciwon kirji da ke fitowa daga zuciya.
Amma yanzu, matsalar ta fi tsanani ita ce ciwon kirji.
Amma ina da matsalar numfashi.
Amma na san mutane da yawa suna ta yi mini ba'a.
Amma muna bukatar mu bi da dukan cututtukan kirji da kyau.
Amma yanzu kana numfashi sosai, ba haka ba?
Wannan ciwon na sa na manta da yin barci.
Kana jin kamar wani yana makale a kirji.
Har ila yau, ina jin kamar ina numfashi.
Shin suna gunaguni cewa suna da irin waɗannan alamun?
Shin kana da ciwon jini ko wani irin cuta?
Shin kana da wasu matsalolin kiwon lafiya kamar ciwon sukari?
Shin kana shan numfashi da ciwon kirji?
Idan ka yi tunani game da irin wannan yanayin, ka yi tunani game da irin wannan yanayin.
Shin zafin jiki yana sa ka yi sanyin jiki?
Ka san abin da yake nunawa?
Kuna ganin hoton?
A yau, ku sha ruwa mai yawa.
Na yi gwajin jini don ciwon sukari.
Duk da haka, yana da alamun da na samu.
Ka yi tunani a kan yadda za ka iya yin hakan.
Yaya za a iya gwada hawan jini?
Idan kana da ciwon zazzabi,
Idan kana da zafi mai zafi na 100 to 2 farans zuwa sama
Idan ka yi tunanin cewa alamun ka ko kuma matsalarka sun fi kyau,
A jiya na ji zafi sosai.
Ina da zafi sosai.
Na yi zafi sosai a jiya.
Na ji zafi sosai a kirji.
Ina da matsalar numfashi.
Zan aika muku da hoton.
Ina ciwon kirji a yau.
Na ji zafi sosai a yau.
A ganina, cutar tana kama da mura.
A ganina, wannan cuta ce ta yau da kullum.
Shin, yana kama da wani mutum mai nauyi yana zaune a kirjinka?
Yana farawa da ciwon kai da kuma zafi a lokaci guda.
Yana ciwo a tsakiyar ƙirjina.
Wannan yana da wuya kamar ciwon kirji.
A cikin ƙirjina
Yana cikin ƙirjina.
Yana cikin tsakiyar kirji.
Ina da ciwo a cikin kirji.
Wannan ciwon na sa ni baƙin ciki sosai.
Ina so ku gaya mini game da wannan ciwon kirji.
Alal misali, muna da ciwon jini mai yawa ko kuma ciwon sukari.
Kamar dai a tsakiyar kirji na dama
Yanzu, don barci mai zafi, za ka iya shan maganin tachipirina.
Maryamu ta yi kwanaki da yawa tana da alamun cutar.
Yanzu ka ce kana ciwon kirji.
A wasu lokatai, na ji zafi sosai a ƙirjina.
A'a, ba ka da wata alama a waje da wannan ciwon kirji?
Ko kuwa wani yana zaune a kirjinka?
Hakazalika, akwai ciwon kumburi, ciwon kai, da kuma ciwon tsoka.
A tsakiyar ƙirjina, a hannun dama.
Ka nuna mini inda kake ji zafi a wannan hoton.
Amma, ba a taɓa yin hakan ba.
Shin kana ganin waɗannan alamun suna da alaƙa da ciki?
Shin yaranku suna da irin waɗannan alamun?
Ka gaya mini game da ciwon kirjinka.
A cikin dare, zafin yana daɗa ƙaruwa.
Na yi rashin lafiya na kwanaki biyu da suka gabata.
A daren jiya, yanayin zafi ya yi tsanani.
Wannan shi ne mataimakin likitancin a cikin dakin gaggawa a cibiyar rarraba cututtuka.
Za ka iya gaya mini game da ciwon kirjinka?
Na ji zafi a gaban kaina, a nan a cikin kirji.
Na ji zafi sosai a kirji.
A lokacin da nake da irin wannan ciwon a kirjina,
Shin, ƙirjinka yana ciwo?
A wane lokaci ne ciwon ya soma?
Wane irin ciwo ne kake ji a ƙirjinka?
Shin kana jin zafi a gefen ƙirjinka?
Kana jin kamar kana da wuya a kirji.
Na kamu da ciwon sukari da kuma wasu cututtuka.
Ka ce kana ciwo a kirji.
Saurin karuwa a cikin cutar coronavirus (COVID-19) a cikin Tarayyar Turai / Yankin Tattalin Arziki na Turai da Burtaniya daga 1 ga Janairu zuwa 15 ga Maris, 2020
Kasashen da ke fama da cutar korona (COVID-19) suna nuna irin wannan yanayin a cikin ƙasashen EU/Yankin Tattalin Arzikin Turai, kuma Burtaniya ta bayyana cewa yayin da take cikin matakai daban-daban dangane da kowace ƙasa, cutar COVID-19 tana ci gaba da sauri a cikin dukkan ƙasashe.
Bisa ga gogewar Italiya, asibitoci da hukumomin kula da mutane ya kamata su kara kasancewa a shirye don karuwar masu cutar COVID-19 da za su bukaci kulawar lafiya da kuma kulawa mai mahimmanci.
A ranar 31 ga watan Disamba na shekarar 2019, an samu rahoton wani mutum da ke fama da cutar kumburi mai suna Ramrai, wanda ba a san asalinsa ba, a Wuhan, Hubei, China.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta kasar Sin ta ruwaito cewa wata sabuwar nau'in coronavirus ce ta hanyar cutar coronavirus 2 ta hanyar cutar ta hanyar cutar ta hanyar numfashi mai tsanani (SARS-CoV-2).
Tun daga wannan lokacin, cutar da ke haifar da kamuwa da cutar SARS-CoV-2 ta kasance ana kiranta cutar Coronavirus (COVID-19).
Dalilin ya zuwa yanzu shine cewa kashi 80% na mutanen da ke da COVID-19 suna da wannan cutar mai sauƙi, wato kamuwa da cutar ta iska tare da ko ba tare da cutar huhu ba, kuma yawancin waɗannan marasa lafiya sun warke.
Kashi 14 cikin 100 na COVID-19 sun zama na musamman da ke buƙatar asibiti, yayin da kashi 6 cikin 100 ke da ciwon da ke buƙatar kulawa sosai.
Yawan mutuwar marasa lafiya da ke asibiti saboda COVID-19 ya kai kashi 4 cikin 100.
A cikin wannan binciken, mun kimanta yanayin karuwar cutar COVID-19 a cikin kowace ƙasa ta EU/EEA da Burtaniya, kuma mun kwatanta su da lardin Hubei, China.
Mun kuma kwatanta yawan adadin cututtukan COVID-19 na yanzu a cikin ƙasashen EU/Yankin Tattalin Arziki na Turai da Burtaniya da adadin cututtukan a Italiya tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Kasuwancin COVID-19 a cikin ƙasashen EU / Yankin Tattalin Arziki na Turai da Burtaniya.
Bayan mamaye kasar Sin, cutar COVID-19 ta ci gaba da yaduwa, kuma annobar COVID-19 da ke yaduwa a duniya a yanzu tana bin hanyar kasar Sin.
A ranar 11 ga Maris, 2020, babban darektan Hukumar Lafiya ta Duniya (WHO) ya sanar da cewa COVID-19 cuta ce ta yaduwa.
A cikin Bayanai na 5 na Eurosurveillance 2020, Spiteri da sauransu sun ba da rahoton COVID-19 da aka fara tabbatar da shi ta Turai dangane da yanayin cutar ta WHO.
A cikin kasashen Turai / Yankin Tattalin Arziki na Turai, Faransa ta fara bayar da rahoton sabbin mutane uku da aka tabbatar da su a ranar 24 ga Janairu, 2020 ga mutanen da suka dawo daga Wuhan, Hubei, China.
Ya zuwa 15 ga Maris, 2020, an gano shari'o'in COVID-19 a cikin ƙasashe 30 na Tarayyar Turai / Yankin Tattalin Arzikin Turai da Burtaniya, wanda tsakanin 31 ga Disamba, 2019 kuma zai kasance a wannan ranar, an ƙidaya ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigardigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙ
Ka yi la'akari da yawan adadin da kuma abubuwan da suka faru a cikin jerin adadin adadin COVID-19.
A Cibiyar Tarayyar Turai don Rigakafin Cututtuka da Kulawa (ECDC), an sabunta adadin adadin shari'o'in COVID-19 da aka ruwaito a kowace ƙasa a duk faɗin duniya, daga tushe na hukuma kamar Ma'aikatar Lafiya, Hukumomin Lafiya na Kasa da na Yankin, da Hukumar Lafiya ta Duniya a kowace rana a 8:00 am.
Duk waɗannan bayanan ana amfani dasu don kimanta cutar COVID-19 a cikin ƙasashen EU/Yankin Tattalin Arzikin Turai da kuma Burtaniya, kuma ana kwatanta duk waɗannan bayanan da bayanan Italiya.
A matsayin wakilin cutar COVID-19 mai aiki, mun lissafa jerin abubuwan da suka faru na COVID-19 da suka kwantar da hankali a cikin kwanaki 14 dangane da yanayin yanayin COVID-19 a cikin kowace ƙasa ta EU/EEA da Burtaniya tsakanin 1 ga Janairu zuwa 15 ga Maris, 2020.
Mun kuma nuna karuwar adadin shari'o'in da aka samu a kowace ƙasa da aka sanar a ranar 15 ga Maris, 2020 da karfe 8:00 na safe, idan aka kwatanta da Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Halin da ake ciki na COVID-19 a cikin ƙasashen Turai / Yankin Tattalin Arziki na Turai da Burtaniya
A cikin kwanaki 14 na al'amuran COVID-19 da suka faru a cikin EU / Yankin Tattalin Arziki na Turai da Burtaniya, an bi misalin lamarin a lardin Hubei (China) (Figure 1).
Ga EU/Yurofan Tattalin Arziki da kuma Birtaniya baki daya, abubuwan da suka faru na COVID-19 sun fara tashi a ranar 21 ga Fabrairu, sannan sun tashi sosai a ranar 28 ga Fabrairu, 2020. (ƙarin bayani)
Wannan yafi yawa ne saboda saurin karuwar adadin shari'o'in da aka ruwaito daga Italiya, amma kasashen Turai/Yankin Tattalin Arziki na Turai da Birtaniya sun nuna irin wannan karuwar yanayin COVID-19 (ƙarin bayani).
Hoto na 2 ya nuna jimlar adadin adadin kamuwa da cutar COVID-19 a cikin ƙasashen Turai / Yankin Tattalin Arzikin Turai (EU/EEA) da Burtaniya idan aka kwatanta da Italiya a cikin Janairu 31 zuwa 15 ga Maris, 2020.
Rahoton ya tabbatar da cewa a ranar 15 ga Maris da karfe 8:00 na safe, wasu kasashe 15 na EU / Yankin Tattalin Arzikin Turai da Burtaniya sun ba da rahoton adadin ɓarnatar da hankali, idan aka kwatanta da adadin Italiya da suka kasance kawai makonni 3 da suka gabata ko ma ƙasa da haka.
Sakamakonmu ya nuna cewa adadin shari'o'in COVID-19 da aka bayar da rahoton sun karu cikin sauri a cikin ƙasashen EU/Yankin Tattalin Arzikin Turai da Burtaniya.
Abubuwan da aka lura a cikin abubuwan da suka faru na COVID-19 sun nuna cewa annobar tana ci gaba da haɓaka cikin ƙididdiga a cikin dukkan ƙasashe.
Wannan ya bambanta da yadda ƙasashe ke cikin matakai daban-daban, canza amsar lafiyar jama'a da kuma ma'anar shari'o'i daban-daban a cikin ƙasashe da kuma ayyuka daban-daban don zaɓar marasa lafiya don tabbatar da COVID-19, gami da gwajin gwaji.
A farkon watan Maris na shekarar 2020, likitoci a yankin da kasar Italiya ta sha wahala sosai sun ruwaito halin da ake ciki a yankin cewa kashi 10% na marasa lafiya na COVID-19 suna bukatar kulawa mai kyau, kuma wasu kafofin sun ruwaito cewa asibitoci da kuma cibiyoyin gaggawa a yankunan suna aiki da iyakar iyawarsu.
Bayanai game da karɓar COVID-19 a asibitoci da/ko cibiyoyin kula da marasa lafiya a halin yanzu suna samuwa a matakin EU/Yankin Tattalin Arzikin Turai don kashi 6% da 1% na shari'o'in, kowanne (ba a bayyana bayanan ba).
Duk da haka, ya kamata a tattara su a cikin tsari don ƙara bayanan bin diddigin da ke kan adadin shari'o'in da aka ruwaito da yawan mutuwar.
Wani binciken da aka gudanar a 2010-11 ya nuna cewa akwai babban canji a cikin damar bayar da kulawa da matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsaka
Wannan yana nufin cewa ƙasar tana da albarkatu fiye da ko ƙasa da Italiya (wani matsakaici na wurare 12.5 don kulawa da gado don mutane 100,000 a shekara ta 2010-11).
An bayar da samfurin da ya shafi rashin iyawar kiwon lafiya a cikin sabon sabon kimantaccen haɗarin COVID-19 na shida na ECDC, tare da kimantawa ga ƙasashen EU/Yankin Tattalin Arziki na Turai da Burtaniya cewa yawan masu cutar COVID-19 suna da haɗari fiye da yadda za a iya ba da gadon kulawa mai tsanani &gt; 90%.
Saboda da yawa daga cikin lokuta sun faru, suna tattare a wasu yankuna a cikin ƙasashen Turai, Yammacin Turai da Burtaniya, kuma asibitoci da cibiyoyin kulawa suna yawanci kawai bauta wa yawan mutanen yankin da aka ƙayyade, don haka ya kamata a ba da bayani game da shari'o'i da kuma yanayin kula da kulawa a ƙarƙashin Sashin Gida na Cibiyar Kula da Yanki na 2 (NUTS-2).
Kwarewar Italiya da kuma halin da ake ciki a wasu ƙasashe ya nuna cewa cutar COVID-19 ta duniya tana tasowa cikin sauri a cikin ƙasashen EU/Yankin Tattalin Arzikin Turai (EU/EEA) da Burtaniya.
Saboda haka, ya kamata a kula da ƙasashe, asibitoci da hukumomin kulawa da su don su kasance a shirye don sabon yanayin watsawar SARS-CoV-2 zuwa al'umma da ke faruwa a cikin sauri da kuma karuwar yawan marasa lafiya na COVID-19 da ke buƙatar kulawa ta kiwon lafiya da kuma musamman kulawa mai mahimmanci kamar yadda lamarin yake faruwa a yankunan da aka shafa a Italiya.
Kamar yadda aka nuna a cikin sabon saurin kimanta hadarin ECDC, saurin amsawa mai dacewa da kuma cikakkiyar hanya tana da mahimmanci a jinkirta yaduwar SARS-COV-2-virus, tare da sauyawa daga juriya zuwa hanyoyin ragewa, yayin da saurin karuwa a cikin adadin lokuta bazai ba masu ɗaukar shawara da asibitoci isasshen lokaci don gano karɓa da amsa yadda ya kamata idan ba a aiwatar da shi ba da wuri.
Ƙididdigar haɗarin haɗari mai sauri ta kuma gabatar da matakan kiwon lafiyar jama'a don rage tasirin cutar.
Akwai gajeren lokaci da za a samu a yayin da kasashe ke da damar kara inganta kokarin su na hana yaduwar SARS-CoV-2 da kuma rage matsin lamba a kan hukumomin kiwon lafiya.
Idan hakan bai yi nasara ba, tsarin kula da lafiyar kasashen Turai da na sauran kasashen Turai na iya fuskantar karuwar marasa lafiya da ke bukatar kulawa mai tsanani a cikin 'yan kwanaki ko makonni masu zuwa.
Cutar cutar coronavirus ta 2019 (COVID-19) da ta haifar da cutar sankarar cuta ta hanyar numfashi (SARS) ta hanyar cutar coronavirus 2 (SARS-CoV-2) ya zuwa yanzu ta kashe mutane sama da 3,000 da kamuwa da cutar sama da 80,000 a China da sauran wurare a duniya, wanda ya haifar da bala'i ga mutane.
Wannan kwayar cutar tana kama da kwayar cutar, wanda ke da nasa fasalin guda daya, SARS-CoV, wanda ya haifar da cutar SARS a kan dubban mutane a shekara ta 2003. SARS-CoV-2 na iya kamuwa da cutar daga tsutsotsi kuma yana haifar da alamun bayyanar cututtuka ta hanyar daukar hoto kamar SARS-CoV.
Koyaya, COVID-19 yana da ƙananan haɗari da ƙarancin mutuwa fiye da SARS, amma yana da yawa kuma yana shafar tsofaffi fiye da matasa, maza kuma suna da yawa fiye da mata.
Don amsa yawan wallafe-wallafen da ke gudana a kan cutar da ke yaduwa, wannan labarin yana son samar da cikakken bayani game da batutuwan bincike da ke ci gaba da sauri.
Za mu tattauna game da cututtuka, abubuwan da ke haifar da cututtuka, ilimin lissafi, bincike, magani, tsinkaya da rigakafin cututtuka.
Duk da cewa akwai tambayoyi da yawa da ba a amsa ba, muna fatan wannan bita zai taimaka mana mu gano kuma mu magance wannan cuta mai barazana.
Bikin hutun bazara a ranar 25 ga Janairu, 2020 ya zama abin mamaki da ba za a iya mantawa da shi ba ga duk 'yan kasar Sin da aka ba da shawarar su kasance a gida don hutu da kuma makonni bayan barkewar cutar.
Wannan kwayar cutar tana kama da cutar coronavirus (CoV), wanda ya haifar da barkewar cutar ta hanyar numfashi mai tsanani (SARS) a cikin 2003. Saboda haka, an sake masa suna SARS-CoV-2 ta Hukumar Lafiya ta Duniya (WHO) a ranar 11 ga Fabrairu, 2020, kuma sauran cututtukan da suka shafi an sake masa suna COVID-19 (COVID-19).
An fara barkewar cutar ne a birnin Wuhan, China, tare da yaduwar cutar a cikin ƙasa da kuma zuwa kusan ƙasashe 50 a duniya.
Ya zuwa ranar 2 ga Maris, 2020, cutar ta haifar da kamuwa da cutar COVID-19 guda 80000 inda aka sallami marasa lafiya sama da 40,000 kuma an kashe marasa lafiya sama da 3000.
Hukumar lafiya ta duniya ta yi gargadin cewa COVID-19 ita ce babbar magabcin jama'a kuma tana da matukar tasiri fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/) a cikin kasa da watanni biyu, an wallafa fiye da 200 na binciken COVID-19 da suka hada da nazarin cutar, kamuwa da cuta, ganewa da magani tun daga farkon rahoton da aka bayar a ranar 7 ga Janairu, 2020, wanda ya gano jerin cututtukan da ke ware daga marasa lafiya daban-daban.
Wannan bita yana ƙoƙarin taƙaita yanayin bincike a cikin sabbin fannoni masu tasowa da sauri.
A duk lokacin da zai yiwu, za mu gwada COVID-19 da cutar sankara ta SARS, wani cuta da cutar coronavirus (CoV) ke haifarwa, wato cutar MERS ta hanyar numfashi ta Gabas ta Tsakiya (wanda ya barke a shekarar 2012).
Za mu kuma tattauna abin da muka koya game da rigakafi da kuma hasashen cututtuka, da kuma tambayoyin da muke bukatar mu amsa da gaggawa.
Yawancin lokaci, ana ɗaukar ƙwayoyin cuta na CoVs a matsayin masu cutar da ba su da haɗari ga mutane, waɗanda galibi ke haifar da cutar mura ta yau da kullun, kusan 15% na cutar mura ta 4.
A cikin wannan karni, duk da haka, mun sami cututtukan coronavirus (CoVs) masu saukin kamuwa da cututtukan mutum sau biyu, wanda shine SARS-CoV da cutar sankara (MERS-CoV), wanda ya haifar da barkewar cutar a China a 2003 da Saudi Arabia a 2012 kuma daga baya ya bazu zuwa wasu ƙasashe tare da ƙarin kisa da yawan mutuwa.
Saboda haka, COVID-19 a halin yanzu shine fashewar cutar coronavirus (CoV) ta uku a tarihin ɗan adam.
Kamar yadda aka nuna a hoto na 1.1 an fara bayar da rahoton wasu cututtukan huhu da ba a san asalin su ba daga Wuhan a ranar 31 ga Disamba, 2019 ga Hukumar Lafiya ta Kasa ta kasar Sin.
Kwana bakwai bayan haka, an saki jerin sunayen cutar coronavirus (CoV).
A ranar 15 ga Janairu, 2020, an fara samun mutuwar farko daga Wuhan.
A halin yanzu, cutar ta bazu cikin sauri zuwa garuruwan da ke kusa da shi, larduna da ƙasashe.
A ranar 20 ga Janairu, an samu rahoton kamuwa da cutar daga mai ba da sabis na kiwon lafiya, wanda ya tabbatar da cewa kamuwa da cutar daga mutum zuwa mutum na iya faruwa.
A ranar 23 ga Janairu, Wuhan ta rufe ba tare da jigilar jama'a ba.
A ranar 24 ga watan Janairu, binciken farko na gwaji na cutar ya nuna cewa daga cikin marasa lafiya 41 da suka kamu da cutar, 21 ne kawai ke da alaƙa kai tsaye da kasuwar jiragen ruwa ta Wuhan, wanda aka ɗauka a matsayin wurin da ba a san asalin cutar ba.
A ranar 30 ga Janairu, Hukumar Lafiya ta Duniya ta bayyana annobar a matsayin dokar ta baci ta duniya.
A lokacin da aka fitar da rahoton, cutar ta bazu ko'ina cikin China da kusan ƙasashe 50 a duniya (Figure 2).
Yayin da yanayin ke ci gaba da sauri, yanayin ƙarshe da kuma yadda mummunan fashewar ke ci gaba da kasancewa mafi kulawa.
A ranar 11 ga Fabrairu, 2020, wani bincike na cibiyar da aka yi a kan marasa lafiya 8866, wanda ya hada da marasa lafiya 4021 da aka tabbatar da COVID-19 ya nuna yaduwar cutar ta hanyar: https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA.
Masu kamuwa da SARS-CoV-2 suna da shekaru daban-daban, amma yawanci suna faruwa ne a tsakanin shekaru 30-65.
Kusan rabin (47.7%) na masu kamuwa da cutar sun fi shekaru 50, kaɗan ne ke ƙasa da shekaru 20, kuma kawai 14 daga cikin waɗanda suka kamu da cutar suna ƙasa da shekaru 10.
Maza sun fi kamuwa da cutar SARS-CoV-2 (0.31/100,000) fiye da mata (0.27/100,000).
Cutar COVID-19 ta bazu ko'ina ko kuma a cikin mafi yawan yankuna a cikin da kewaye da lardin Hubei.
COVID-19 yana ɗaukar matsakaici na kwanaki 5 (2-9) daga farkon kamuwa da cutar zuwa ganewar asali.
Matsakaicin tsawon lokacin kamuwa da cutar yana tsakanin kusan kwanaki 4.8 (3.0-7.2).
Matsakaicin lokacin daga farkon kamuwa da cuta zuwa mutuwa shine 9.5 (4.8-13) days.
Yawan ci gaba na asali (R0) shine 3.77 (95% CI: 3.51-4.05) kuma daidaitaccen R0 shine 2.23-4.82.
Yawan masu kamuwa da cutar ya karu sosai kafin 23 ga Janairu, 2020, lokacin da ake buƙatar manyan jigilar kaya kafin bikin bazara a China.
Yawan mutuwar marasa lafiya da aka tabbatar da cutar ya kasance 1.44% (95% CI: 1.10-1.86%) kuma yawan mutuwar marasa lafiya da aka daidaita ya kasance 3.06% (95% CI: 2.02-4.59%).
Abubuwan haɗari guda uku na COVID-19 sune jima'i, maza, shekaru 60, da waɗanda ke da ciwon huhu mai tsanani.
Kwayar cutar korona ko CoVs sune kwayoyin cuta masu girma da yawa waɗanda ke dauke da RNA guda ɗaya.
Ana iya rarraba su zuwa nau'i hudu, alpha, gamma, da tetra, kuma ana iya gano beta-CoVs da ke watsawa zuwa mutane.
Spike (S) glycoprotein yana da alaƙa da ƙwayoyin cuta na karɓar enzymes 2 wanda ke lalata angiotensin (ACE2) da dipeptidyl peptidase 4 (DPP4) don SARS-CoV da MERS-CoV daban-daban, sannan kuma haɗuwa da haɗin gwiwa ya faru.
Amma an tura RNA na kwayar zuwa cytoplasm. Bayan an rarraba kwayar cutar, RNA ɗin ya haɗu da glycoproteins da nucleocapsids don samar da ƙananan ruwa, wanda ke narkewa tare da aikin flatulence don sake fitar da kwayar.
An fara samun labarin farkon kwayar cutar SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano cutar SARS-CoV-2 a matsayin sabon nau'in kwayar cutar beta-CoV, wanda ke da asalin kwayoyin halitta sama da kashi 99.98% na samfurori 10 da aka tattara daga asalin wurin barkewar cutar, kasuwar ruwan teku ta Hunan a Wuhan.
SARS-CoV-2 yana da kwayoyin da suka fi kama da SARS-CoV fiye da MERS-CoV.
A cikin wani hoto na hoto na lantarki, an gano SARS-CoV-2 a cikin mafi girman ɓangaren epithelium na numfashi na mutum.
An gano cewa ACE2 na mutum yana hana karɓar SARS-CoV-2 da SARS-CoV-2.
Koyaya, ƙwayoyin S na SARS-CoV-2 da ke danganta da ACE2 na ɗan adam sun fi rauni fiye da haɗin kai ga SARS-CoV, wanda ya danganta da gaskiyar cewa SARS-CoV-2 yana haifar da ƙananan kamuwa da cutar a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 na iya haifar da sabon nau'in ƙarancin ƙwayoyin cuta wanda aka yi wa lambar ta orf3b da kuma ƙwayoyin cuta waɗanda aka yi wa lambar ta orf8.
Orf3b na cutar sankara (SARS-CoV-2) na iya taka rawa wajen kamuwa da cutar da kuma hana fitar da IFNβ. Koyaya, orf8 ba shi da wani aiki ko sanannen tsari.
A ranar 18 ga Fabrairu, 2020, Joe da sauransu sun ruwaito wani tsari na cryoEM na ACE2, wanda ke da cikakken girman mutum 2.9 A, tare da wani tsari (complex) wanda ya ƙunshi B0AT1 na mai aika amino acid.
Sun gano cewa yana da daidaituwa, tare da buɗewa da rufewa, an samar da kwayoyin a cikin dimer, kuma an haɗa S2 (ACE2-B0AT1) complex, dukansu sun ba da shaida ga ganewa da kamuwa da cutar coronavirus.
B0AT1 na iya zama manufa ta magani don duba magungunan don kawar da kamuwa da cutar SARS-CoV-2.
Amma, ba a taɓa yin hakan ba.
An san cewa SARS-CoV ya fito ne daga tsuntsaye kuma an watsa shi zuwa mutane ta hanyar civet foxes, kuma MERS-CoV ya fito ne daga kwayoyin halitta.
Ta hanyar kwatanta kwayoyin halitta na SARS-CoV-2 da sauran coronavirus (CoVs), an dauki tsutsotsi a matsayin asalin kwayar cutar SARS-CoV-2 saboda sabon kwayar cutar ya kasance 96% daidai da coronavirus (CoVs) wanda yayi kama da SARS guda biyu daga tsutsotsi suna da suna bat-SL-CoVZX45 da bat-SL-CoVZX21.
Amma, abin da ke sa kwayar ta samu karuwa daga dabba zuwa mutum, ko kuma hanyar da take kaiwa, ba a sani ba.
Ji da sauransu sun ce macizai suna karbar kwayar cutar daga beraye zuwa mutane, suna da alaƙa da sake haɗuwa da ke cikin S.
A cewar wani bincike, masu bincike a Guangzhou, China sun nuna cewa, anadrol, wanda ake amfani da shi a maganin gargajiya na kasar Sin, shine babban nau'in SARS-CoV-2 wanda ke da tasiri dangane da kwayoyin halitta, 99% na kama da coronavirus da aka samu a cikin anadrol da SARS-CoV-2.
Duk da haka, bambancin 1% da ya shafi jinsunan biyu ya kasance babban bambanci. Saboda haka, sakamakon da aka yi na ƙarshe don hujja ta zahiri yana jiran (Figure 33).
Ba a san yawancin sunadarai na SARS-CoV-2 ba.
Kwayar SARS-CoV da MERS-CoV na iya rayuwa na tsawon awanni 48 a cikin yanayin bushe, kuma yana rayuwa na kwanaki 5 a ƙarƙashin 20 ° C da 40%-50% na danshi.
SARS-CoV-2 na iya zama irin wannan.
An ruwaito cewa SARS-CoV-2 ba shi da ƙarancin haske da zafi a zazzabi na 56 ° C na tsawon minti 30. Ethylene, ether, 75% ethanol, chlorine mai ƙonewa, yana dauke da perocetic acid, chromium, da sauran kayan maye gurbin mai ba chlorhexidine.
Yawan mutanen duniya ba su da kariya ga SARS-CoV-2 kuma saboda haka suna da saukin kamuwa da sabon kwayar cutar.
A halin yanzu, babu cikakken binciken da aka ruwaito game da amsawar tsarin garkuwar ga SARS-CoV-2.
Don haka, mun kalli wasu binciken da aka yi a baya game da wasu CoVs, musamman SARS-CoV da MERS-CoV (Figure 4) 4.
Yawancin lokaci, bayan kwayar cutar ta shiga cikin kwayoyin halitta, tsarin garkuwar kwayoyin halitta na farko yana gane ta ta hanyar hana ganewar asali (PRRs), wanda ya haɗa da hana C-type lectin-like receptors, Toll-like receptor (TLR), receptor-like-NOD (NLR), da RIG-I-like receptor (RLR).
A hanyoyi daban-daban, cutar ta haifar da fitowar wakili wanda ke haifar da kumburi, tsufa na ƙwayoyin cuta na jini da kuma maganin hana cutar (IFNs) na farko, wanda ke hana yaduwar cutar, kuma yana haɓaka saurin cutar ta bacillus macrocytic.
Koyaya, ƙwayoyin N na SARS-CoV na iya taimakawa ƙwayoyin cuta su tsere daga tsarin rigakafi.
Nan ba da daɗewa ba, tsarin rigakafi mai daidaitawa zai shiga cikin yaƙi da cutar.
T lymphocytes na jini, ciki har da CD4 + da CD8 + T, suna taka muhimmiyar rawa wajen kare lafiyar jiki.
CD4+T yana motsa kwayar B don yin aiki na musamman da ƙwayoyin cuta, kuma CDC8+T tana kashe kwayar ta atomatik.
Kwayoyin T suna samar da cytokines masu kare cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cut
Koyaya, kwayar cutar tana iya hana T cell aiki ta hanyar haifar da mutuwar T cell.
Tsarin rigakafin mutum, ciki har da C3a da C5a da kuma kwayoyin halitta, suna da mahimmanci wajen tsayayya da kamuwa da cutar.
Alal misali, an cire wani abu daga cikin waɗanda suka warke, kuma ya sa cutar ta MERS-CoV ta zama ta al'ada.
A wani ɓangare kuma, yawan ƙwayar cuta na tsarin rigakafi yana haifar da adadin radicals na yau da kullum, wanda zai iya haifar da mummunan lalacewar hanta da sauran kwayoyin halitta, kuma a mafi munin yanayin, rashin cin nasara da mutuwa.
Kwayar cutar SARS-CoV-2 da aka nuna ta hanyar farawar bayyanar cututtuka a cikin rukuni na iya shafar tsofaffi masu cutar da mata masu ciki.
Yana da kyau a ga mutane da ke fama da wasu manyan ƙwayoyin cuta ko kuma waɗanda ke da rauni a cikin rigakafin su, suna da mafi yawan damar kamuwa da su fiye da wasu.
Matsakaicin lokacin kamuwa da kwayar cutar SARS-CoV-2 ya kasance daga kwanaki 1-14 wanda mafi yawa ya kasance kwanaki 3-7, dangane da nazarin farkon shari'o'i 425 a Wuhan.
Koyaya, nazarin shari'o'i 1099 ya nuna cewa tsawon lokacin rashin lafiya yana da matsakaici na kwanaki 3 kuma yana daga 0 zuwa 24 kwanakin.
Wani sabon bincike kamar wanda aka bayyana a sama ya nuna cewa lokacin farkawa daga cutar ya kasance kwanaki 4.8 (3.0-7.2) dangane da yawan mutane 8,866.
Yana da matukar muhimmanci ga hukumomin lafiya su daidaita lokutan yin gwajin asibiti da suka dace bisa ga lokutan farkawa da suka dace, don haka su hana masu kamuwa da cutar amma ba su da alamun cutar daga watsawa ga wasu.
A cikin al'ada, ana buƙatar mutum da ya kamu da cutar ko kuma ya kamu da cutar don yin gwaji na kwanaki 14.
Shin zan iya yin takardar shaidar kwanaki 24?
Cutar zafin jiki ita ce farkon bayyanar cutar COVID-19, wanda ba shi da wata alama ko kuma yana da wasu alamomi kamar bushewa, gajeren numfashi, ciwon tsoka, ciwon kai, ciwon fuska, ciwon hanci, ciwon kirji, ciwon kirji, ciwon kirji, kumburi, da kuma tari.
Wasu marasa lafiya sun sami matsala da kuma/ko rashin iskar oxygen a cikin jini a mako guda bayan fara cutar.
A cikin matsanancin hali, marasa lafiya sun fara haɓaka zuwa alamun numfashi mai ƙyama, rashin lafiyar jiki, zubar da abinci mai gina jiki, da kuma zubar da jini.
Maza da ke da zazzabi da/ko alamun cutar numfashi da zazzabi, ko da ba a da rashin daidaituwa a cikin tsarin huhu, ya kamata a fara duba su da ƙwayoyin cuta don ganewar asali.
Nazarin binciken a ƙarshen Disamba 2019 ya nuna cewa yawan alamun cututtuka ya kasance 98% don zazzabi, 76% don ciwon sukari, 55% don cututtukan zuciya, 3% don cutar sankara, kuma 8% na marasa lafiya suna buƙatar iskar iska.
Wani bincike mai kama da wannan ya nuna cewa, a cikin wani sabon bincike, an gano cewa mutane biyu da suka kamu da cutar sun kamu da cutar daga mutanen da ba su da wata alama.
Idan aka kwatanta da haka, binciken binciken mutane na 2012 ya nuna cewa masu cutar MERS-CoV suna da zazzabi 98%, tari 47%, rashin numfashi 55%, wanda shine babban alamar su.
Koyaya, kashi 80% na waɗannan marasa lafiya suna buƙatar taimakon iska fiye da waɗanda ke cikin COVID-19, kuma wannan ya yi kama da cutar MERS, wacce ta fi COVID-19 muni.
An kuma lura da cutar sankara (26%) da kuma ciwon daji (21%) a cikin marasa lafiya (MERS).
A cikin marasa lafiya na SARS, an nuna cewa zafin jiki (99%-100%) sanyi (29%-75%), gudu (40%-42%), ciwon sukari (20-25%) da ciwon huhu (13-25%) sune alamun bayyanar cututtuka, kuma ana buƙatar goyon bayan iska mai shigowa don kusan 14%-20% na marasa lafiya.
A ranar 14 ga Fabrairu, mutuwar COVID-19 ta kasance 2% yayin da aka tabbatar da cewa akwai 66576 a duk duniya.
Idan aka kwatanta da mutuwar SARS a watan Nuwamba na 2002, kashi 10% na adadin sun tabbatar da cewa akwai mutane 8,096.
A cikin cutar MERS, bisa ga binciken alƙaluma na Yuni 2012, yawan mutuwar ya kai kashi 37 cikin dari na 2,494 da aka tabbatar.
Wani binciken da aka yi a baya ya ruwaito cewa R0 na SARS-CoV-2 yana da matsakaicin matsakaici na 6.47, wanda ke tsakanin 95% amintacce (CI) na 5.71 zuwa 7.23, yayin da R0 na SARS-CoV ke tsakanin 2 zuwa 4 kawai.
Ana kwatanta SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da bayyanar cututtuka, kuma ana nuna shi a cikin tebur 1.1.
Bayanan da ke sama sun nuna cewa SARS-CoV-2 yana da mafi kyawun damar yadawa fiye da MERS-CoV da SARS-CoV, amma yana da ƙasa da haɗari fiye da waɗannan biyu.
Saboda haka, yana da wuyar sarrafa yaduwar SARS-CoV-2 fiye da MERS-CoV da SARS-CoV.
Ainihin cutar ta samo asali ne daga iyali ɗaya ko ta fito ne daga wani taro ko kuma daga hawa jirgin ruwa ɗaya kamar jirgin ruwa.
Mai haƙuri yana da tarihin tafiya ko zama a Wuhan ko wasu yankunan da aka shafa, ko kuma yana da dangantaka da mutum mai cutar ko mai haƙuri a cikin makonni biyu na ƙarshe kafin fara cutar.
Koyaya, an ruwaito cewa mutane na iya samun cutar ba tare da bayyanar wata alama ba har tsawon makonni biyu, kuma marasa lafiya da suka warke kuma suka bar asibiti suna iya samun cutar kuma, wanda ya nuna sanarwar gaggawa don ƙara lokacin yin gwaji.
Mai haƙuri na iya samun ƙarancin adadin kwayoyin jini (lymphoctyes) a farkon matakin.
Alal misali, an gano wani kwayar cutar da ke dauke da adadin kwayar cutar 4×109/L, wanda ya hada da kwayar cutar 1×109/L da kuma samun kwayar cutar a cikin jini da kuma yawan aminos a cikin aspartate, wanda ya karu a cikin mutane 1,099 da ke fama da cutar COVID-19.
Ƙarfin ƙwayar cuta, ƙwayoyin cuta da ƙwayoyin cuta na myoglobin sun ƙaru a cikin jinin wasu marasa lafiya, kuma sun ƙaru da ƙwayoyin C da kuma ƙwayoyin lantarki a cikin jinin wasu marasa lafiya.
A cikin marasa lafiya masu tsanani, matakan D-dimer, wanda shine raguwar fibrin da ke cikin jini, ya karu kuma yawan lymphocytes ya ragu.
An gano rashin daidaituwa a cikin yin radiation na kirji a cikin yawancin marasa lafiya na COVID-19 kuma an nuna su da hawan jini na biyu ko kuma hawan gilashi a cikin huhu.
A yawancin lokuta, marasa lafiya suna ci gaba da kamuwa da cutar huhu, rauni na huhu, da kuma bayyanar cututtukan cututtukan numfashi mai tsanani (ARDS).
Lokacin da ake fuskantar alamun numfashi masu tsanani, rashin kula da kumburi, haɓakar ruwa, da kuma ci gaba da kumburi na huhu na iya haifar da rashin iyawar motsa iska ko iska a cikin jiki.
Rashin tsari na nau'in I da nau'in II na ƙwayoyin cuta na huhu yana haifar da raguwar matakan surfactant da kuma ƙara ƙarfin farfajiyar waje, yana rage rashin haɓaka na huhu da kuma haɗarin lalacewar huhu.
Saboda haka, sakamakon da aka samu na yin tawaye a cikin mafi munin sassan kirji sau da yawa ya dace da mafi munin yanayin cutar.
A ranar 18 ga Fabrairu, 2020, bincike na farko na ilimin kimiyyar cuta na COVID-19 ya nuna karuwar huhu, sake fasalin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan
Gano SARS-CoV-2 RNA ta hanyar hanyar polymerase chain reaction (RT-PCR) an yi amfani da shi azaman babban ƙayyadaddun don gano COVID-19.
Duk da haka, saboda yawan rashin daidaito na gaskiya wanda zai iya hanzarta yaduwar, an fara amfani da nunin asibiti don ganewar asali (wanda ba ya dogara da RT-PCR kawai) a China a ranar 13 ga Fabrairu, 2020.
Irin wannan yanayin ya faru ne da gano cutar SARS.
Saboda haka, haɗa bayanan da ke nuna sakamakon gwaji, gwajin gwaji, hotunan X-ray yana da mahimmanci kuma yana da amfani ga ingantaccen bincike.
A ranar 14 ga Fabrairu, 2020, Feng Zheng sun bayyana wani aikin da suka yi na amfani da fasaha ta SHERLOCK, wanda ke da tushen CRISPR don gano kwayar SARS-CoV-2, wanda ke gano kwayar SARS-CoV-2 RNA mai sauti a 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (10-100 dokoki a kowace micron na shigarwa) ta amfani da man fetur, yana auna sinadarin sinadarin sinadarai a cikin ƙasa da awa ɗaya ba tare da buƙatar amfani da kayan aiki mai ƙarfi ba.
Muna fatan wannan sabuwar fasaha za ta taimaka wajen inganta fahimtar muhimman bayanai da kuma samar da sauƙin idan aka daidaita su cikin gwajin gwaji na zahiri.
Saboda rashin kwarewa a maganin cutar ta CoV, likitoci sun ba da magani na kulawa ta gaba ga marasa lafiya na COVID-19 yayin da suke ƙoƙarin gwada wasu magunguna da aka riga aka yi amfani da su ko kuma an riga an ba su don magance sauran cututtukan corona (CoV) kamar SARS-CoV, MERS-CoV, da sauran cututtukan cutar. (Table (Table2)).
Wadannan jiyya sun hada da magani na zamani da kuma magani mai mahimmanci tare da maganin rigakafi, maganin rigakafi, steroids, plasma daga marasa lafiya da suka warke, magani na kasar Sin, da kuma bada taimako na ruhaniya.
Ko da an ba da shawarar yin amfani da filastik daga marasa lafiya da suka warke don magani.
Yawancin kamfanonin magunguna suna fafatawa don samar da maganin rigakafi da rigakafin cutar.
Kwayar SARS-CoV-2 ta fara kai hari ga kwayoyin huhu a farkon matakin, kuma tana ci gaba da kai hari ga sauran kwayoyin da ke samar da ACE2, kamar tsarin narkewa da koda, da sauransu.
Duk da haka, rashin aiki da rashin ciwon numfashi suna da babbar barazana ga marasa lafiya kuma suna da sanadin mutuwa.
Saboda haka, tallafin numfashi yana da mahimmanci don rage bayyanar cututtuka da ceton rai, kuma ya haɗa da maganin oxygen na yau da kullun, iskar oxygen mai yawa, iska mai shigowa da ba ta da tsoro, da iska mai iska da ke haifar da shi, dangane da yanayin cutar.
Marasa lafiya da ke fama da cututtukan rashin lafiyar zuciya suna bukatar a yi musu magani da maganin oxygenation na extracorporeal membrane (ECMO), wata fasaha da ke tallafawa tsarin jini na zuciya da na huhu da ake amfani da ita wajen magance cututtukan zuciya da kuma rashin lafiyar numfashi da ke barazanar rayuwa.
Bugu da kari, kula da daidaiton electrolyte, rigakafi da kuma maganin kamuwa da cutar bayan kamuwa da cutar, da kuma maganin rigakafi ga kwayoyin cuta da kuma aikin rigakafin kwayoyin halitta na wadannan muhimman kwayoyin ne ake bukata ga masu cutar SARS-CoV-2.
An san cewa cutar ta kamu da cutar ta kamuwa da cutar ta hanyar tasirin tsarin rigakafi akan SARS da MERS.
Cytokine shine nau'in amsawar kumburi wanda ke nuna tsarin da aka nuna ta hanyar sakin kwayoyin cuta masu yawa, ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Wadannan kwayoyin suna sa kwayoyin rigakafi su fitar da wasu manyan radicals na calcium, wanda shine tushen ARDS da kuma rashin nasarar kwayoyin halitta.
Rage rigakafi yana da mahimmanci a cikin maganin cytocin, musamman a cikin marasa lafiya masu tsanani.
Ana amfani da corticosteroids da tocilizumab, masu hana IL6 daga kwayoyin halitta, don magance cutar ta sukari.
Sauran magunguna na maganin rigakafi don haɓakar cytokine sun haɗa da daidaita tsarin garkuwar jiki wanda ke jagorantar ƙwayoyin T, hana IFN-γ, IL-1, da TNF, hana JAK, amfani da maganin blinatumomab, hana siginar 4 na cytokine, da hana HDAC.
Ana amfani da steroids, magungunan rigakafi, a cikin maganin SARS don rage mummunan rauni wanda ke haifar da kumburi.
Duk da haka, steroids masu amfani da yawa ba su da amfani wajen magance mummunan rauni na huhu na SARS da COVID-19.
A maimakon haka, suna iya haifar da mummunan sakamako, musamman cututtukan ƙwayoyin cuta, wanda ke shafar tsinkayar cutar.
Koyaya, an ba da shawarar yin amfani da ƙananan ƙananan ƙananan ƙananan ƙwayar corticosteroids a cikin ƙananan ƙananan ƙananan ƙwayar cuta don masu cutar COVID-19 masu tsanani.
A lokacin rubuce-rubuce, babu wani maganin rigakafi da aka tabbatar da tasiri.
Duk da haka, an gano cewa maganin Remdesivir, wanda shine kwayoyin halitta na kwayoyin halitta, yana da tasiri ga wani mai cutar COVID-19 a Amurka.
Remdesivir wani sabon maganin rigakafi ne wanda kamfanin Gilead Pharmaceuticals ya kirkira don magance cututtukan da cutar Ebola da Marlburg ke haifarwa.
Daga baya, remdesivir ya nuna cewa yana iya hana kwayoyin RNA da suka haɗu, kamar MERS da SARS.
Bisa ga wannan, Gilead ta ba da kayan aiki ga China don gudanar da gwaje-gwaje guda biyu na gwaji akan mutane da ke kamuwa da cutar SARS-CoV-2, kuma sakamakon yana da kyau.
Bugu da ƙari, baricitinb, interferon-α, lopinavir / ritonavir, da ribavirin an ba da shawarar su zama magunguna masu yuwuwa ga marasa lafiya da ke fama da cututtukan numfashi.
Ƙarƙashin zuciya, kumburi, lalata ƙwayoyin cuta, da sauran ayyuka na iya faruwa bayan an haɗa lopinavir/ritonavir.
Ya kamata a yi la'akari da yadda waɗannan magunguna suke aiki tare da sauran magunguna da ake amfani da su a cikin marasa lafiya.
Wannan shi ne sakamakon da aka samu daga warkewar da aka yi da kuma kafa wani dakin motsa jiki.
Ana yin tattara jini daga marasa lafiya da suka warke daga kamuwa da cutar don magance wasu marasa lafiya da ke fama da irin wannan cuta ko kuma don hana mutane lafiya kamuwa da cutar.
Hakika, marasa lafiya da suka warke sun yi aiki sosai don su magance cututtukan da ke cikin jininsu.
Magungunan kwayoyin halitta sune immunoglobulin (ig) da kwayoyin B suke samarwa don yaki da kamuwa da cuta, da kuma kwayoyin halitta wadanda ba a cikin jiki ba, kuma suna iya gano kwayoyin cutar da ke kashe su kai tsaye.
Bisa ga wannan, za a saka kwayar cutar da aka tattara daga jinin marasa lafiya 10 da suka warke daga COVID-19.
A cikin sa'o'i 24 na ƙarshe, bayyanar cututtukan sun inganta ta hanyar rage kumburi da ƙwayar cuta da kuma inganta oxygen a cikin jini.
Duk da haka, ana buƙatar daidaitawa da tabbatarwa don bayar da shawarar hanyoyin yin amfani da manyan fayiloli kafin a sami wani magani na musamman.
Bugu da ƙari, saboda tasirin warkarwa, wasu halaye masu alaƙa da filastik ya kamata a yi la'akari da su da kyau.
Alal misali, motsa jiki zai iya sa tsarin garkuwar jiki ya yi tsananin ƙarfi kuma ya haifar da alamun fitowar cytokine wanda zai iya haifar da mutuwa.
Yawan jini a cikin jini yana da ƙananan ƙananan kuma yana buƙatar ƙarin plasma don kula da marasa lafiya masu tsanani.
Yana da wuya a ci gaba da samar da takamaiman kwayoyin halitta da sauri don magance yaduwar cutar a duniya.
Saboda haka, yana da muhimmanci kuma ya fi dacewa a cire kwayar cutar B daga marasa lafiya da suka warke kuma a gano asalin asalin da aka sanya a cikin kwayar cutar ko kuma a bincika kwayar cutar da ke aiki da manyan ƙwayoyin cutar.
Ta yin haka, za mu iya ƙara yawan masu yin amfani da kayan aiki da sauri.
TCM an yi amfani da ita wajen magance cututtuka a kasar Sin na dubban shekaru.
Duk da haka, tasirinsa ya dogara ne da haɗuwa da abubuwa da yawa a cikin tsari guda ɗaya, wanda ya bambanta dangane da gano cutar bisa ga ka'idodin TCM.
Yawancin abubuwan da ke aiki har yanzu ba a sani ba ko kuma ba a sani ba saboda yana da wuya a cire da kuma daidaita irin waɗannan abubuwan ko kuma a adana su yadda ya kamata.
A halin yanzu, saboda rashin ingantaccen magani da takamaiman magani ga COVID-19, TCM ya zama babbar hanyar magani ta maye gurbin marasa lafiya masu cututtuka ko matsakaici ko waɗanda suka dawo daga mummunan mataki.
Misali, maganin maganin sulfangeedu da maganin hujjain da aka gano suna da tasiri wajen magance COVID-19.
An lura cewa mafi yawan farfadowa daga cutar ta COVID-19 a wasu larduna a kasar Sin, ta hanyar amfani da maganin TCM, inda kashi 87% na marasa lafiya daga lardunan Guangzhou (63.7%) da Ningxi (50%) da Hunan (50%) da Hubei (50%) suka yi amfani da maganin TCM, a kusan kashi 30% na marasa lafiya na COVID-19 suna da mafi ƙarancin farfadowa (13%).
Duk da haka, wannan kwatanta ce mai sauri, saboda wasu dalilai masu tasiri kamar yawan marasa lafiya da kuma tsanani ya kamata a saka su cikin kimantawa.
A ranar 18 ga Fabrairu, 2020, Bolli Zheng da abokan aikinsa sun buga wani bincike don kwatanta maganin gargajiya na yamma (WM) da na haɗin gwiwa tsakanin WM da TCM.
Sun gano cewa tsawon lokacin da ake bukata don sauya yanayin jiki, rage bayyanar cututtuka, da kuma asibiti ga WM+TCM ya fi na WM.
Abin sha'awa, yawan cututtukan da ke ci gaba da lalacewa (daga cikin ƙananan zuwa matsananciyar) yana da mahimmanci ga ƙananan rukunin WM + TCM (7.4% vs. 46.2%) da ƙananan mutuwar ga ƙananan rukunin WM + TCM (8.8% vs. 39%).
Duk da haka, inganci da aminci na TCM suna jiran kyakkyawan gwajin gwaji a manyan dandamali da kuma cibiyoyi da yawa.
Hakanan yana da ban sha'awa a tantance tsarin aikin da kuma tabbatar da ingantattun abubuwan da ke cikin maganin TCM ko kuma maganin haɗin gwiwa idan ya yiwu.
Yawancin marasa lafiya da ake zargi ko kuma suka tabbatar da COVID-19 suna da matukar tsoron kamuwa da cutar kuma suna iya zama masu haɗari ga rayuwa, kuma mutanen da aka keɓe suna da damuwa, rashin jin daɗi da fushi.
Bugu da ƙari, alamun cututtuka kamar zazzabi, numfashi da tari, da kuma sakamako masu illa na magani kamar rashin barci da ake samu daga shan corticosteroids na iya haifar da damuwa da kuma rashin jin dadi.
A farkon farkon barkewar cutar SARS, an ruwaito wasu cututtukan cututtukan hankali masu mahimmanci kamar damuwa, damuwa, damuwa, rashin hankali, alamun rashin hankali, da kashe kansa.
Kula da cutar da kuma yin takaddun shaida na wajibi, wanda shine ɓangare na amsawar lafiyar jama'a ga barkewar COVID-19, na iya haifar da wasu mutane su kasance masu hankali da rashin fahimta game da tasirin kamuwa da cutar, yin takaddun shaida da kuma yin wahayi zuwa ga iyalansu da abokai.
Saboda haka, ya kamata a ba da kulawar lafiyar hankali ga marasa lafiya na COVID-19, mutane da ake zargi da cutar da mutanen da ke da alaƙa da su, da kuma jama'a da ke bukatar kulawar.
Tallafin tunani ya kamata ya haɗa da kafa ƙungiyoyin kula da lafiyar hankali masu ƙwarewa, sadarwa mai kyau tare da sabuntawa na yau da kullun da daidai game da tsarin magani da fashewar SARS-CoV-2, da amfani da na'urorin lantarki da ƙwararrun software don kauce wa kusanci ko kusanci.
Magungunan rigakafi masu tasiri suna da mahimmanci wajen hana karuwar kwayar cutar daga dabbobi da mutane zuwa ƙwayoyin cuta masu saurin kamuwa da cutar, kuma waɗannan magungunan suna da mahimmanci a cikin ƙari ga maganin rigakafi don sarrafa yanayin barkewar cutar da sabon kwayar cuta ke haifar da shi.
An yi ƙoƙari don samar da allurar rigakafi daga furotin S don ƙirƙirar tsarin mutum mai ƙarfi da rigakafi na dogon lokaci da SARS-CoV.
An gwada rigakafin rai a cikin samfurin dabba don cutar SARS.
Koyaya, ingancin alluran rigakafin da aka yi wa tsofaffi da samfuran da ke fuskantar haɗari da kuma kariya daga kamuwa da cutar kwayar cutar (tabbatacce daga dabba zuwa mutum) dole ne a tantance kafin a fara nazarin gwaji.
Wannan na iya kasancewa saboda cutar SARS ta ɓace shekaru 17 da suka gabata kuma babu wani sabon hali da aka ruwaito.
A gefe guda, duk wani kamuwa da cutar da ke yaduwa da kuma kamuwa da cutar MERS na ci gaba da faruwa a Gabas ta Tsakiya da kuma yadawa zuwa wasu yankuna saboda rashin yaduwar tushen kwayoyin cuta (mutanen da ke yaduwa daga dabba zuwa mutum) a yankin da cutar ta kamu.
An kirkiro dabarun samar da rigakafi don cutar MERS ta amfani da kwayoyin da ba su da aiki, plasmids na DNA, masu ɗaukar hoto, nanoparticles, ƙwayoyin cuta kamar ƙwayoyin cuta, da kuma sake tattara ƙwayoyin ƙwayoyin cuta, kuma an gwada wasu dabarun da aka yi amfani da su don tantance samfurori a cikin dabbobi.
Ci gaban wannan ingantaccen kuma amintaccen rigakafin SARS-CoV-2 ga mutanen da ba su da rigakafi na jiki shine gaggawa da kuma mahimmin alhakin hana wannan annoba.
Duk da haka, har yanzu yana da wuya a shawo kan wannan mawuyacin hali saboda dogon lokaci (yawanci watanni 18) yana buƙatar haɓaka alluran rigakafi da saurin maye gurbin nau'ikan CoVs.
Saboda sabon nau'in cutar COVID-19 ne, an fara samun cikakken ci gaba a cikin gwaji, yayin da dubban marasa lafiya ke cikinta.
A mafi yawan lokuta, marasa lafiya suna iya warkewa ba tare da wata matsala ba.
Koyaya, COVID-19, wanda yayi kama da SARS da MERS, an danganta shi da yawan kamuwa da cuta da yawan mutuwa a cikin marasa lafiya masu tsanani.
Saboda haka, samar da samfurin hasashen cutar yana da mahimmanci ga hukumomin kiwon lafiya su ba da fifiko ga samar da ayyukansu, musamman a yankunan da ba su da albarkatu.
Bisa ga binciken da aka yi a baya, wasu daga cikin abubuwan da ke biyo baya na iya shafar ko kuma danganta da yanayin rashin lafiyar COVID-19 (tebur (tebur 33):
Shekaru: Shekaru sune mafi mahimmancin dalilai don kimanta yiwuwar kamuwa da cutar SARS da COVID-19.
COVID-19 ya faru ne a mafi yawan mutane a cikin shekaru 30-65, tare da 47.7% na marasa lafiya a cikin shekaru 50 da haihuwa a cikin binciken binciken 8,866 na shari'o'i kamar yadda aka bayyana a sama.
Marasa lafiya da ke bukatar kulawa mai yawa suna da haɗari da kuma sakamakon haɗari, kuma sun tsufa fiye da waɗanda ba su da (ƙananan shekaru 66 da 51) wanda ya nuna cewa shekaru suna da mahimmanci ga sakamakon COVID-19 na marasa lafiya.
A cikin jima'i, SARS-CoV-2 ya fi kamuwa da maza fiye da mata (0.31/100,000 vs. 0.27/100,000), kamar yadda aka bayyana a sama.
Rashin hankali da rashin ƙarfi: Marasa lafiya na COVID-19 da ke buƙatar kulawa mai tsanani suna iya fuskantar ciwon zuciya da bugun zuciya mai tsanani.
Har ila yau, cututtukan zuciya ne ke haifar da mutuwar mutane da ke fama da cutar SARS.
An ruwaito cewa SARS-CoV-2 na iya shiga cikin ACE2-positive cholangioctues, wanda ke haifar da tasirin rashin daidaituwa na huhu na masu cutar COVID-19.
Ya kamata a lura cewa shekaru da cututtuka suna da alaƙa sosai, wanda zai iya haifar da sakamako mai illa.
Ganowar asibiti mai ban mamaki: matakan C-type reaction protein (CRP) a cikin jini suna nuna tsanani na kumburi ko rauni na jiki, kuma an ba da shawarar yin hasashen yiwuwar kamuwa da cuta, amsawa ga magani da kuma warkewa ta ƙarshe.
An kuma yi magana game da alaƙar matakan CRP da tsanani da kuma hasashen COVID-19.
Bugu da ƙari, karuwa a lactate dehydrogenase (LDH), aspartate aminotransferase (AST), aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Wadannan enzymes suna bayyana a fili a cikin kwayoyin halitta da yawa, musamman zuciya da hanta, kuma ana fitar da su yayin lalacewar kwayoyin.
Saboda haka, suna da alamun alamun rashin aiki na zuciya ko hanta.
Alamomin manyan gwaje-gwaje na gwaji: daukar hoto na kirji da kuma ci gaban lokaci na alamun daga gwaje-gwajen gwaji ya kamata a yi la'akari da su tare da sauran al'amurran da suka shafi hasashen sakamakon da sakamakon COVID-19.
Amfani da steroids: Kamar yadda aka ambata a sama, steroids suna da ƙarancin ƙwayar cuta wanda ake amfani da shi a cikin maganin ƙwayoyin cuta don wasu cututtuka masu kamuwa da cuta don rage yawan ciwon.
Ana amfani da kwayoyi masu yawa na corticosteroid don magance marasa lafiya masu tsanani na SARS. Masu tsira sun sha wahala daga cututtukan jini da ƙashi wanda ke haifar da rashin lafiya na rayuwa ko kuma rage rayuwarsu.
Saboda haka, idan ana bukatar amfani da steroids, ya kamata a yi amfani da su a cikin ƙananan da kuma gajeren lokaci don marasa lafiya na COVID-19.
Matsanancin damuwa: Kamar yadda aka ambata a sama a lokacin barkewar COVID-19, marasa lafiya da yawa sun sha wahala daga matsanancin damuwa saboda jimrewa da tsawo da kuma rashin tsaro, rashin tabbas, da kuma ganin mutuwar dangi da sauran marasa lafiya.
Yana da muhimmanci a ba da shawara ta tunani da kuma goyon baya na dogon lokaci don taimakawa waɗannan marasa lafiya su tsira daga damuwa kuma su koma ga rayuwarsu ta al'ada.
A cikin binciken da aka yi a kan al'umma, COVID-19 ya bambanta da annobar SARS.
Baya ga yaduwar da ake samu a cikin ƙananan huhu, SARS-CoV-2 na iya yaduwa cikin sama da kuma haifar da bayyanar cututtuka ko rashin bayyanar cututtuka a farkon matakin kamuwa da cutar, wanda yayi kama da sauran cututtukan corona, wanda ke haifar da cutar mura.
Saboda haka, marasa lafiya da suka kamu da cutar a farkon matakin ko kuma a cikin lokaci mai zuwa, suna iya samar da ƙwayoyin cuta masu yawa a yayin ayyukan yau da kullun, wanda ke haifar da wahalar sarrafa cutar.
Koyaya, ana ɗaukar ci gaba da watsa ko watsa kwayar SARS-CoV a lokacin da mai haƙuri ya sami ciwon daji, yayin da yawancin kamuwa da cutar ba su faru a farkon matakin ba.
Saboda haka, barkewar cutar COVID-19 a yanzu ta fi muni da kuma wahala a sarrafa fiye da barkewar cutar sankara ta SARS.
A halin yanzu, ana yin babban ƙoƙari a China, wanda ya haɗa da rufe ƙofofin Wuhan da garuruwan da ke kewaye da shi da kuma yin jerin gwaje-gwaje na kusan dukkanin jama'a da fatan zai iya hana ci gaba da yaduwar SARS-CoV-2.
Duk da cewa wadannan ayyukan sun yi wa tattalin arzikin kasar da sauran bangarorin lahani, adadin sabbin cututtuka na raguwa, wanda ke nuna raguwar kamuwa da cutar.
Mafi kyawun hasashen shine cewa fashewar zai ƙare a watan Maris, kuma matakin raguwa zai ɗauki watanni 3-4 na ƙarshe.
Amma, wasu masana ba su da irin wannan ra'ayi.
Paul Hunter da sauransu sun kiyasta cewa COVID-19, wanda ya fi SARS ƙarfi, ba zai ƙare ba a shekarar 2020.
Ira Longini da sauransu sun kirkiro wani tsari don hango sakamakon yaduwar cutar, kuma sun ba da shawarar cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan duniya.
Wata kungiya a Kanada ta ruwaito cewa an gano SARS-CoV-2 a cikin hanci da hanci na marasa lafiya da suka warke kuma suka bar asibiti makonni 2 da suka gabata, wanda ya nuna cewa sabon sanannen cutar na iya zama matakin da ya dace da mura.
Duk da haka, alamu sun bayyana a China bisa ƙarancin adadin sababbin cututtuka, wanda ke nuna cewa dabarun da ake amfani da su yanzu suna iya gudana.
An yi hasashen cewa cutar Ebola za ta iya haifar da mutum miliyan daya da mutuwar mutane miliyan biyar.
Duk da haka, ta hanyar yin gyare-gyare da kuma warewa, cutar ta kasance cikin iko.
Wannan na iya faruwa ne saboda yana kama da SARS-CoV, wanda SARS-CoV-2 zai iya zama mai rauni a cikin kamuwa da cuta kuma a ƙarshe ya ɓace ko ya zama ƙarancin cutar mutum.
Ana kwatanta fashewar COVID-19 da SARS da MERS a cikin teburin da ke ƙasa (tebur 55).
Kwayar SARS-CoV-2 tana da yawan kamuwa da cutar ta hanyar tari ko kuma ta iya kamuwa da cutar ta hanyar kai tsaye.
An kuma gano cutar a cikin hanji, wanda ke ƙara sabon yiwuwar kamuwa da cutar daga hanji zuwa baki.
Wani sabon bincike kan shari'o'i 138 ya ruwaito cewa kashi 41% na jimlar shari'o'in na iya haifar da yaduwar asibiti, tare da marasa lafiya 17 da ke fama da cutar, ciki har da masu ba da sabis na kiwon lafiya 40.
Saboda haka, ya kamata a yi matuƙar tsaro wajen kare mutane a duniya, musamman ma masu ba da sabis na kiwon lafiya, ma'aikatan jin kai, danginsu, abokan aiki, da kuma waɗanda ke fuskantar marasa lafiya ko waɗanda ke da cutar.
Kayan kariya na farko da za a iya amfani da shi don rage haɗarin kamuwa da cuta shine ta hanyar sanya masks. Dukkanin amfani da masks na tiyata da masks na numfashi na N95 (series # 1860s) suna taimakawa wajen sarrafa yaduwar kwayar cutar.
Tsakanin aikin, ana hana ruwa daga cutar ta mutum ta hanyar hana shi daga iska ko kuma ya fada a saman wasu abubuwa, inda za a iya tura su zuwa wasu.
Koyaya, kawai nau'in N95 (series # 1860s) na iya karewa daga shigar da ƙwayoyin cuta masu ƙanƙanta daga 10 zuwa 80 nm, kuma kashi 5% na ƙwayoyin cuta ne kawai ke shiga cikin wannan nau'in. SARS-CoV-2 yayi kama da SARS-CoV wanda girmansa ya kai 85 nm.
Saboda ƙwayoyin cuta suna iya shiga ta hanyar masks biyar na tiyata, masu ba da sabis na kiwon lafiya da ke da alaƙa da marasa lafiya dole ne su sa N95 (wanda aka saki a lokacin 1860) amma ba dole ba ne su sa masks.
Baya ga saka abin rufe fuska, masu ba da sabis na kiwon lafiya ya kamata su sanya kayan magani daban-daban don rage ƙarin haɗuwa kai tsaye da kwayar cutar.
Hakanan za a iya samun kwayar cutar ta idanun mutum.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da cutar SARS-CoV-2 duk da cewa ya sa masks N95. Kwayar cutar na iya shiga cikin kansa ta hanyar idanunsa na gani.
Saboda haka, masu ba da sabis na kiwon lafiya suna bukatar su saka abin rufe fuska ko kuma na'urar kare idanu yayin aiki tare da marasa lafiya.
Ga talakawan da ke cikin yankunan da ke da kamuwa da cutar ko kuma waɗanda ke da kamuwa da cutar sosai, an shawarce su da su wanke hannuwansu da sabulu mai kashe cututtuka sau da yawa, kuma su yi ƙoƙari su zauna a gida don yin takardar shaida da kansu da kuma yin hulɗa da waɗanda za su iya kamuwa da cutar.
An yi la'akari da cewa ƙafa uku ne ya dace da mutum ya kasance a nesa da mai haƙuri.
Wadannan ayyukan suna da tasiri sosai wajen rage haɗarin kamuwa da cutar da kuma hana yaduwar cutar.
Ko da yake SARS-CoV-2 ya zama sabon kwayar cutar ga ɗan adam, kamanceceniya da cutar sankara ta SARS-CoV kamar yadda aka ruwaito a ranar 7 ga Janairu, 2020 ya kamata ya sa China ta yi taka tsantsan sosai kuma ya kamata ta tuna da barkewar cutar sankara ta SARS a cikin 2003.
Duk da haka, har zuwa 19 ga Janairu, 2020, darektan Cibiyar Kula da Cututtuka ta Duniya ya yaudari 'yan kasarsa da cewa sabon kwayar cutar tana da ƙananan yaduwa, kuma ci gabanta na iya kasancewa daga mutum zuwa mutum, kuma ba shi da matsala wajen hana da kuma hana cutar.
Wannan sakon ya rage sanarwar gaggawa ga jama'a musamman a lokacin da duk kasar ke shirin bikin hutun bazara kuma lokaci ne mai muhimmanci da aka kasa a hana cutar a lokacin da ta kasance a cikin ƙananan matakan a Wuhan.
Hukumar kula da cututtuka a kasar Sin za ta iya koyan darasi mai wuya kuma ta yi aiki tuƙuru a nan gaba.
Alal misali, waɗannan hukumomi ya kamata (1) su yi hankali sosai a lokacin yin sanarwa a fili, domin duk wani bayani yana da mahimmanci ga jama'a kuma yana iya canza halayensu da yanke shawara. (2) su yi hankali kuma su amsa da kyau ga rashin daidaito da ke fitowa daga asibiti maimakon jiran wani rahoto na hukuma daga jami'an gwamnati. (3) su yi ƙarin tsaurara don hana barkewar cutar da za ta iya faruwa a farkon matakin maimakon ƙoƙarin ƙoƙarin rinjayar jama'a. kuma (4) su yi ƙoƙari sosai don gudanar da gwaje-gwaje masu ma'ana da inganci don haɓaka fahimtar jama'a game da cutar da kuma yadda za a amsa da kuma amsawa.
An fara barkewar cutar COVID-19 da ta haifar da cutar SARS-CoV-2 a ƙarshen Disamba 2019.
A cikin kasa da watanni biyu, ya bazu ko'ina cikin China da kuma kusan sauran ƙasashe 50 a duniya a lokacin rubuce-rubuce.
Saboda cutar tana kama da SARS-CoV, kuma alamun suna kama da COVID-19 da SARS, barkewar COVID-19 ta haifar da wani motsin rai cewa SARS na ƙaruwa.
Duk da haka, akwai wasu bambance-bambance masu mahimmanci tsakanin COVID-19 da SARS, waɗanda ake buƙata don hana yaduwa da kuma kula da marasa lafiya.
COVID-19 yana shafar tsofaffi fiye da matasa, maza fiye da mata, kuma yawan kamuwa da cuta da mutuwa ga tsofaffi marasa lafiya ya fi na matasa.
SARS ya fi yawan mutuwar COVID-19 (10.91% da 1.44%).
Masu cutar COVID-19 na iya watsa cutar ga wasu ko da ba su da wata alama, yayin da masu cutar SARS ba su da wata alama lokacin da suka kamu da cutar, wanda hakan ya sa ya zama da wuya a hana yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana wasu dalilan da yasa SARS-CoV-2 ke yaduwa da sauri fiye da SARS-CoV.
RNA mai laushi na SARS-CoV-2 na iya zama ba a cikin wasu marasa lafiya na COVID-19.
A wani bangare kuma, marasa lafiya da suka warke sun iya samun cutar.
Waɗannan binciken sun ƙara haɗarin yaduwar cutar sosai.
Tare da irin wannan ci gaban da ake samu a binciken COVID-19, akwai wasu manyan batutuwa da za a magance:
Daga ina cutar ta SARS-CoV-2 ta fito?
Ko da yake an gano kashi 96% na kamanceceniyar kwayoyin halitta tsakanin SARS-CoV-2 da SARS daga tsuntsaye, har yanzu ba za mu iya yin zato cewa SARS-CoV-2 ya fito ne daga tsuntsaye ba.
Wane dabba ne a tsakiyar duniya zai iya canja kwayar cutar daga dabba zuwa mutum, kamar tsuntsu?
Ba tare da sanin amsoshi na 1 da na 2 ba, ba za mu iya rage watsawa ko watsawa yadda ya kamata ba, kuma fashewar za ta iya sake faruwa a kowane lokaci.
Ko da yake an yi amfani da kwayoyin kwayoyin da kuma gwajin sinadarai, an gano cewa cutar ta SARS-CoV-2 tana iya shiga cikin ACE2, amma yadda za ta shiga cikin ƙwayoyin huhu da ke haifar da cutar ba a sani ba.
Shin kwayar cutar za ta iya haɗa ƙwayoyin da ke fitar da ACE2 zuwa wasu kwayoyin?
Idan babu amsoshin waɗannan tambayoyin, ba za mu iya samun ganewar asali da sauri da kuma magani mai kyau ba.
Amma, a lokacin da ake yin wannan annoba, mutane da yawa suna tunanin cewa za a yi annobar.
Ta yaya kwayoyin suka samo asali a lokacin da suke kamuwa da cutar?
Shin zai zama annoba ta duniya ko kuwa zai ɓace kamar SARS ko kuma ya sake dawowa kamar cutar sankara?
Yana da muhimmanci, amma yana iya ɗaukar lokaci don yin bincike don amsa waɗannan tambayoyin da kuma wasu tambayoyi.
Duk da haka, ba mu da wani zaɓi, dole ne mu dakatar da yaduwarmu da sauri kuma mu dawo da rayuwarmu zuwa al'ada.
An samo asali ne daga kwayar cutar korona ta mutum.
Canji da kuma hanawa sun haifar da haɗin gwiwar kwayar cutar coronavirus (CoVs) da harsunan rayuwa, gami da ɗan adam, na dubban shekaru.
Kafin 2003, an gano mutane biyu da ke dauke da kwayar cutar CoVs (HCoVs), wanda ke haifar da rashin lafiya mai laushi kamar mura.
Fitowar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Fitowar SARS-CoV-2 a tsakiyar kasar Sin a ƙarshen 2019 ya sake sanya kwayar cutar cikin yanayi mai zafi, yana ba mu mamaki game da yaduwar ta, amma ya rage yiwuwar kamuwa da cutar idan aka kwatanta da 'yar'uwarta SARS-CoV.
HCoVs suna da kwayar halitta, kuma gano asalin kwayoyin HCoVs na iya taimaka mana.
Yawancin HCoVs sun fito ne daga tsutsotsi, wanda ba su da ƙwayoyin cuta.
An gano wasu kwayoyin cuta na HCoVs.
Idan aka gano dabbobi, hakan zai iya shafar rigakafin mutum.
Binciken game da yadda CoV-host ke rayuwa a cikin dabbobi na iya ba da ƙarin haske game da yadda CoV ke kamuwa da cutar a cikin mutum.
A wannan bita, za mu gabatar da ilimin da ake da shi game da HCoVs bakwai, kuma za mu mai da hankali kan tarihin ganowa da kuma asalin watsawa daga dabba zuwa mutum da kuma watsawa daga iri zuwa iri.
Mafi mahimmanci, muna kwatanta bambance-bambance tsakanin HCoVs da ra'ayoyin juyin halitta na kwayar, da kuma sake tattara kwayoyin halitta.
An tattauna game da annobar COVID-19 a wannan yanayin.
Bugu da ƙari, an jaddada bukatar sauya halaye da nasara da kuma tasirin juyin juya halin kwayar cutar a kan cutar.
Coronaviruses (CoVs) suna cikin Coronaviridae, wanda shine rukuni na RNA wanda ke da nau'i mai kyau da kuma layi daya.
Wadannan kwayoyin suna ba da umarni ga manyan kwayoyin 26 zuwa 32, lobes a cikin RNA na kwayar cuta, wanda aka kira CoVs saboda tsarin jikinsa kamar na allon lantarki.
A cikin CoVs, akwai ƙwayoyin cuta marasa ɓarna waɗanda ke ƙarƙashin irin wannan ƙura.
Kimanin kashi biyu bisa uku na sinome suna da nau'ikan manyan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau' na nau'ikan nau'u na nau'ikan nau'u na nau'u.
Ana kuma sarrafa polythreins don samar da sunadarai 16 wadanda ba a tsara su ba, wanda aka ƙayyade ta nsp1~16.
Sauran kwayoyin halitta sun ƙunshi ORFs don ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙ
Wasu furotin masu taimakawa na wasu nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'an nau'an nau'an nau'an nau'an nau'an nau'an nau'an nau'an nau'an.
A cewar bambancin a cikin jerin sunadarai, an rarraba COVs zuwa nau'i hudu (alpha-CoV, beta-CoV, gamma-CoV, da delta-CoV), daga cikin waɗannan nau'ikan beta-CoVs ne mafi yawan HCoVs, kuma an rarraba su zuwa nau'i hudu (A, B, C, da D).
Shaidar da ke haifar da kwayar halitta ta nuna cewa tsuntsaye da dabbobi masu rarrafe suna aiki da yawa a matsayin tushen al'adun alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune tushen tushen gamma-CoVs da delta-CoVs.
A cikin dubban shekaru, CoVs sun shiga cikin nau'ikan dabbobi, wasu daga cikinsu sun zama manyan cututtukan mutum.
A halin yanzu, an gano mutane bakwai da ke dauke da cutar CoV (HCoVs).
Daga cikinsu HCoV-229E da HCoV-NL63 sune alpha-CoVs.
Sauran nau'ikan beta-CoV guda biyar sun hada da HCoV-OC43, HCoV-HKU1, cutar huhu mai tsanani, cutar huhu mai tsanani (SARS-CoV), cutar huhu mai dauke da kwayar cutar ta tsakiya (MERS-CoV), da SARS-CoV-2.
HCoV-NL63, HCoV-229E da HCoV-OC43, HCoV-HKU1 galibi suna haifar da alamun bayyanar cututtuka masu sauƙi kamar cututtukan cututtuka na yau da kullun da/ko kumburi.
A gefe guda, sabon SARS-CoV, MERS-CoV, da SARS-CoV-2 sune manyan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttuk
An fara gano HCoV-229E, nau'in B814, daga cikin magungunan da ke cikin hanci na marasa lafiya da ke fama da cutar mura ta hanyar tsakiyar shekarun 1960.
Tun daga wannan lokacin, an tattara ilimin da yawa ta hanyar nazarin HCoV-229E da HCoV-OC43, wanda waɗannan ƙwayoyin cuta biyu ke haifar da alamun bayyanar cututtuka na dogon lokaci.
A gaskiya ma, an yarda da wannan ra'ayin cewa kamuwa da cutar HCoVs ba ta da haɗari har sai an fara cutar SARS.
Cutar SARS da ta barke a shekara ta 2003 ita ce babbar annoba a tarihin zamani, ta yi wa mutane sama da 8000 rauni kuma ta haifar da mutuwar fiye da 10%.
Shekaru goma bayan haka, barkewar cutar ta hanyar numfashi ta Gabas ta Tsakiya ta haifar da ci gaba da yaduwar cutar a nahiyar Larabawa, tare da yaduwar cutar zuwa duniya.
Kwayar cutar HCoV ta 2019 (2019-nCoV), wanda aka sake suna SARS-CoV-2, ita ce mai haifar da yaduwar cutar coronavirus 2019 (COVID-19) wacce ta kashe mutane sama da 3120 da kamuwa da cutar sama da 91,000 a ranar 3 ga Maris, 2020.
Ana jin muryar alfahari, kuma duniya ta shirya don barkewar cutar SARS-CoV-2.
HCoVs bakwai na asali sun fito ne daga tsuntsaye, tsutsotsi ko dabbobi masu kiwo.
Akwai shaidu da yawa da ke tallafawa asalin asalin dukkanin HCoVs daga tsuntsaye, inda kwayar cutar ta kasance mai sauyawa da ba ta haifar da cutar ba, amma tana nuna juyin halitta mai ban mamaki.
Cutar COVID-19 ta nuna manyan kalubalen kiwon lafiya, kimiyya, zamantakewa da ɗabi'a ga China da duniya.
Bin asalin HCoVs yana ba da tsarin don gano yanayin yanayi, motsi, da kuma girman nau'ikan nau'ikan cututtuka.
Wannan kuma na iya taimakawa wajen jagorantar ko sauƙaƙe gano masu ɗaukar hoto, masu ɗaukar hoto, masu ɗaukar hoto na SARS-CoV-2 tare da mahimman tasirin hana barkewar cutar a nan gaba.
A cikin wannan binciken, mun nuna wani hangen nesa game da asalin watsa daga dabba zuwa mutum, watsa daga jinsuna zuwa jinsuna, da kuma haifar da HCoVs.
Musamman, mun ambaci kuma mun tattauna batun da ya ce asalin kwayoyin HCoVs ba za su iya zama masu cutarwa ba lokacin da suke rayuwa a cikin asalin su, amma za su iya zama masu cutarwa bayan sun shiga cikin sabon tsarin.
Mun kuma sake nazarin yanayin juyin halitta na HCoV, inda karuwar watsawa na iya faruwa sau da yawa tare da raguwar cutar.
Sakamakon barkewar cutar SARS-CoV-2 da ke gudana ana tattaunawa a cikin wannan mahallin.
An san CoVs a cikin dabbobi tun daga ƙarshen shekarun 1930.
Kafin farkon yaduwar cutar HCoV-229E, nau'in B814 daga cikin ruwan da ke cikin hanci na masu cutar mura na yau da kullun, an ware CoVs daban-daban a cikin dabbobi masu kamuwa da cututtuka daban-daban, gami da kaza, kaza, alade, alade, da karnuka.
A cikin shekarun da suka gabata, an gano HCoVs bakwai.
Takaita tarihin gano HCoV ta hanyar tsari (Table 1) zai ba da bayani da shawara.
An fara cire HCoV-229E daga cikin masu shan numfashi na marasa lafiya da ke da cutar ta sama a shekara ta 1966 kuma daga baya an daidaita shi don girma a cikin ƙwayoyin cuta na huhu WI-38.
Masu kamuwa da cutar HCoV-229E suna da alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Daga baya a 1967, HCoV-OC43 ya rabu da kwayoyin halitta da kuma ci gaba da karuwa a cikin kwakwalwar jarirai.
Halin cututtukan cututtukan HCoV-OC43 na kama da bayyanar cututtukan da HCoV-229E ke haifar da su, wanda aka gano a matsayin alamun ba kamar yadda yake ba, ya bambanta da kamuwa da sauran cututtukan huhu kamar mura mai tsanani A, ƙwayoyin cuta da rhinoviruses.
HCoV-229E da HCoV-OC43 sun bazu ko'ina cikin duniya, kuma suna da yawan watsawa a lokacin hunturu a cikin yanayin zafi.
Yawanci, lokacin farkawa na waɗannan ƙwayoyin cuta ba ya wuce mako guda, sannan kuma yana da kusan mako biyu.
A cewar wani binciken da aka yi na son rai na mutum, mutanen da suka kasance cikin koshin lafiya kuma suna dauke da cutar HCoV-229E sun zama irin wannan cutar ta mura.
Ba a san cewa marasa lafiya da ke da tsarin rigakafi na jiki suna da mummunan cututtukan huhu a cikin ƙananan hanyoyi.
SARS, wanda aka fi sani da cutar huhu ta yau da kullun, an rubuta shi a matsayin annoba ta farko da ta haifar da HCoV a tarihin ɗan adam, kuma wakili na ilimin lissafi wanda ya haifar da cutar shine SARS-CoV, HCoV na uku da aka gano.
An fara samun cutar SARS a ƙarshen 2002 a lardin Guangdong na kasar Sin.
Sakamakon barkewar cutar SARS, an ruwaito cewa akwai mutane 8096 da suka mutu, 774 sun bazu zuwa kasashe da nahiyoyi da yawa.
Baya ga yaduwar cutar, an kiyasta cewa kowane hali na iya haifar da wasu lokuta biyu na farkawa a cikin kwanaki 4 zuwa 7 da farkawa, kuma mafi girman adadin cutar ya bayyana a ranar 10 ga watan Maris lokacin da cutar ta kamu.
Masu kamuwa da SARS-CoV sun fara da ciwon tsoka, ciwon kai, zazzabi mai tsanani da kuma shan wahala, sannan kuma suna yin hawaye, tari da kuma numfashi, a matsayin alamun bayyanar cututtuka.
Lymphophenia, gwajin rage karfin hanta da kuma karuwar Creatine kinase, wani abu ne da ya saba faruwa a cikin dakin gwaje-gwaje na SARS.
An lura da masu cutar SARS da samun karuwar kwayoyin huhu, karuwar kwayoyin halitta da kuma karuwar jini.
Kimanin kashi 20-30 na marasa lafiya suna buƙatar kulawa mai kyau da kuma fitar da iska ta atomatik.
Baya ga kamuwa da cutar ta hanyar numfashi, wasu kwayoyin halitta, ciki har da hanji, hanji, huhu da kuma jijiyoyi, suna iya kamuwa da cutar a wasu lokuta masu tsanani, yawanci tare da karuwar sinadarin da ke iya zama mai haɗari ga marasa lafiya da ke da rashin ƙarfi.
An fara gano cutar ne daga kwayar cutar huhu ta dangin wanda ya yi tafiya zuwa Hong Kong daga garin Zhao.
Tun daga wannan lokacin, an yi ƙoƙari sosai don nazarin HCoV.
HCoV-NL63 an kwace shi ne daga jarirai masu watanni 7 da suka fito daga Netherlands a lokacin marigayi 2004.
Da farko an gano cewa yana da yawa a cikin yara, tsofaffi, da marasa lafiya da ke da rashin ƙarfi da kuma cututtukan numfashi.
Bayyanar cutar mura, cututtukan hanci na coryza, cututtukan ido, zazzabi, da kumburi na huhu na kowa ne a cikin cututtukan da ke haifar da HCoV-NL63.
Wani bincike na daban ya nuna cewa an samu kwayar cutar daga hanci na wani dan shekara takwas da ke fama da cutar huhu a Netherlands.
Ko da yake an gano shi a cikin Netherlands, an rarraba shi a duniya.
An kiyasta cewa HCoV-NL63 yana da kusan kashi 4.7% na cututtukan huhu na yau da kullun, kuma mafi yawan hawan yana faruwa a farkon bazara, bazara da hunturu.
HCoV-NL63 yana da alaƙa da cutar kwayar cuta da cuta mai cutar da aka sani da cutar Croup.
A wannan shekarar ne aka ware HCoV-HKU1 daga wani mutum mai shekaru 71 da haihuwa wanda aka yi masa asibiti saboda cutar kumburi da kumburi a Hong Kong.
Baya ga cutar kumburi da kumburi da aka samu ta hanyar HCoV-HKU1 al'umma, an ruwaito cewa yana da alaƙa da cututtukan zuciya masu tsanani.
Kamar HCoV-NL63, HCoV-229E, da HCoV-OC43, HCoV-HKU1 an gano shi a duk duniya wanda ke haifar da ƙananan cututtukan numfashi.
HCoVs da aka samu a cikin waɗannan al'ummomi huɗu sun daidaita sosai a cikin mutum kuma ba su da wataƙila za su haifar da cutar ta kamuwa da cutar, kodayake akwai wasu abubuwan da ba a san dalilin ba, kamar yadda a cikin ƙarancin nau'in HCoV-NL63 da aka ruwaito kwanan nan, wanda ya haifar da mummunan kamuwa da cutar huhu a China.
Yawanci, lokacin da waɗannan HCoVs suka sami ikon watsa kwayoyin da kyau kuma su ci gaba da kasancewa cikin mutum, suna zama masu ƙarancin ƙwayoyin cuta ko ƙwayoyin cuta.
An fara gano cutar MERS-CoV a shekarar 2012 daga huhu na wani mutum mai shekaru 60 da haihuwa wanda ya kamu da cutar kumburi da kumburi a Saudiyya.
A mafi yawan lokuta da aka tabbatar da cewa asibitocin sun fito ne daga Gabas ta Tsakiya, an ruwaito cewa an shigo da wasu lokuta, tare da samun karuwar ta biyu saboda kusanci da ke tsakanin kasashen Turai da Tunisia.
Wani fashewar cutar ta biyu ta faru a Koriya ta Kudu a shekarar 2015, inda aka samu mutane 186 da suka kamu da cutar.
Aikin likita na MERS yana nuna alamun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Ba kamar SARS ba, yawancin marasa lafiya da ke da cutar MERS sun ci gaba da zama marasa lafiya na hanji, wanda ke da bambanci ga cutar MERS a cikin cutar da HCoV ke haifar.
Fiye da kashi 30 cikin dari na marasa lafiya suna da alamun cututtukan ciki kamar ciwon huhu da kumburi.
A ranar 14 ga Fabrairu, 2020, an tabbatar da fiye da 2,500 lokuta a cikin dakin gwaje-gwaje da aka ruwaito da yawan mutuwar 34.4%, wanda ya sa MERS-CoV ya zama ɗayan cututtukan da suka fi muni da mutane suka taɓa fuskanta.
A tsakiyar watan Disamba na 2019, an gano wasu marasa lafiya na huhu da suka kasance suna da alaƙa da cutar SARS-CoV-2 a Wuhan, Hubei, China.
Hukumar lafiya ta duniya ta bayyana barkewar cutar ta hanyar huhu ta hanyar cutar SARS-CoV-2 a matsayin gaggawa na lafiyar jama'a na damuwa ta duniya kuma ta sanya sunan cutar COVID-19.
A ranar 3 ga Maris, 2020, an tabbatar da kamuwa da cutar a duniya, a cikin kashi 90,053, tare da jimlar mutuwar kashi 3.4%.
Ya kamata a lura cewa adadin mutuwar a Hubei, China, ya kai kashi 4.2% kuma a wajen kashi 1.2% ne.
SARS-CoV-2 yana haifar da cututtukan huhu masu tsanani kamar SARS-CoV da MERS-CoV, wanda aka nuna a matsayin zafi, tari da kuma damuwa.
An kuma gano wasu marasa lafiya da suke da ciwon kumburi.
Cutar huhu ta kasance ɗaya daga cikin alamun cututtuka masu tsanani kuma tana iya ci gaba da zama mummunan rikici na numfashi.
Ko da yake SARS-CoV da SARS-CoV-2 suna da kamanceceniya saboda kamawar kashi 82% na babban tsarin nucleotides, sun rarraba zuwa rassan daban-daban a cikin kwayoyin halitta.
SARS-CoV-2 ba shi da ƙarancin ƙwayar cuta, amma yana iya kamuwa da sauri idan aka kwatanta da SARS-CoV da MERS-CoV.
An ruwaito cewa batutuwan da ba su nuna alamun cutar SARS-CoV-2 ba sun kamu da cutar kuma suna iya taimakawa wajen saurin yaduwar ta a duniya.
Kwatanta da bambance-bambance tsakanin SARS-CoV-2 da sauran rukuni shida na HCoVs sun nuna kamanceceniya da bambance-bambance na fa'idodi masu ban mamaki.
Na farko, farkawa da kuma tsawon lokacin da HCoV ke faruwa sun yi kama da juna.
A wannan yanayin, SARS-CoV-2 ya bi tsarin HCoVs guda shida.
Na biyu, yadda ake fuskantar cutar ta COVID-19 ya dogara da SARS-CoV da kuma kungiyoyin HCoVs guda hudu (misali HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, wannan kamuwa da cutar SARS-CoV-2 ta nuna wasu halaye da suka yi kama da kamuwa da cutar a cikin HCoVs, tare da rashin tabbas kaɗan ko babu alamun bayyanar cututtuka.
A wata ma'anar, ana iya ganin karamin adadi na mummunan COVID-19 kamar yadda yake a cikin SARS-CoV, ko da yake a cikin ƙananan ƙwayoyin cuta.
Na uku, SARS-CoV-2 ya kuma nuna wasu samfurori masu ban sha'awa na HCoVs da SARS-CoV da aka samo daga al'umma.
A gefe guda kuma, aƙalla ikon watsa SARS-CoV-2 na iya zama kamar HCoVs da aka samu a cikin al'umma.
A gefe guda kuma, har yanzu ana buƙatar sake tantancewa ko akwai raguwar kamuwa da SARS-CoV-2 bayan kamuwa da cutar ga mutane, kamar yadda yake a cikin SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 a cikin samfurin kumfa.
Ko kuma ko yaduwar SARS-CoV-2 daga numfashi zuwa baki tana taka muhimmiyar rawa kamar yadda yake a SARS-CoV, aƙalla a ƙarƙashin wasu mahallin da za a tabbatar da su ta hanyar nazarin gaba.
Hakanan yana da ban sha'awa ganin ko SARS-CoV-2 na iya bayyana a cikin yanayi kamar yadda HCoVs ke samun al'umma.
Koyaya, yanayin SARS-CoV-2 da ke haifar da shi, gami da kamuwa da cuta, kamuwa da cutar, da kuma yaduwar ta daga mutum zuwa mutum, zai haifar da barkewar COVID-19.
HCoVs guda hudu da aka samu daga al'umma da ke haifar da bayyanar cututtuka sun daidaita sosai a cikin mutum.
A wasu ra'ayoyi, yana iya zama gaskiya cewa mutane sun saba da HCoVs guda huɗu.
A wasu kalmomi, su biyu na iya zama masu tsira daga cutar HCoV na zamanin d ̄ a.
HCoVs da ke haifar da mummunan cutar a cikin mutane da kuma mutanen da suka ci gaba da cutar HCoV mai tsanani an kawar da su.
Domin duk wannan ya faru, HCoVs dole ne su ware kansu a cikin jikin mutum don samun isasshen ƙarfin da zai iya tattara su a kan rigakafin.
Wannan yana nufin cewa idan SARS-CoV-2 ya daɗe kuma mutane da yawa sun kamu da shi, zai fi dacewa su daidaita da mutane.
Idan kwayoyin sun daidaita da kyau, zai yi wuya a hana su, ko dai ta hanyar kiyaye mutuncin jama'a ko wasu matakan hana kamuwa da cutar.
A cikin 'yan shekarun nan, an samu nau'ikan cov guda hudu da ke kamuwa da cututtukan da ke kama da cututtukan da ke cikin jiki, wanda ke da tsarin rigakafi mai ƙarfi.
Waɗannan ƙwayoyin ba sa bukatar ƙwayoyin cuta a cikin dabbobi.
A gefe guda, SARS-CoV da MERS-CoV masu cutar ba su da kyau a cikin mutum, kuma watsa su a cikin jikin mutum ba zai iya zama mai dorewa ba.
Suna bukatar su ci gaba da kuma samar da jinsuna a cikin kwakwalwar su na sonta kuma su nemi damar da za su kai ga mutane masu kamuwa da cutar a matsayin mai yiwuwa ta hanyar ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba.
SARS-CoV-2 yana da halaye iri ɗaya da SARS-CoV/MERS-CoV da kuma rukuni huɗu na HCoV.
Yana yaduwa cikin sauri kamar HCoVs da aka samu a cikin al'umma, aƙalla a yanzu.
Koyaya, yana da ƙarfi fiye da HCoVs da aka samu a cikin al'umma kuma yana haifar da ƙarancin kamuwa da cutar fiye da SARS-CoV ko MERS-CoV.
Har yanzu ana ganin cewa zai iya daidaitawa cikin mutum, kuma ya yi aiki a cikin mutum ba tare da buƙatar dabba ko dabba ba.
Kafin tattauna asalin dabbobi na HCoV, zai taimaka mana sosai mu tattauna ma'anar da halayyar juyin halitta na HCoVs, da tsakiya da tsakiya.
Hanyar HCoV tana da tasiri sosai idan tana da dangantaka ta kusa da kakanninta, wanda ke da babban rabo a cikin tsarin nucleotides.
A yawancin lokaci, tsofaffin ƙwayoyin cuta suna daidaitawa da kyau kuma ba sa shafar wannan ƙwayoyin cuta.
Hakanan, wuraren da ake adana cutar HCoV za su ci gaba da kasancewa na dogon lokaci.
A lokuta biyu, ƙwayoyin cuta suna da yawa kuma suna da alaƙa da HCoV ko kuma asalinsa.
A akasin haka, idan HCoV ya bayyana a cikin sabon hali a cikin matsakaiciyar halittar ko lokacin da ya bayyana ga mutane, ba zai iya daidaitawa da sabon halittar ba kuma sau da yawa ba zai haifar da cutar ba.
Wannan ƙwayar ta tsakiya tana da tushen watsa kwayoyin daga dabba zuwa mutum, tana aiki a matsayin mai faɗaɗa, ta hanyar ba da damar ƙwayoyin cutar su rabu da kansu kuma su ci gaba da watsawa zuwa mutane don faɗaɗa watsawar kwayoyin halitta.
HCoV zai iya dakatar da yaduwar idan kwayar cutar ba ta iya yaduwa daga tsakiyarta ba.
HCoVs, a akasin haka, suna iya daidaitawa zuwa matsakaiciyar cuta kuma har ma suna haifar da yaduwar lokaci.
A wannan yanayin, tsakiya ta zama babban ajiyar halitta.
Bayanai daga nazarin annobar sun nuna cewa an riga an gano SARS a cikin tarihin da ke da alaƙa da dabbobi.
Sakamakon gwajin jini ya nuna cewa masu sayar da dabbobi suna da mafi yawan IgG anti-SARS-CoV idan aka kwatanta da yawan jama'a.
Dabbobin da aka sayar da su a cikin kantin sayar da dabbobi masu rai sune farkon wuraren da aka gano cewa akwai kwayar cutar SARS-CoV, kusan daidai da SARS-CoV.
Wannan ya goyi bayan gaskiyar cewa babu wani rahoton cutar SARS bayan an kashe duk dabbobin da ke kasuwa.
Koyaya, an ruwaito cewa dabbobi masu tasowa daga daji ko gonaki ba tare da tasiri ga kasuwar dabbobi ba suna da mummunan tasiri ga SARS-CoV, yana nuna cewa dabbobi na iya zama matsakaiciyar hanyar watsawa kawai, amma ba asalin SARS-CoV ba.
Ya kamata a lura cewa, saboda kashi 80% na dabbobi daban-daban a kasuwar Guangzhou suna da maganin anti-SARS-CoV, ba za a iya lissafa yiwuwar cewa ƙananan dabbobi masu yawa zasu iya zama babban abin tsoro na SARS-CoV ba.
Dukkanin waɗannan sun zama na ƙarshe na SARS-CoV.
Binciken da aka yi na SARS-CoV na dabbobi na halitta ya nuna cewa akwai alaƙa ta kusa da CoV a cikin fararen fata, wanda ake kira SARS-related Rhinolophus bat CoV HKU3 (SARSr-Rh-BatCoV HKU3), wanda ke cikin fararen fata na kasar Sin.
Wadannan kwayoyin sun kasance masu kyau ga kwayoyin halitta na SARS-CoV da kuma tsarin SARSr-Rh-BatCoV HKU3.
Wannan kwayar cuta da sauran nau'ikan CoVs na kwayar cuta suna da kashi 88-92% na daidaito na nau'ikan kwayoyin halitta.
Waɗannan binciken sun kafa tushen wani sabon ra'ayi game da yadda tsutsotsi ke zama wakili na kwakwalwar mutum.
An kuma gano wasu nau'ikan SARS-like CoVs (SL-CoVs) daga berayen, amma an gano WIV1 guda ɗaya ne kawai wanda zai iya zama kwayar cutar mai rai.
An san mutum da angiotensin mai rikitarwa na 2 (ACE2) a matsayin mai karɓar SARS-CoV.
WIV1, wanda aka samo daga kwayoyin halittun dabbobin dabbobi, an nuna shi a cikin kwayoyin halittun dabbobin dabbobi, da kuma mutane da ACE2 a matsayin mai karɓa don shigar da kwayoyin.
Abin sha'awa, ƙwayar cutar SARS (SERA) tana iya hana cutar ta WIV1.
WIV1 yana wakiltar mafi kusa da SARS-CoV a cikin tsuntsaye, wanda ke raba 95% na kwayoyin cuta tare da kwayoyin cuta.
Ko da yake sun yi kama da juna, an yi imanin cewa WIV1 ba asalin SARS-CoV ba ne, kuma tsuntsaye ba su da tsakiya na SARS-CoV.
Nazarin kwayoyin halitta ya tattara MERS-CoV zuwa ƙungiyoyi iri ɗaya kamar CoV-HKU4 da CoV-HKU5 na fuka-fuki.
Bat CoV-HKU4 da MERS-CoV suna amfani da kwayar mai karɓa guda ɗaya, peptidase 4 (DPP4) don shigar da kwayar.
Tsarin RNA-dependent RNA polymerase na MERS-CoV yana da kusancin kusancin beta-CoV a cikin berayen da aka gano daga Turai da Afirka.
Har zuwa yanzu ba a gano cutar MERS-CoV a cikin tsuntsaye ba.
MERS-CoV da CoV-HKU25 a cikin tsuntsaye, mafi kusantarsa, suna da kashi 87% na daidaitattun tsarin nucleotides.
Saboda haka, ƙwari ba su da tushe na MERS-CoV.
A gefe guda, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa tsutsa suna da takamaiman hali na tsutsa da MERS-CoV kamar yadda tsutsa ke da asali a Gabas ta Tsakiya a yawancin ƙasashen Afirka.
An cire kwayar cutar MERS-CoV mai rai, wanda yayi kama da kwayar cutar da aka samu a cikin mutane, daga cikin samfurin hanci na Ostromyrhmy Medium, wanda ya ƙara nuna cewa Ostromyrhmy yana taka rawa a matsayin ainihin kayan ajiya na MERS-CoV.
Yana da mahimmanci a lura cewa a cikin yawancin cututtuka, an lura da karuwar ƙwayar cuta a cikin kwayoyin da suka zo gwajin da ke dauke da cutar MERS-CoV.
Ya kamata a lura cewa, ƙwayoyin cuta masu kamuwa da cutar ba kawai suna watsa kwayar ba ta hanyar numfashi, amma kuma ta hanyar bakin bakin, wanda kuma yana da mahimmanci ga watsa kwayar daga fuka-fuki.
Duk da haka, tambaya ta kasance saboda yawancin lokuta da aka tabbatar da MERS ba su da tarihin da ya shafi ƙwayoyin cuta kafin a fara bayyanar cututtuka da aka tabbatar da cewa za a iya watsa su daga mutum zuwa mutum ko kuma hanyar da ba a san ta ba ta shafi nau'in ƙwayoyin cuta da ba a san su ba wanda ke ba da izinin MERS-CoV.
SARS-CoV-2 yana da kashi 96.2% na daidaitattun nucleotides tare da CoV RaTG13 a cikin fuka-fuki, wanda ya bambanta da fuka-fukan Rhinolophus affinis.
Kamar yadda yake a SARS-CoV da MERS-CoV, an yi amfani da nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau
Wannan na iya nuna cewa tsuntsaye ba za su kasance babban adadi na SARS-CoV-2 ba, sai dai idan an gano CoVs a cikin tsuntsaye da ke da kusan identical a nan gaba.
A cewar wani rahoto, matsakaiciyar cutar SARS-CoV-2 ta kasance daga cikin nau'ikan dabbobin daji da aka sayar da su kuma aka kashe a cikin kasuwar sayar da kayan teku ta Hunan, inda yawancin farkon shari'o'in COVID-19 aka danganta, wanda ke nuna al'amuran watsawa daga dabbobi zuwa mutane.
Yawancin binciken da aka yi kwanan nan, dangane da tsarin tsarawa na metagenetic, sun nuna cewa ƙananan ƙananan ƙananan dabbobi masu ƙarewa, waɗanda aka sani da ƙwari (Manis-vannica), na iya zama magungunan zuwa beta-CoVs na asali waɗanda ke da alaƙa da SARS-CoV-2.
CoVs a cikin waɗannan sababbin kwayoyin sun sami daidaitattun daidaitattun kashi 85-92% na nucleotides tare da SARS-CoV-2.
Duk da haka, suna da dangantaka mai kyau da RaTG13, wanda ke da kusan 90% na ainihi a matakin nukiliya.
Suna rarraba ƙananan kwayoyin SARS-CoV-2 guda biyu kamar kwayar cutar a cikin babban ɓangaren kwayar cutar, wanda kwayar cutar tana da ƙwayoyin karɓar kama da SARS-CoV-2 da amino acid iri ɗaya 97.4%.
A akasin haka, RBDs na SARS-CoV-2 da RaTG13 sun bambanta, ko da yake jerin sunayen sun kasance mafi girma.
A cikin binciken da aka yi kwanan nan a kan dabbobi masu cutar, an gano cewa akwai ƙwayoyin cuta a cikin samfurori na huhu waɗanda suka yi kama da SARS-CoV-2.
Wannan binciken ya yi amfani da wasu hanyoyin tattarawa da kuma karuwa na wani ɓangare na kwayar halitta, wanda ya kai kashi 86.3% na girman kwayar cutar.
Ba za mu iya lissafa cewa tsuntsaye suna ci gaba da daukar hoto na SARS-CoV-2 ba.
Koyaya, a halin yanzu babu wata hujja da ke tallafawa asalin SARS-CoV-2 daga dabbobi masu fuka-fuki, saboda daidaitaccen tsarin SARS-CoV-2 da SARS-CoV-2-related beta-CoVs a cikin dabbobi masu fuka-fuki.
Bugu da ƙari, nisan tsakanin SARS-CoV-2 da RaTG13 ya fi nisan tsakanin SARS-CoV-2 da SARS-CoV-2-related beta-CoVs a cikin dabbobi masu tasowa.
Har yanzu ba a iya samar da hanyar juyin halitta na SARS-CoV-2 a cikin tsuntsaye, tsuntsaye da sauran dabbobi masu tallafawa ba.
Duk da yake an gano mafi girman daidaituwa a cikin RBDs tsakanin SARS-CoV-2 da SARS-CoV-2-related beta-CoVs, SARS-CoV-2 da RaTG13 suna da mafi girman daidaituwa na tsarin genomic.
An kiyasta cewa babban matakin kamanceceniya tsakanin RBDs na SARS-CoV-2-related beta-CoVs a cikin dabbobi masu fuka-fuki da SARS-CoV-2 an yi shi ne ta hanyar juyin halitta wanda ya daidaita zaɓin.
An yi amfani da wannan takaddama don maye gurbin SARS-CoV-2-related beta-CoV a cikin dabbobi masu rarrafe da RaTG13 a cikin nau'in dabbobi na uku.
A matsayin mai motsawa a cikin juyin halitta, sake haɗuwa yana da yawa a cikin beta-CoVs.
Har yanzu dai, ba a yanke hukunci ba game da asalin asalin SARS-CoV-2 na asali.
Baya ga HCoV mai cutarwa, an kuma yi nazarin asalin kwayoyin HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Shaidar da ke tattare da kwayoyin halitta ta nuna cewa HCoV-NL63 da HCoV-229E na iya fitowa daga CoVs a cikin fararen fata, yayin da HCoV-OC43 da HCoV-HKU1 sun samo asali ne daga kwayoyin cuta.
An ruwaito cewa CoV a cikin fox, wanda ake kira ARCoV.2 (Appalachian Ridge CoV), an samo shi a cikin nau'in fox mai launi uku a Arewacin Amurka wanda ya nuna irin wannan hali ga HCoV-NL63.
A gefe guda, HCoV-229E yana da kwayoyin da suka yi kama da CoV na wani fox mai suna Hipposideros/GhanaKwam/19/2008 wanda aka samo a Ghana, kuma ana zargin shi da cutar ta ci gaba da kamuwa da cutar a cikin kwayoyin halitta.
Don tabbatar da gaskiyar, ilimin da ake samu game da asalin HCoVs a cikin dabbobi da aka sani an taƙaita su a cikin Hotuna 1 da 2 na tebur.
Nazarin mutum-mutumin dabbobin shuka ya ba da hujja game da abubuwan da suka faru na HCoVs daga dabba zuwa mutum a tarihi.
An rubuta labarin barkewar cutar ta hanyar numfashi lokacin da HCoV-OC43 ya wuce dabbobi zuwa mutane daga dabbobi na gida a cikin 1890s.
Ba a san yadda HCoV-229E ke yaduwa daga dabba zuwa mutum ba.
An gano cewa alpha-CoVs a cikin fuka-fuki suna da alaƙa da HCoV-229E.
Daga cikinsu akwai alpaca alpha-CoV.
Akwai shaidu da yawa da suka nuna cewa mutum yana iya kamuwa da cutar daga tsuntsaye zuwa mutum.
Da farko, mutane ba su da alfanu, kuma suna iya yin tarayya da tsuntsaye a wurare masu rarrabe.
A maimakon haka, mutane suna da dangantaka ta kusa da alfans.
Na biyu, alpha-CoVs na fuka-fuki da ke da alaƙa da HCoV-229E suna da ƙwayoyin cuta kuma ba su da ƙwayoyin cuta a fuka-fuki, amma alpha-CoV na alpaca (alpaca alpha-CoV) yana haifar da cutar ta hanyar numfashi a cikin masu kamuwa da cutar.
A ƙarshe, ba a sami alpaca alpha-CoV a cikin dabbobi masu lalata ba.
Saboda haka, ba za a iya cire yiwuwar cewa alpacas sun karɓi alpha-CoV da ke da alaƙa da HCoV-229E daga mutane ba.
A gaskiya, tsuntsaye sune ainihin tushen ƙwayoyin cuta na mutum, ciki har da kwayar cutar kare, cutar Ebola, cutar Nifa, da cutar Hendra.
Saboda haka, ba abin mamaki ba ne cewa tsuntsaye za su iya watsa HCoV-229E zuwa mutum kai tsaye.
A gefe guda, yayin da alpha-CoVs a cikin fox ke taka rawa a matsayin asalin HCoV-229E a cikin alpha da medial oestrogens, yana iya taka rawa a matsayin matsakaiciyar hanyar watsa kwayar cutar zuwa mutum, kamar yadda yake a cikin MERS-CoV.
MERS-CoV yana taka muhimmiyar rawa wajen canja wurin dabba zuwa mutum daga fox zuwa dromedary fox da kuma daga dromedary fox zuwa mutum.
An gano asalin MERS-CoV daga tsuntsaye a farkon gano shi, kuma an faɗaɗa shi ta hanyar ganowa.
A bayyane yake cewa tsuntsaye suna ba da ƙwayoyin cuta masu yawa don canja wurin kwayoyin halitta da kuma canja su daga jinsin zuwa jinsin.
Tsayawa mai tsawo, yawan dabbobi, kusanci da kuma iyawar tashi suna da matukar muhimmanci ga tsuntsaye su zama 'yan wasa masu yaduwa'.
A wani bangare kuma, an riga an yi amfani da cutar MERS-CoV wajen shekaru da yawa a cikin dabbobi masu tsufa.
Ya yi aiki sosai da waɗannan ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwar ƙwararrun ƙwararrun ƙ
MERS-CoV yana haifar da rashin lafiya mai tsanani da kuma rage yawan canji a cikin waɗannan dabbobi.
Cutar da ta saba wa mutane ta faru ne ta hanyar haɗari, kuma mutane sun kasance ƙarshen MERS-CoV wanda ba zai iya zama tabbatacce ba.
Idan akwai bambanci tsakanin rawar da kwayoyin halitta ke takawa wajen watsa kwayar cutar MERS-CoV da kuma rawar da kwayoyin halitta ke takawa wajen watsa kwayar cutar SARS-CoV-2, to, akwai bambanci.
Musamman, beta-CoVs na fuka-fuki sune manyan masu cutarwa a cikin fuka-fuki.
Suna iya zama na ƙarshe ga SARS-CoV-2-related beta-CoVs, wanda yayi kama da na dabbobi a cikin SARS-CoV.
Yawancin yiwuwar watsawar SARS-CoV-2 daga dabba zuwa mutum dole ne a sarrafa ko a magance su a cikin nazarin gaba.
Da farko, tsuntsaye na iya zama tushen SARS-CoV-2, wanda ke da kusan daidaituwa da SARS-CoV-2.
Mutane za su iya raba matsayin halittu tare da tsuntsaye ta hanyar neman nama ko nama.
Na biyu, tsuntsaye na iya zama wani ɓangare na tsakiya na tsakiya inda aka fara watsa cutar da ke da alaƙa da SARS-CoV-2.
Mutane suna kamuwa da cutar ta hanyar kashe dabbobi da kuma cin naman su.
Yana yiwuwa cewa dabbobi masu yawa, ciki har da dabbobi masu gida suna da saukin kamuwa da SARS-CoV-2.
Ana ba da tabbacin yin nazarin dabbobi na gida da na namun daji don masu yin amfani da su.
Na uku, kamar yadda aka bayyana a sama, sake haɗuwa da kuma kamuwa da SARS-CoV-2 na iya faruwa a cikin nau'in dabbobi na uku da ke da alaƙa da tsuntsaye da kuma tsuntsaye.
Ana ci gaba da bincike kan asalin SARS-CoV-2 a cikin dabbobi.
Baya ga nau'ikan kwayoyin halitta, manyan abubuwa uku na kwayoyin halitta suna da mahimmanci wajen daidaita CoVs a cikin wucewar kwayoyin halitta.
Da farko, jijiyoyin suna canzawa sosai game da kwafin RNA.
Idan aka kwatanta da wasu kwayoyin RNA guda daya, ana iya kwatanta yawan canjin da aka kiyasta na CoVs a matsayin matsakaici zuwa matsakaici, tare da matsakaiciyar maye gurbin 10 zuwa 4 sauyawa a shekara, a wani wuri 2 dangane da matakin daidaitawar CoV zuwa sabon abu.
CoVs suna da nauyin nukiliya na atomatik wanda ke da aikin sarrafawa, kawar da su, wanda ke haifar da canje-canje masu yawa da ƙananan ko ma rashin iyawa.
Abin sha'awa, ƙwayar ƙwayar Remdesivir ta san yadda za ta iya hana CoV ta hanyar hana enzymes exoribonuclease da RNA-dependent RNA polymerase.
Remdesivir yana daya daga cikin mafi kyawun wakilai masu kare cutar SARS-CoV-2 da aka gwada a cikin gwajin gwaji.
Duk da haka, yawan canjin siffar kwayar cutar ya fi na siffar da ke cikin kwayoyinta sau miliyoyin.
Bugu da ƙari, yawan canji yana da yawa a lokacin da CoVs ba su daidaita da kyau tare da al'ada ba.
Idan aka kwatanta da SARS-CoV tare da yawan canjin canji, yawan canjin SARS-CoV-2 ya kasance ƙasa da na asali, wanda ke nuna ƙimar haɓakawa ga mutane.
A wasu kalmomi, yana daidaitawa da sauran abubuwa da ke kusa da mutum.
Bugu da ƙari, SARS-CoV-2, wannan ya shafi MERS-CoV, wanda ya dace da kwayar cutar.
A ka'idar, ba zai yiwu ba cewa kwayoyin halitta na iya samar da allurar rigakafi da anti-SAES-CoV-2 da sauri.
Na biyu, babban RNA a cikin CoVs yana da sassauci, yana ba da kyauta a cikin rarrabuwa da sake ginawa. Saboda haka, juyin halitta daga nau'i zuwa nau'i na iya faruwa, wanda ke ba da kyauta a cikin barkewar cutar CoVs a lokaci guda.
Yana da cikakken tsarin karatun daban-daban da aikin gina jiki wanda ya canza lambar zuwa ƙarshen 3rd synom.
Na uku, CoVs suna canza tsarin samfurin a cikin lokaci mai tsawo da kuma jinkiri yayin da RNA ke rarrabuwa ta hanyar zaɓuɓɓukan kwafin daban-daban.
A cikin kwayoyin da ke aiki a matsayin masu rarraba, sauya layin yakan faru sau da yawa yayin da ake yin kwafin CoV RNA.
Babban daidaituwa na cikakken tsawon da RNAs na farko na iya haɗuwa don ƙirƙirar sabon CoV.
An gano shaidar juyin halitta na halitta na sake haɗuwa a cikin HCoV-HKU1 da HCoV-OC43, da kuma CoVs na dabba kamar SL-CoV na fox da CoV-HKU9 na fox.
Ana amfani da kwayoyin cuta da kuma kwayoyin cuta don yin kwafin.
Baya ga abubuwa uku da aka ambata a sama, yin amfani da kwayar cutar tare da ƙwayoyin cuta masu karɓa na mai ɗaukar hoto wani babban abu ne wanda ke shafar watsawa daga dabba zuwa mutum.
A nan, an yarda da sake haɗuwa da SARS-CoV a matsayin misali na halitta, wanda kuma ya nuna hujja na zaɓi mai kyau a lokacin yanayin watsawa daga dabba zuwa mutum.
Bisa ga nazarin kwatancen tsakanin mutum da kuma dabba SARS-CoVs, ana tunanin SARS-CoV ya wuce cikin sauri a cikin masu ɗaukar kaya daban-daban, musamman tare da canje-canje a RBD na S-protein.
A yawancin lokaci, RBD a cikin Protein S na CoV yana aiki tare da mai karɓar kwayoyin kuma an zaɓi shi don amsawa ga tsarin mutum.
A cikin SARS-CoV RBD, amino acid 318 zuwa 510 suna kan S1 wanda ke haɗe da ACE2 na mutum da kuma coreceptors don shigar da kwayar.
RBD na SARS-CoV yana da ikon gane ƙwayoyin cuta na ACE 2 na dabbobi daban-daban, gami da karnuka, foxes, aljanu, da kuma karnuka waɗanda ke ba da damar kamuwa da cutar.
A zahiri, an lura da amino acid guda shida kawai a cikin RBD, waɗanda ke bambanta da bambancin kwayar cutar mutum da civet, kuma dukansu huɗu suna cikin haɗin kai na ƙwayoyin cuta don karɓar magani tare da ƙwayoyin cuta na ACE2.
SARS-CoV a cikin dabbobi yana da nau'ikan K479N da S487T a cikin RBD wanda zai iya haɓaka haɗakarwar haɗakar manyan ƙwayoyin cuta tare da masu karɓar ACE2 na mutum.
Amma, maye gurbin amino acid biyu na iya zama da muhimmanci wajen kamuwa da cutar ga mutane.
Ya kamata a lura cewa SARS-CoV-2 yana da sashi na karɓar kwayoyin halitta iri ɗaya da SARS-CoV.
Bambanci 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na S-protein ya nuna cewa haɗin haɗin S-protein tare da mutane tare da ACE2 na iya canzawa.
A gaskiya ma, binciken cryo-EM ya nuna cewa akwai haɗuwa da yawa fiye da sau 10 zuwa 20 na wannan haɗin fiye da tsakanin mutane da ACE2 da kuma SARS-CoV S.
Hakanan yana da ban sha'awa a tantance ko ana iya buƙatar wasu ƙwayoyin cuta don watsa SARS-CoV-2.
Abin sha'awa, HCoV-NL63 yana da alaƙa da ACE2, amma tare da wani ɓangare na S.
Akwai wasu kwayoyin halitta masu karɓar HCoVs kamar aminopeptidase N don HCoV-229E da 9-O-acetylated sialic acid don HCoV-OC43.
Suna iya zama masu alhakin nasarar aiwatar da CoVs a cikin mutum bayan an canja su daga dabba zuwa mutum daga dabba.
Baya ga ƙwayar cuta don karɓar kwayoyin, sakamakon watsa HCoVs daga dabba zuwa mutum yana kuma sarrafawa ta hanyar sauran masu ɗaukar hoto da sauran ƙuntatawa.
Bambancin ƙwayoyin halitta tsakanin mutane da ƙwayoyin halitta na HCoVs, kamar su fungi, dromedary da kuma parasites, na iya zama matsala ga watsawa daga jinsin zuwa jinsin.
HCoVs dole ne su ɗauki tushen tushen tushen tushen kuma su daidaita yanayin tushen tushen don nasarar watsa kwayar cutar.
A wannan yanayin, ƙwayoyin da ke cikin babban ɓangaren ƙwayar cuta na ƙwayar cuta sun kasance suna ganowa da kuma gano halaye.
Ana iya samun 'ya'yan itace ta hanyar yin cikakken bincike na tsarin halittu na dogaro da kuma ƙuntatawa ga SARS-CoV-2 ta amfani da fasahar CRISPR ta zamani.
Fitowar sabbin HCoVs: Komawa zuwa Zero
Cutar CoVs a cikin tsuntsaye tana ba da dama ga sabon HCoV.
A wannan yanayin, CoVs na tsuntsaye suna aiki a matsayin kwayoyin HCoVs.
Bugu da ƙari, sauye-sauye da kuma sake fasalin kwayoyin halitta suna haifar da juyin HCoV kuma suna taka muhimmiyar rawa biyu a cikin wannan tsari.
Alal misali, karɓar ko rasa wani sabon furotin yana da ikon yin gyare-gyare na musamman ga furotin.
ORF8 na SARS-CoV daban-daban an gano shi yana da mahimmanci a cikin tsarin mutum kamar SARS-CoV, wanda aka keɓance a cikin warkewa amma an gano ya ɓoye wani furotin daban na ORF8.
Sun gano halaye na kawar da 29-nucleotide na SARS-CoVs a cikin layin da ya ɓace a farkon barkewar cutar ga mutane.
Wannan kawar ta raba ORF8 zuwa ORF8a da ORF8b, wanda aka fahimta a matsayin rarrabuwa ta kai tsaye wanda ke haifar da canjin tsoka (ɓarkewar jiki).
Bugu da ƙari, SARS-CoV yana da haɗuwa da alpha da gamma-CoVs, wanda ƙananan wuraren ajiya da yawa aka sani a cikin RNA-dependent RNA polymerase.
An kuma gano wuraren da aka sake yin amfani da su a cikin nsp9, mafi yawan nsp10, da kuma sassa daban-daban na nsp14.
Hakazalika, ya nuna cewa yaduwar cutar MERS-CoV ta sake fuskantar haɗuwa tsakanin layuka daban-daban da suka faru a cikin dromedary a Saudi Arabia.
Baya ga SARS-CoV da MERS-CoV, an lura da sake maimaitawa a cikin sauran HCoVs, inda HCoV ke haɗuwa da sauran CoVs na dabba a cikin kwayoyin halitta marasa tsari.
Zaɓin kwayoyin halitta ya kamata a yi shi da hankali, saboda yana iya haifar da juyin halitta na kwayoyin halitta da gangan, wanda zai iya haifar da raguwar ƙwayar ta hanyar matsa lamba a cikin zaɓin, kamar tsarin rigakafin kwayoyin.
Misali na waɗannan tasirin shine asarar cikakken adadin ORF4 a cikin HCoV-229E, wanda ya haifar da ɓarkewar nucleotides biyu.
Duk da yake ORF4 gaba ɗaya za a iya gani a cikin ƙwayoyin cuta a cikin beraye da kuma kwayoyin cuta masu alaƙa da HCoV-229E, alpha-CoV alpha-CoV yana nuna shigar da nucleotide guda ɗaya wanda ke haifar da canzawa.
A ƙarshe, juyin halittar sababbin HCoVs an kuma motsa su ta hanyar zaɓin matsin lamba a cikin ƙwayar ajiyarsu.
Ana gano alamun bayyanar cututtuka ko alamun bayyanar cututtuka lokacin da aka kamu da CoVs a cikin foxes, wanda ke nuna cewa akwai haɗuwa tsakanin CoVs da foxes.
Ya nuna cewa tsuntsaye sun dace da ilimin lissafi da ilimin halittu na CoVs.
Alal misali, rashin kunnawa na maganin antiinflammatory a cikin tsutsotsi yana rage cututtukan da CoVs ke haifarwa.
Bugu da ƙari, an rage aikin kwayoyin halitta a cikin ratsan saboda karuwar amsawar kwayoyin halitta na kwayoyin halitta masu karɓar kwayoyin halitta NKG2/CD94 da kuma matakin ƙarancin ƙwayoyin cuta na farko na ƙwayoyin cuta na bambancin yanayi.
Bugu da ƙari, kwayoyin oxygen masu aiki mai ƙarfi (ROS) waɗanda suka samo asali daga babban metapolitic na ratsan na iya hana watsa CoV da kuma rinjayar ganowa ta hanyar exoribonuclease, don haka samar da matsin lamba don ƙirƙirar ƙwayoyin cuta masu cutarwa lokacin da suka shiga cikin sabon ƙwayoyin cuta.
Wasu cututtukan CoV na iya haɓaka ta hanyar sake haɗuwa, yana haifar da sabon kwayar halitta ko kuma ƙwayoyin da ke da ƙwarewar haɓakawa zuwa ga ƙwayoyinta.
Saboda haka, ba zato ba tsammani ne cewa HCoVs guda uku sun bayyana a cikin shekaru biyu da suka gabata.
CoVs ba su da ƙwayoyin cuta ko kuma suna haifar da alamun cutar a cikin kwayoyin halitta kamar su tsutsotsi da ƙwayoyin cuta.
Suna yin kwafin da ƙarfi ba tare da yin amsa ga ƙarfin rigakafin ba.
Ga asirin gano mutum mai cutar da babu alamun cutar da kuma dalilin da ya sa mutane ke kamuwa da cutar.
Yawancin cututtuka masu tsanani suna haifar da raguwar tsarin rigakafi da yawan cytokines, wanda amsawar tsarin rigakafi ke haifar da mummunan lalacewar hanta.
A akasin haka, idan kana da kwayar cutar kuma ba ka da wata alama, hakan yana nufin cewa tsarinka na rigakafi bai riga ya yi aiki ba don ya rage yawan cutar.
Irin wannan dabarun a cikin yanke amsawar tsarin rigakafi na iya zama tasiri mai kyau a cikin maganin cutar SARS-CoV-2.
Maganin antipherone yana da ƙarfi musamman a cikin tsuntsaye.
Saboda haka, amfani da nau'in I na furotin mai nuna alamar interferon aƙalla a farkon matakin kamuwa da cutar SARS-CoV-2 a cikin mutane ya kamata ya amfane.
Bugu da ƙari, ba a yi amfani da NLRP3 ba a cikin tsuntsaye.
Saboda haka, hana cutar NLRP3 tare da MCC950 na iya zama da amfani wajen magance COVID-19.
Aikin SARS-CoV-2 ya kasance a cikin ɓangaren da SARS-CoV da MERS-CoV suka faru.
Beta-CoV ya rarraba kashi 95% na kwayoyin halitta da suka yi kama da SARS-CoV da muka gano. Hakazalika, Beta-CoV ya rarraba kashi 96% na kwayoyin halitta da suka yi kama da SARS-CoV-2.
Dabbobin daji da sauran dabbobi a kasuwa sun sami irin wannan kwayar cutar da SARS-CoV, amma ainihin matsakaiciyar hanyar SARS-CoV-2 ba a san ta ba.
An gano cewa beta-CoVs a cikin kwayoyin cuta suna da kamanceceniya da SARS-CoV-2, wanda ke nuna cewa kwayoyin cuta na iya zama ɗaya daga cikin manyan masu riƙewa, ko kuma cewa beta-CoVs na iya taimakawa wajen samar da kwayar halitta zuwa ƙarni na ƙarshe na SARS-CoV-2.
Duk da haka, har yanzu babu wata hujja da ta nuna cewa SARS-CoV-2 ya samo asali ne daga mutum ko kuma ta hanyar haɗari.
CoVs sun dawo cikin koshin lafiya saboda sabon barkewar cutar SARS-CoV-2.
Nazarin CoVs a cikin tsuntsaye da sauran dabbobi ya canza ra'ayinmu sosai game da mahimmancin asalin watsa daga dabba zuwa mutum da kuma wuraren da HCoVs ke cikin watsawa zuwa mutum.
Shaidar yaduwar cutar ta nuna cewa SARS-CoV, MERS-CoV, da SARS-CoV-2 sun fito ne daga tsuntsaye kuma an watsa su zuwa mutane ta hanyar matsakaiciyar taska.
Saboda kamuwa da cutar SARS-CoV ya samo asali ne daga hulɗar da ke tsakanin mutane da civet (kamar zuma) a cikin kasuwa, rufe kasuwanni da ke sayar da nama da wuraren da aka kashe da kuma kashe civet ya kamata ya kawo ƙarshen yaduwar cutar SARS.
Saboda wannan dalili, ya kamata a cire al'ada daga cikin ruwan zãfi don hana kamuwa da cutar (daga dabba zuwa mutum) saboda ra'ayoyin biyu na yawancin nau'ikan al'ada, wanda beta-CoVs na al'ada suna da alaƙa da SARS-CoV-2.
Koyaya, yadda kuma ko SARS-CoV-2 ya kamu da mutane ta hanyar dabbobi masu rarrafe da sauran masu tallafawa dabbobi ya kamata a tabbatar da shi a cikin binciken da za a yi a nan gaba.
A wani bangare kuma, MERS-CoV ya kasance a cikin kwayar cutar dromedary na dogon lokaci.
Wadannan dabbobi suna taka muhimmiyar rawa a matsayin kayan sufuri, kuma suna da mahimmanci a matsayin nama, madara, fata da tumaki ga mazauna yankin.
Sun yi yawa a Gabas ta Tsakiya da Afirka.
Saboda haka, ba zai yiwu a kashe dukkan kwayoyin cutar ba don sarrafa cutar MERS kamar yadda ake yi a kasuwar namun daji a kasar Sin don hana yaduwar SARS-CoV da SARS-CoV-2.
Don hana barkewar cutar ta MERS ta sake faruwa, ya kamata a yi wata hanya don samar da ingantaccen rigakafin cutar MERS-CoV ga kwayoyin cuta a cikin tarin fuka tare da sauran matakan sarrafa cututtukan cututtukan cututtukan.
Saboda ba za mu iya kawar da waɗannan ƙwayoyin ba, sababbin kwayoyin halitta za su iya fitowa don haifar da fashewa.
CoVs da aka haifa daga dabbobi zuwa mutane suna yawo a cikin daji.
A cikin tsuntsaye, musamman, CoV, wanda za a iya watsawa daga dabba zuwa mutum, ya bambanta.
Akwai yiwuwar cewa waɗannan ƙwayoyin cuta na iya tasowa ko kuma sake dawowa, wanda ke haifar da sabon ƙwayoyin cuta na CoVs, wanda zai iya haifar da kamuwa da cutar da mutuwar mutane a nan gaba.
Ya kamata kasar Sin ta yi watsi da al'adun cin dabbobi a wasu sassan kasar domin rage rashin bukatar dabbobi da mutane.
Ya kamata a sami shiri da kuma shirin amsawa mafi kyau tare da ƙwarewar cutar SARS, MERS da COVID-19.
A gaskiya, akwai ƙwayoyin cuta da yawa a duniya tun da daɗewa.
Sun yi ta yin aiki a cikin ɗakunan su na yau da kullum har sai sun sami damar yin amfani da kayan.
Ko da yake tsuntsaye suna da halaye masu yawa da ke taimakawa wajen yaduwar cutar, mutane na iya rage yawan lokacin da suke hulɗa da tsuntsaye da sauran jinsunan daji idan sun yi nesa da su.
Kulawa da dabbobi ba tare da tsayawa ba yana da mahimmanci don samun kyakkyawar fahimtar yanayin halittu na CoVs da masu riƙe su na halitta, wanda zai nuna fa'idodin hana kamuwa da cutar daga dabba zuwa mutum da barkewar cutar a nan gaba.
A ƙarshe, hanya mafi inganci don hana kamuwa da cututtukan dabba ita ce, mutane su nisanta kansu daga yanayin halittu, inda ƙwayoyin cuta suke iya kamuwa da mutane.
Har yanzu ba a gano wasu abubuwa masu yawa a cikin bayanan asalin SARS-CoV-2 na asali ba.
Na farko, idan tsuntsaye sun maye gurbin SARS-CoV-2 zuwa tsuntsaye, yana da ban sha'awa a ga yadda tsuntsaye da tsuntsaye zasu iya zama daidai da yanayin halittu.
Na biyu, idan tsuntsaye suna taka rawa a kai tsaye wajen watsawa zuwa ga mutane, to ya kamata a lura da yadda mutane ke hulɗa da tsuntsaye.
Na uku, idan mai ba da kyautar dabba na uku ya yi aiki a matsayin mai riƙe da kayan, ana iya bayyana yadda yake hulɗa da nau'ikan dabbobi daban-daban, ciki har da mutane, tsuntsaye, da kuma tsuntsaye.
A ƙarshe, wasu dabbobi masu tallafi, gami da dabbobin gida, na iya zama masu saukin kamuwa da cutar SARS-CoV-2, ya kamata a lura da su kuma a yi gwaji.
Idan tsuntsu ne, ko kuma dabba ko kuma dabba mai tallafawa, ana sa ran SARS-CoV-2 ko kuma asalinsa, wanda kusan iri ɗaya ne, zai kasance a cikin ɗabi'arsa na gaba.
Ci gaba da bincike a wannan sashin zai taimaka wajen gano yadda SARS-CoV-2 ke juyawa a cikin dabbobi, wanda ke da alaƙa da rigakafi da sarrafa COVID-19 a cikin mutane.
Ana bukatar sabunta alamun cutar COVID-19, masu zargin kamuwa da cutar da cutar COVID-19 da kuma wadanda suka kamu da cutar COVID-19.
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta fitar da jagororin gaggawa don ganowa da kuma magance kamuwa da cutar coronavirus 2019 (2019-nCoV), kuma jagorar ta ba da kwarewarmu da kuma takaddun da aka tsara don yaƙar cutar a duniya.
Amma cutar korona ta 2019 (COVID-19) sabuwar cuta ce, fahimtarmu da iliminmu suna ci gaba da ƙaruwa dangane da sakamakon binciken da ake yi da kuma kwarewar aikace-aikacen. Saboda haka, ana ci gaba da sabunta dabarun bincike da magani.
A cikin wannan takarda, mun amsa wata shawara kan ka'idodinmu kuma mun samar da sabbin bayanai game da masu cutar da suka kamu da cutar bisa ga ka'idodin bincike da magani na ƙarshe don COVID-19 (salla na bakwai) da Hukumar Lafiya ta Jama'ar Sin ta bayar.
A watan Disambar 2019, sabon kwayar cutar coronavirus ta 2019 (2019-nCoV) ta haifar da barkewar cutar, wanda yanzu ana kiranta cutar coronavirus ta 2019 (COVID-19) kuma an sanya sunan cutar ta hanyar cutar ta hanyar numfashi mai tsanani, wanda ake kira coronavirus 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya ta bayyana COVID-19 a matsayin annoba.
Don yaki da kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta kirkiro ƙa'idodin sauri kuma ta buga su akan Intanet a cikin binciken likita na soja a ranar 06 ga Fabrairu, 2020.
Ya yi matukar sha'awa tun lokacin da aka saki shi.
Duk da haka, bari mu lura cewa COVID-19 sabon cuta ne, fahimtarmu da iliminmu suna ƙaruwa dangane da sakamakon bincike da ke gudana da kuma kwarewar aikin asibiti, don haka dabarun bincike da magani suna ci gaba da sabuntawa.
Misali, jagorar bincike da magani don cutar COVID-19 da Hukumar Lafiya ta Kasa ta Jamhuriyar Jama'ar Sin (Janairu 16, 2020 zuwa Maris 3, 2020) ta fitar da sanarwar, a cikin total, wallafe-wallafe bakwai, wasu mahallin sun canza sosai.
Yanzu da Zhou et al suka bayyana ka'idodinmu, sun gabatar da shawarwari masu sauki bisa ga kwarewarsu ta asibiti.
Aikin su ya kara da cewa, akwai sabon hujja a kan manufofinmu, kuma yana da muhimmanci wajen tsara yadda za a magance annobar a duniya.
Muna goyon bayan aikin da suka yi kuma muna godiya.
Amma aikin su na bukatar sabuntawa bisa ga ka'idojin bincike da magani na COVID-19 (na bakwai) da kuma binciken da aka yi kwanan nan.
A cewar fitowar ta bakwai (3 ga Maris, 2020), don tabbatar da wata sanadiyar cutar, dole ne a haɗa wani abu na tarihin annobar tare da abubuwa biyu na bayyanar cututtuka don yin cikakken bincike ko kuma buƙatar cika alamun cututtuka uku idan tarihin annobar bai tabbata ba:
Tarihin kamuwa da cutar: (1) Tarihin tafiya ko zama a Wuhan da kewaye da shi ko wasu al'ummomin da aka ruwaito wani COVID-19 a cikin kwanaki 14 da suka gabata kafin kamuwa da cutar; (2) Tarihin hulɗa da wani SARS-CoV-2 kamuwa da cutar (tare da gwajin kwayar cutar nucleic acid mai kyau); (3) Tarihin hulɗa da wani mai zafin jiki ko alamun numfashi daga Wuhan da kewaye da shi ko wasu al'ummomin da aka ruwaito COVID-19 a cikin kwanaki 14 da suka gabata kafin kamuwa da cutar; (4) Tarihin hulɗa da wani yanki na kamuwa da cutar (≥ 2 lokuta / alamun cutar da ke faruwa a cikin gidajen da ke ke kewaye da shi, da kuma sauran al'ummomin da suka ruwaito COVID-19 a cikin kwanaki 14 da suka gabata kafin kamuwa da cutar; (4) Tarihin hulɗa da al'ummomin da ke cikin gidajen da ke cikin gidajen da ke cikin gidajen da ke cikin gidajen da ke cikin gidajen da ke cikin gidajen da ke ke ke ke kewaye da su.
Bayyana alamun likita: (1) zazzabi da/ko bayyanar cututtukan numfashi; (2) tare da bayyanar cututtukan da ke nuna kamuwa da COVID-19. (3) Yawan kwayar cutar jini ya nuna raguwa na al'ada ko raguwar yawan lymphoma a farkon matakin.
Dole ne a yi bincike kan kamuwa da cutar bisa ga wata shakka, da wata hujja ko kuma wata shaida mai zuwa: (1) yin gwajin PCR a kan lokaci don cutar SARS-CoV-2; (2) a cikin jerin sunayen gaba ɗaya; cutar ta nuna irin wannan inganci ga sanannen kwayar cutar coronavirus; (3) inganci ga magungunan IgM na musamman da magungunan IgG na musamman ga SARS-CoV-2 a cikin gwajin jini; ko canza magungunan IgG na musamman na SARS-CoV-2 daga tabbatacce zuwa tabbatacce; ko kuma karuwa zuwa kashi 4 cikin kashi na gaba ɗaya na cutar.
Mun ga cewa an gabatar da gwajin aikin polymerase na atomatik na nucleic acid a cikin samfurin jini ko jini a cikin bugu na biyu (18 Janairu 2020) da na uku (22 Janairu 2020).
An gabatar da binciken cutarwa na samfurin jini a cikin bugu na huɗu (27 ga Janairu, 2020) da na biyar (8 ga Fabrairu, 2020), sannan kuma an gabatar da hujjojin nazarin jini a cikin bugu na bakwai.
Waɗannan canje-canjen sun dogara ne akan masu bincike da ke ci gaba da aiki don gano mafi kyawun kayan aikin gano nucleic acid don saurin ganewa da kuma samfurin daga cikin hanyoyin numfashi, gami da ɗaukar jini wanda ke haɓaka samun samfurori daban-daban da taimakawa wajen kawo sakamako mai kyau na antigen zuwa ga yanayin kamuwa da cuta.
Ban da haka ma, akwai wasu dalilai da suka nuna cewa ya kamata mu yi hankali da waɗanda suke da alamun rashin ƙarfi da marasa lafiya.
Saboda haka, ya kamata a sabunta jadawalin Zhou et al. domin sun ƙayyade cewa mutanen da ba su da alamun cutar ba suna da haɗari.
Tsarin ƙididdigar yana buƙatar daidaitawa a cikin ƙarin aikin da nazarin ilimin lissafi.
A ƙarshe, muna fatan ƙarin hujjoji na ainihi za su zo kuma muna roƙon masu karatu su ba da shawarwari.
A lokacin da ake gano mutum da ake zargi da kamuwa da cutar, muna ba da shawarar cewa a bi kuma a bi sababbin ka'idojin ƙasarsu.
Ƙungiyarmu za ta sabunta shawarwarinmu a kan lokaci don ba da taimako.
Bangladesh ta ba da rahoton sabbin mutane biyar da suka mutu sakamakon COVID-19, wanda shine mafi yawan adadin yau da kullun
Jiya Bangladesh ta tabbatar da cewa an samu wasu mutane biyar da suka mutu sakamakon cutar COVID-19 a wannan rana.
Wannan shi ne adadin mutuwar da aka yi a kowace rana da cutar.
A kwanakin baya, Cibiyar Kula da Kula da Cutar da Cututtuka da Bincike (IEDCR) ta Bangladesh ta ba da rahoton cewa an samu mutane 114 da suka kamu da cutar, da kuma mutane 33 da suka warke daga cutar.
An samu jimillar mutuwar mutane 17.
A wani shirinsa na yanar gizo, darektan IEDCR, Dakta Meerjady Sabrina Flora, ta ce wadanda suka mutu sun hada da maza hudu da mace daya.
A cewar rahoton, Dr. Meerjady ya bayyana cewa, akwai wasu mutane biyu da suka wuce shekaru 60, wasu biyu suna tsakanin shekaru 51 zuwa 60 da kuma wani daga cikinsu yana tsakanin shekaru 41 zuwa 50.
Ta kuma ce wasu daga cikin wadanda suka mutu sun fito ne daga Dhaka.
A ranar 11 ga Maris, Hukumar Lafiya ta Duniya (WHO) ta bayyana COVID-19 a matsayin annoba.
Jami'an asibiti sun shaidawa Anadolu, wata majiya ta gida, cewa daya daga cikin wadanda suka mutu shi ne Jalal Saifur Rahman, shugaban hukumar yaki da cin hanci da rashawa ta Bengali, wanda ake kula da shi a asibitin Kuwait Mai.
A wani sakon da aka wallafa a shafin yanar gizo a ranar Asabar, ministan sufuri da hanyoyin sadarwa na Bangladesh, Obaidul Quader, ya ce za a rufe zirga-zirgar jama'a fiye da yadda aka tsara har zuwa ranar Asabar mai zuwa.
Wannan rufewar ta fara ne a ranar 26 ga watan Maris kuma an shirya ta ta kare ne a ranar Asabar, 4 ga watan Afrilu.
Ana iya jigilar kayayyaki masu mahimmanci kamar kayan kiwon lafiya, man fetur da abinci.
Wani rikodin farko da aka yi a ranar 8 ga watan Maris ya nuna cewa an samu kamuwa da cutar Covid-19 a Bangladesh a kan mutane biyu da suka dawo daga Italiya, wata mace da matar wani daga cikinsu ta kamu da cutar.
Dukkanin jikokin sun warke a ranar 19 ga Maris.
An kamu da cutar SARS-CoV-2 da mutane sama da miliyan a duniya
A cewar bayanan da Jami'ar Johns Hopkins ta bayar a ranar Alhamis, adadin wadanda suka kamu da cutar SARS-CoV-2 ya karu da sama da miliyan a duniya.
Akalla mutane dubu 52 ne suka mutu sakamakon kamuwa da COVID-19 wanda ya haifar da cutar coronavirus.
Wani muhimmin abin ya faru a rana guda, Malawi ta tabbatar da kamuwa da cutar ta farko, kuma Fiji ta samu mutuwar mutane da suka fara kamuwa da cutar coronavirus.
Koriya ta Arewa ta ce a ranar Alhamis ta kasance daya daga cikin kasashe da suka rage a cikin wadanda ba su da cutar.
A jiya, Hukumar Lafiya ta Duniya ta ruwaito cewa an samu karin mutane 1,051,635 da suka kamu da cutar, daga cikinsu akwai 79,332 a cikin sa'o'i hudu kafin 10 na safe a tsakiyar Turai (0800 UTC) a ranar 4 ga Afrilu.
A Amurka, an samu karin mutane 244,000 da suka kamu da cutar coronavirus, kuma akalla mutane 5,900 sun mutu sakamakon cutar.
Labarin CBS ya ruwaito, yana ambaton bayanan jami'ar Johns Hopkins, cewa mutane sama da 1,000 sun mutu a ranar Laraba sakamakon kamuwa da cutar coronavirus.
A duniya, kasashe da dama sun sanar da tsauraran matakan hana yaduwar cutar.
A ranar Alhamis, magajin birnin Moscow Sergei Sobyanin ya ci gaba da rufe ƙofofin birnin har zuwa 1 ga Mayu.
A fadin kasar, shugaban kasar Vladimir Putin ya sanar da cewa a ranar 30 ga watan Afrilu, za a ba wa 'yan Rasha albashi ba tare da yin aiki ba.
Majalisar dokokin kasar ta Turkiyya ta kara wa'adin dokar ta baci ta kwanaki 15 ta amince da zaben da aka kada da kuri'u 215 a baya, 10 a baya da kuma daya a kan.
Saudiyya ta kara da cewa ana yin amfani da dokar hana fita a manyan biranen Makka da Madina a duk rana. A baya dokar hana fita tana aiki tsakanin 3 da 6 na safe.
Thailand na shirin yin hutun shanu tsakanin 10 na dare zuwa 4 na safe.
Gwamnan Ohio Mike DeWine ya sanar da cewa jihar ta dage dokar hana fita zuwa ranar 1 ga Mayu.
Shaguna a Ostiraliya suna da ƙarancin amfani da takarda a cikin aiki
A ranar Lahadi da Asabar da yamma, shagunan sayar da kayayyaki na Australiya Woolworths da Coles sun rage sayen su na takarda zuwa biyu da kuma guda ɗaya a kowace ma'auni a duk shagunan da ke cikin ƙasa.
A ranar Litinin, ALDI ta ba da shawarar yin amfani da takardun da aka ƙayyade.
Wadannan iyakoki an sanya su a cikin sakonnin bincike da kuma shafin Facebook.
An ruwaito cewa abokan ciniki suna sayen kayan ajiya saboda tsoron COVID-19 idan sun bukaci zama a wuri mai zaman kansa.
A ranar Laraba, kamfanin Woolworths ya rage yawan kayayyakin da ake amfani da su don jigilar kayayyaki zuwa gida a kowane tsari.
Wadannan canje-canjen sun kasance bisa ga matakan da aka yi na cinyewa na hudu a cikin sayayya na farko da Woolworths da Coles suka gabatar a ranar 4 da 5 daban.
"A cikin wata sanarwa ta 8 ga watan Maris, Coles mall ya ruwaito cewa tare da sanyawa na fakiti hudu, ""manyan shaguna suna sayar da su daga shaguna a cikin sa'a daya na jigilar kayayyaki"" kuma ya kira wannan bukatar "ba a taba gani ba", yayin da ALDI mall ya kira ta "ba a yi tsammani ba" a cikin shafin Facebook na Talata. "
A cewar wani kakakin Woolworths, tallace-tallace sun karu sosai a makon da ya gabata.
Shagon Costco a Canberra ya kuma sanya adadin da aka ba da izinin a cikin fakiti biyu a makon da ya gabata.
Don rage rashi, Coles ya ba da umarni ga manyan kaya daga masu samarwa da kuma kara yawan jigilar kayayyaki, Woolworths ya ba da umarni ga ƙarin ajiya, yayin da ALDI ta samar da ajiya don ayyukan da aka tsara don musamman dutse.
Russell Zimmerman, shugaban kungiyar masu sayar da kayayyaki ta Australiya, ya ce masu sayar da kayayyaki suna kokarin shigo da kayayyakin zuwa kantin sayar da kayayyaki, amma matakin da hukumar ta dauka a yankin da ake ajiye motocin sayar da kayayyaki ya kawo matsala.
Ya yi tsammanin cewa farashin samarwa zai karu saboda masu samarwa suna ƙoƙari su cika buƙatun kuma suna da ƙarancin ƙwarewa.
A ranar Talata, ALDI ta sanar da cewa bayan fitowar kayan farko, wasu shaguna ba za su iya gudanar da shirin ranar Laraba ba.
A cikin rahoton News.com.au, Dr. Gary Mortimer, masanin sayar da kayayyaki daga Jami'ar Fasaha ta Finland, ya ce wadannan shaguna suna cike da kayayyaki a daren.
Ya lura cewa takarda mai ban ruwa na gida biyu ne wanda ke samar da wadataccen ajiya, kuma idan aka sayar da shi, sai ya bar babban ajiyar kudin da ke barin yana sa ya zama kamar babu shi.
Russell Zimmerman ya shaida wa ABC cewa, "Kolas da Wolves suna da ra'ayi [da] cewa idan akwai abubuwa da yawa a cikin kantin sayar da kayayyaki, idan ana iya sayen kayayyaki kamar su toiletries da washing machines, kuma akwai yiwuwar, za a iya rage yawan tsoro".
Kamfanin Who Gives a Crap, wanda ke yin takarda mai amfani da takarda mai amfani da takarda, ya ce a ranar Laraba sun rasa kayayyakin da suke ajiyewa.
Kamfanin Kimberly-Clark, wanda ke samar da Kleenex Toilet Tissue da Solaris da kuma kayan shakatawa, ya ce suna aiki 24/7 don kiyaye wadatar, a cewar rahoton News.com.au.
Domain.com, wani shafin yanar gizon gidaje, ya ruwaito cewa mai sayarwa ya ba da takardun amfani da gidan wanka kyauta ga masu yin gwanjo na farko a wani gwanjo a Melbourne lokacin da aka yi biyu ko uku, saboda masu sayarwa sun huta a karshen mako na ranar hutu.
Labarin da NT News ta wallafa a ranar Alhamis, wanda ake buga kullum a Darwin, ya hada da shafukan da ake nufi da a yanka su kuma yi amfani da su a matsayin takarda.
Da farko dai, shagunan sun yi ta yin tambaya game da sanya wannan takunkumin, a cewar rahoton ABC Australia a ranar 3 ga Maris, inda suka ce ba su da shirin gabatar da takunkumin sayan.
Russell Zimmerman ya kara da cewa wasu kayayyakin suna da matukar bukatarsu, ciki har da masks, kayan tsabtace jiki, kayan bushewa, kayan bushewa da kayan shafawa.
Hakazalika, a yammacin Lahadi a waje da Ostiraliya, an lura da wani ƙuntatawa a kan sayen takarda don Andres brand toilet har zuwa 12 na akwatin.
Hukumar lafiya ta duniya ta sanar da barkewar cutar COVID-19
A ranar Laraba ne Hukumar Lafiya ta Duniya (WHO) ta sanar da barkewar cutar COVID-19 da ke haifar da kwayar cutar SARS-CoV-2.
Ko da yake kalmar "annoba" tana nufin yadda cutar ta yadu kuma ba ta nufin wasu lokuta masu haɗari ba, amma Hukumar Lafiya ta Duniya ta nuna bukatar ƙarfafa gwamnatoci su ɗauki mataki:
Dukkanin kasashe na iya canza yanayin annobar.
Tedros Adhanom Ghebreyesus, babban darektan Hukumar Lafiya ta Duniya, ya ce idan kasashen suka gano cewa ana yin gwaji da kuma sanya su a waje da su kuma suna tattara al'ummarsu a matsayin martani, to, za su yi hakan.
"Muna matukar damuwa da matakin gaggawa na yaduwar cutar da kuma yadda ake daukar cutar da kuma matakin gaggawa na rashin aiki.
A cewar Dr. Tom Frieden, tsohon shugaban cibiyoyin kula da cututtuka na Amurka, cutar ta kasance mai ban mamaki.
A cikin jawabinsa da aka buga ta Sin TV a watan Fabrairu, ya ce ba a biye da wani kwayar cutar ta hanyar numfashi ba sai da cutar ta fara yaduwa a duniya.
Ghebreyesus ya yi irin wannan ra'ayi, yana cewa: "Ba mu taɓa ganin annobar coronavirus ba.
Ya ci gaba da cewa, "kuma ba mu taba ganin annobar da za a iya sarrafawa ba a lokaci guda".
Sabuwar annobar ta biyo bayan wani hukunci na WHO a watan Janairu da ya bayyana yaduwar cutar a matsayin gaggawa ga lafiyar jama'a, na da matukar damuwa a duniya.
Darakta Anthony Fauci, shugaban cibiyar kula da cututtuka da cututtuka na Amurka, ya ce cutar za ta kara tsanani.
A ranar Alhamis, hukumomin yada labarai sun ruwaito cewa akwai akalla shari'o'i 126,000 na COVID-19 a duniya, wanda ya haifar da mutuwar mutane sama da 4,600.
Cutar coronavirus ta 2019-20 ta ci gaba da barkewar cutar coronavirus ta 2019 (COVID-19) wanda ya haifar da bayyanar cututtukan cutar ta jiki ta Coronavirus 2 (SARS-CoV-2).
An gano barkewar cutar a Wuhan, China, a watan Disambar 2019, inda aka bayyana ta a matsayin dokar ta baci ta lafiyar jama'a ta kasa da kasa ta damuwa a ranar 30 ga Janairu, 2020 kuma aka gane ta a matsayin annobar a ranar 11 ga Maris, 2020.
A ranar 10 ga Afrilu, 2020, an samu kimanin mutane miliyan 1,61 da suka kamu da cutar COVID-19 daga kasashe da yankuna 210, kuma an samu kusan mutane 97,000 da suka mutu.
An warkar da mutane 364,000.
An kiyasta yawan mutuwar kashi 4 cikin 100 a kasar Sin, yayin da a duniya, ya kasance tsakanin kashi 13.04% a Algeria da 0.08% a New Zealand.
A cikin waɗannan cututtuka, ana iya samun ciwon daji da kuma ciwon daji.
Sakamakon zai iya haɗawa da cututtukan huhu da cututtukan numfashi masu tsanani.
Daga lokacin da mutum ya kamu da cutar zuwa lokacin da ya fara bayyanar cututtuka, ana iya gano su cikin kwanaki biyar, amma ana iya gano su cikin kwanaki biyu zuwa goma sha huɗu.
Babu allurar rigakafi ko magani na musamman.
Maganin farko shine maganin dogara da bayyanar cututtuka da tallafi. Hanyoyin da aka ba da shawarar su haɗa da wanke hannu, rufe baki yayin da suke yin cuta, nisantar da su daga wasu, da kuma sanya ido da zama a wuri mai zaman kansa ga waɗanda ake zargi da kamuwa da cutar.
Hukumomi a duk faɗin duniya sun amsa da aiwatar da tsauraran matakan tafiye-tafiye, keɓewa, hanawa, sa ido kan hatsarin a wuraren aiki da rufewa.
Cutar ta haifar da matsalolin tattalin arziki da zamantakewa a duniya, jinkirta ko soke abubuwan wasanni, siyasa da al'adu da tsoro, rashin wadataccen kayayyaki da ake samu daga sayayya.
Makarantu da jami'o'i sun rufe a ko'ina ko kuma a yankuna a cikin kasashe 193, suna shafar yawan ɗalibai a duniya kusan kashi 99.4.
Labaran karya game da cutar sun bazu a duk faɗin Intanet, kuma akwai wasu abubuwan da ke haifar da tsoron baƙi da nuna bambanci ga Sinawa, wasu mutane sun fito ne daga gabashin Asiya da Gabas ta Gabas, kuma wasu mutane sun fito ne daga yankunan da ake samun kamuwa da cutar.
Rage tafiye-tafiye da kuma rufe masana'antu na haifar da raguwa a cikin iska da kuma carbon dioxide.
Hukumomin lafiya a Wuhan, China (babban birnin lardin Hubei) sun ruwaito wani mummunan hali na cutar huhu daga wani sanannen dalili a ranar 31 ga Disamba, 2019, kuma an fara bincike a farkon Janairu, 2020.
Yawancin lokuta ana danganta su da shagunan sayar da abincin teku na Hunan, saboda haka ana tunanin cewa kwayar cutar ta samo asali ne daga Juno.
Kwayar cutar da ta haifar da barkewar cutar ta zama SARS-CoV-2 wanda aka gano kwanan nan, yana da alaƙa da kwayar cutar coronavirus a cikin fuka-fuki, kwayar cutar coronavirus a cikin dabbobi masu rarrafe, da kwayar cutar SARS-CoV. An gano cewa mutumin da ya fara kamuwa da cutar ya kamu da cutar a ranar 1 ga Disamba, 2019, kuma ba a kai tsaye ba ne ya shafi rukunin ƙwayoyin cuta da aka gano a cikin kayan ado.
A cikin farkon shari'o'in da aka ruwaito a watan Disamba na 2019, kashi biyu bisa uku na marasa lafiya sun samo asali daga wannan kasuwa.
A ranar 13 ga watan Maris, 2020, wani rahoto da ba a tabbatar da shi ba daga jaridar South China Morning Post ya nuna cewa, wani mutum mai shekaru 55 daga lardin Hubei ya faru a ranar 17 ga watan Nuwamba, 2019, wanda zai iya zama farkon lamarin. A ranar 26 ga Fabrairu, 2020, Hukumar Lafiya ta Duniya ta ruwaito cewa, an ruwaito cewa sabon kamuwa da cutar ya ragu a kasar Sin, amma nan da nan an samu karuwa a Italiya, Iran da Koriya ta Kudu.
Wataƙila ba a samu rahoton kamuwa da cutar ba, musamman a cikin waɗanda ke da alamun cutar.
A ranar 26 ga Fabrairu, an ruwaito wasu lokuta a tsakanin matasa masu shekaru 19 da haihuwa, kuma a karkashin kashi 2.4% na lokuta a duk duniya. Patrick Vallance, mai ba da shawara kan kimiyyar Birtaniya ya kiyasta cewa kashi 60% na yawan mutanen Birtaniya za su kamu da cutar kafin su sami rigakafi mai tasiri.
Wannan ya shafi yawan mutanen da aka gwada su da COVID-19 kuma an tabbatar da sakamakon gwajin su a cikin wani bikin da aka yi.
A ranar 23 ga watan Maris, babu wata ƙasa da ta gwada kashi 3 cikin 100 na yawanta, kuma ƙasashe da yawa sun ba da ƙa'idodin ba su gwada waɗanda ke da alamun cutar ba, kamar Italiya, Netherlands, Spain da Switzerland.
Wani binciken da aka buga a ranar 16 ga Maris ya gano cewa a kasar Sin, har zuwa 23 ga Janairu, kimanin kashi 86% na kamuwa da COVID-19 ba a gano su ba, kuma wannan kamuwa da cutar da ba a rubuta ba ita ce tushen kamuwa da kashi 79% na shari'o'in da aka rubuta.
Nazarin kididdigar da aka fitar a ranar 30 ga Maris ya kiyasta cewa adadin kamuwa da cutar a Italiya ya fi yawan wadanda aka ruwaito.
Kimanin farkon adadin ci gaba na asali (R0) don COVID-19 shine 1.4 zuwa 2.4.
Wani binciken da cibiyoyin kula da cututtuka da rigakafin cututtuka suka fitar ya ce zai iya zama 5.7.
Yawancin mutanen da ke da cutar COVID-19 sun warke.
Ga mutanen da ba su da lokaci na ci gaba da bayyanar cututtuka har mutuwa, yana tsakanin kwanaki 6 zuwa 41, tare da mafi yawan kwanaki 14.
A ranar 10 ga Afrilu, 2020, an yi kusan mutuwar 97,000 sakamakon COVID-19.
A kasar Sin, kamar yadda aka yi a ranar 5 ga Fabrairu, kusan kashi 80% na wadanda suka mutu sun wuce shekaru 60 da haihuwa, kuma kashi 75% na wadanda suka kamu da cututtukan zuciya da ciwon sukari. Yawan mutuwar da aka yi a hukumance daga annobar COVID-19 galibi yana nufin wadanda suka mutu da aka tabbatar da COVID, bisa ga al'adar hukuma.
Yawan mutanen da suka mutu daga COVID-19 na iya zama mafi girma, saboda ba ya haɗa da waɗanda suka mutu ba tare da yin gwaji ba - misali, a gida, a wurin kulawa, da sauransu.
Wani rahoto daga Italiya ya gano cewa yawan mutuwar da aka samu a lokacin annobar ya fi yawan mutuwar da aka samu a cikin ayyukan gwamnati da kashi 4-5x.
Ma'aikatan kula da cibiyoyin kula da cututtuka na Amurka sun amince cewa mun san cewa [ƙididdigar mutuwar] wani abu ne mai ban mamaki. Wani bayani ya tabbatar da cewa ba a ƙidaya yawan adadin a Amurka. Irin wannan abin mamaki yana faruwa ne a lokutan annobar annoba, kamar cutar H1N1 a shekara ta 2009.
Mutuwar farko a wajen kasar Sin ta faru ne a ranar 1 ga watan Fabrairu a kasar Philippines, kuma mutuwar farko a wajen Asiya a Faransa a ranar 14 ga watan Fabrairu.
A ranar 28 ga watan Fabrairu, a wajen kasar Sin, an samu mutuwar mutane da dama a Iran, Koriya ta Kudu da Italiya.
A ranar 13 ga Maris, fiye da kasashe da yankuna arba'in sun ba da rahoton mutuwar a duk nahiyoyi sai dai Antarctica. Ana amfani da matakan da yawa don ƙayyade mutuwar.
Wadannan adadi sun bambanta ta hanyar yankuna da lokaci, kuma suna rinjaye ta hanyar sikelin, ingancin tsarin kiwon lafiya, zaɓin magani, lokacin da cutar ta fara, da kuma alƙaluma kamar shekarun jima'i da lafiyar gaba ɗaya.
Bisa ga kididdigar Jami'ar Johns Hopkins, yawan mutuwar duniya ya kai kashi 6.0% (97,039/1617,204) a ranar 10 ga Afrilu, 2020.
Yawan adadin ya bambanta daga yanki zuwa yanki.
A kasar Sin, kiyasta yawan mutuwar ya ragu daga 17.3% (ga wadanda ke da alamun fara daga 1-10 ga Janairu 2020) zuwa 0.7% (ga wadanda ke da alamun fara bayan 1 ga Fabrairu 2020). Sauran matakan sun hada da mutuwar kashi (CFR) wanda ke nuna kashi na wadanda aka gano wadanda suka mutu saboda cutar, da kuma yawan mutuwar kamuwa da cutar (IFR) wanda ke nuna kashi na wadanda suka kamu (suna da ganewar asali da wadanda ba a gano su ba) wadanda suka mutu saboda cutar.
Wadannan bayanan ba su ba da lokaci ba kuma ba su bi wasu mutane daga kamuwa da cutar ta hanyar magance su.
Wasu karatu sun yi ƙoƙarin lissafa waɗannan lambobin ga wasu al'ummomi.
Cibiyar Kula da Lafiya ta Jami'ar Oxford ta kiyasta cewa yawan kamuwa da cutar a cikin cutar ta kasance tsakanin 0.1% da 0.39%.
Wannan kimantawar ta dace da sakamakon gwajin farko na COVID-19 a Jamus da kuma nazarin kididdigar nazarin tasirin gwajin akan kimantawar CFR.
WHO ta ce za a iya sarrafa cutar.
Lokaci da kuma lokacin da za a yi fashewar ba a san shi ba kuma zai iya bambanta da wuri.
Maciej Boni, daga Penn State University ya ce, a yayin da ake rashin kulawa, cutar ta ƙaru, sai ta fara raguwa idan ba a sami masu cutar ba.
Amma yana da wuya a yi hasashen abin da zai faru a yanzu.
Babban mai ba da shawara kan harkokin likitancin gwamnatin kasar Sin, Zhong Nanshan, ya ce zai iya ƙare a watan Yuni idan duk ƙasashe za su iya haɗuwa don bin shawarar Hukumar Lafiya ta Duniya game da matakan da za a iya ɗauka don hana yaduwar cutar.
"A ranar 17 ga watan Maris, Adam Kucharski, daga makarantar ilimin likitanci da na kiwon lafiya ya bayyana cewa SARS-CoV-2 ""zai iya ci gaba da cutar a cikin shekara guda ko biyu"."
"A cewar wani binciken da aka gudanar a Imperial College karkashin jagorancin Neil Ferguson, ana bukatar kwafin jiki da sauran matakan da ake bukata ""har sai an samu maganin (watannin 18 ko fiye)"."
William Schaffner daga Jami'ar Vanderbilt ya ce, "Ina ganin ba zai yiwu ba cewa cutar ta coronavirus ta riga ta kasance a shirye don juyawa, ba za ta ɓace gaba ɗaya ba, kuma za ta iya zama cuta ta yanayi, ta sake dawowa kowace shekara".
Za a iya sake haifar da fashewar cutar ta hanyar dogaro da rigakafin mutum da kuma girman canjin.
Alamun COVID-19 na iya kasancewa cikin rashin tabbas, kuma mutum mai cutar na iya zama ba shi da alamun cutar.
Abubuwa biyu da suka fi kama da juna sune zazzabi (88%) da kuma tari (68%).
Alamomin da ba sa faruwa a yau da kullum sun haɗa da gajiya, ɓarkewar numfashi, rashin wari, gajeren numfashi, ciwon tsoka da ƙashi, ciwon kai, sanyi, kumburi, zubar da jini, rufi ko kuma canza launin fata. WHO ta ce mutum ɗaya cikin shida yana fama da ciwon jiki da kuma rashin numfashi.
Cibiyoyin Kula da Cututtuka na Amurka (CDC) sun rubuta alamun cututtuka na yau da kullum kamar kumburi, ciwon kirji ko damuwa mai tsanani, damuwa da farkawa da fuska ko kuma launin shuɗi. Ana ba da shawarar kula da likita na gaggawa idan waɗannan alamun sun kasance. Ci gaba da ci gaba da cutar na iya haifar da ciwon huhu mai tsanani, bayyanar cututtuka na numfashi, ciwon sukari, rashin lafiya na jini, da mutuwa.
Wasu masu kamuwa da cutar ba za su iya nuna alamun cutar ba, amma sakamakon gwajin da ke nuna cewa sun kamu da cutar ya bayyana, don haka masu bincike sun ba da shawarar cewa waɗanda ke da dangantaka ta kusa da waɗanda suka kamu da cutar su kamata a bincika su kuma a bi su sosai don hana kamuwa da cutar.
China ta kiyasta cewa rashin nuna gaskiya yana da ƙasa da kashi 44 cikin ɗari.
Lokacin farkawa na al'ada (lokacin da ke tsakanin kamuwa da cuta da bayyanar cututtuka) yana daga rana ɗaya zuwa kwanaki 14, misali, na kwana biyar. Misali, yawan mutanen da ke fama da COVID-19 da suka rasa ƙanshi da farko ya kai 30% sannan ya ragu zuwa 15%.
Ba a san cikakken bayani game da yadda cutar ta yadu ba.
Ana ganin cewa cutar tana yaduwa ne a lokacin da suke kusa da juna kuma ta hanyar ƙananan ruwa da ke samarwa yayin da suke taho ko magana, tare da kusanci tsakanin mita 1 zuwa 2 (3 zuwa 6 feet).
Nazarin ya nuna cewa, idan mutum ya yi tari ba tare da ya yi shiru ba, zai iya yin ruwan da ya fi tsayi daga mita 4.5 zuwa mita 8.2.
Wasu sun ce ƙwayoyin cuta na iya kamuwa da su ta hanyar ƙananan ƙwayoyin cuta na tsawon lokaci a cikin yanayi, wanda zai iya faruwa yayin magana. Ƙwayoyin cuta na iya faruwa yayin numfashi, wanda ya haɗa da lokacin magana, kodayake ƙwayoyin cuta ba sa wucewa ta iska.
Ruwan da ke cikin bakinka zai iya sauka a bakin mutum ko a hancinsa ko kuma ya shiga cikin huhu ta hanyar numfashi.
Wasu hanyoyin magani kamar su jini a kwakwalwa da kuma ceto zuciya (CPR) na iya haifar da numfashi wanda ke fitar da iska kuma yana iya haifar da iska.
Yana iya yaduwa idan mutum ya taɓa fuskarsa, ciki har da fata, sannan ya taɓa idanunsa, hanci ko bakinsu.
Duk da yake akwai damuwa cewa zai iya zama sanadiyyar cutar ta hanyar tushen iska, an yi imanin cewa haɗarin yana da ƙananan.
Gwamnatin kasar Sin ta musanta yiwuwar kamuwa da cutar ta SARS-CoV-2. Kwayar cutar tana da yawa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yaduwar na iya faruwa kafin bayyanar cututtuka da kuma a cikin matakan cutar.
Mutane sun gwada cutar har kwana uku kafin bayyanar cututtuka, wanda ya nuna cewa kamuwa da cutar zai yiwu kafin bayyanar cututtuka.
Labaran da aka tabbatar da rashin bayyanar cututtuka sun kasance kaɗan, amma wasu ƙasashe sun ƙayyade iskar cutar a lokacin binciken.
Cibiyar Tarayyar Turai don Rigakafin Cututtuka da Kulawa (ECDC) ta ce yayin da ba a san yadda cutar ta yadu ba, mutum zai iya kamuwa da mutane biyu zuwa uku. Kwayar cutar na iya rayuwa na awanni zuwa kwanaki a kan wani farfajiyar.
A bayyane yake, an gano cewa kwayar cutar tana rayuwa a kan polypropylene na kwana uku da awanni 304 a kan karfe mai amfani da inodes na kwana daya a kan takarda, kwali da kuma har kwana hudu a kan igiyoyi.
Koyaya, wannan ya bambanta dangane da yanayin zafi da yanayin zafi. Dabbobi da sauran dabbobi sun gwada COVID-19 a bayyane.
Babu wata hujja da ta nuna cewa dabbobi za su iya watsa kwayar cutar ga mutane, ko da yake hukumomin Burtaniya sun ba da shawarar wanke hannayensu bayan sun yi hulɗa da dabbobi kamar yadda suke yi bayan sun yi wasu hulɗa na waje da mutane masu kamuwa da cutar.
Cutar huhu mai tsanani ta Coronavirus 2 (SARS-CoV-2) ita ce cutar da ba a taɓa gani ba, ta rabu da mutane uku da ke fama da cutar huhu da ke tattare da cutar ta huhu a Wuhan.
Dukkanin siffofin SARS-CoV-2 suna cikin kwayar cutar da ke da alaƙa da coronavirus a cikin yanayi. A waje da jikin mutum, kwayar za ta kasance tare da sabulu don amfani a gida wanda zai iya narkar da shi a ƙarƙashin kariya. Kwayar SARS-CoV-2 tana da alaƙa da SARS-CoV.
Ana tunanin cewa cutar ta samo asali ne daga kamuwa da dabba.
Binciken kwayoyin ya nuna cewa kwayar cutar tana da alaƙa da kwayoyin halittar Betacoronavirus, wanda ke cikin nau'in B na kwayar cutar, tare da nau'in da ya fito daga nau'in beraye biyu.
Ya kasance daidai da kashi 96 cikin dari a cikin kwayoyin halitta zuwa wasu nau'ikan cutar coronavirus a cikin foxes (BatCov RaTG13).
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa akwai bambanci guda daya na amino acid a cikin takamaiman sassan kwayoyin halitta tsakanin kwayoyin cuta daga dabbobi da kwayoyin halitta daga mutane.
Kusan kwatancen kwayoyin ya gano cewa kusan kashi 92% na kwayoyin da aka rarraba tsakanin tsuntsaye da SARS-CoV-2 ba su isa su tabbatar da cewa tsuntsaye suna da matsakaicin matsakaici ba.
Ana iya gano kamuwa da cutar ta hanyar kwayar cutar ta wucin gadi bisa ga alamun farko, kodayake dole ne a tabbatar da tabbatarwa ta ƙarshe ta hanyar yin kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta hanyar kwayar cutar ta CT.
Nazarin kwatancen da aka yi tsakanin maganin polyurethane da citric acid a Wuhan ya nuna cewa maganin polyurethane ya fi ƙarfin maganin polyurethane, tare da halaye na hotuna da yawa da ke nuna shi tare da cututtukan huhu da sauran cututtuka, kodayake ba a ƙayyade su ba.
A watan Maris na shekarar 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa kada a yi amfani da CT don gano ko kuma ba a yi amfani da shi a matsayin zaɓi na farko don gwajin COVID-19.
Hukumar lafiya ta duniya ta fitar da wasu gwaje-gwajen RNA don SARS-CoV-2, tare da fitowar farko a ranar 17 ga Janairu.
Ana yin gwajin ta amfani da rRT-PCR.
Ana iya gwada su ta hanyar numfashi ko jini.
Yawanci, sakamakon yana faruwa a cikin sa'o'i da yawa ko rana.
A yawancin lokuta ana yin gwajin ne akan hayaki mai ƙwanƙwasawa, kodayake ana iya amfani da hayaki mai ƙwanƙwasawa. Yawancin dakunan gwaje-gwaje da kamfanoni suna haɓaka gwajin ƙwayoyin cuta waɗanda ke gano ƙwayoyin cuta.
A ranar 6 ga Afrilu, 2020, waɗannan takardun ba su tabbatar da cewa sun isa su zama daidai ba don a yarda da su don amfani da su.
A Amurka, gwajin kwayar halitta da aka yi da silin an yarda da shi don amfani da gaggawa ne kawai ta hanyar gwajin gwaji.
Abubuwan da ke cikin hotunan hoto na MRI da kuma daukar hoto na CT (CT) a kan mutane da ke da alamun sun hada da ƙwanƙwasawa a ƙasa da kuma rashin haske.
The Italian Radiological Society tana tattara bayanai a kan intanet na duniya game da binciken a matsayin hoto don shari'ar da aka tabbatar.
Saboda yin amfani da wasu cututtuka kamar adenovirus, yin hotunan hoto ba tare da tabbacin PCR ba yana da mahimmanci wajen gano COVID-19.
Wani babban bincike a kasar Sin ya kwatanta sakamakon gwajin CT na ƙirjin da PCR kuma ya nuna cewa, ko da yake hoton bai da ma'ana sosai ga kwafin, ya fi sauri da kuma amsawa, yana ba da shawarar cewa gwajinsa na kayan bincike ne a yankin da cutar ta barke.
An gina cibiyar sadarwa ta hanyar maganin kwakwalwa ta kwakwalwa don kama hotunan kwayar cuta wanda ya ƙunshi duka MRI da CT.
Dabaru don hana kamuwa da cutar sun hada da kiyaye tsabtace jiki, wanke hannu, guje wa taɓa idanu, hanci ko baki, ba tare da wanke hannuwanku da ƙuƙwalwarku ko ƙuƙwalwarku ba, amfani da takardar shafawa, da kuma jefa takardar shafawa a cikin shara nan da nan.
Duk wanda ya riga ya kamu da cutar an shawarce shi da ya sa abin rufe fuska a fili.
An kuma ba da shawarar yin amfani da matakan keɓewa don hana kamuwa da cutar. Gwamnatoci da yawa sun sanya wasu takunkumi ko kuma sun hana yin tafiya ba tare da buƙatar fita da shiga cikin ƙasashe da yankuna da cutar ta shafa ba.
Koyaya, cutar ta kai ga yaduwar al'umma a manyan sassan duniya.
Wannan yana nufin cewa cutar tana yaduwa a cikin al'umma, kuma wasu membobin al'umma ba su san inda suka kamu ba ko ta yaya. Masu ba da sabis na kiwon lafiya da ke kula da wanda ke da cutar suna ba da shawarar yin amfani da matakan tsaro, sadarwa da kariya ta ido. Kula da sadarwa yana da muhimmiyar hanya ga hukumomin lafiya don gano tushen kamuwa da cutar da kuma hana ƙarin kamuwa da cutar.
Amfani da bayanan wuri daga wayoyin hannu ta gwamnati don wannan dalili ya haifar da damuwa game da tsare sirri, Amnesty International da fiye da kungiyoyi 100 sun fitar da wata sanarwa, suna kira ga iyakance irin wannan sa ido.
An aiwatar da aikace-aikacen wayar hannu daban-daban ko kuma an ba da shawarar don amfani da su ta hanyar son rai, kuma a ranar 7 ga Afrilu, 2020, akwai ƙwararrun masana da ke aiki a kan hanyoyin sirri kamar amfani da Bluetooth don gano wuri kusa da mai amfani.
Masu amfani za su sami saƙo idan suna da dangantaka ta kusa da wani wanda ya gwada COVID-19 a matsayin mai cutar. Kuskuren da ake yadawa game da yadda za a hana kamuwa da cutar. Misali, wanke hanci da wanke bakinka da ruwan sha ba su da tasiri.
Babu allurar rigakafi ga COVID-19, duk da cewa ƙungiyoyi da yawa suna aiki don ƙirƙirar allurar.
Ana ba da shawarar yin wanka a hannu don hana yaduwar cutar.
CDC ta shawarci mutane su wanke hannayensu a kai a kai da sabulu da ruwa aƙalla na tsawon dakika biyu, musamman bayan sun shiga gidan wanka ko kuma idan hannayensu sun iya zama marasa tsabta kafin cin abinci da kuma bayan sun yi tawaye, sun yi ta kuka ko sun yi kumburi.
Wannan shi ne saboda a waje da jikin mutum, ana kashe kwayar cutar ta sabulu a cikin iyali, wanda ke haifar da fashewar garkuwar ta.
CDC ta kuma ba da shawarar yin amfani da ruwan wanka na hannu da ke da akalla kashi 60% na barasa lokacin da babu sabulu da ruwa da za a iya amfani da su.
WHO ta shawarci mutane da su guji taɓa idanunsu, hanci ko bakinsu da hannayensu da ba a wanke su ba.
A saman, ana iya wanke wasu ƙwayoyin cuta (a cikin minti ɗaya bayan an yi maganin kashe kwayoyin cuta don ƙarfe mai ƙarfe) wanda ya haɗa da ethanol 6271% isopropanol 50100% sodium ipoglyceride 0.1% androgen peroxide 0.5% da iodine iodine 0.27.5%.
Sauran magunguna kamar benzalkonium chloride da chrohexidine gluconate ba su da tasiri sosai.
Cibiyar Kula da Cututtuka da Cututtuka (CDC) ta ba da shawarar cewa idan akwai wata sanarwa ko kuma an tabbatar da cutar COVID a wurare kamar ofisoshin ko wuraren kula da yara na yau da kullun, kamar su ofisoshin wanka, wuraren taruwa, da kuma na'urorin lantarki da aka raba kamar kwamfutar hannu, na'urorin taɓawa, na'urorin sarrafawa, da na'urorin ATM da marasa lafiya ke amfani da su, ya kamata su yi amfani da su don kashe ƙwayoyin cuta.
Hukumar lafiya ta shawarci mutane su rufe bakinsu da kuma hanuwansu ta hanyar yin amfani da takardar wanka a lokacin da suke kuka ko cizon sa, kuma su jefa takardar nan da nan.
Ana ba da shawarar yin amfani da masks na likita ga waɗanda za su iya kamuwa da cutar, ta hanyar yin amfani da masks, ƙididdigar yawan kamuwa da cuta da kuma zubar da ruwa yayin magana, kuka da kuma tari.
Hukumar Lafiya ta Duniya (WHO) ta fitar da shawarwari kan lokacin da kuma yadda ake amfani da abin rufe fuska.
A cewar Stephen Griffin, masanin kimiyyar cutar a jami'ar Leeds, sanya abin rufe fuska zai iya rage yawan mutane daga fuskokinsu, wanda shine babban tushen kamuwa da cutar ba tare da tsabtace hannu ba. An kuma ba da shawarar yin amfani da abin rufe fuska ga masu kula da waɗanda za su iya kamuwa da cutar.
Hukumar lafiya ta duniya ta ba da shawarar cewa masu lafiya su sa abin rufe fuska a lokuta masu haɗari kamar masu kula da marasa lafiya na COVID-19, da sauransu. Duk da haka, sun kuma yarda cewa yin amfani da abin rufe fuska zai iya taimakawa wajen hana mutum taɓa fuskarsa.
Wasu ƙasashe sun fara ƙarfafa amfani da abin rufe fuska ta hanyar membobin jama'a.
A Amurka, CDC ta ba da umarnin yin abin rufe fuska daga takarda, wanda ba na likita ba. China ta ba da shawarar musamman ga jama'a, musamman ga waɗanda ke da kusanci (na mita 3 ko kusa) da wasu don amfani da abin rufe fuska na likita.
Birnin Hong Kong ya ba da shawarar yin amfani da abin rufe fuska lokacin da mutane ke tafiya ta hanyar sufuri na jama'a ko kuma lokacin da suke cikin wurare masu yawa.
Jami'an lafiya na Thailand sun bukaci mutane su yi amfani da kayan shafa a gidajen su kuma su wanke su a kullum.
Kasashen Czech da Slovakia sun hana mutane fita a wuraren da ba su da abin rufe fuska ko abin da ke rufe hanci da bakinsu.
A ranar 16 ga watan Maris, Vietnam ta ba da umarnin ku saka abin rufe fuska a gabanku lokacin da kuke zuwa wuraren jama'a don kare kanku da kuma wasu.
Gwamnatin Austria ta ba da umarnin cewa duk wanda ya shiga kantin sayar da kayayyaki ya kamata ya sa abin rufe fuska.
Isra'ilawa sun umurci dukan mutane su sa abin rufe fuska a wuraren jama'a.
Taiwan, wadda ta samar da masks miliyan goma a rana tun tsakiyar watan Maris, ta bukaci fasinjoji a kan jiragen kasa da manyan motoci su sa masks a ranar 1 ga Afrilu.
Panama ta bukaci a saka abin rufe fuska a duk lokacin da ta fita waje, kuma ta kuma ba da shawarar yin kayan rufe fuska da hannu ga waɗanda ba za su iya saya ba.
Ana amfani da masks a Japan, Korea ta Kudu, Malaysia da Singapore.
Yin hijira ta zamantakewa (ko kuma a sani da nisa) ya ƙunshi matakan sarrafa watsawa waɗanda ke nufin tsawaita yaduwar cutar ta hanyar rage kusanci tsakanin mutane.
Hanyoyi sun haɗa da keɓewa, ƙuntatawa kan tafiya da rufe makarantu, wuraren aiki, wuraren shakatawa, shagunan sayar da kayayyaki, da sauransu.
Kowane mutum zai iya yin amfani da hanyoyin yin zaman lafiya ta wajen kasancewa a gida, yin tafiya a waje, yin liyafa, ba tare da yin hulɗa da mutane ba, da kuma ware kansa daga wasu.
Yanzu haka gwamnatoci da dama suna saita ko kuma bada shawarar yin zaman lafiya a yankunan da cutar ta shafa.
An rage yawan adadin da hukumomin Amurka, gwamnati da kungiyoyin kiwon lafiya suka gabatar daga 250 (ba tare da yaduwar COVID-19 a yankin ba) zuwa 50 kuma daga baya zuwa 10.
A ranar 22 ga Maris, 2020, Jamus ta haramta taron jama'a, wanda ya ƙunshi mutane biyu ko fiye. Manya da waɗanda ke da cututtuka kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, cutar jini, da kuma rashin lafiyar jiki suna fuskantar haɗarin kamuwa da cuta mai tsanani da kuma sakamako mai yawa. A ƙarshen Maris, 2020, Hukumar Lafiya ta Duniya da sauran kungiyoyin kiwon lafiya sun fara maye gurbin amfani da kalmar "tambaya ta zamantakewa" da "tambaya ta zamantakewa" don tabbatar da cewa manufar ita ce rage yawan cin zarafin jiki yayin da ke ci gaba da kasancewa da dangantaka ta zamantakewa, ko kusa ko nesa.
Yin amfani da kalmar "tambaya ta zamantakewa" ya haifar da tasirin da mutane zasu yi hulɗa da su a cikin yanayin da ke keɓewa daga al'umma gaba ɗaya maimakon ƙarfafa su su yi hulɗa da wasu ta wasu hanyoyi. Wasu hukumomi sun ba da shawarar yin amfani da lafiyar jima'i don amfani a lokacin annobar.
Waɗannan sun haɗa da umurnin yin jima'i da mutanen da suke zama tare da ku waɗanda ba su da cutar ko alamun cutar.
Ana ba da shawarar keɓe kai a gida ga waɗanda aka gano cewa suna da COVID-19 da waɗanda ake zargin suna da cutar.
Hukumomin lafiya sun ba da cikakkun bayanai game da yadda za a yi zaman lafiya a wuraren da ke da kyau. Gwamnatoci da yawa sun ba da umarni ko kuma sun ba da shawarar yin takardun shaida na kansu ga duk mutanen da ke zaune a yankunan da cutar ta kamu.
An ba da shawarar ware kansu ga waɗanda ke cikin rukunin haɗari.
Wadanda suka kasance cikin haɗuwa da COVID-19 da waɗanda suka yi tafiya zuwa wata ƙasa ko yanki mai yaduwa an ba da shawarar sanya kansu keɓewa na kwanaki 14 daga lokacin da aka sami cutar ta ƙarshe.
Aikin da ake yi wajen sarrafa cutar shi ne sarrafawa, ragewa da rage tsanani.
Ana yin hakan ne a farkon matakan yaduwar cutar, kuma ana nufin bin diddigin waɗanda suka kamu da cutar da keɓe su, da kuma gabatar da wasu matakan sarrafawa, watsawa da yin allurar rigakafi don hana cutar yaduwa ga dukan mutane.
Lokacin da ba za a iya hana yaduwar cutar ba, sai a yi ƙoƙari don ragewa: ana yin matakan da za a rage yaduwar da kuma rage tasirinsa a kan tsarin kiwon lafiya da zamantakewa.
Ana iya amfani da haɗuwa da matakan sarrafawa da rage nauyi a lokaci guda.
Dakatar da cutar tana buƙatar tsauraran matakan da za a iya ɗauka don kauce wa yaduwar ta hanyar rage yawan ci gaba da kwayar zuwa ƙasa da kashi 1 cikin ɗari na sarrafawa. Yaduwar cutar tana ƙoƙarin rage matsakaicin matakin yaduwar da aka sani da cutar ta hanyar yaduwar.
Wannan tsari ya rage hadarin rashin lafiyar da ke tattare da cutar kuma ya ba da ƙarin lokaci don samar da alluran rigakafi da magani.
Abubuwan da ba na magani ba da ke kula da wannan barkewar cutar sun haɗa da matakan kariya na mutum kamar tsabtace hannu da rufe fuska da keɓewa, kuma an yi amfani da su ne don kawar da yunwa daga jiki, kamar rufe makarantu da kuma kawar da manyan tarurruka.
Sauran ƙasashe sun kuma ɗauki matakai daban-daban da ke nufin rage yaduwar cutar.
Koriya ta Kudu ta gudanar da bincike mai zurfi da tilasta keɓewa a kan tushen kuma ta ba da sanarwar ƙaurawar mutanen da suka kamu.
Singapore ta ba da tallafi na kudi ga masu yin kwayar cutar da kuma yin takardun shaida, kuma ta yi amfani da tsauraran hukunci ga wadanda ba su yi biyayya ba.
Taiwan ta kara yawan samar da kayan rufe fuska da kuma takunkumi kan sayen kayayyakin kiwon lafiya. Rahotanni ga Burtaniya da Amurka sun nuna cewa rage (rage amma ba a dakatar da yaduwar cututtuka ba) da kuma matsa lamba (rage, karuwa) suna da manyan kalubale.
Mafi kyawun tsarin rage yawan za su iya rage yawan bukatun kiwon lafiya da kashi biyu cikin uku da kuma mutuwar da rabi, amma har yanzu suna haifar da mutuwar dubban dubbai, kuma tsarin kiwon lafiya yana cikin lalacewa.
Ana iya zaɓar matakin da za a ɗauka, kuma ana buƙatar yin shi muddin cutar tana yaduwa zuwa ga mutane (ko har zuwa lokacin da akwai riga-kafi, idan akwai) lokacin da aka yi saurin turawa yayin da aka rage matakan.
Yin amfani da dogon lokaci don hana cutar yana haifar da asarar zamantakewa da tattalin arziki.
Babu takamaiman maganin rigakafin cutar da aka amince da shi don amfani da COVID-19, amma ana ci gaba da ci gaba da ƙoƙari, gami da gwajin magunguna na yanzu.
Yin amfani da maganin sanyi, shan ruwa da kuma hutawa zai iya rage alamun cututtukan.
Dangane da tsanani, ana iya buƙatar maganin oxygen, allura na fiber, da taimakon numfashi.
Yin amfani da kwayoyi masu amfani da steroids zai iya sa sakamakon ya zama mafi muni.
Abubuwan da aka riga aka amince da su don magance cututtukan da wasu ƙwayoyin cuta ke haifarwa suna bincike don amfani dasu wajen magance COVID-19.
Hukumar lafiya ta duniya ta kuma tabbatar da cewa wasu hanyoyin gargajiya da na gida na iya taimakawa wajen warkar da bayyanar cututtukan da cutar SARS-CoV-19 ta haifar.
Ƙarfafawa da daidaitawa, kula da lafiya ga tsarin kula da marasa lafiya na COVID-19 an bayyana shi ta WHO a matsayin matakin mayar da martani ga barkewar cutar.
ECDC da WHO a Turai sun sanar da dalilin da ya sa manyan asibitoci da kuma cibiyoyin kiwon lafiya ke sauya albarkatu a matakai da yawa, tare da turawa kan ayyukan gwaji don gwajin COVID-19, kawar da tsarin zabin lokaci, warewa da keɓe masu cutar COVID-19, da haɓaka ikon kulawa da kulawa ta hanyar horo ta hanyar ma'aikata da haɓaka yawan kayan aiki, iska da gado.
Akwai ra'ayoyi daban-daban game da inda farkon (wanda ake kira marasa lafiya) zai iya fitowa.
Wani sabon hali na cutar, wanda aka sani da farko, zai iya faruwa a ranar 1 ga Disamba, 2019 a Wuhan, Hubei, China.
A cikin wata daya, adadin mutanen da suka kamu da cutar a Hubei ya karu.
Yawancin waɗannan marasa lafiya suna da alaƙa da kasuwar sayar da abincin teku ta Huanan, wanda kuma ke sayar da dabbobi masu rai, kuma wata majiya ta ce cutar ta fito ne daga wasu nau'ikan dabbobi daga cikin waɗannan dabbobi, ko kuma ana iya cewa ta fito ne daga dabbobi. An gano cutar huhu da ba a san asalinta ba a ranar 26 ga Disamba kuma Dr. Zhang Jixian ya kula da shi a asibitin asibiti na lardin Hubei, inda ya sanar da Cibiyar Kula da Cututtuka da Rigakafin Wuhan a ranar 27 ga Disamba.
A ranar 30 ga watan Disamba, wani rukuni na likitoci a Wuhan Central Hospital ya sanar da abokan aikinsa game da SARs kamar coronavirus.
'Yan sanda sun yi gargadin likitoci takwas, ciki har da Li Wenliang, saboda yada jita-jita, kuma wani mai suna Ai Fen ya zargi shi da yin ta'addanci.
Bayan haka, hukumar lafiya ta Wuhan ta fitar da sanarwar ta a ranar 31 ga watan Disamba kuma ta sanar da Hukumar Lafiya ta Duniya.
An bayar da rahoton isasshen lokuta na cutar huhu da ba a taɓa gani ba ga hukumomin lafiya a Wuhan don gudanar da bincike a farkon watan Janairu. A farkon farkon barkewar cutar, adadin ya ninka sau biyu a cikin kwanaki bakwai da rabi.
A farkon tsakiyar watan Janairu na shekarar 2020, cutar ta yada zuwa wasu larduna a kasar Sin sakamakon gudun hijira a bikin shiga kasar Sin, kuma Wuhan babban cibiyar sufuri ne da kuma cibiyar hanyoyin dogo.
A ranar 20 ga watan Janairu, kasar Sin ta ruwaito cewa akwai kusan sabbin mutane 140 a kowace rana, ciki har da mutane biyu a Beijing da kuma daya a Shenzhen.
Bayan haka, bayanan hukuma sun nuna cewa mutane 6,174 sun fara kamuwa da cutar a ranar 20 ga Janairu, 2020. A ranar 26 ga Maris, Amurka ta tashi sama da China da Italiya a matsayin mafi yawan masu kamuwa da cutar a duniya. A ranar 9 ga Afrilu, 2020, an samu karin mutane miliyan 1.61 a duniya, fiye da mutane 97,000 sun mutu, kuma fiye da mutane 364,000 sun warke.
A kusan ƙasashe 200 da yankuna akwai akalla wani.
Saboda annobar a Turai, ƙasashe da yawa a yankin Schengen sun takaita motsi da kuma gudanar da dubawa a kan iyakoki.
Ayyukan kasa sun hada da matakan hanawa kamar ware (wanda aka sani da yin oda daga gida, oda daga gidaje ko kulle kofa) da kuma lalata gidajen gidaje, da dai sauransu. A ranar 2 ga Afrilu, mutane miliyan 300, ko kusan kashi 90% na yawan jama'a suna ƙarƙashin kulle gidaje a Amurka. Mutane fiye da miliyan 50 suna tsare a cikin Philippines.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya sun kasance a cikin yanayin zaman gida, wanda ya karu zuwa 2.6 miliyan a cikin kwanaki biyu, wanda ya kai kashi uku na yawan mutanen duniya.
An samu mutum na farko da ya kamu da cutar COVID-19 tun ranar 1 ga watan Disamba, 2019 a Wuhan, kuma rahotanni da ba a tabbatar da su ba sun nuna cewa an samu mutum na farko a ranar 17 ga watan Nuwamba.
Dokta Zhang Jixian ta gano wani nau'i na cututtukan huhu wanda ba a san asalinsa ba a ranar 26 ga Disamba, wanda asibitinta ya sanar da Wuhan Jianghan CDC a ranar 27 ga Disamba.
Gwajin farko na samfurin marasa lafiya a ranar 27 ga Disamba, 2019, ya nuna kasancewar kwayar cutar coronavirus kamar SARS.
Bayanin da aka fitar a hukumance ne hukumar kula da lafiyar Wuhan ta fitar a ranar 31 ga watan Disamba.
An sanar da Hukumar Lafiya ta Duniya a ranar.
"Lokacin da aka sanar da hakan, 'yan sanda sun gargadi likitoci a Wuhan game da "" yada jita-jita"" game da barkewar cutar".
Hukumar lafiya ta kasar Sin ta ce babu wata hujja da ta nuna cewa cutar ta kamu da mutum.
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani babban yunkuri wanda shugaban jam'iyyar kwaminis ta kasar Sin Xi Jinoing ya bayyana a baya a matsayin yakin da ake yi na 'yan Adam don hana barkewar cutar.
A cikin abin da aka bayyana a matsayin mafi girma a cikin tarihin ɗan adam, an sanar da rufe tashar jiragen ruwa a ranar 23 ga Janairu, dakatar da zirga-zirga a cikin Wuhan da wajen birnin, wanda aka faɗaɗa zuwa birane 15 a Hubei, wanda ya shafi yawan jama'a kusan miliyan 57.
An haramta amfani da motocin hawa na sirri a cikin birni.
An soke bikin shiga kasar Sin (kwanan Janairu 25) a wurare da dama.
Hukumomi sun kuma yi sanarwar gina asibitin wucin gadi, Huoshenshan Hospital, wanda aka gina a cikin kwanaki 10.
Daga baya, aka gina wani asibiti, wato, Leishenshan Hospital, don kula da marasa lafiya.
Baya ga sabon asibitocin da aka gina, kasar Sin ta sake sauya wasu wurare 14 a Wuhan, kamar cibiyar taro da kuma filin wasa, zuwa asibitoci na wucin gadi. A ranar 26 ga Janairu, gwamnatin ta gabatar da wasu matakan hana yaduwar COVID-19, ciki har da fitar da sanarwar lafiya ga fasinjoji da kuma tsawaita hutun hutu na bazara.
Jami'o'i da makarantu a fadin kasar sun rufe.
Yankunan Hong Kong da Macau sun kafa wasu matakan musamman game da makarantu da jami'o'i.
An kafa tsarin aiki na nesa a yankuna da yawa na kasar Sin.
An amince da tsauraran matakan tafiye-tafiye a ciki da wajen Hubei.
An gyara sufuri na jama'a, kuma an rufe gidajen tarihi na kasar Sin.
"An yi amfani da tsarin tafiye-tafiye na jama'a a birane da yawa, kuma an kiyasta cewa kusan mutane miliyan 760 (fiye da rabin yawan jama'a) suna fuskantar wasu nau'ikan warewar waje. Bayan barkewar cutar ta shiga matakin ta duniya a watan Maris, hukumomin China sun ɗauki matakan da suka dace don hana kwayar daga " shigowa " daga wasu ƙasashe. "
Alal misali, birnin Beijing ya ba da umarnin a yi wa matafiya na duniya kwanaki 14 da su shiga birnin. A ranar 23 ga Maris, kasar Sin, an samu mutum daya da ya kamu da cutar a cikin kwanaki biyar da suka gabata.
A ranar 24 ga watan Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya ruwaito cewa an hana yaduwar cutar a cikin gida kuma an sarrafa barkewar cutar a kasar Sin.
A ranar da aka yi rajista, an rage tafiye-tafiye a Hubei, sai dai Wuhan, watanni biyu bayan fara dokar hana fita. Ma'aikatar harkokin wajen kasar Sin ta sanar a ranar 26 ga Maris, 2020 cewa za a dakatar da shiga don biza ko masu lasisin zama daga ranar 28 ga Maris, ba tare da cikakken bayani game da lokacin da za a kammala wannan manufa ba.
Duk wanda ya so ya je China dole ne ya nemi izinin zama a ofishin jakadancin kasar ko kuma a ofishin jakadancin kasar.
Gwamnatin kasar Sin ta karfafa wa kamfanoni da masana'antu su sake budewa a ranar 30 ga watan Maris kuma ta ba da wani kudade mai yawa ga kamfanoni. Majalisar jihar ta sanar da ranar makoki don fara da zaman lafiya na minti uku na kasa a karfe 10:00 na dare a ranar 4 ga Afrilu, daidai da bikin cin abinci, kodayake gwamnatin tarayya ta bukaci iyalai su bi hanyar intanet a cikin aiwatar da bayanan sirri don kauce wa barkewar COVID-19.
An tabbatar da cewa COVID-19 ta bazu zuwa Koriya ta Kudu a ranar 20 ga Janairu, 2020 daga China.
Hukumar Lafiya ta Kasa ta ruwaito wani karuwa mai ban mamaki na shari'o'in da aka tabbatar a ranar 20 ga Fabrairu, wanda yafi haifar da taron a Daegu na wani addini da aka sani da Shincheonji.
Shincheonji da ke zuwa Daegu daga Wuhan sun yi zargin cewa shi ne tushen cutar.
A ranar 22 ga Fabrairu, daga cikin masu bin addini 9,336, 1,261 ko kusan 13% sun ba da rahoton bayyanar cututtuka. Koriya ta sanar da gagarumin gaggawa a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga Fabrairu, an samu karin shari'o'i 2,000 a kasar ta Koriya, inda suka karu zuwa 3,150 a ranar 29 ga Fabrairu.
An ware dukkan sansanonin sojin Koriya ta Kudu bayan an tabbatar da cewa sojoji uku sun kamu da cutar.
Kalandar jiragen sama ma sun shafar, don haka an sauya su. Koriya ta kawo abin da ake kira mafi girma da kuma mafi kyawun shirye-shirye a duniya don saka idanu kan mutane don gano cutar da ke dauke da cutar da ke keɓe masu kamuwa da ita, da kuma bin diddigin waɗanda suka kamu da cutar da keɓewa.
Hanyar yin gwajin fuska, wanda ya haɗa da bayar da rahoton bayyanar cututtuka na mutum ga waɗanda suka zo daga ƙasashen waje kwanan nan ta hanyar aikace-aikacen wayar hannu, gwajin ƙwayoyin cuta tare da sakamako a rana mai zuwa, da haɓaka ƙwarewar gwajin, wanda ke ba mutane damar yin gwajin 20,000 a kowace rana.
An yi la'akari da shirin Koriya ta Kudu na cin nasara wajen sarrafa fashewar duk da rashin tabbacin birnin. Jama'ar Koriya ta Kudu sun rabu game da yadda Shugaba Moon Jae-in ya amsa wannan matsalar.
Yawancin 'yan Koriya sun yi rajistar takardun da ke da zaɓuɓɓuka biyu, kamar su zargi Moon game da abin da suka ce gwamnatin ta yi da rashin adalci game da magance cutar ko kuma ya yaba masa don magance ta.
A ranar 23 ga watan Maris, an ruwaito cewa Koriya ta Kudu tana da mafi karancin adadin masu cutar a kowace rana idan aka kwatanta da kowace rana na makonni hudu da suka gabata.
A ranar 29 ga watan Maris, an ruwaito cewa daga 1 ga Afrilu, duk sababbin masu zuwa daga kasashen waje za a tilasta musu keɓewa na makonni biyu.
A cewar wani rahoto na kafofin watsa labarai a ranar 1 ga watan Afrilu, Koriya ta Kudu ta karbi takardun tallafi na gwaji daga kasashe daban-daban 121.
Iran ta ba da rahoton wani sabon kamuwa da cutar SARS-CoV-2 da aka fara tabbatarwa a ranar 19 ga Fabrairu a Qom, inda mutane biyu suka mutu, a cewar ma'aikatar kiwon lafiya da ilimin likitanci.
Matakan da gwamnatin ta sanar sun hada da soke kide kide da sauran al'adu, wasanni da kuma bukukuwa, ranar Juma'a da kuma rufe jami'o'i, manyan makarantu da makarantu.
Iran ta ba da dala tiriliyan biyar don yaki da cutar.
Shugaban kasar Hassan Rouhani ya ce a ranar 26 ga watan Fabrairun 2020 babu wani shiri na ware yankunan da cutar ta shafa, kuma an ware mutane ne kawai.
An sanar da shirin da za a yi na karfafa zirga-zirga daga gari zuwa gari a watan Maris, duk da cewa ana ci gaba da samun karin zirga-zirga daga gari zuwa gari kafin bikin sabuwar shekara na mutanen Biritaniya.
Masallacin Shia a Qom ya ci gaba da budewa masu aikin jinya har zuwa 16 ga Maris, 2020. Iran ta zama cibiyar kamuwa da cutar bayan China a watan Fabrairu.
A game da ikirarin rufewa, fiye da kasashe goma sun biye da su zuwa Iran a ranar 28 ga Fabrairu, wanda ya nuna cewa yanayin barkewar cutar na iya zama mafi tsanani fiye da 388 da gwamnatin Iran ta ruwaito a wannan lokacin.
Majalisar dokokin Iran ta rufe, tare da mambobi 23 daga cikin 290 da aka ruwaito sun yi gwajin cutar a ranar 3 ga Maris.
A ranar 12 ga watan Maris, kungiyar kare hakkin bil adama ta bukaci hukumomin gidan yari na Iran da su saki masu kare hakkin bil adama da ake tsare da su da gangan da ke nuna rashin amincewa da zanga-zangar lumana, sannan su sake masu zaman kansu da ke da dukkan hakkoki.
An ce cutar tana da haɗari sosai a cikin kamuwa da cutar a cikin cibiyoyin da aka rufe kamar cibiyoyin tsare mutane, inda kuma rashin kulawar lafiya ke kasancewa.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana, wanda ya kasance mafi girma a kasar tun lokacin da cutar ta fara.
Akalla 'yan siyasa da jami'an gwamnati 12 na Iran sun mutu daga cutar a ranar 17 ga watan Maris.
A ranar 23 ga watan Maris, Iran ta samu sabbin mutane 50 a kowace awa, kuma ta samu wani sabon mutuwar a cikin minti 10 sakamakon cutar.
A cewar jami'an Hukumar Lafiya ta Duniya (WHO), a Iran akwai yiwuwar samun adadin mutane biyar fiye da yadda aka ruwaito.
Ya kuma nuna cewa takunkumin da Amurka ta dauka a Turai zai iya shafar karfin tattalin arzikin kasar wajen magance cutar.
Babban jami'in Majalisar Dinkin Duniya mai kula da haƙƙin ɗan adam ya bukaci a yi wa kasashen da cutar ta shafa tanadin takunkumi, ciki har da Iran.
An tabbatar da barkewar cutar ta bazu zuwa Italiya a ranar 31 ga Janairu lokacin da wasu baƙi na kasar Sin suka gwada cutar SARS-CoV-2 a Rome.
A sakamakon haka, gwamnatin Italiya ta dakatar da dukkan jiragen da ke zuwa da kuma fitowa daga kasar Sin, kuma ta sanar da dokar ta baci.
An gano wasu shari'o'i marasa alaƙa na COVID-19 daga baya, farawa da shari'o'i 16 a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, majalisar dattijai ta sanar da sabon umarni don hana barkewar cutar, gami da tsare mutane sama da 50,000 daga garuruwa daban-daban 11 a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce a yankunan da cutar ta kamu, ba za a ba da izinin shiga da fita ba.
A ranar 4 ga watan Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar, inda aka kashe mutane 100.
Duk manyan wasanni, ciki har da wasan kwallon kafa na Serie A, an yi su ba tare da masu sauraro ba har zuwa watan Afrilu, amma a ranar 9 ga Maris, an dakatar da duk wasanni gaba ɗaya na akalla wata guda.
A ranar 11 ga watan Maris, Firayim Minista Conte ya ba da umarnin dakatar da duk ayyukan kasuwanci sai dai kantuna da asibitoci. A ranar 6 ga watan Maris, Cibiyar Nazarin Magunguna, Ceto da Kulawa ta Italiya (SIAARTI) ta fitar da jagorar ka'idojin kiwon lafiya dangane da bikin zabar marasa lafiya da za a iya magance su.
A ranar 19 ga watan Maris, Italiya ta ce kasar Sin ce ta fi yawan mutanen da suka mutu sakamakon kamuwa da cutar a duniya bayan mutuwar 3,405 sakamakon annobar.
A ranar 22 ga watan Maris, an ruwaito cewa Rasha ta tura jiragen saman soja tara tare da kayan aikin likita zuwa Italiya.
A ranar 5 ga Afrilu, an sami mutane 128,948 da suka kamu da cutar, 15,887 sun mutu, kuma 21,815 sun warke a Italiya, yawancin lokuta a cikin Lombardy.
Rahotanni daga CNN sun nuna cewa yawan adadin tsofaffi da kuma rashin iyawar gwajin marasa lafiya har zuwa yanzu na iya zama babban dalilin rashin mutuwa.
Amsar da Birtaniya ta bayar game da cutar ta kasance daya daga cikin mafi yawan kasashen da aka yi wa cuta, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta gabatar da wani nau'i na tsare-tsaren zamantakewar jama'a ko matakan tilasta wa manyan 'yan kasar su ware kansu ba.
A sakamakon haka, an soki gwamnati saboda rashin daidaito da kuma yadda take amsa tambayoyin da jama'a ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar da ke ba da shawarar kauce wa duk wani tafiya da zamantakewar da ba ta da muhimmanci, da kuma ba da shawara ga mutane su yi aiki daga gida idan ya yiwu, da kuma kauce wa wurare kamar shagunan giya, gidajen cin abinci da gidajen wasan kwaikwayo.
A ranar 20 ga watan Maris, gwamnatin kasar ta sanar da cewa duk wuraren shakatawa kamar shaguna da wuraren motsa jiki su zama wuri-wuri, kuma ta yi alkawarin biyan ma'aikata albashi har zuwa kashi 80 cikin dari zuwa takamaiman £ 2500 a wata don hana rashin aikin yi a lokacin rikicin. A ranar 23 ga watan Maris, Firayim Minista ya sanar da tsaurara matakan keɓewar jama'a, ta haramta tarurruka fiye da biyu, da kuma hana tafiye-tafiye da kuma fita daga gidajen da ake ganin wajibi ne.
Ba kamar matakan da suka gabata ba, an ƙarfafa wannan matakin ta hanyar sanar da takunkumi da kuma soke taron.
"An umarci rufe yawancin kasuwancin sai dai waɗanda aka ɗauka ""daidaitacce"" ciki har da shagunan sayar da kayayyaki, kantunan magani, bankuna, shagunan kwamfuta, tashoshin mai da tashoshin jiragen ruwa".
A ranar 20 ga Janairu, an fara tabbatar da wani hali na COVID-19 a jihar Washington ta Pacific Northwest, wanda ya faru da wani mutum da ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa rundunar yaki da cutar korona ta fadar White House a ranar 29 ga watan Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta sanar da dokar ta baci ta kiwon lafiya ga jama'a kuma ta takaita shigar da matafiya daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka, cibiyar kula da lafiyar jama'a ta gwamnatin Amurka ta sanar da cewa sun kirkiro kayan aikin gwaji na kansu.
Duk da haka, Amurka ta yi jinkirin farawa a cikin gwajin da ya ɓoye ainihin yanayin fashewar a lokacin.
Gwajin ya lalace saboda kayan aikin gwajin cututtuka da gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewar gwamnatin tarayya ga kayan aikin gwajin ba na gwamnati ba (ta hanyar jami'an majalisa, kamfanoni da asibitoci) har zuwa karshen Fabrairu, da kuma yanayin da ya dace don mutanen da suka isa su yi gwaji har zuwa farkon Maris (an buƙaci umarnin likita bayan haka).
A ranar 27 ga Fabrairu, jaridar The Washington Post ta ruwaito cewa an yi gwaji kasa da 4,000 a Amurka.
A ranar 13 ga watan Maris, yankin Atlantic ya ba da rahoton cewa an yi gwajin gwaji sama da 14,000.
A ranar 22 ga watan Maris, Associated Press ta ruwaito cewa: "Mutane da dama suna da alamun cutar, kuma likitoci suna jira na sa'o'i ko kwanaki don yin gwaji. Bayan an samu mutuwar farko a Amurka a Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya sanar da dokar ta baci, kuma sauran jihohi sun yi aiki nan da nan.
Makarantun yankin Seattle sun soke aji a ranar 3 ga Maris, kuma a tsakiyar watan Maris, makarantu a duk faɗin ƙasar sun rufe. A ranar 6 ga Maris, 2020, an shawarci Amurka ta yi kimantawa game da tasirin sabon coronavirus a cikin ƙasar ta hanyar ƙungiyar ƙwararrun masanan cututtuka a Imperial College London.
A wannan ranar, Shugaba Trump ya sanya hannu kan Dokar Karfafawa da Karfafawa da kuma Shirye-shiryen Korona, wanda ya ba da dala biliyan 8.3 na kudade ga hukumar tarayya don magance barkewar cutar.
Kasuwanci sun sanya takunkumin hana masu aiki tafiya, sun soke tarurruka, kuma sun ƙarfafa masu aiki su yi aiki daga gida.
A ranar 11 ga watan Maris, Trump ya sanar da cewa za a dakatar da tafiye-tafiye na Turai da yawa, ba tare da Birtaniya ba, na tsawon kwanaki 30 da za su yi tasiri na minti 13.
A rana ta gaba, ya faɗaɗa takunkumin don ya haɗa da Burtaniya da Ireland.
A ranar 13 ga watan Maris, ya sanar da dokar ta baci ta kasa, wanda ya sa kudaden tarayya suka iya magance matsalar.
Farawa a ranar 15 ga Maris, yawancin kasuwancin sun rufe ko rage lokutan aiki a duk faɗin Amurka don ƙoƙarin rage yaduwar cutar.
A ranar 17 ga Maris, an tabbatar da cutar a duk jihohi 50 da kuma District of Columbia. A ranar 23 ga Maris, an ruwaito cewa New York ta sami adadin mutane 10,700 da suka kamu da cutar fiye da yadda aka samu a Koriya ta Kudu.
A ranar 25 ga watan Maris, magajin garin ya ce, ana ganin an samu ci gaba da gudanar da bincike kan al'amuran jama'a yayin da ake ganin an rage yawan wadanda suka kamu da cutar daga kwanaki 2.0 zuwa kwanaki 4.7.
A ranar 28 ga watan Maris, a birnin New York, an tabbatar da cewa akwai mutane 32,308 da suka kamu da cutar, kuma mutane 672 sun mutu saboda cutar. A ranar 26 ga watan Maris, an tabbatar da cewa Amurka ta kasance mafi yawan mutanen da suka kamu da cutar a duniya, tare da China da Italiya. A ranar 8 ga Afrilu, Amurka ta samu mutane 400,335 da suka kamu da cutar, kuma mutane 12,841 sun mutu.
A cewar rahotanni na kafofin watsa labarai a ranar 30 ga Maris, Shugaba Trump ya yanke shawarar tsawaita ka'idodin ka'idojin zamantakewar jama'a har zuwa 30 ga Afrilu.
A ranar da ta gabata, jirgin ruwa na USNS Comfort, wanda ke da asibiti a kan jirgin ruwa mai dakuna kusan 1,000, ya sauka a New York.
A ranar 3 ga watan Afrilu, Amurka ta samu mutuwar mutane 884 sakamakon cutar coronavirus a cikin awanni 24.
A jihar New York, an kai mutane sama da 100,000 a ranar 3 ga Afrilu. An soki fadar White House saboda ta yi ta lura da barazanar da kuma gudanar da saƙonnin da jami'an lafiya da masana kimiyya suka yi ta shirya jawabai ga jama'a da kuma gabatar da jawabai game da cutar tare da mataimakin shugaban kasa Mike Pence.
An rarrabe yarda da tsarin Trump game da rikicin a cikin layi na 'yan adawa.
Jami'an Amurka da wasu masana sun soki Amurka da ta dogara da shigo da manyan kayayyaki, gami da kayayyakin kiwon lafiya masu mahimmanci daga China.
Ana amfani da nazarin samfurin tafiya ta iska don taswirar da kuma duba samfurin yaduwar, kuma an buga shi a cikin mujallar asibitin yawon bude ido a tsakiyar Janairu 2020.
Bisa ga bayanan 2018 daga kungiyar sufuri ta kasa da kasa, birnin Beijing, Hong Kong, Tokyo da Taipei sun fi yawan matafiya daga Wuhan.
An kuma ba da rahoton cewa Dubai, Sydney da Melbourne sun zama wuraren da aka fi so ga masu tafiya daga Wuhan.
An ruwaito cewa Bali ce mafi ƙarancin yiwuwar daga cikin 20 mafi yawan biranen da aka fi so a cikin shirye-shirye, yayin da biranen Ostiraliya ke da mafi yawan nasara. Ostiraliya ta fitar da shirin gaggawa na gaggawa don sabon annobar coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Sanarwar ta ce, yawancin shari'o'in COVID-19 ba a gano su ba tukuna, kuma Ostiraliya za ta mai da hankali kan kula da sadarwa a kan iyaka, a matsayin martani ga annobar.
A ranar 21 ga Maris, an sanar da dokar ta baci ta mutum a Australia.
Ta hanyar ingantaccen tsarin sufuri na jama'a a Wuhan da Hubei, kasashe da dama sun yi shirin kwashe mazauninsu da jami'an diflomasiyya daga yankin, galibi ta hanyar jiragen sama na ƙasar mai masaukin baki, tare da izinin da hukumomin kasar Sin suka bayar.
Kasashen Kanada, Amurka, Japan, Indiya, Chile, Ostiraliya, Faransa, Argentina, Jamus da Thailand na cikin kasashe na farko da suka yi shirin kwashe 'yan kasarsu.
Pakistan ta ce ba za ta fitar da 'yan kasar daga kasar Sin ba.
A ranar 7 ga watan Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko kuma danginsu, tare da wasu 'yan Poland hudu, Sin da Indiya.
'Yan kasar Poland, China da Indiya sun sauka daga jirgin a Poland, inda jirgin Brazil ya tashi kafin ya tashi zuwa Brazil.
An ware 'yan Brazil da suka je Wuhan a wani sansanin soja kusa da Brasília.
A wannan ranar, an kwashe 'yan Kanada 215 (176 daga jirgin farko da 39 daga jirgin na biyu da gwamnatin Amurka ta shirya) daga Wuhan zuwa tashar CFB Trento don keɓe su na makonni biyu.
A ranar 11 ga Fabrairu, wani jirgin sama mai dauke da 'yan Kanada 185 daga Wuhan ya sauka a tashar jiragen sama ta CFB Trenton.
Hukumomin Australia sun kwashe mutane 277 a ranar 3 da 4 ga Fabrairu zuwa gidan kurkuku na Christmas Island, wanda aka sauya zuwa wurin sake yin takardar shaidar, inda za su zauna har kwana 14.
Jirgin ruwan ya isa Auckland a ranar 5 ga Fabrairu. An ware fasinjojinsa (ciki har da wasu daga Australia da Pacific) a wani sansanin soja a Whangaparoa, arewacin Auckland.
A ranar 15 ga Fabrairu, Amurka ta sanar da cewa za ta yi aikin kwashe 'yan Amurka a kan jirgin Diamond Princess.
A ranar 21 ga Fabrairu, wani jirgin sama ya ɗauki fasinjoji 129 na Kanada da aka kwashe daga jirgin Diamond Princess wanda ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasar daga Iran. A ranar 14 ga watan Maris, wani jirgin saman jirgin saman South African Airlines wanda gwamnatin Afirka ta Kudu ta yi aiki da shi ya kai 'yan kasar 112 gudun hijira.
An yi gwajin lafiyar kafin tashi, kuma an bar 'yan Afirka ta Kudu hudu da ke nuna alamun cutar don rage haɗarin.
Sai dai 'yan Afirka ta Kudu da suka yi gwajin rashin lafiya ne kawai suka yi aikin juyin juya hali.
Sakamakon gwajin ya kawar da dukkan 'yan Afirka ta Kudu, ciki har da' yan iska, ma'aikatan dakin karatu, 'yan sanda, da sojoji da suka shiga aikin agaji, wanda shine matakin hana su, duk suna karkashin bincike kuma ba tare da sun hada da kwanaki 14 a sansanin radadi ba.
A ranar 20 ga watan Maris, Amurka ta fara janye wasu sojojinta daga Iraki saboda yaduwar annobar.
A ranar 5 ga watan Fabrairu, ma'aikatar harkokin wajen kasar Sin ta tabbatar da cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da tallafi ga kasar Sin.
Wasu daliban kasar Sin a jami'ar Amurka sun hada kai don taimakawa wajen mika tallafi ga sassan da suka kamu da cutar a kasar Sin, tare da wani rukuni na abokan hulɗa a yankin Chicago da ke bayar da rahoton cewa sun aika da N95 masu nauyin 50,000 zuwa asibitoci a Hubei Province a ranar 30 ga Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun ba da kyautar dala miliyan 100 ga Hukumar Lafiya ta Duniya don tallafawa bincike kan alluran rigakafi da magani, tare da kare rayukan da ke cikin haɗari a Afirka da Kudancin Asiya.
Kamfanin Interaksyon ya ruwaito cewa gwamnatin kasar Sin ta bai wa kasar ta Philippines kayan ado 200,000 a ranar 6 ga watan Fabrairu, bayan da Sanata Richard Gordon ya tura kayan ado miliyan 3.16 zuwa birnin Wuhan.
A ranar 19 ga watan Fabrairu, Kamfanin Red Bull ya sanar da cewa za su tura tallafin dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da kayan masarufi miliyan daya ga Wuhan, kasar Sin ta tura kayan aikin likita da yawa, Rasha ta tura kayan aikin likita tan 13 zuwa Wuhan, Malaysia ta ba da kyautar kayan hannu na likita miliyan 18 ga China, Armenia ta ba da kayan aikin likita da suka hada da kayan ado na likita 10,000, kuma Amurka ta ba da tan 17.8 na kayan aikin likita, kuma ta yi alkawarin ba da ruwa ga wasu kasashe 100 da ke da cutar ta kamuwa da cuta don tallafawa kasar Sin.
A watan Maris, kasar Sin, Cuba da Rasha sun tura kayayyaki da kwararrun likitoci don taimakawa Italiya wajen magance barkewar cutar.
Jack Ma ya tura kayan gwaji miliyan 1.1 da fuska miliyan 6 da kuma rigakafi 60,000 zuwa Addis Ababa, Habasha don rarraba ta Afirka.
Daga nan sai ya tura kayan gwaji 5,000, kayan masarufi 100,000 da kuma jiragen sama 5 zuwa Panama.
Ma'aikatar ta kuma ba da gudummawar kayan aikin likita ga Kanada. Netherlands, Spain, Turkiyya, Kyrgyzstan da Jamhuriyar Sin sun nuna damuwa game da allunan gwaji da kayan aikin gwaji da ke samar da Sin.
Alal misali, Spain ta cire kayan gwajin cutar coronavirus 58,000 da kasar Sin ta kera, wanda ke da kashi 30 cikin 100 na amincinsa, yayin da Netherlands ta karɓi kayan masarufin China 600,000.
Belgium ta tattara kayan kwalliya 100,000 da ba a sake amfani da su ba, wanda ake zaton an shigo da su daga China, amma a zahiri an shigo da su daga Colombia.
A gefe guda, tallafin da kasar Sin ke bayarwa ya samu karbuwa a wasu sassan Latin Amurka da Afirka. A ranar 2 ga watan Afrilu, Bankin Duniya ya kaddamar da aikin gaggawa na tallafawa kasashe masu tasowa.
Hukumar lafiya ta duniya ta yaba da kokarin da gwamnatin kasar Sin ke yi na sarrafa da kuma hana annobar.
Hukumar lafiya ta duniya (WHO) ta lura da bambancin da ke tsakanin barkewar cutar SARS a 2002-2004, inda hukumomin kasar Sin suka zargi ɓoye ɓoye ɓoye da suka hana rigakafi da kokarin sarrafa halin da ake ciki, da kuma rikicin da ke faruwa a yanzu inda gwamnatin kasar ta ba da damar sabuntawa don hana rikice-rikice kafin bikin shiga kasar Sin.
A ranar 23 ga watan Janairu, a cikin martani ga shawarar da hukumar tsakiya ta yanke game da aiwatar da dokar hana zirga-zirga a Wuhan, wakilin WHO Gauden Galea ya lura cewa yayin da ba shawarar da WHO ta bayar ba ce, amma kuma muhimmin nunawa ne na sadaukarwa don magance cutar a wuraren da cutar ta fi taruwa, kuma ya kira cutar cutar "ba a taɓa gani ba a tarihin lafiyar jama'a". A ranar 30 ga Janairu, bayan an tabbatar da cewa an yi kamuwa da cutar daga mutane zuwa mutane a waje da China da kuma karuwar wannan adadin a wasu ƙasashe biyar, WHO ta bayyana wannan annobar a matsayin farkon annobar cutar ta duniya ta farko da za a iya amfani da ita a lokacin da ake kira ICES (PICES).
Babban daraktan Hukumar Lafiya ta Duniya, Tedros Adhanom, ya ce, PHEIC na da haɗarin yaduwa a duniya, musamman ga ƙasashe masu karamin da matsakaitan kudade, ba tare da ingantaccen tsarin kiwon lafiya ba.
"A cikin martani ga aiwatar da takunkumin tafiye-tafiye, Tedros ya bayyana cewa ""babu wani dalili ga matakan da za su hana ba dole ba tafiya da cinikayya ta kasa da kasa"" kuma ""World Health Organization ba ta bada shawarar yin iyakance cinikayya da ƙaura""".
"A ranar 5 ga watan Fabrairu, Hukumar Lafiya ta Duniya ta yi kira ga al'umma ta duniya da ta ba da gudummawar dala miliyan 675 don samar da kudade don shirye-shiryen dabaru a cikin ƙasashen da ke da ƙananan kuɗaɗe, ta ba da shawarar gaggawa don tallafawa waɗancan ƙasashen da ba su da tsarin gano mutanen da suka kamu da cutar, duk da cewa an yi ta".
"Tedros ya kara da cewa, ""dukan al'ummai idan akwai matalauta, suna da daidaito ga matalauta"" kuma ya bukaci al'ummar kasa da kasa da "kasuwanci a yau ba zai rasa fiye da haka ba a nan gaba". A wani taron manema labarai a ranar 11 ga Fabrairu, Hukumar Lafiya ta Duniya ta kira cutar COVID-19".
A ranar da Tedros ya tabbatar da cewa Sakataren Majalisar Dinkin Duniya António Guterres ya amince da bai wa dukkan tsarin Majalisar Dinkin Duniya ikon amsawa.
"An kafa ƙungiyoyin kula da rikicin Majalisar Dinkin Duniya, wanda hakan ya ba da damar daidaita ayyukan Majalisar Dinkin Duniya gaba ɗaya, wanda Hukumar Lafiya ta Duniya za ta ba su damar mai da hankali kan aikin lafiya yayin da sauran hukumomi za su iya kawo ƙwarewarsu don tallafawa tattalin arzikin zamantakewa da tasirin ci gaban barkewar cutar".
A ranar 14 ga watan Fabrairu, an kafa wata kungiya ta WHO tare da kasar Sin don samar da kwararrun masana na duniya da WHO na halin da ake ciki a kasar Sin don taimakawa wajen sarrafa cututtukan na gida da kuma tantance yadda cutar take da tsanani da kuma yiwuwar kamuwa da cutar ta hanyar kafa bita da taro tare da manyan cibiyoyin matakin kasa da kuma gudanar da ziyara ta musamman don fahimtar tasirin matakan amsawa a larduna da yankuna, gami da wuraren da ake da cutar. A ranar 25 ga watan Fabrairu, WHO ta sanar da cewa ya kamata a dauki matakan da yawa don shirya wa kasashen da ke fama da cutar, wanda ta dauki matakin da ya dace a lokacin da ake kira a matsayin matakin da ya dace na kamuwa da cutar.
Don amsawa ga yaduwar barkewar cutar a Iran, Hukumar Lafiya ta Duniya ta tura wata kungiya ta musamman a wurin don tantance halin da ake ciki. A ranar 28 ga Fabrairu, jami'an Hukumar Lafiya ta Duniya sun ce za a kara yawan darajar barazanar cutar ta coronavirus a duniya daga  zuwa , wanda shine matakin mafi girma na kulawa da kimantawa.
Mike Ryan, darektan shirin gaggawa na WHO ya yi magana a cikin wata sanarwa cewa wannan wani abu ne mai ban mamaki ga gwamnatocin duniya: "Ku tashi".
"Wannan kwayar cutar tana iya zuwa, don haka dole ne ku kasance a shirye, kuna mai da hankali cewa matakan da suka dace na iya taimaka wa duniya ta guji mummunan sakamako".
"Ryan ya kara da cewa, ba a tabbatar da bayanan da ke nan ba don jami'an lafiya na jama'a su sanar da yaduwar annobar a duniya, yana mai cewa, irin wannan sanarwar za ta nufin ""mun amince da cewa kowa a duniya zai kamu da cutar""".
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya ta sanar da barkewar annobar coronavirus.
Babban daraktan ya ce WHO ta damu sosai saboda matakin gaggawa na yaduwar cutar da kuma yadda gaggawa da gaggawa na rashin tsaro suke. WHO ta fuskanci sukar da yawa saboda abin da ake ganin babu isasshen maganin cutar, gami da tsauraran sanarwar gaggawa ga lafiyar jama'a da kuma sanya cutar a matsayin annobar.
Amsar ta hada da wata takarda ga Tedros Adhanom, babban darektan Hukumar Lafiya ta Duniya, don neman ya yi murabus daga mukaminsa, wanda mutane 733,000 suka sanya hannu a ranar 6 ga Afrilu.
A ranar 26 ga Maris, 2020, da dama daga cikin masana kare hakkin bil adama na Majalisar Dinkin Duniya sun jaddada girmama hakkin mutum a lokacin annobar COVID-19.
Masana sun ce kowa yana da hakkin ya yi amfani da taimakon da zai iya ceton rayuka, kuma gwamnati ce ke da alhakin hakan.
Kungiyar ta jaddada cewa, rashin albarkatu ko inshorar lafiya ba za a iya la'akari da shi a matsayin wata hanyar nuna bambanci ga wani rukuni ba.
Kwararru sun tabbatar da cewa kowa yana da hakkin samun lafiya, ciki har da nakasassu da ke cikin ƙananan al'umma, tsofaffi, waɗanda aka tilasta musu su ƙaura zuwa kan iyaka, marasa gida da ke zaune cikin yanayi mai wuya, waɗanda ke cikin fursuna, da 'yan gudun hijira da sauran kungiyoyin mutane marasa takaddun shaida waɗanda ke buƙatar taimakon gwamnati.
Kungiyar ta kasa da kasa na magance tasirin tattalin arziki da zamantakewar al'umma na annobar COVID-19.
Kungiyar hadin gwiwa da ci gaban tattalin arziki ta kirkiro wata hanyar samar da bayanai masu dacewa da zurfi game da martani ga manufofin kasashen duniya, da ra'ayoyi da shawarwari.
Ta hanyar karfafa manufofin kiwon lafiya da tattalin arzikin duniya don magance tasirin kullewa da iyakancewar tafiya, cibiyar ta dijital ta haɗa da shirin bin manufofin ƙasa da nufin taimaka wa ƙasashe su koya daga juna da kuma taimakawa cikin daidaitaccen amsawa ga matsalolin cutar coronavirus.
Gwamnatin kasar Sin ta fuskanci sukar Amurka, tsohon ministan harkokin wajen kasar Michael Gove da Eduardo Bolsonaro, dan shugaban kasar Brazil Jair Bolsonaro, kan yadda suka magance annobar, wanda ya fara ne a lardin Hubei, kasar Sin.
An dakatar da wasu gwamnatocin larduna na jam'iyyar kwaminis ta kasar Sin (CPC) saboda yadda suke magance kokarin yin takardun shaida a yankin tsakiyar kasar Sin, wanda ya nuna rashin jin dadin yadda siyasa ta amsa barkewar cutar a cikin wadannan yankuna.
Wasu masu sharhi sun yi imanin cewa wannan matakin na nufin kare kwamishinan jam'iyyar kwaminis ta kasar Sin, Xi Jinping daga fushin jama'a game da barkewar cutar.
Wasu jami'an kasar Sin kamar Zhao Lijian sun yi watsi da amincewar da aka yi da barkewar cutar a Wuhan, amma sun goyi bayan ka'idar da ke nuna cewa cutar COVID-19 ta fito ne daga Amurka ko Italiya.
Gwamnatin Amurka karkashin Donald Trump ta kira coronavirus cutar Sin ko Wuhan, inda ta ce, rufewar kasar Sin kan cutar, wadda yanzu ta zama annoba a duniya, an soki irin wannan maganar ne saboda nuna wariyar launin fata da kuma kusantar da gwamnatin ta gaza wajen hana cutar.
Jaridar The Daily Beast ta karbi siginar sadarwa ta gwamnatin Amurka da ke nuna cewa akwai wata dabara ta sadarwa da ta samo asali a cikin Majalisar Tsaro ta Kasa, da aka yi amfani da ita a matsayin "duk abin da ke game da China".
Ya kuma ce ya kamata mu yi kokarin tura wannan sakon ta kowace hanya da za mu iya, ciki har da taron manema labarai da kuma fitowar ta talabijin. Jaridu kamar Politico, Foreign Policy da Bloomberg sun yi ikirarin cewa kokarin da kasar Sin ke yi na tura tallafi ga kasashen da ke fama da cutar wani bangare ne na kokarin neman samun karfin duniya.
"Shugaban siyasar kasashen waje na EU Josep Borrell ya yi aiki don tunatar da cewa akwai dalilai na siyasa na geography, ciki har da wahalar samun tasiri ta hanyar sauyawa da 'yancin kai' siyasa".
Borrel ya ce ba kamar Amurka ba, kasar Sin ta yi ta yada labarai sosai cewa ita ce ta zama mai laifi kuma tana da amintaccen abokin tarayya.
China ta kuma yi kira ga Amurka ta janye takunkunta daga Siriya, Venezuela da Iran, yayin da ake zargin ta tura tallafi ga kasashen biyu.
An haramta kyautar Jack Ma na kayan kwalliya 100,000 ga Cuba ta hanyar takunkumin Amurka a ranar 3 ga Afrilu.
An kuma zargi hukumomin Amurka da yin amfani da taimakon da aka bar wa wasu ƙasashe don amfani da kansu.
An kuma ruwaito rikice-rikice game da masassa tsakanin wasu kasashe kamar Jamus, Austria, Switzerland, Czech Republic da Italiya.
Bugu da ƙari, Turkiyya ta kama ɗaruruwan injunan iska da ke zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin haɗin kai na Tarayyar Turai da Italiya da ke fama da cutar coronavirus.
A cewar Maurizio Massari, jakadan Italiya a kungiyar Tarayyar Turai, kasar Sin ce kawai ta amsa da juna.
Wannan ba alama ce mai kyau na haɗin kai na Turai ba.
A ranar 22 ga watan Maris, bayan tattaunawa ta waya da Firayim Ministan Italiya Giuseppe Conte, shugaban Rasha Vladimir Putin ya umarci sojojin Rasha da su tura likitocin soja, jiragen sama, magungunan kashe kwayoyin cuta na musamman da sauran kayan aikin likita zuwa Italiya.
Jaridar La Stampa ta Italiya ta yi ƙaulin wani sanarwa daga wata majiya mai suna Senior Politics, inda ta ce kashi 80 cikin dari na taimakon da Rasha ke bayarwa ba shi da amfani ko kuma yana da amfani ga Italiya.
Majiyar ta zargi Rasha da kaddamar da harin da ya shafi ilimin geography da siyasa da kuma diplomasiyya.
Shugaban Lombardy Attilio Fontana da Ministan Harkokin Wajen Luigi Di Maio sun musanta rahoton kafofin watsa labarai da kuma nuna godiyarsu.
Rasha ta kuma tura wani jirgin sama mai dauke da kayan aikin likita zuwa Amurka.
"Maganar majalisar Dmitry Peskov ya ce ""a lokacin da yake ba da tallafi ga 'yan sandan Amurka [Putin] ya yi zaton cewa idan kamfanonin samar da kayayyakin magani da kayan aikin Amurka suka yi gaggawa, za su iya samun sakamako idan sun cancanta""".
A yakin basasa na NATO na 2020 da aka shirya a Jamus, Poland da Baltic, wanda shine yakin basasa mafi girma tun bayan ƙarshen Cold War, za a yi shi a cikin ƙananan matakan.
Sakataren yakin neman kawar da makaman nukiliya, Kate Hudson, ta soki yakin kare hakkin 2020: "A cikin rikicin lafiyar jama'a na yanzu, yana barazana ga rayuwar ba kawai sojojin Amurka da kasashen Turai da ke shiga ba, har ma da mutanen kasashen da suke aiki. Gwamnatin Iran ta yi fama da cutar, tare da kusan 'yan majalisa hudu da suka kamu da cutar, da kuma tsoffin' yan siyasa da kuma wasu 'yan siyasa goma sha biyar.
Shugaban Iran Hassan Rouhani ya rubuta wata wasika ta jama'a ga shugabannin duniya a ranar 14 ga Maris, 2020, yana neman taimako, yana mai cewa kasarsa tana fuskantar matsaloli wajen yaki da yaduwar cutar saboda rashin samun dama ga kasuwannin duniya sakamakon takunkumin Amurka a kan Iran. Yaduwar cutar ta sa Amurka ta dauki gaggawa wajen yanke muhimman shawarwari kan aiwatar da ka'idojin zamantakewa da aka saba amfani da su a wasu kasashen, ciki har da tsarin kula da lafiya, kula da lafiyar yara, da kuma sanya dokoki kan iyalan da ke da albashi mai yawa da kuma bayar da kudade ga jama'a.
Masu sharhi kan siyasa sun yi tsammanin hakan zai iya shafar damar Donald Trump na sake zabar shugaban kasa a zaben shugaban kasa na 2020. Dangantakar diplomasiyya tsakanin Japan da Koriya ta Kudu ta yi rauni saboda annobar.
Koriya ta Kudu ta yi ta sukar kokarin da kasar Japan ta yi na ware mutane da ba a bayyana ba, bayan da kasar Japan ta sanar da cewa za a ware kowa daga Koriya ta Kudu na tsawon makonni biyu a wurin da gwamnati ta tsara.
Da farko dai, jama'ar Koriya ta Kudu sun kasance cikin rikici game da yadda Shugaba Moon Jae-in ya amsa wannan matsalar.
Yawancin 'yan Koriya sun sanya hannu kan takardun da suka bukaci a tuhumi Moon game da abin da suka ce ba daidai ba ne ga gwamnatin a kan fashewar ko kuma sun yaba da martani.
Wasu masu sharhi sun nuna damuwa cewa zai iya ba da damar gwamnati ta karfafa ikon su.
A Hungary, majalisa ta amince da firaministan kasar Viktor Orbán ya yi mulki ba tare da iyaka ba, ya jinkirta zaben majalisa, kuma ya hukunta wadanda ake zargi da yada labaran karya game da cutar da kuma magance matsalar gwamnati.
An yi zargin cewa cutar ta korona ta barke ne saboda dalilai da dama, kamar rashin wadata, karuwar amfani da kayan aiki don yaki da cututtuka, cinikin tsoro da matsaloli, zuwa masana'antu da masu sarrafawa, sufuri, da kuma duniya.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargadi game da rashin magani da kayan aikin likita saboda karuwar buƙatun masu amfani da ƙuntatawa ga masu samarwa.
Ƙari ga haka, yankuna da yawa sun ga cinikin kayayyaki da yawa, wanda ya haifar da cinikin kayayyaki masu mahimmanci daga kayan aiki, kamar abinci, takarda, da ruwa mai narkewa, wanda ke haifar da karancin wadata.
An yi gargadin wasu masana'antun fasaha game da jinkirta jigilar kayayyakin lantarki.
A cewar Tedros Adhanom, babban darektan WHO, bukatar kayan kariya ta mutum ta karu sau 100.
Wannan bukatar ta sa an kashe kudin sau biyu na farashin da aka saba yi, kuma hakan ya sa an jinkirta samar da kayayyakin asibiti na tsawon watanni hudu zuwa shida.
Wannan ya haifar da rashin tsaro a duniya, saboda haka, Hukumar Lafiya ta Duniya ta yi gargadin cewa zai zama haɗari ga ma'aikatan kiwon lafiya.
A Ostiraliya, annobar ta ba da sabuwar dama ga masu sayen kayayyaki na yau da kullum su sayar da kayayyakin kasar zuwa China.
Wannan aikin ya haifar da karancin abinci, da kuma abinci, da jarirai a cikin shagunan sayar da kayayyaki, kuma an dakatar da su daga gwamnatin Ostiraliya. Duk da cewa yawan cututtukan COVID-19 ya kasance mai girma a arewa maso gabashin Italiya da yankin Wuhan, kuma bukatar abinci ta ci gaba da ƙaruwa, waɗannan yankuna biyu sun sami ceto daga mummunan rashin abinci.
Kudurin kasar Sin da Italiya na yaki da cinikin kayayyaki da ba bisa ka'ida ba ya ci nasara wajen kauce wa rashin abinci mai gina jiki da ake tsammani a Turai da kuma Arewacin Amirka.
A arewacin Italiya, manyan masana'antun noma ba su ragu sosai ba, amma farashin zai iya tashi, a cewar wakilan masana'antu.
Abincin ya ƙare daga kantunan sayar da kayayyaki na wucin gadi, har ma a Wuhan, yayin da jami'an gwamnatin kasar Sin suka fitar da naman alade don tabbatar da samar da abinci ga jama'a.
Hakazalika, a Italiya, ana da irin wannan dokar da ta bukaci masana'antun abinci su ajiye kayan abinci don irin wannan gaggawa.
An ga lalacewar tattalin arzikin duniya a China: A cewar rahotanni a kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin kasar Sin ya sha wahala sosai a farkon watanni biyu na 2020 saboda matakan da gwamnati ta dauka na rage yaduwar cutar da kuma sayar da kayayyaki. Talla ta ragu da kashi 20.5%.
A kasar Sin, ƙasa tana da mahimmanci ga tattalin arziki da masana'antu, saboda haka an ga barkewar cutar ta kasance babbar barazana ga rashin kwanciyar hankali ga tattalin arzikin duniya.
Agathe Demarais na Economist Intelligence Unit ya yi hasashen cewa kasuwanni za su kasance masu karko har sai an bayyana sakamakon da zai yiwu.
A watan Janairun 2020, wasu manazarta sun kiyasta cewa koma bayan tattalin arziki sakamakon barkewar cutar ta duniya zai iya wucewa barkewar cutar SARS ta 2002-2004.
Wani ƙididdiga daga masana a Jami'ar Washington a St. Louis ya ba da fiye da dala biliyan 300 ga tasirin tasirin samar da kayayyaki na duniya wanda zai iya wuce shekaru biyu.
Kungiyar kasashen da ke fitar da man fetur (OPEC) ta ruwaito cewa akwai rikice-rikice bayan da farashin man fetur ya ragu saboda karancin bukatar kasar Sin.
Kasuwancin jari na duniya ya fadi a ranar 24 ga Fabrairu saboda karuwar annobar COVID-19 a kasashen waje.
A ranar 27 ga watan Fabrairu, saboda damuwa game da barkewar cutar coronavirus, tattaunawar hannun jari a Amurka, ciki har da NASDAQ-100, S&amp;P 500 Index, da Dow Jones Industrial Average, ta ba da rahoton saurin koma baya tun shekara ta 2008, tare da Dow ya faɗi da maki 1,191, wanda shine mafi girma a kowace rana tun lokacin rikicin kudi na 2007-08.
A wannan makon, tattaunawar ta ƙare a kasa da kashi 10 cikin ɗari.
A ranar 28 ga watan Fabrairu, kamfanin Scope Ratings GmbH ya tabbatar da matsayin China na ikon mallaka, amma ya ci gaba da kasancewa da hangen nesa.
Kasuwancin hannun jari ya sake faɗuwa saboda tsoron cutar coronavirus, mafi muni ya faru a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa tattalin arziki zai iya zama abin da ba za a iya gujewa ba.
Masanin tattalin arziki Mohamed El-Erian ya yaba da matakin gaggawa da aka dauka na babban bankin kasar da na jihar.
Babban bankin ya yi aiki da sauri fiye da yadda ya yi a lokacin rikicin kudi na 2008.
Kasuwancin yawon bude ido ya sha wahala mafi muni daga sauran bangarori saboda hanawa, tafiye-tafiye, rufe wuraren jama'a, gami da jan hankalin yawon bude ido da kuma shawarwarin gwamnati game da tafiye-tafiye a duk duniya.
A sakamakon haka, kamfanonin jiragen sama da yawa sun soke jiragen saboda karancin buƙatu, ciki har da British Airways, China Eastern Airlines da Qantas, yayin da kamfanin jirgin sama na yankin Burtaniya Flybe ya fadi.
Tasirin da ake yi a masana'antar jirgin ruwa a cikin jirgin ruwa ya kasance ba a taɓa gani ba.
An kuma rufe tashoshin jirgin kasa da dama da kuma tashoshin jiragen ruwa.
Wannan annoba ta faru ne a daidai lokacin bikin Jun Jun Jun, babban lokacin tafiya da ya shafi hutun shiga shekara ta kasar Sin.
Gwamnatoci da na ƙasa sun soke abubuwa da yawa da suka shafi taron jama'a, gami da bikin sabuwar shekara tare da kamfanoni masu zaman kansu, sun rufe shagunan su da wuraren yawon buɗe ido kamar Disneyland a Hong Kong da Shanghai.
An rufe wasu bukukuwan sabuwar shekara da kuma wuraren yawon bude ido don hana manyan taro, ciki har da Forbidden City a Beijing da kuma bikin alfarma na gargajiya.
A larduna 24 da yankuna 31 na kasar Sin, hukumomi sun kara wa ranar 10 ga watan Fabrairu hutun sabuwar shekara, suna ba da shawarar cewa mafi yawan wuraren aiki ba za su sake buɗewa ba.
Wadannan yankuna suna wakiltar kashi 80 cikin 100 na GDP na kasar da kuma kashi 90 cikin 100 na fitarwa.
Hong Kong ta kara yawan yadda ake amsawa ga annobar kuma ta bayyana dokar ta baci, ta rufe makarantu har zuwa watan Maris kuma ta soke duk bukukuwan shekara ta gaba.
Yawan masu sayar da kayayyaki a Turai da Latin Amurka ya ragu da kashi 40 cikin dari.
Masu sayar da kayayyaki a Arewacin Amirka da Gabas ta Tsakiya sun ga raguwar 50 zuwa 60%.
Wannan kuma ya haifar da raguwar 3343% na zirga-zirgar jiragen sama zuwa kantin sayar da kayayyaki a watan Maris idan aka kwatanta da Fabrairu.
Shugabannin kasuwannin duniya sun fitar da wasu karin matakan kamar karuwar abinci mai gina jiki, shigar da na'urori masu duba zafi don duba yanayin yanayin masu tafiya a kasuwa da kuma kawar da abubuwan da ke faruwa. A cewar kimantawar kwamitin tattalin arzikin Majalisar Dinkin Duniya don Latin Amurka, rikicin da ya haifar da yaduwar annobar zai iya kasancewa tsakanin mutane miliyan 14 da 22 da ke cikin matsanancin talauci a Latin Amurka fiye da a cikin wannan halin ba tare da barkewar cutar ba.
A cikin watan Janairu da Fabrairu na shekarar 2020, a lokacin da annobar ta yi tsanani a birnin Wuhan, kimanin mutane miliyan biyar a kasar Sin sun rasa ayyukansu.
A watan Maris na shekarar 2020, fiye da mutane miliyan 10 na Amurka sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Cutar Corona na iya haifar da asarar ayyuka miliyan 47 a Amurka, kuma yawan marasa aikin yi na iya ƙaruwa zuwa 32%, a cewar hasashen Federal Reserve Bank of St. Louis. Rashin gidaje a Indiya ya sa ma'aikatan Indiya miliyan goma suka rasa aikin su (wanda suke karɓar kuɗin shiga na yau da kullun). Wani bincike daga Cibiyar Angus Reid ya gano cewa iyalai a Kanada sun sami kashi 44% na rashin aikin yi. Kimanin ma'aikata 900,000 a Spain sun rasa ayyukansu tun lokacin da ƙasar ta ba da umarnin zama gida a tsakiyar watan Maris na 2020.
A tsakiyar watan Maris, ma'aikata miliyan 4 na Faransa sun nemi amfanin rashin aikin wucin gadi, kuma ma'aikata miliyan 1 na Burtaniya sun nemi amfanin bashi na duniya. Kimanin rabin miliyan a Jamus sun tura ma'aikatansu cikin shirin aiki na gajeren lokaci tare da tallafin gwamnati, wanda aka sani da Kurzarbeit.
An amince da shirin aikin ɗan gajeren lokaci na Jamus da Faransa da Ingila.
Masana'antu da al'adu sun sha wahala sosai daga annobar, wanda ya shafi ayyukan ƙungiyoyi da kuma mutane, aiki da 'yanci a duk duniya.
Kungiyoyin fasaha da al'adu sun yi ƙoƙari su inganta manufofin su (sau da yawa ana tallafawa su ta hanyar jama'a) don ba da damar samun kyautar al'adu ga al'umma, kare lafiyar ma'aikatansu da jama'a, da tallafawa masu fasaha kamar yadda zai yiwu.
A watan Maris na shekarar 2020, a duk faɗin duniya da kuma a kowane mataki, gidajen tarihi, dakunan karatu, gidajen wasan kwaikwayo da sauran cibiyoyin al'adu sun rufe gaba daya, saboda an soke ko kuma an jinkirta nune-nunen su, abubuwan da suka faru, da kuma wasan kwaikwayon su.
A sakamakon haka, an yi ƙoƙari sosai wajen samar da madadin sabis ta hanyar dandamali na dijital. A kwanan nan, raguwar cutar ta kasance mai sauri da sauri, tare da soke ayyukan addini, manyan wasanni da abubuwan zamantakewa kamar bukukuwa da bukukuwa, tarurruka na fasaha da kuma nunin motoci.
A lokacin da aka yi bikin, an yi watsi da bikin da ake yi a birnin Roma, wanda ya faru a makon ƙarshe na lokacin bikin Kirista.
Ƙungiyoyin da ke ƙarƙashin shugabanni a cikin addinai da yawa na Kirista sun ba da shawarar dattawa da suka tsufa su zauna a gidajen Kirista maimakon tarurruka a ranar Lahadi. Wasu majami'u suna ba da sabis ta hanyar rediyo, watsa shirye-shiryen kai tsaye ta yanar gizo ko talabijin, yayin da wasu majami'u za su iya yin ibada ta hanyar shiga.
Da aka rufe Roman Catholic Diocese of Rome da ƙananan cocinsa da kuma St. Peter's Square ba tare da wani mai ba da sabis na Kirista ba, sauran cocin sun soke ayyukan ibada ga maigidan, kuma an sanya tarurruka a cikin majami'u, addinai na Islama, majami'u, majami'u, da kuma majami'u na Sikh, da sauransu.
Ma'aikatar lafiya ta Iran ta sanar da soke sallar ranar Juma'a a wasu yankunan da cutar ta yadu da kuma rufe wuraren ibada, yayin da Saudiyya ta haramta masu aikin haikalin kasashen waje shiga kasar, da kuma hana 'yan kasar zuwa wuraren haikalin da ke garin Mekka da Madina.
Cutar ta haifar da babbar matsala ga jadawalin wasanni na duniya tun lokacin yakin duniya na biyu.
Yawancin manyan wasanni an soke ko kuma an dage su, ciki har da gasar zakarun Turai ta 2019-20, gasar zakarun Turai ta 2019-20, gasar zakarun Turai ta 2020, gasar zakarun Turai ta 2019-20 da gasar zakarun Turai ta 2019-20 da gasar zakarun Turai ta 2019-20 da gasar zakarun Turai ta 2019-20 da gasar zakarun Turai ta 2019-20 da gasar zakarun Turai ta 2019-20 da gasar zakarun Turai ta 2019-20 da gasar zakarun Turai ta 2019-20 da gasar zakarun Turai ta 2019-20 da gasar zakarun Turai ta 2019-20 da gasar zakarun Turai ta 2019-20 da gasar zakarun Turai ta 2019-20 da gasar zakarun Turai ta 2019-20 da gasar zakarun Turai ta 2019-20 da gasar zakarun Turai ta 2019-20 da gasar zakarun Turai ta 2019.
A ranar 24 ga watan Maris, Hukumar Olympic ta kasa da kasa ta sanar da cewa za a sake shirya wannan taron bayan shekarar 2020 amma ba da dadewa ba kafin lokacin bazara na 2021. Gidajen caca da sauran wuraren caca a duniya sun rufe, kuma an dage ko kuma an soke wasannin.
Wannan aikin ya sa yawancin masu caca suka koma yin caca ta yanar gizo, tare da shafukan caca na yanar gizo da yawa da ke ba da rahoton ƙaruwa mai ban mamaki a cikin yawan sababbin rajista. An kuma shafi masana'antar nishaɗi ta hanyar ƙungiyoyi daban-daban da suka dakatar ko soke bukukuwa.
Yawancin manyan gidajen wasan kwaikwayo, kamar na Broadway, sun dakatar da duk wasan kwaikwayon.
Wasu masu fasaha sun sami hanyoyin ci gaba da samar da kuma raba aikin ta hanyar Intanet, suna ganin shi a matsayin wani zaɓi maimakon yin wasan kwaikwayo na ainihi, kamar yin wasan kwaikwayo na ainihi ta yanar gizo ko ƙirƙirar wani taro a kan yanar gizo don masu fasaha su nuna, rarraba da kuma nuna ayyukansu.
A cewar wani shafin yanar gizo, batutuwan da ke shafi cutar korona sun bazu sosai, mutane da yawa suna son yin dariya da kuma yin magana a lokacin da ba a san yadda za a yi ba.
Tun bayan barkewar cutar COVID-19, an lura da karuwar nuna bambanci, tsoron baƙi da nuna bambanci tsakanin Sinawa da mutanen da ke fitowa daga Gabashin Asiya da kuma mutanen da ke fitowa daga ƙasashen da ke da yaduwar cutar a Turai, Amurka da sauran ƙasashe.
An lura da abubuwan da ke haifar da tsoro, shakku da damuwa a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amurka da Asiya Pacific.
Rahoton da aka fitar a watan Fabrairu (lokacin da aka samu mafi yawan masu kamuwa da cutar daga kasar Sin) ya nuna cewa an nuna nuna wariya ga jama'ar kasar Sin a fadin duniya cewa sun cancanci kamuwa da cutar ko kuma sun karɓi abin da ake ganin ya zama haraji daga abin da suka aikata.
Wasu ƙasashen Afirka sun kuma ga nuna ƙiyayya game da 'yan kasar Sin.
Mutane da yawa a Wuhan da Hubei sun ruwaito nuna bambanci bisa ga asalin yankin su.
Akwai tallafi ga jama'ar kasar Sin a kan layi da kuma wajen layi, da kuma ga wadanda ke cikin yankin da aka hana su kamuwa da cutar.
Yayin da cutar ta barke a wasu ƙasashe, mutane daga Italiya, wadda ta kasance ƙasa ta farko a Turai da ta fuskanci mummunan kamuwa da COVID-19, sun fara yin shakku da ƙiyayya da baƙi. 'Yan ƙasa a wasu ƙasashe kamar Malaysia, New Zealand, Singapore, da Koriya ta Kudu sun fara yin rajista, suna neman a hana Sinawa shiga ƙasarsu don dakatar da yaduwar cutar.
A Japan, alamar haramcin #Hammas na kasar Sin zuwa Japan tana da matukar tasiri a Twitter.
Kasashen Sin da sauran kasashen Asiya a Birtaniya da Amurka sun ruwaito karuwar yawan cin zarafin nuna wariyar launin fata da cin zarafin.
Shugaban Amurka Donald Trump ya fuskanci zargi da cewa coronavirus shine cutar Sin, kalma da ake ganin ta nuna wariya ga launin fata da kuma adawa da Sinawa.
Masu zanga-zangar a Ukraine sun kai hari kan motocin da ke dauke da 'yan Ukraine da kuma kasashen waje da ke gudun hijira daga yankin Wuhan zuwa Novi Sanzhary.
Dalibai daga yankin Indiya mai nisa, wanda ke da iyaka da China, da dalibai da ke karatu a manyan biranen Indiya sun ruwaito cewa an tsananta musu saboda barkewar cutar.
Shugaban jam'iyyar Bharatiya Janata a jihar West Bengal, Dilip Ghosh, ya ce, kasar Sin ta lalata yanayi, kuma shi ya sa Allah ya yi musu rashawa.
A kasar Sin, tsoron baƙi da nuna bambanci ga waɗanda ba Sinawa ba sun sha wahala daga annobar da ake kira cutar baƙi da ake kira baƙi da kuma ƙazanta.
Yawancin jaridu da suka biya don shiga sun cire wannan takaddar don wasu ko duk wani watsa shirye-shirye da suka shafi cutar coronavirus.
Yawancin wallafe-wallafen kimiyya sun yi amfani da bincike na kimiyya game da cutar.
Wasu masana kimiyya sun yi saurin raba sakamakon su zuwa kan shirye-shiryen preprint kamar bioRxiv.
Cutar da ke fitowa - Cutar da ke fitowa daga wani abu mai cutarwa, sau da yawa a cikin wani nau'i na fashewa ko sabon nau'i na kamuwa da cuta
Ƙungiyar Harshen Turanci da Cututtuka - Bayani na Ƙungiyar Harshen Turanci da Cututtuka
Cutar annoba da annoba - Jerin adadin wadanda suka mutu sakamakon kamuwa da cutar
Dabbobin daji da kuma cututtukan dabbobi - haɗarin kiwon lafiya da ke tattare da cinikin dabbobi
Gwajin dakin gwaje-gwaje na 2019 na sabon nau'in kamuwa da cuta na huhu (COVID-19) da kuma SARS-CoV-2 da ya danganci ya haɗa da hanyoyin gano kasancewar cutar da waɗanda suka gano kwayoyin halitta da aka samar don amsawa ga kamuwa da cuta.
An tabbatar da kasancewar kwayar a cikin samfurin ta hanyar aikin RT-PCR (rashin amfani da siginar polymerase chain reaction) wanda ke gano RNA na kwayar cutar Corona.
Wannan gwajin na musamman ne kuma an tsara shi ne don gano RNA na SARS-CoV-2 kawai.
Ana amfani da su don tabbatar da sabon kamuwa da cuta ko aiki.
Ana iya amfani da binciken kwayoyin halitta don ganewar asali da kuma nazarin al'umma.
Ana gwada rigakafin mutum a kan yawan mutanen da ke da cutar, ciki har da waɗanda ba su da alamun bayyanar cututtuka da waɗanda ke da alamun bayyanar cututtuka da za a iya bayar da rahoton su.
Ana iya tantance daidaito na mutuwar mutum daga cutar da kuma matakin rigakafin mutum ta hanyar sakamakon wannan gwajin.
Saboda gwajin da aka yi a watan Maris na shekarar 2020, babu wata ƙasa da ke da tabbacin adadin ƙwayoyin cuta a cikin yawan jama'arta.
A ranar 23 ga watan Maris babu wata ƙasa da ta yi gwajin sama da kashi 3 cikin 100 na yawan jama'arta, kuma wannan ya bambanta sosai da yawan gwajin da aka yi a duk faɗin ƙasar.
Wannan bambancin na iya shafar yawan mutuwar da aka ruwaito, wanda zai iya zama da yawa a wasu ƙasashe.
Ta hanyar amfani da magungunan polymerase na ainihin lokacin watsawa (rRT-PCR), ana iya yin gwaji akan samfurin numfashi wanda aka samu ta hanyoyi daban-daban, ciki har da samfurin sauti na hanci, hanci, ko hanci, da sauransu.
Ana iya samun sakamako a cikin sa'o'i biyu zuwa kwanaki biyu.
Ana iya yin gwajin RT-PCR tare da ƙwayar cuta a cikin makonni na farko na cutar.
Daga baya, cutar za ta iya komawa cikin hanji yayin da ta shiga cikin huhu.
Ga waɗanda suka kamu da cutar da aka gwada a mako na biyu, ana iya ɗaukar wani abu na madadin daga cikin numfashi mai zurfi, ana iya amfani da bututun ƙarfe ko na'urar kwaskwarima.
An kirkiro daya daga cikin gwajin PCR na farko a Charité a Berlin a watan Janairun 2020 ta amfani da hanyar sadarwar polymerase, ta hanyar yin amfani da lokaci na lokaci (rRT-PCR), kuma ya kafa tushen tushen 250,000 don rarraba ta Hukumar Lafiya ta Duniya (WHO).
Birtaniya ta kuma kafa wata jarrabawa a ranar 23 ga Janairu, 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya kafa wani magani na PCR na SARS-CoV-2 (PowerChek Coronavirus) a ranar 28 ga Janairu, 2020.
"Wannan hanyar tana bincika kwayoyin ""E"" da aka rarraba ta hanyar dukkanin kwayar cutar coronavirus da kuma RdRp genes na SARS-CoV-2. A China, BGI Group ta kasance farkon kamfanin da ya sami izini don gaggawa don amfani da na'urar gano cutar SARS-CoV-2 bisa ga aikin PCR daga China's National Medical Products Administration. A Amurka, Cibiyar Kula da Kula da Cututtuka da Cututtuka (CDC) tana rarraba gwajin gwajin cutar ta hanyar canja wurin allurar rigakafin cutar ta hanyar 2019-2019-nCoV zuwa sabon asibiti don gwajin lafiyar jiki".
Wani abu daga cikin na'urori uku na gwajin da ya sa sakamakon ba shi da tabbas saboda kuskuren da kuma sakamakon gwajin a CDC a Atlanta, wanda ya haifar da a kan matsakaici, sama da samfurori 100 a rana an yi nasarar sarrafa su a cikin watan Fabrairu na 2020.
Gwaje-gwaje da aka yi da abubuwa biyu ba a tabbatar da su ba har zuwa 28 ga Fabrairu, 2020, kuma ba a ba da izinin fara gwajin ba ga manyan dakunan gwaje-gwaje da na jihar.
Hukumar Abinci da Magunguna ta amince da gwajin a karkashin wani asibitin da aka ba da izini na gaggawa.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da samar da gwajin COVID-19 a duk faɗin ƙasar bisa RT-PCR.
An kafa binciken binciken a duk faɗin ƙasar, ana ba da sabis na gwajin COVID-19 daga 9 ga Maris, 2020.
Babu iyakar adadin da aka sanar, tarin samfurori da gyare-gyare dole ne su bi bukatun CDC.
A Rasha, cibiyar bincike ta VECTOR ta samar da gwajin COVID-19 da kuma samar da shi.
A ranar 11 ga Fabrairu, 2020, an yi rajistar gwajin ne ta hanyar Hukumar Kula da Lafiya ta Amurka. A ranar 12 ga Maris, 2020, Clinic Mayo ta ruwaito ta kirkiro gwajin don gano kamuwa da cutar COVID-19. A ranar 13 ga Maris, 2020, Roche mai bincike ya sami amincewar FDA don gwajin da za a iya aiwatarwa a cikin awanni 3.5 a cikin babban adadin, don haka yana ba da damar inji ɗaya ya yi gwajin 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, Hukumar Abinci da Magunguna (FDA) ta ba da izinin amfani da gaggawa (EUA) ga Abbott Laboratories don gwaji akan tsarin Abbott m2000. A baya, Hukumar Abinci da Magunguna ta ba da irin wannan izinin ga Hologic, LabCorp da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ta karɓi EUA daga FDA ta hanyar gwajin da ya ɗauki kimanin minti 45.
FDA ta amince da gwajin da ke amfani da fasahar nucleic acid dilation a madadin fasahar PCR.
Saboda ba ta buƙatar ci gaba da zafin jiki mai haske, wannan hanyar tana iya ba da sakamako mai kyau a cikin minti biyar da sakamako mara kyau a cikin minti 13.
Akwai kimanin 18,000 na'urori a Amurka, kuma Abbott na sa ran kara samar da su don samar da gwaje-gwaje 50,000 a rana. Gwaje-gwaje da ke amfani da kwayoyin halitta masu ƙayyadaddun haɗi zuwa ƙwayoyin cuta na coronavirus (N) na sabon nau'in coronavirus da ke faruwa a Taiwan, tare da niyyar samar da sakamako a cikin minti 15 zuwa 20 kamar gwajin ƙwayar cuta mai sauri.
"Binciken binciken na Maris 2020 ya kammala cewa, an samu karamin amfani da allurar rigakafin kirji wajen gano cututtukan a farkon matakin, saboda haka CT [hoto na wani wuri na jiki] na iya kasancewa a gaban bayyanar cututtuka. """
Abubuwan da ke faruwa a kan CT sun haɗa da haske na tabarau masu yawa tare da rarrabuwa a baya, siffar da ba ta dace ba, da kayan ado.
Yawan kwayoyin halitta a cikin huhu, ƙwayoyin cuta, da kuma haɗuwa suna ci gaba yayin da cutar ta ci gaba.
Wani bincike na kwatanta polymerase chain reaction (PCR) da CT a Wuhan, tushen cutar a halin yanzu, ya nuna cewa CT ya fi PCR hankali, tare da siffofinsa da yawa na hoto suna aiki tare da cututtukan huhu da sauran cututtuka, kodayake ba a ƙayyade su ba.
"A watan Maris na shekarar 2020, Kwalejin Kimiyya ta Amurka ta ba da shawarar"" bai kamata a yi amfani da CT don yin rikodin ba ko kuma a matsayin gwajin layi na farko don gano COVID-19". "A watan Maris na shekarar 2020, CDC ta ba da shawarar PCR don fara bin sawu".
Wani ɓangare na tsarin rigakafi na amsawa ga kamuwa da cuta shine samar da kwayoyin cuta, wanda ya hada da IgM da IgG.
Ana iya amfani da waɗannan ayyukan don haifar da kamuwa da cuta ta mutum daga kwanaki 7 ko bayan bayyanar cututtuka don ƙayyade rigakafi da kuma lura da yawan jama'a. Ana iya yin gwaji a cikin cibiyar gwaji (CLT) ko ta hanyar gwaji tare da kulawa ta gwaji (PoCT).
Tsarin sarrafa kansa na ci gaba a cikin dakunan gwaje-gwaje masu yawa na maganin cututtuka zai iya aiwatar da waɗannan nazarin, amma amfani da tsarin zai dogara da yawan samarwa ga kowane tsarin.
Don samfurin guda ɗaya wanda ya maye gurbin ƙarin jini, ana kiran CLT sau da yawa, kodayake ana iya amfani da samfurin gaba don bin tsarin garkuwar jiki.
A cikin PoCT, ana samun kwayar jini guda ɗaya ta hanyar cututtukan fata.
Ba kamar hanyoyin PCR ba, ba a buƙatar saukar da su kafin a kama su. A ranar 26 ga Maris, 2020, FDA ta sanya sunayen hukumomi 29 da ke ba da sanarwar ga hukumar bisa buƙata kuma yanzu suna iya rarraba gwajin su.
A ranar 7 ga Afrilu, 2020, kawai gwajin da aka amince da shi ta FDA a ƙarƙashin izinin amfani na gaggawa. A ƙarshen Maris, 2020, Euroimmun Lab Diagnostics da Epitope Diagnostics sun sami amincewar Turai don gwajin su wanda zai iya kare kwayoyin IgG da IgA daga ƙwayoyin cuta a cikin jinin.
Wannan gwajin yana da damar yin samfurin cikin 'yan sa'o'i kaɗan, don haka ya fi sauri fiye da PCR na RNA.
A cikin watan Afrilu, Birtaniya ta gano cewa daga cikin gwajin gwajin da ta saya, babu wani da ya dace da amfani.
"Hong Kong ta shirya wani shiri da ake ganin marasa lafiya za su iya zama a gida, ""ma'aikatar gaggawa za ta ba da samfurin ga marasa lafiya"" za su yi nadama, su dawo da gwajin, kuma bayan wani lokaci za su samu sakamakon gwajin. Hukumar kula da lafiyar Birtaniya ta NHS ta sanar da cewa suna gwada wannan shirin don yin gwajin da ake zargi da cutar a gida wanda zai iya rage haɗarin kamuwa da cutar idan sun zo asibiti ko kuma idan akwai motar gaggawa mai kashewa idan an yi amfani da ita. A cikin gwajin gwajin Covid-19, wanda ake zargi da cutar ga masu kula da lafiya, ana yin hankali sosai".
Cibiyar ta taimaka wa Koriya ta Kudu ta gudanar da gwaje-gwaje mafi sauri da kuma mafi girma na kowace ƙasa. A Jamus, likitocin inshorar lafiya na jihar sun sanar a ranar 2 ga watan Mayu cewa yana da damar yin gwajin kusan mutane 12,000 a rana a cikin motar motar motar motar kuma 10,700 an gwada su a makon da ya gabata.
Ana biyan kuɗin da inshorar lafiya ta ba su lokacin da likita ya umurce su su yi gwaji.
A cewar shugaban cibiyar Robert Koch, Jamus tana da damar yin gwaji 160,000 a mako.
A ranar 19 ga watan Maris, an ba da gwajin a wasu manyan birane.
A ranar 26 ga Maris, 2020, ba a san yawan gwajin da aka yi a Jamus ba, saboda an ba da rahoton sakamako mai kyau.
Binciken farko na dakin gwaje-gwaje ya nuna cewa a mako guda 12/2020 an gwada aƙalla samfura 483,295, wanda ya haɗa da mako 12/2020 da kuma samfura 33,491 (6,9%) waɗanda aka gwada tabbatacce ga SARS-CoV-2. A Isra'ila, masu bincike a Cibiyar Fasaha ta Isra'ila (Technion) da asibitin Rambam sun ƙirƙira kuma sun gwada wata hanyar don yin gwaji daga marasa lafiya 64 a lokaci guda, suna tattara samfura da ƙarin gwaji, amma idan sun gano cewa samfurorin da aka tattara suna da halaye na gida kawai. A dakin gwaje-gwaje na Isra'ila (Rambam) Laboratory, wanda ya yi aiki a ranar 5 ga watan Mayu, 2020, ya buɗe ɗakunan gwaji na BIG-Fire, wanda ya ƙunshi fiye da 10,000 na'urori.
Wanda ya kafa BGI, Wang Jian, ya duba aikin, kuma ya ɗauki kwanaki biyar kafin a yi samfurin samfurin a cikin wani abu mai ban mamaki, wanda ya kai kashi 47 cikin ɗari, kuma farashin da ya shafi magance matsalar warewar kwamfuta ya ninka idan ba a yi amfani da damar gwaji ba.
Nan take ne Wuhan Laboratory aka bi ta da Hunan-Yan Laboratories a Shenzhen, Tangxi, Beijing, da Shanghai a birane 12 a fadin kasar Sin.
A ranar 4 ga Maris, 2020, jimillar gwajin ya kai sau 50,000 a rana. An saki wani bincike na Origami Assays wanda ya gwada samfurin marasa lafiya 1,122 da suka kamu da COVID-19 ta amfani da gwaji 93 kawai. Ana iya yin waɗannan ƙirar masu daidaitawa a cikin ƙananan dakunan gwaje-gwaje ba tare da buƙatar ɗaukar kayan aiki na atomatik ba.
A watan Maris, rashin ƙarfi da rashin amincewa da tuba ya zama matsala ga manyan gwaje-gwaje a cikin Tarayyar Turai da Ingila da Amurka.
Wannan ya sa wasu marubuta suka nemi wani shiri na shirya samfurin da ya shafi samfurin zafin jiki na 98 °C (208 °F) na minti 5 don fitar da RNA don ƙarin gwaji. A ranar 31 ga watan Mayu, an sanar da cewa Larabawa suna gwada yawan jama'arsu don gano cutar coronavirus a cikin wani mutum fiye da sauran ƙasashe kuma suna kan hanya don faɗaɗa yawan gwajin don isa ga yawancin jama'a.
"Wannan ta hanyar hada-hadar da ikon bunkasa da kuma sayen manyan dakunan gwaje-gwaje daga yawan jama'a daga kungiyoyin 42 da BGI (wanda ya dogara da dakunan gwaje-gwaje na gaggawa na ""Hu Yan"" a kasar Sin)".
An gina shi a cikin kwanaki 14, dakin gwaje-gwaje na iya gwada dubban RT-PCR a rana, kuma shi ne na farko a duniya da ke aiki a waje da China.
An kirkiro wasu nau'ikan gwaji daban-daban da suka shafi sassa daban-daban na tsarin kwayar cutar a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar lafiya ta duniya ta karbi takardar iznin Jamus don kayan aikin da aka tura wa ƙasashen da ke da ƙananan kuɗin shiga ba tare da albarkatun da za su iya ci gaba da kansu ba.
An buga sigar Jamus a ranar 17 ga Janairu, 2020. Cibiyar Kula da Cututtuka ta Amurka ta kafa wata yarjejeniya da ba ta wuce ba har zuwa ranar 28 ga Janairu. Ana jinkirta gwajin da ke akwai a Amurka da Amurka, suna da matsala game da amincin kayan aikin gwaji a farkon fasalin barkewar cutar, kuma waɗannan ƙasashe da Ostiraliya ba su da isasshen kayan aiki don biyan buƙatu da shawarwari don gwajin da masu ilimin likitanci suka yi.
Akasin haka, masana sun ce, gwajin da Koriya ta Kudu ta yi ya taimaka wajen rage yaduwar sabon nau'in coronavirus.
Yawancin gwajin gwaji a cikin dakunan gwaje-gwaje na masu zaman kansu an gina su a cikin shekaru da yawa ta gwamnatin Koriya ta Kudu.
A ranar 16 ga watan Maris, Hukumar Lafiya ta Duniya ta yi kira ga karfafa shirye-shiryen gwaji, wanda shine hanya mafi kyau don rage yaduwar cutar COVID-19. Babban buƙatar gwaji saboda yaduwar cutar ya haifar da dubban dubban gwaji a cikin dakunan gwaje-gwaje masu zaman kansu a Amurka da kuma samar da samfuran samfurin da aka yi da kayan aikin gwaji na zama ruwan tabarau.
A watan Maris na shekarar 2020, kasar Sin ta ba da rahoton matsalolin da suka shafi ingancin kayan gwajin ta.
"A Amurka, gwajin da CDC ta yi ya kasance da ""laifuka""; sai gwamnati ta soke ofishin jakadancin da ke hana yin gwaje-gwaje na sirri.
Kamfanin ya bayyana cewa sakamakon da bai dace ba zai iya faruwa ne saboda rashin samun samfurori ko amfani da kayan aiki daidai.
Ma'aikatar kasar ta Spain ta ce za ta cire kayan aikin da suka ba da sakamako mara kyau kuma za ta maye gurbin su da wasu kayan aikin gwaji da Shenzhen Bioeasy ta bayar. Kashi 80 cikin dari na kayan aikin gwajin da Jamhuriyar ta Sakiya ta saya daga China sun ba da sakamako mara kyau. Slovakia ta sayi kayan aikin gwaji miliyan 1.2 daga China wanda aka gano ba daidai ba.
"Firai Minista Matovič ya ba da shawarar jefa shi cikin kogin Danube. Ateş Kara na ma'aikatar lafiya ta Turkiyya ya ce kayan gwajin da Turkiyya ta saya daga China suna da "ƙimar kuskure" da kuma "ba a amfani da su ba". Birtaniya ta sayi kayan gwaji miliyan 3.5 daga China, amma a farkon watan Afrilu 2020 ta sanar da cewa ba za a iya amfani da su ba".
Ana yin gwaje-gwaje masu biyowa tare da waɗanda suka yi gwajin gwaji mai kyau da kuma waɗanda suka yi gwajin SARS-CoV-2 sun yi hulɗa da sakamakon da ke da sakamako mai kyau.
Masu bincike a Vò, Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun yi gwaje-gwaje biyu a kan kusan mutane 3,400 da ke keɓewa na kwanaki goma.
Kimanin rabin mutanen da aka gwada da kyau ba su da wata alama, kuma an ware duk waɗanda aka gano.
Ta hanyar tafiya zuwa yankin da aka iyakance, za a iya kawar da sabon kamuwa da cuta gaba ɗaya.
Tare da tsauraran hanyoyin sadarwa, takunkumin tafiye-tafiye na cikin gida, gwaji da keɓewa, 2020 annobar cutar Corona a Singapore ta yi jinkiri fiye da sauran ƙasashe masu tasowa amma ba tare da takunkumi masu ƙarfi ba kamar tilasta rufe gidajen abinci da wuraren siyarwa.
An soke wasu abubuwan da suka faru, kuma Singapore ta fara gabatar da mazaunan gida a ranar 28 ga Maris, amma makarantu sun sake buɗewa jim kadan bayan hutu a ranar 23 ga Maris.
Wasu ƙasashe sun kuma magance cutar ta hanyar tsauraran hanyoyin sadarwa, tsauraran matakan tafiya, gwaji da keɓewa, amma tare da zama a gida ba tare da damuwa ba kamar Iceland da Koriya ta Kudu.
Wani bincike da aka yi a kan alkaluman ya gano cewa kasashen da suka yi gwaje-gwaje da yawa game da yawan mutuwar sun fi kasa, wataƙila saboda sun fi iya hana bayyanar cututtuka.
Hukumar lafiya ta duniya ta ba da shawarar cewa kasashen da ba su da damar yin gwaji da kuma dakin gwaje-gwaje na kasa da ke da iyakantaccen kwarewa game da COVID-19 su aika da samfurori na farko na COVID-19 guda biyar da kuma samfurori na farko na COVID-19 zuwa ɗayan dakin gwaje-gwaje 16 na Hukumar lafiya ta duniya don tabbatarwa.
Daga cikin dakunan gwaje-gwaje guda 16, akwai bakwai a Asiya, biyar a Turai, biyu a Afirka, ɗaya a Arewacin Amirka, ɗaya kuma a Ostiraliya.
"A cikin teburin da ke ƙasa, jerin abubuwan da suka kasance ""mai kyau a matsayin kashi na gwaji"" sun kasance suna shafar manufofin gwaji na kasar".
Kasar da ta gwada mutanen da suka shiga asibiti ne kawai za su samu kashi 100 na gwajin da ya fi na kasar da ta gwada dukkan 'yan kasar, ko suna da alamun cutar ko a'a, kuma duk abin da ya bambanta.
Wanke hannu, wanda aka fi sani da tsabtace hannu, shi ne aikin wanke hannuwan mutum don wanke ƙasa, mai, kayan motsa jiki, ko wasu abubuwa da ba mu buƙata.
Wanke hannu da sabulu yana da muhimmanci a wasu lokutan yau da kullum don hana yaduwar cututtuka, kamar cututtuka masu yaduwa da kuma cututtuka masu yaduwa ta hanyar baki.
Mutane kuma suna iya kamuwa da cututtukan numfashi, kamar mura ko kuma mura, idan ba su wanke hannuwansu kafin su taɓa idanunsu, hanci ko bakinsu ba (misali, hawan jini).
Abubuwa biyar da suka fi muhimmanci a kowace rana su ne wanke hannu da sabulu, ciki har da kafin da bayan wanka, bayan wanke jikunan yara, ko kuma motsa ɗakunan yara kafin yin amfani da abinci kafin cin abinci, kafin ko bayan shirya abinci, ko kuma bayan dafa nama, kifi da tsuntsu.
Hukumar Lafiya ta Duniya ta ba da shawarar yin wanka a hannu: Za mu iya yin wanka da wanka idan ba mu da ruwa da sabulu.
Kafin lokacin da kuma bayan da aka shirya abinci.
Kafin ka yi magani, kuma bayan ka yi, kana rashin lafiya.
Bayan an canja kayan wanka, wanka ko wanke wanka, an yi amfani da wanka.
Bayan an yi masa wanka, ya yi tari ko ya yi tari.
Bayan ya taɓa dabba, dabba ko kuma dabba.
Aikin tsabtace hannu na ilimin kimiyya ya shafi aikin tsabtace hannu wanda ya shafi tsarin jagorar mala'iku.
Yin wanka kafin shan magani ko kuma magani zai iya hana ko rage yaduwar cutar.
Babban manufar maganin wanke hannu shine wanke hannuwan da ke da ƙwayoyin cuta (kayan cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta) da kuma sunadarai masu haɗari ko cututtuka.
Yana da mahimmanci ga masu kula da abinci ko masu aiki a cikin likita, amma kuma yana da mahimmanci ga aikace-aikacen magani.
Yin wanka yana da fa'idodi masu yawa ga lafiyar jiki, gami da rage yaduwar mura, cutar coronavirus da sauran cututtukan cututtuka; hana kamuwa da cutar sankara; rage kamuwa da cutar huhu.
Kuma rage yawan mutuwar jarirai a lokacin haihuwar gida.
Wani binciken da aka gudanar a shekara ta 2013 ya nuna cewa yin wanka da hannu na iya inganta haɓakar yara a cikin shekaru biyar.
A cikin ƙasashe masu tasowa, ana iya rage yawan mutuwar yara da ke tattare da cututtukan numfashi da cututtukan huhu ta hanyar gabatar da canje-canje na halayyar da ba a saba yi ba, kamar wanke hannu da sabulu, da sauransu.
Wannan aikin na iya rage yawan mutuwar da ake samu daga cututtukan nan da kusan 50%.
Yin amfani da ruwa mai tsafta don wanke hannu zai iya rage kamuwa da cutar ta kwayar cuta da kashi ɗaya bisa uku, idan aka kwatanta da samar da ruwa mai tsabta a yankunan da ba su da isasshen kuɗi.
Kashi 48% na rage yawan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Ciwon huhu, babban ARI, shine sanadin farko na mutuwar yara a ƙarƙashin shekaru biyar, wanda ke kashe kusan yara miliyan 1.8 a kowace shekara.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cut
A cewar UNICEF, wanke hannu da sabulu kafin cin abinci da bayan wanka ya zama al'ada mai ceton rai fiye da allurar rigakafi ko wani magani, ta hanyar rage mutuwar kamuwa da cutar sankara da rabi da kuma mutuwar da ake samu daga kamuwa da cutar huhu da kashi hudu.
Aikin wanke hannu yawanci ana haɗa shi da sauran hanyoyin tsabtace jiki, wanda shine ɓangare na aikace-aikacen ruwa, tsabtace jiki da tsabtace jiki.
Yin wanka a hannu zai iya hana kamuwa da cututtukan fata da ke faruwa ta hanyar tuntuɓar kai tsaye.
Wani mummunan sakamako na wanke hannu shine cewa wanke hannu sau da yawa na iya haifar da lalacewar fata saboda bushewar fata.
Wani bincike na Denmark na 2012 ya gano cewa wanke hannu da yawa zai iya haifar da cututtukan fata, wanda aka sani da cututtukan hannu ko cututtukan fata, wanda ke faruwa a cikin ma'aikatan kiwon lafiya.
Yin wanka a kai a kai yana nuna cewa mutum yana da rashin tunani.
Abubuwa guda biyar da ake bukata a rana da za a yi amfani da sabulu a hannu shi ne don rage kamuwa da cutar ta hanyar taɓawa da hanci da baki: bayan yin amfani da wanka (karamin kafa da ƙafafun ƙafa), bayan wanke kayan yara (canza tukunyar ruwa), kafin a ajiye abinci ga jariri bayan cin abinci, kafin ko bayan shirya abinci ko dafa abinci ko kuma bayan shan nama na kifi ko tsuntsu.
Sauran lokuta idan akwai fasahar wanke hannu daidai ya kamata a yi amfani da ita don hana kamuwa da cutar, ciki har da kafin da bayan maganin rauni ko rauni. Bayan ka shawo kan tari, ka yi tari ko ka wanke hanci, ka taɓa dabbobi ko ka taɓa dabbobi, kuma bayan ka taɓa shara.
A wasu ƙasashe, yawan wanke hannu da sabulu yana da ƙasa.
Wani binciken da aka gudanar a kan wanke hannu a cikin kasashe 54 a shekarar 2015 ya gano cewa, a matsakaita, kashi 38.7% na yawan mutanen gida sun yi wanke hannu da sabulu. Wani binciken da aka gudanar a shekarar 2014 ya nuna cewa, Saudiyya ce ta fi yawan wanke hannu, wato kashi 97 cikin 100, Amurka 77% da kasar Sin kashi 23 cikin 100 na kasa. Wasu hanyoyin sauya halaye a yanzu suna nufin kara wanke hannu da sabulu a lokacin da ake shuka.
Shirin kula da lafiya mai mahimmanci, wanda aka aiwatar da shi ta hanyar Cibiyar Ilimi a cikin Philippines, misali ne na ayyukan sadaukarwa don inganta lafiyar yara da ilimi.
Yin wanke kwari sau biyu a shekara, da kuma wanke hannu kullum da sabulu, wanke hakora kullum da fluoride, shine babban mahimmancin shirin na kasa.
An yi amfani da shi sosai a Indonesia.
Yin wankewar fata daga fata yana nufin yin wankewa ta hanyar ƙara sabulu ko wanka a cikin ruwa.
Babban aikin sabulu da maganin kashe kwayoyin cuta shine rage sulfuran kwayoyin halitta da kuma kara narkewa.
Ruwa ba shi da tasiri sosai a jikin mutum, saboda kitse da furotin, da suke cikin jikin mutum, ba su narkewa cikin ruwa.
Amma, ƙarfin ruwan da ke gudana a cikin iska zai iya taimaka wajen wanke.
Saboda yawanci sabulu mai tauri da za mu iya amfani da shi a sake amfani da shi yana dauke da kwayoyin da ke tattare da sabulu bayan an yi amfani da shi sau ɗaya.
Wani karamin bincike da ya duba yadda ake canja kwayoyin daga sabulu mai ƙanshi ya kammala cewa ba za a iya canja su ba domin sun wanke su da sabulu kuma sun riga sun gama.
"CDC ta ci gaba da cewa ""sabo a cikin tukunya tare da kai mai matsi ya fi kyau""".
Sun yi amfani da su sosai daga sabulu da kwayoyin cuta zuwa ga lafiyar jama'a.
Har zuwa yanzu babu wata hujja da ta nuna cewa amfani da wani kwayoyin cuta ko kwayoyin cuta da aka ba da shawarar za a zaba don kwayoyin da ke da nauyin maganin rigakafi a cikin yanayi.
Duk da haka, sabulu mai ƙonewa yana dauke da wani wakili na antibacterial, kamar titroglycerin, wanda ya fi ƙarfin jiki.
Idan ba a zaɓi wasu kwayoyin da ke amfani da maganin rigakafi ba, sabulu na hana kwayoyin ba zai yi tasiri kamar yadda aka tallata ba.
Baya ga maganin hana cutar da ake amfani da shi a cikin huhu da kuma kare fata, wannan kayan lambu na karya yana dauke da acidic acid, acetic acid, lactic acid, wanda ke wakiltar PH. Ana kashe kwayoyin cuta da kuma maganin rigakafi na fata (kamar su maganin ciwon daji, bitamin, mantoles, da kuma kwayoyin halitta). Wani bincike na Jami'ar Oregon School of Public Health ya nuna cewa sabulu na yau da kullum yana da tasiri ga maganin rigakafi, wanda ke dauke da maganin rigakafi (triclosan) a cikin rigakafi da cututtuka da kuma kashe cututtuka a hannu.
Ruwan da ke da ruwan zãfi don wanke hannu ba shi da zafi don kashe ƙwayoyin cuta.
Kwayoyin suna girma sosai a jiki (zazzabi 37 °C).
Koyaya, ruwan zafi, sabulu, yana da tasiri fiye da ruwan sanyi da sabulu a cikin wankewar ƙwayoyin halitta masu ƙwayoyin cuta da ƙwayoyin cuta.
Wani bincike na kimiyya, wanda ya sabawa imani da yawa, ya nuna cewa amfani da ruwan zafi ba shi da tasiri wajen rage microorganisms a hannu.
Ruwan wanke hannu ko maganin kashe kwayoyin cuta a hannu shine mai tsabtace hannu wanda ba ya amfani da ruwa.
A ƙarshen 1990s da farkon karni na 21, kayan tsabtace hannu ba tare da ruwa ba, giya (wanda aka fi sani da ruwan giya, wanke hannu, disinfectant, wanke hannu) sun fara samun karbuwa.
Yawancin su suna dogara ne akan isoprotrolyline, ko ethanol, don yin aiki tare da wakili mai laushi kamar kabur (wani abu mai laushi na acrylic acid) zuwa gel, ko kuma wasu abubuwa kamar chlorine zuwa wani abu mai sauƙi ko foam don sauƙaƙe amfani da kuma rage yawan ƙarfin bushewa na alcohol.
Ƙara sinadarin hydrogen-peroxide yana ƙara aikin kashe ƙwayoyin cuta. Ruwan wanka da ke dauke da barasa tsakanin 60 zuwa 95% yana da isasshen maganin kashe ƙwayoyin cuta.
Alcohol yana wanke kwayoyin cuta na yau da kullun, kwayoyin cuta masu ƙwayoyin cuta (MRSA da VRE), cututtukan jini da wasu ƙwayoyin cuta (ciki har da cutar AIDS, cutar ta RSV, cutar sankara, cutar mura, allurar riga-kafi, da ciwon huhu) da kuma sinadarai.
Ruwa mai amfani da giya yana wanke ƙwayoyin cuta, wanda ya ƙunshi 70% na barasa, yana kashe 99.97%, rage 3.5 daidai yake da rage 35 decibels) na kwayoyin a hannu30 seconds bayan amfani, da kuma 99.99% zuwa 99.999% (rage 4 zuwa 5 lokuttan) na kwayoyin a hannu minti 1 bayan amfani. Ruwa mai amfani da giya yana da tasiri sosai a kan kwayoyin kuma yana da tasiri sosai a kan wasu ƙwayoyin cuta.
Ruwan wanke hannu na barasa yana da kusan rashin tasiri a kan ƙwayoyin norovirus (ko Norwalk), wanda shine mafi yawan dalilin kamuwa da cutar kumburi. Dole ne a yi amfani da wanke hannu ko wanke hannu da yawa don wanke hannu ko kuma wanke hannu.
A cikin wanka, a wanke hannayen hannu, a wanke duka biyu da kuma tsakanin hannayen hannu na tsawon dakika 30 har sai an wanke kayan, an yi wanka ko an bushe su.
Ƙarshen hannu kuma ya kamata a wanke shi, idan ba haka ba za su wanke hannuwan su. Cibiyar Kula da Cututtuka ta Amurka ta ba da shawarar wanke hannuwanka da ruwan sha, musamman idan hannuwanka sun dubi duhu.
Yawan amfani da waɗannan wakilai ya dogara ne akan sauƙin amfani da saurin kashewa da kuma kashewa da sauri akan maganin saurin jiki. Amma bai kamata su maye gurbin wanke hannu da kyau ba sai dai idan babu sabulu da ruwa.
Yin amfani da wanke hannu sau da yawa na iya haifar da fata ta bushe idan an ƙara sinadarin fata da / ko ruwan zãfi a cikin hoto.
Ana iya rage ko kawar da ingancin barasa ta hanyar ƙara glycerin da/ko wasu kayan shafawa zuwa cikin furotin.
A cikin gwaji na likita, wanke hannu da ke dauke da sinadarin wanke fata ya haifar da ƙananan kumburi da kuma bushewar fata fiye da sabulu ko sabulu mai ƙonewa.
Fata ta jiki ta hanyar taɓa wani abu mai ƙarancin allergy, taɓawa ta jiki, taɓawa mai ƙarfi, taɓawa mai ƙarfi, ko taɓawa ta barasa ko ƙarin abubuwa a cikin wanka na hannu, suna faruwa sosai.
Rashin amfani da shi zai iya haifar da cututtukan fata na jiki daga tuntuɓar maganin shafawa ya zama abin sha'awa idan aka kwatanta da wanke hannu da sabulu da ruwa.
Baya ga ingancinsa, wakili da ba ruwa ba zai iya wanke hannayensu da ke dauke da waɗannan ƙwayoyin ba, amma zai iya kashe su a hanya mai sauƙi.
Saboda haka, wanke hannu ba shi da tasiri kamar sabulu da ruwa wajen hana yaduwar kwayoyin cuta da yawa, saboda akwai sauran masu cutarwa a hannu.
Aikin wanke hannu ba tare da barasa ba ya dogara da sinadarai da zane-zane, kuma a tarihi akwai ruwan sha da wanke hannu ba tare da tasiri ba.
Kwanan nan, an nuna cewa nau'in benzalkonium yana da ci gaba da antibacterial kuma yana ƙaruwa bayan amfani, ba kamar yadda ake nunawa da barasa ba, wanda ya rage tasiri bayan sake amfani, watakila saboda ƙarin halayen fata.
Mutane da yawa a cikin ƙananan al'ummomin ba su da damar sayen sabulu kuma su yi amfani da ƙasa ko ƙasa a maimakon haka.
Yin wanka da ruwa ko ƙasa zai iya zama da inganci fiye da yin wanka da ruwa ɗaya, amma ba shi da inganci kamar wanka da sabulu.
Wani abin damuwa shi ne, idan ƙasa ko ƙasa ta kamu da kwayoyin cuta, zai iya ƙara yaduwar cutar fiye da rage ta.
Ruwan ya zama kamar sabulu, domin idan ya yi amfani da ruwa, yakan zama alkaline sulfide.
Hukumar Lafiya ta Duniya ta ba da shawarar yin amfani da ƙasa ko sandstone a matsayin zaɓi lokacin da babu sabulu.
Cibiyar Kula da Cututtuka ta Amurka ta gabatar da dabarun wanke hannu daidai don hana kamuwa da cutar, wanda ke da matakai kamar haka:
Ka wanke hannunka da ruwan zafi ko ruwan sanyi da ke gudana.
An ba da shawarar yin amfani da ruwa mai gudana saboda tankuna na iya zama masu duhu yayin da yanayin zafin jiki na ruwa ba ya bambanta.
Ka wanke hannayenka da sabulu mai yawa, ka wanke su da sabulu mai yawa, ciki har da wuyan hannu, tsakanin yatsunsu da kuma ƙarƙashin gwiwoyinka.
Sabulu yana iya hana kamuwa da cuta daga fata, kuma bincike ya nuna cewa mutane da yawa suna jin daɗin wanke hannu sosai a lokacin wankewa da sabulu fiye da wankewa da ruwa.
Aƙalla minti 20.
Yin wanka yana da amfani sosai wajen kawar da ƙwayoyin cuta daga fata, kuma wanka na dogon lokaci zai taimaka wajen kawar da ƙwayoyin cuta.
Ka wanke kanka sosai a ƙarƙashin ruwan da ke gudana.
Yin wanka a cikin wanka (ruwa ko a'a) zai iya sa hannuwanka su sake samun ƙwayoyin cuta.
Ka zo da wanka mai tsabta, ka wanke hannunka, ko kuma ka bar su su bushe.
Hannun da suka yi ruwa da kuma hannayen da suka yi kumburi suna da saukin kamuwa da cutar. Mafi yawan wuraren da suka lalace sune hannayensu, hannayensu, yankin da ke tsakanin yatsunsu da kuma ƙarƙashin yatsunsu.
Magunguna masu amfani da maganin shafawa da magungunan shafawa na iya zama mafaka ga ƙwayoyin cuta na jiki.
Ana yawan amfani da labule mai ruwan zãfi don kiyaye hannayen hannu daga bushewa. Gashin da ya bushe zai iya haifar da lalacewar fata wanda zai iya ƙara haɗarin kamuwa da cutar.
Za a iya yin zaɓuɓɓukan da yawa masu ƙarancin kuɗi don sauƙaƙe wanke hannu a wuraren da babu ruwan inji da/ko sabulu, alal misali, yin ruwa daga tankuna masu tsabtace ruwa ko tafkuna masu daidaitaccen gudu, da/ko yin amfani da ruwa idan ya cancanta a cikin ƙasashe masu tasowa. A cikin yanayin da aka iyakance samar da ruwa (kamar makarantu ko yankunan karkara a cikin ƙasashe masu tasowa), akwai hanyoyin magance matsalar ruwa kamar "tippy-taps" da sauran zaɓuɓɓukan ƙarancin farashi.
Tushen ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa mai ruwa
Yin wanka da hannu yana da muhimmanci sosai a cikin wanke hannu, amma akwai wasu muhawara game da yadda za a yi wanka a cikin gidan wanka.
Ƙarin bincike ya nuna cewa takardar wanka tana da tsabta fiye da na'urorin wanka da aka yi amfani da su a cikin ɗakunan wanka.
A shekara ta 2008, wani bincike da Jami'ar Westminster, London ta gudanar da shi kuma da kamfanin masana'antar kayan shafawa na Turai Tissue Symposium suka yi hadin gwiwa don kwatanta yawan kayan shafawa daga kayan shafawa da na'urorin wanke hannu da sauran na'urorin wanke hannu na zamani.
Bayan wanke hannu da kuma wanke hannu da na'urar wanke hannu, an gano cewa adadin kwayoyin ya karu da kashi 194% a kan tablespoons, kuma 254% a kan tablespoons.
Yin amfani da na'ura mai yin amfani da na'ura mai yin amfani da na'ura mai yin amfani da na'ura mai yin amfani da na'ura mai yin amfani da na'ura mai yin amfani da na'ura mai yin amfani da na'ura mai yin amfani da na'ura mai yin amfani da na'ura mai yin amfani da na'ura mai yin amfani da na'ura mai yin amfani da na'ura mai yin amfani da na'ura mai yin amfani da na'ura mai yin amfani da na'ura mai yin amfani da na'ura mai yin amfani da na'ura mai yin amfani da na'ura mai yin amfani da na'ura mai yin amfani da na'ura mai yin amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na yin amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na yin amfani da na'ura mai amfani da na yin amfani da na'ura mai amfani da na'ura mai amfani da na'ura mai amfani da na yin amfani da na yin amfani da na'ura mai amfani da na'ura mai amfani da na yin amfani da na yin amfani da na'ura mai amfani da na'ura mai amfani da na yin amfani da na yin amfani da na yin amfani da na yin amfani da na yin amfani da na'ura mai amfani da na yin amfani da na yin yin yin yin yin yin yin yin amfani da na'ura na'ura na'ura mai amfani da na yin yin
Bayan wanke da kuma wanke hannu da takarda mai tsabta, adadin kwayoyin ya ragu a kan matsakaici zuwa 76% a kan wanka da kuma a kan tawul har zuwa 77%. Masana kimiyya sun kuma gudanar da gwaje-gwaje don sanin ko akwai yiwuwar kamuwa da cutar ga sauran masu amfani da wanka da kuma yanayin wanka sakamakon kowace hanya ta wanka.
Injin sanyaya iska wanda ke fitar da iska daga injin a cikin saurin 180 m/s (650 km/h, 400 mph) yana da ikon fitar da kwayoyin cuta daga hannayensu da injin sanyaya, kuma yana iya haifar da hazo ga sauran masu amfani da wanka da kuma yanayin da ke kewaye da wanka mai tsawon mita 2.
Yin amfani da na'ura mai nauyi zai iya yada jijiyoyin jiki (ƙananan kwayoyin halitta) har zuwa 0.25 mil daga na'ura mai nauyi.
A shekara ta 2005, wani binciken da TÜV Produkt und Umwel ya yi ya yi la'akari da wasu ka'idojin tsabtace hannu daban-daban.
An gano cewa an samu canje-canje a yawan kwayoyin bayan an bushe hannu:
Akwai kamfanoni daban-daban da suka samar da na'urori masu tsabtace hannu, kuma ana kwatanta na'urorin wanke hannu da wanke tare da takarda mai tsabta.
Yin amfani da wanka na hannu don wanke hannu yana da kyau a lokacin da muke tafiya ba tare da isasshen sabulu da ruwa ba.
Ruwan wanka na hannu da giya ya kamata ya ƙunshi aƙalla kashi 60% na giya.
Yin wanke hannu a likita ya zama dole bayan likitan Hungary Ignaz Semmelweis, wanda ya gano (a 1846) ingancinsa wajen hana kamuwa da cuta a cikin yanayin asibiti.
Akwai na'urori masu amfani da lantarki da ke tunatar da ma'aikatan asibiti su wanke hannayensu idan sun manta su yi hakan.
Wani bincike ya gano cewa yawan kamuwa da cutar ya ragu da amfani da su.
Aikin wanke hannu na tsawon dakika 15 ne, ta amfani da sabulu da ruwa ko kuma wanka mai yawa don wankewa da kuma wanke kowane ɓangaren hannu.
Ya kamata ku yi wa juna ta'aziyya da hannuwanku.
Ya kamata ka yi amfani da hanci don cire kayan da ke ƙarƙashin yatsanka idan akwai.
Yana da muhimmanci a wanke hannuwanka sosai kuma a bushe su da tawul mai tsabta, domin ƙwayoyin cuta suna iya kasancewa a cikin ruwa a hannun.
Bayan wanke hannu, ya kamata a yi amfani da takarda mai tsabta don rufe ruwa (da kuma buɗe kofa ta waje idan ya cancanta).
Wannan shi ne don hana kamuwa da cutar daga hannu zuwa gefe.
Manufar wanke hannu a wuraren kiwon lafiya ita ce kawar da ƙwayoyin cuta da kuma hana su kamuwa da su.
Sabon tarihin likitancin Ingila ya ruwaito cewa rashin wanke hannu ya kasance a cikin mafi yawan wuraren kula da lafiya, tare da likitoci da likitoci da yawa sun manta da wanke hannu kafin su taɓa marasa lafiya, wanda ya haifar da canja wurin kwayar cutar.
Wani bincike ya nuna cewa wanke hannu da wasu hanyoyi masu sauki na iya rage yawan kamuwa da cutar ta jini da ke tattare da jini da kashi 66 cikin dari. Hukumar lafiya ta duniya ta wallafa takardar jagora da ta nuna wanke hannu da kuma wanke hannu a fannin kiwon lafiya.
Ana kuma samun takardar jagorar tsabtace hannu ta hanyar ƙungiyar a shafinta na yanar gizo don neman ra'ayoyin jama'a.
Wani bincike na sake dubawa ya faru da Whitby et al.
Kayan aiki na kasuwanci na iya auna da kuma tsabtace hannu idan an nuna bukatar a yi amfani da su a kan matakan da aka saba.
Hukumar lafiya ta duniya ta ba da lokaci guda biyar don wanke hannu:
Bayan an taɓa jini ko wani abu a jikin mutum,
Kafin yin aikin tsabtace kwayoyin cuta da kuma
Bayan kula da marasa lafiya, ƙara sinadarai masu kashe ƙwayoyin cuta zuwa sabulu ( " magani " ko " kashe ƙwayoyin cuta ") wanda zai iya haifar da maganin kashe ƙwayoyin cuta a cikin wakili mai wanke hannu.
Irin wannan aikin kashe kwayoyin cuta zai iya zama abin so kafin tiyata ko a wuraren da kwayoyin ke da babban cutar rigakafi. Saboda haka, wanke hannuwanka a lokacin tiyata yana bukatar a yi amfani da rubin da ke buɗewa da kuma rufewa ba tare da taɓa shi ba, ta amfani da ruwan wanke hannu chlorhexidine ko iodine, wanke hannu mai tsabta don wanke bayan wanke, kuma wanke hanci don wanke hanci da kayan aikin tsabtace hannu a ƙarƙashin hannu.
Ya kamata a cire dukan kayan haɗi.
Wannan tsari yana buƙatar wanke hannu da kuma motsa hannu har sai hannuwansa na tsawon minti 2 zuwa 6.
Ba a bukatar yin dogon jira na minti goma.
Ya kamata su hana ruwan da ke cikin hannuwan su koma hannayensu a lokacin wanka.
Ka wanke hannunka da labule mai tsabta, ka kuma wanke su da tufafin da suka dace.
Don rage yaduwar cutar, yana da kyau a wanke hannuwanku ko kuma a yi amfani da maganin kashe ƙwayoyin cuta kafin da bayan kula da marasa lafiya.
Don gudanar da kamuwa da kwayar cutar staphylococcal a asibiti, an gano cewa mafi yawan fa'idodi daga wanke hannu sun fito ne daga kashi 20 cikin ɗari na farko na wanke hannu, kuma ƙananan ƙarin fa'idodi da aka samu daga wanke hannu sau da yawa sun karu da sama da kashi 35 cikin ɗari.
Yin wanka da sabulu na yau da kullum yana da sau uku na karɓar ƙwayoyin cuta daga abinci fiye da yin wanka da sabulu na wanka. Kwatanta tsakanin wanke hannu da giya da wanke hannu da sabulu na dakika 30 ya nuna cewa wanke hannu da giya na iya rage kamuwa da cuta da kashi 26% fiye da wankewa da sabulu.
Amma sabulu da ruwa sun fi wanke hannu da ƙwayoyin cuta don rage cutar H1N1, cutar kwayar cuta da kuma cutar kumburi da ke fitowa daga hannayen. Taron don inganta tsabtace hannu a wuraren kiwon lafiya na iya haɗawa da ilmantar da ma'aikata daga wanke hannu, ƙara yawan lokutan hannu tare da ruwan sha, da kuma tunatar da ma'aikata a rubuce da kuma kai tsaye.
Akwai bukatar ƙarin bincike game da wane irin magani ne ya fi tasiri a wurare daban-daban na kiwon lafiya.
A ƙasashe masu tasowa, wanke hannu da sabulu an gane shi a matsayin mai amfani da kayan aiki don samun lafiya da kuma samun abinci mai gina jiki.
Amma rashin ruwa mai tsabta, sabulu ko wuraren wanke hannu masu aminci a gidajen mutane, makarantu da wuraren aiki yana sa ya yi wuya a cimma ɗabi'ar wanke hannu a duniya.
Alal misali, wuraren wanka a mafi yawan yankunan Afirka da ke kusa da wuraren wanka na jama'a da na masu zaman kansu ba su da yawa, duk da cewa suna da tsada wajen gina wuraren wanka.
Duk da haka, wannan ƙananan yawan wanke hannu na iya zama dalili ne na rashin wanke hannu fiye da rashin ruwa ko sabulu.
Tallafawa da kuma inganta wanke hannu da sabulu na iya tasiri kan yanke shawara kan manufofi, ya kara wayar da kan jama'a game da fa'idodin wanke hannu, kuma ya haifar da sauyin hali na mutane na dogon lokaci.
Don yin wannan aikin, ana bukatar dubawa da kimantawa.
Binciken tsarin bincike kan bincike 70 ya gano cewa hanyoyin da ake amfani da su a cikin al'umma sun yi tasiri wajen kara yawan wanke hannu a cikin LMICs yayin da kamfen ɗin talla na zamantakewa bai yi tasiri ba. Misali na inganta wanke hannu a makarantu shine: Hanyar uku ta UNICEF, wanda ke ƙarfafa makarantu su aiwatar da matakai masu sauƙi da ƙarancin farashi don tabbatar da cewa ɗalibai sun wanke hannu tare da sabulu, a tsakanin sauran sharudda.
Idan aka cika wannan misali, makarantar za ta iya canja daga taurari zuwa taurari uku.
Gina wuraren wanka da yawa yana cikin wani ɓangare na inganta wanka na hannu wanda ke taimakawa rage kamuwa da cuta da rage mutuwar yara.
Aikin wanke hannu a duniya misali ne na wani yunkuri na wayar da kan jama'a da ke kokarin kawo sauyi a dabi'a. A sakamakon yaduwar cutar coronavirus ta 2019-20, UNICEF ta inganta amincewa da alamar hannu.
Wasu ƙananan karatu sun yi la'akari da yadda ake amfani da wanke hannu a ƙasashe masu tasowa da ke da alaƙa da DALYs.
Amma wani bincike ya nuna cewa yin amfani da sabulu wajen wanke hannu yana da tsada fiye da yin amfani da ruwa da kuma tsabta.
Muhimmancin wanke hannu ga lafiyar mutum, musamman ga waɗanda ke cikin yanayi mai rauni, kamar mahaifiyar da ta haifi jariri ko kuma soja da aka ji rauni a asibiti, an fara gane shi a tsakiyar karni na 19 ta hanyar masu tsabtace hannu biyu: Ignaz Semmelweis, wani likita na Hungary, wanda ke aiki a Vienna, Austria, da Florence Nightingale, wani dan Ingila, wanda ya kafa aikin jinya na zamani.
A lokacin, mutane da yawa sun yi imani cewa cutar ta samo asali ne daga wani abu da ake kira miasmas.
A shekarun 1980, barkewar cututtukan abinci da cututtukan da ke tattare da kiwon lafiya sun sa Cibiyoyin Kula da Cututtuka na Amurka su yi aiki sosai don inganta tsabtace hannu, wanda shine babbar hanyar hana yaduwar cututtuka.
Bayan barkewar cutar kwayar cutar alade a shekarar 2009 da kuma barkewar cutar COVID-19 a duniya a shekarar 2020, wasu kasashe sun fahimci cewa wanke hannu da sabulu yana da matukar muhimmanci wajen kare kansu daga kamuwa da cutar.
Alal misali, ana yin zane-zane da ke dauke da kalmar nan "Hanyar yin wanka da kyau" a kusa da wuraren wanka a wuraren wanka na jama'a da kuma a cikin wanka na gine-ginen ofis da filayen jiragen sama a Jamus.
Yin wanka don cire wani abu yana nufin cewa ba ka son ka ɗauki alhakin wani abu ko kuma ka raba daidaito a cikin labarin.
An samo asali ne daga nassi a cikin Matta, inda Pontius Pilate ya wanke hannunsa daga yanke shawarar giciye Yesu Kristi, amma ya zama kalmar da aka fi amfani da ita a wasu al'ummomin Ingila.
Halin Ma'abeda a cikin satin ya fara matsa wa hannunta ta hanyar yin amfani da rigar da ta dace na tunanin da ke nuna fahimtar laifinta game da laifin da ta aikata da kuma tilasta wa mijinta ya aikata.
An gano cewa mutane bayan sun tuna ko sun yi tunanin yin aiki marar kyau, suna yin tunani game da wanke hannu fiye da wasu, kuma suna ba da ƙarin darajar kayan wanke hannu.
Bugu da ƙari, waɗanda aka ba da izinin wanke hannu bayan irin wannan tunanin ba su da wataƙila su shiga cikin "tsabtace laifi" ko wasu ayyukan gyara kamar masu aikin sa kai.
Wasu addinai sun yi ikirarin wanke hannu don kiyaye tsabta da kuma wasu dalilai. Alamar wanke hannu ta amfani da ruwa ba tare da amfani da sabulu ba, yana daga cikin halaye na musamman na wanke hannu a wasu addinai, kamar Bahá'í Faith, Hinduism, tevilah da netilat yadayim a Yahudanci, Lavabo a Kristanci, da Wudhu a addinin Islama. Dukansu addinai sun kuma tabbatar da cewa dole ne a wanke hannu musamman bayan wasu ayyuka.
Hindu, Yahudawa da Musulmai suna bukatar su wanke hannuwansu bayan sun yi baftisma.
Addinai na addinai na Hindu, Buddha, Sikh, Yahudawa da Musulmi suna bukatar su wanke hannuwansu kafin su ci abinci ko kuma bayan sun ci abinci.
Gudanar da hatsarin aiki a wurin aiki don COVID-19
Gudanar da haɗarin aiki don COVID-19 shine aiwatar da matakan aminci da lafiya na aiki don gudanar da haɗari don hana cutar Coronavirus 2019 (COVID-19).
Kula da haɗarin aiki a wurin aiki ya dogara da wurin aiki da aiki, dangane da kimanta haɗarin tushen haɗari, haɗarin cutar a cikin al'umma da haɗarin kowane ma'aikaci da zai iya kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA), ma'aikata masu ƙarancin haɗari ba su da alaƙa da jama'a da sauran ma'aikata, waɗanda aka ba da shawarar yin amfani da matakan rigakafin ƙwayoyin cuta na asali, gami da wanke hannu, ƙarfafa ma'aikata su kasance a gida idan suna ciwo, rashin numfashi, da kuma kiyaye tsabtace jiki da kuma kashe ƙwayoyin cuta na al'ada na wurin aiki.
Ayyukan da ke fuskantar haɗari na matsakaici sun haɗa da waɗanda ke buƙatar sau da yawa ko kusanci da mutanen da ba su san su ba ko kuma waɗanda ake zargin suna da COVID-19, amma suna iya kamuwa da cutar ta hanyar ci gaba da kamuwa da cutar ko tafiya ta duniya.
Wannan ya hada da ma'aikatan da ke da alaƙa da jama'a, kamar a makarantun muhalli na aiki, da yawan jama'a da kuma wasu manyan kantunan sayar da kayayyaki.
Gudanar da haɗari ga ƙungiyar, ban da matakan rigakafin kamuwa da cuta na asali, ya haɗa da iska mai inganci, iska mai hana kumburi, da kuma kayan kariya na mutum wanda za a iya amfani da shi a yayin haɗuwa da waɗanda ke da COVID-19.
OSHA ta dauki ma'aikatan kiwon lafiya da wuraren jana'izar da aka sani ko ake zaton suna da cutar COVID-19 a cikin haɗarin haɗari ta hanyar tuntuɓar kai tsaye wanda ke ƙara haɗarin haɗari idan ma'aikatan suka aiwatar da tsarin samar da takaddun shaida ko tattara ko cire samfurori daga mutanen da aka sani ko ake zaton suna da COVID-19.
Gudanar da haɗari ga waɗannan ma'aikatan ya ƙunshi sarrafa injiniyoyi kamar su dakunan iska masu matsin lamba mara kyau da kayan kariya na mutum masu dacewa da aiki.
Cutar COVID-19 na iya shafar wasu wuraren aiki.
A wasu lokatai, ma'aikata suna iya barin aiki don rashin lafiya ko kuma don tsoron haɗari.
Kasuwancin na iya canzawa a cikin sharuddan abin da ake buƙata da kuma hanyoyin samun waɗannan kaya (kamar yin tafiya zuwa kantin sayar da kaya a lokacin mafi girma ko ta hanyar sufuri ko sabis na tuki).
A ƙarshe, an dakatar da jigilar kayayyaki daga yankunan da COVID-19 ya shafa sosai. Za a iya amfani da shirin amsawa da shirye-shiryen kamuwa da cuta don gabatar da ayyukan rigakafi.
Shirin daidaita matakan haɗarin da ke tattare da aiki da ayyuka daban-daban, gami da tushen haɗari, haɗarin haɗarin da ke tattare da shigar gida da al'umma, da haɗarin mutum na mutum, kamar tsufa ko yanayin lafiyar mutum.
Sun kuma tabbatar da yadda ake gudanar da ayyukan da ake bukata don magance wadannan hadarin da kuma tsara yanayin da zai iya faruwa sakamakon barkewar cutar.
Shirya da kuma amsa cutar zai iya zama batun matakin kasa ko na kasa.
Manufofin da ake da su na amsawa ga barkewar cutar sun hada da rage turawa tsakanin ma'aikata, hana mutane da ke da haɗarin mummunan sakamako na kiwon lafiya, kula da ayyukan kasuwanci, da rage tasirin tasiri ga sauran ƙungiyoyi a cikin hanyoyin samar da su.
Matsalolin da ke tattare da cutar a cikin al'umma suna faruwa ne saboda kasuwancin da ke yankunan da aka shafa suna amsawa.
Gudanar da haɗarin haɗari shine babban tsarin da aka yi amfani da shi a cikin aminci da lafiya na aiki don ingantaccen kula da haɗarin haɗari.
Lokacin da hatsarin COVID-19 ba zai iya kawar da shi ba, mafi ingancin sarrafawa shine sarrafa injiniya, sannan gudanarwa da kuma kayan kare kai na ƙarshe.
Gudanar da aikin injiniya ya ƙunshi cire ma'aikata daga haɗarin aiki ba tare da dogaro da halayen ma'aikata ba kuma yana iya zama mafi kyawun mafita don aiwatarwa.
Gudanar da gwamnati canji ne na ka'idoji ko hanyoyin aiki da ke buƙatar aiki daga ma'aikata, ma'aikata ko ma'aikata.
Kayan kare kai (PPE) ana ganin ba su da inganci fiye da na aikin injiniya da na gwamnati, amma suna iya taimakawa wajen hana wasu kalubale.
Duk wani nau'in PPE ya kamata a zaba shi bisa ga haɗarin da ke tattare da ma'aikata. Ma'aikata suna da kyau kamar yadda zai yiwu (misali kayan numfashi), suna sawa da kyau, ana bincika su akai-akai, ana kulawa da su, ana maye gurbin su, kuma ana cire su yadda ya kamata, ana tsabtace su, ana ajiye su, ko kuma ana zubar da su don kauce wa kamuwa da cuta.
A cewar Hukumar Lafiya da Tsaro ta Amurka (OSHA), ƙananan ayyukan haɗari ba su da alaƙa da jama'a da sauran ma'aikata.
Abubuwan da aka gabatar don hana kamuwa da cuta a wuraren aiki sun haɗa da wanke hannuwanmu akai-akai da motsawa, ƙarfafa ma'aikata su zauna a gida idan suna ciwo, jin numfashi, ciki har da tari da tari, samar da takarda ta bakuna da kuma daidaitawa, shirya don sadarwa ko sauya tan idan ya cancanta, ba ƙarfafa ma'aikata daga amfani da kayan aiki da kayan aikin wasu ba, da kuma kiyaye tsabtace jiki da kuma kashe ƙwayoyin cuta na al'ada na wurin aiki.
Bayyana mutum mai kamuwa da cuta da kuma ware shi muhimmin mataki ne wajen kare ma'aikata, abokan ciniki, baƙi da sauransu a wurin aiki.
Cibiyoyin Kula da Cututtuka na Amurka (CDC) suna buƙatar ma'aikata da ke da alamun cututtukan cututtukan numfashi masu tsanani su huta a gida har sai sun daina yin zazzabi, alamun zazzabi da wasu alamun aƙalla awanni 24 ba tare da shan maganin rage yawan zazzabi ko wasu magungunan motsawa ba. Dokokin hutu na rashin lafiya suna da sauƙi, wanda ke ba ma'aikatan gida damar kula da danginsu masu rashin lafiya, kuma ma'aikatan suna buƙatar sanin waɗannan ƙa'idodin.
A cewar OSHA, ayyukan da ke fuskantar matsakaicin haɗari sun haɗa da waɗanda ke buƙatar haɗuwa da juna ko kusa da su a cikin ƙafa shida (1.8 mil) na mutanen da ba a san su ba ko waɗanda ake zargin suna da cutar COVID-19 amma suna iya kamuwa da cutar SARS-CoV-2 saboda kamuwa da cutar ta ci gaba a cikin al'umma a kusa da wurin kasuwanci ko saboda mutumin ya yi tafiya na kwanan nan zuwa wurin da cutar COVID-19 ta yadu.
Waɗannan sun haɗa da ma'aikata masu hulɗa da jama'a gaba ɗaya kamar su makarantu, yanayin aiki, yawan jama'a, da wasu ƙayyadaddun tallace-tallace masu haɗari. Gudanar da aikin injiniya ga waɗannan ƙungiyoyi da ƙungiyoyin haɗari ya haɗa da shigar da iska mai ƙarfi, haɓaka iska, shigar da shinge na kariya kamar filastik, shinge na zamani, da shigar da windows na motoci don sabis na abokin ciniki. Gudanar da gwamnati ga waɗannan ƙungiyoyi da ƙungiyoyin haɗari, ƙyale ƙarfafawa ga ma'aikata su zauna a gida, maye gurbin keɓaɓɓun shinge na jiki, ƙirƙirar kayan aiki waɗanda ke ba da damar yin aiki da yawa, ƙayyade hanyoyin da za su iya hana haɗari da yawa, ƙayyade hanyoyin da za su iya magance COVID-19 da kuma magance cutar.
A cikin wannan yanayin, ana iya amfani da kayan numfashi don yin amfani da su.
Idan mutum ya yi rashin lafiya a cikin jirgin, dole ne a yi bincike don kare ma'aikatan jirgin da sauran fasinjoji, wanda ya ƙunshi raba mai cutar da sauran mutane da ƙafa 6 don sanya wani memba na ƙungiyar don ya yi wa marasa lafiya hidima kuma ya ba da masauki ga marasa lafiya, ko kuma ya nemi marasa lafiya su rufe bakinsu da hancinsu yayin da suke tari ko kuma suna ta taho.
Ma'aikatan jirgin sama su sa kayan aikin likita da za a iya ajiyewa bayan amfani yayin kula da fasinjoji da ke fama da rashin lafiya ko kuma rashin lafiyar jiki, kuma suna iya samun ƙarin kayan kariya idan kuna tafiya da zazzabi, tari ko rashin numfashi.
Ya kamata a jefa kayan hannu da sauran kayan da za a yi watsi da su a cikin jakar mai tsabta, kuma a tsabtace farfajiyar da ke dauke da kumburi da kuma kashe ƙwayoyin cuta. Don sufuri na kasuwanci, ciki har da jiragen ruwa da sauran jiragen ruwa, kula da haɗari ya ƙunshi jinkirta tafiya idan yana ciwo, kuma a keɓe shi, kuma a sanar da asibitin likita a jirgin gaggawa idan wani yana da zazzabi ko wasu alamun cutar yayin da yake cikin jirgin.
Alal misali, dole ne a yi bincike na likita a cikin ɗakin mutum. Don makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan lokaci don tsabtace ko kashe ƙwayoyin cuta idan mutum yana da cutar a cikin ɗakin makaranta ba tare da la'akari da yaduwar cikin al'umma ba.
Lokacin da aka sami matsakaicin matsakaici a cikin al'umma, ana iya aiwatar da dabarun zamantakewar al'umma kamar watsi da tafiya zuwa filin wasa, taro da sauran manyan taro kamar ilimi ko aji ko abinci a cikin kantin kofi, ƙara tsananin tsananin tsananin tsananin tsananin tsananin tashi da tashi, ƙayyade yawan baƙi marasa mahimmanci, da amfani da keɓaɓɓun wuraren kula da lafiya don yara masu alamun cututtuka kamar mura.
Lokacin da akwai yawan sufuri a cikin al'ummomin asali ban da dabarun zamantakewar jama'a, ana iya la'akari da fadada tsarin makaranta. Ga ma'aikatan da ke bin doka da ke aiwatar da ayyukan yau da kullun da sauri an dauke su low-risk ga lafiyar su ta CDC.
Jami'an da ke bin doka da ke da alaƙa da mutanen da aka tabbatar ko ake zargin suna da COVID-19 an shawarce su da su bi umarnin da ke tattare da likitan likitancin gaggawa, gami da kayan kariya na sirri.
Idan an katse sadarwa a lokacin damuwa, ma'aikata ya kamata su wanke da kuma kwantar da ƙwayoyin cuta a kan layin su da kayan aikin likita kafin su sake amfani da su ta hanyar yin amfani da sutura ko wanka, kuma su bi ƙa'idodin hanyoyin aiki na adanawa da zubar da kayan aikin likita da aka sata, da adanawa da kuma lalata tufafi.
OSHA ta ƙayyade cewa ma'aikatan kiwon lafiya da wasu wuraren binne suna da haɗarin haɗari, nau'ikan haɗarin haɗari.
Ayyukan da ke da haɗari sosai sun haɗa da samar da sabis na kiwon lafiya, tallafawa dakin gwaje-gwaje da kuma jigilar ma'aikatan likita waɗanda aka sani da marasa lafiya da ake zargi da COVID-19.
Waɗannan sun zama haɗari sosai idan ma'aikatan aikin sun ƙirƙiri iska ta taimako ko kuma sun tattara ko kuma sun riƙe samfurin sanannen ko mai cutar COVID-19.
Tsarin yin rarraba mai ƙarfi ko mai ruwa zuwa gas ya haɗa da yin amfani da sinadarin, yin amfani da maganin ƙwayoyin cuta, yin nazarin huhu, wasu hanyoyin da kuma nazarin hakora, ko tattara samfurori masu yaduwa.
Ayyukan binne gawayi masu haɗari sun haɗa da ma'aikata da ke aiki don shirya gawawwakin mutane waɗanda suka san ko suna da tabbacin cewa suna da cutar COVID-19 lokacin da suka mutu. Duk waɗannan abubuwan suna da haɗari idan aka yi musu allurar rigakafi. Ƙarin aikin injiniya don waɗannan rukunin haɗari sun haɗa da kamar ɗakin keɓewa don marasa lafiya da aka sani ko ake zargin suna da COVID-19 ya haɗa da lokacin da tsarin ƙirƙirar kayan aikin da kayan aikin ke iya harba ƙananan ɓangarori da aka ɗauka.
Ana iya amfani da iska mai ƙarancin iska a wasu wuraren kiwon lafiya da kuma wuraren binne.
Ya kamata a yi amfani da matakan tsaro na 3 a kan samfurori.
Hukumar lafiya ta duniya (WHO) ta ba da shawarar cewa an rarraba masu zuwa zuwa zuwa yankuna daban-daban na jira dangane da ko suna da cutar COVID-19. Bugu da ƙari, PPE daban-daban OSHA ta ba da shawarar yin amfani da kayan numfashi ga waɗanda ke aiki a nesa da ƙafa 6 na waɗanda aka sani ko ake zargi da cutar SARS-CoV-2 da waɗanda ke bin tsarin samar da iska.
A cikin United Arab Emirates, an yi amfani da nau'in N95 NIOSH na numfashi mai taimako ko mafi kyau a cikin yanayin da aka yi amfani da shi a cikin tsarin tsarin rigakafin numfashi mai mahimmanci wanda ya haɗa da gwaji, horo, da gwaji na likita.
Sauran nau'ikan kayan numfashi na iya samar da ƙarin kariya da inganta lafiyar ma'aikata. WHO ba ta ba da shawarar yin amfani da tufafi ba, saboda COVID-19 na da cututtukan numfashi maimakon na jiki.
Hukumar lafiya ta duniya ta ba da shawarar cewa a yi wa ma'aikatan da ke kula da wuraren shiga kawai.
Ga masu tattara kayan numfashi, masu kula da marasa lafiya ko masu jigilar marasa lafiya na COVID-19 ba tare da aiwatar da rarraba abubuwa masu ƙarfi ko ruwa zuwa gas ba, WHO ta ba da shawarar yin amfani da tabarau, na'urar rigakafi, ko kuma na rufe fuska, tufafi da kuma sutura.
An yi amfani da tsarin yin amfani da kayan kwalliya don yin amfani da kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, kayan kwalliya, da kayan kwalliya, da kayan kwalliya, da kayan kwalliya, da kayan kwalliya, da kayan kwalliya, da kayan kwalliya, da kayan kwalliya, da kayan kwalliya, da kayan kwalliya, da kayan kwalliya, da kayan kwalliya.
Saboda rashin wadatar wadatar PPE, WHO ta ba da shawarar rage bukatar PPE ta hanyar telemedicine, ta ba da izinin yin amfani da kayan aikin jiki kamar su windows, ta ba da izinin shiga cikin ɗakunan da ke da masu kula da COVID-19 kawai ta amfani da PPE da ake buƙata don takamaiman aiki, ta ci gaba da amfani da kayan numfashi iri ɗaya ba tare da cire shi ba yayin kula da marasa lafiya da yawa da ke da cututtuka iri ɗaya, bincika da daidaita layin samar da PPE, da ƙarfafa amfani da rigakafi ga marasa lafiya marasa alamar.
Daga Katherine Maher, babban jami'in Wikimedia Foundation:
Ga dukan ma'aikatan Wikimedia Foundation:
(trg) ="4"> A cikin talifin nan , an tattauna batun da ke cikin talifin nan " Lafiya a kan Aljanna . "
Ranar da lokaci: 14 ga Maris, 2020 a 00:24 UTC
Shiga cikin CC0: Babu haƙƙin mallaka:
A wannan watan, mun fahimci cewa muna cikin yanayi mai ban sha'awa.
Cutar COVID-19 ta nuna yadda mutane da duniyarmu suke da alaƙa da juna da kuma yadda muke da alhakin juna.
Ba mu da wani tsari na kalubalen da muke fuskanta, amma mun san cewa amsarmu ta fi dacewa ta dogara ne akan irin fahimtar duniya, haɗin kai da kuma gina al'umma, wanda shine zuciyar ƙungiyar.
Hotunan da kuma kulawar da muka gani a tsakanin abokan aikinmu ta hanyar imel, kira da tattaunawa, suna da ban mamaki da kuma ban mamaki da mutane da muka yi sa'a sosai mu yi aiki tare.
Ba abin da zan yi wa godiya da shi, da kuma yin taƙama da shi, fiye da yin aiki tare da ku.
A makon da ya gabata, mutane sun zo wurina suna cewa suna jin daɗin aikinmu.
Sun ji na ga abin da ake nufi a duniya ta koma Wikipedia yanzu, da kuma abin da ke nuna cewa wannan muhimmin abu yana da muhimmanci a yanar gizo kuma yana samuwa ga kowa.
Aikinku yana sa wannan ya yiwu, ko mai kula da shafin ya ci gaba da kasancewa, ko abokan aikinmu sun biya, ko kuma al'ummominmu sun kasance cikin aminci.
Duniya tana bukatar bayanan da Wikipedia ke bayarwa yanzu fiye da kowane lokaci.
Wannan lokaci ne da ba wai kawai abin da muke yi ba ne, amma yadda muke yi zai shafi duniya.
Saboda muhimmancin wannan aiki da kuma matsayin ku, za mu yi wasu gyare-gyare ga yadda muke aiki tare, farawa a mako mai zuwa.
A cikin wannan labarin, mun tattauna game da yadda za mu yi amfani da lokaci don yin wa'azi.
Kamar yadda Robyn ta ambata, kungiyar C ta taru a daren jiya don tattauna hanyoyinmu da jadawalinmu na kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun tattauna abin da muke ganin ya dace da abin da muke fuskanta da kuma yadda za mu iya inganta ƙungiyar a wannan lokacin.
Muna so mu kawar da damuwa kuma mu tallafa wa aikinmu a cikin dogon lokaci.
Idan kana bukatar ka sake kira, ba ka da matsala.
Ga dukan ma'aikata, ma'aikata da kuma ma'aikata masu kwangila:
Muna sa ran yin aiki na yau da kullum na kimanin sa'o'i 4 a rana ko sa'o'i 20 a mako har sai an ba da ƙarin sanarwa.
Ba ma yin hutu - idan za ka iya yin aiki fiye da yadda ake yi, aikin zai bukaci ka.
Amma, duniya ba ta iya hango ko za a gani ba a yanzu, kuma ko kana bukatar ka kula da ƙaunataccenka, ka sayi magani, ko ka je asibiti, lafiyarka ita ce mu fi muhimmanci.
Ba mu bin sa'a ba.
Idan kana rashin lafiya, kada ka yi aiki.
Ya kamata mu yi shiru, amma muna magana.
Babu ranar rashin lafiya ko PTO da ake buƙata - kawai gaya wa manajan ku kuma taimaka wa ƙungiyar ku gyara halaye da jadawalin don tabbatar da cewa an rufe mahimman abubuwan aikin.
(Idan mai binciken ya gano cewa kana da COVID-19, ka sanar da Bryan a cikin T&amp;C Ops don T&amp;C ta iya ba da taimako da kuma tabbatar da cewa yanayin ka ya sami kulawa ta musamman daga rukuni na gudanarwa).
Mutane za su yi aiki na awanni da yawa kuma za a biya su cikakken kuɗin.
Mun riga mun faɗi haka, kuma muna sake yin alkawarin cika alƙawarinmu ga ma'aikata da ma'aikatanmu na kowane lokaci.
Kowane mutum zai sami albashinsa bisa ga sa'o'in da suke aiki a cikin yanayi na yau da kullum.
Wannan ya haɗa da idan kana rashin lafiya kuma ba za ka iya aiki ba.
Idan ka yi aiki, za mu goyi bayan ka.
Mutane da yawa suna amfani da aiki a matsayin hanyar sadar da damuwarsu ga duniya da ke kewaye da mu.
Abin da muke yi zai iya zama sakamako mai ban mamaki, musamman a lokacin da muke cikin irin wannan yanayi.
Wannan kuma yana nufin cewa kana kula da kanka.
Muna rokon ka ka tuntubi manajanka don mu san abin da ake bukata kuma mu daidaita shi.
Aikin da ake yi a matsayin wajibi ne.
Akwai wasu abubuwa da dole ne mu ci gaba da yi.
Kungiyoyin SRE, HR Ops, Trust & Safety, da kuma HR (a tsakanin sauran kungiyoyin) suna yin aiki mai mahimmanci wanda zai iya buƙatar ƙarin taimako.
Za mu fara aiki tare da dukkan ofisoshin don tantance manufofinmu na yanzu da kuma karfafa hankalinmu ga tallafawa abin da ake bukata don aikinmu.
Akwai ayyuka da yawa da za mu yi, kuma muna mai da hankali ga ayyukan da suka fi muhimmanci.
Saurin saurin yanzu ba zai cutar da mu ba.
Ba mu da shirin bin sawun sau biyu lokacin da annobar ta wuce.
Ba za a sa ran ka yi aiki na tsawon lokaci ba don ka cika takaddama da ba a yi amfani da su ba.
Muna karɓar yanayin da ya canza kuma za mu yi aiki da sababbin manufofi da jadawalin da suka dace.
Menene ya faru game da shirin?
Don daidaitawa da sabon yanayi da kuma tsammanin aiki na yau da kullun, muna da niyyar daidaita lokacin don samar da shirin shekara-shekara na 2020-2021.
Manufarmu ita ce mu ba da shawarar tsawaita shirinmu na 2019-2020 wanda zai ba da ƙarin lokaci don tsara kasafin kuɗi don ba da damar ma'aikata su ba da fifiko ga mahimman ayyuka, kula da kansu da kula da ƙaunatattun mutane yayin karɓar waɗanda suke buƙata ko kuma suna son rage ƙididdigar a cikin makonni biyu masu zuwa.
Wannan tsawaita lokacin lokaci yana rage yawan nauyin aikin da ake yi a yanzu da kuma matsin lamba a duk faɗin ƙungiyar.
Za mu gabatar da shawarwarinmu ga hukumar mako mai zuwa kuma za mu sabunta shugabannin da kungiyoyin a mataki na gaba idan muka samu tabbaci.
Ina godiya ga ma'aikatan APP saboda jagorancinku a wannan aikin.
A cikin wannan labarin, an rubuta wasu littattafai da aka rubuta a cikin Littafi Mai Tsarki.
A makon da ya gabata, mun san cewa wani abokin aikinmu na SF na iya kamuwa da COVID-19.
Duk da haka, mun yi taka tsantsan sosai wajen daukar ma'aikatan tsabtace kwayar cutar don tsabtace duk wuraren da ke ofisoshi a San Francisco.
Sun yi amfani da maganin rigakafi a asibitoci don kashe ƙwayoyin cuta a ko'ina, kamar dakunan jiran aiki da kuma ɗakin ajiyar jiragen sama zuwa ga bene.
Gidan yana amfani da bikin kula da kansa wanda ke amfani da kayayyakin da ke tallafawa lafiyar marasa lafiya.
Mun ji cewa za a shirya ofishin sosai sa'ad da muka yanke shawarar komawa.
Ofishinmu na DC yana cikin WeWork, wanda ke raba bikin COVID-19 tare da mu da duk ma'aikatan DC.
A makon da ya gabata ne ofishinmu na DC ya koma kan tsarin nesa bisa ga shawarwarin da aka raba tare da San Francisco.
Kamar yadda wasu abokan aikinmu na NYC suka sani, mun tattauna batun haya a Brooklyn.
Waɗannan tattaunawar suna ci gaba amma ana iya jinkirta su.
Wasu abokan aikinmu suna aiki nesa a karon farko.
Abokan aikinmu na nesa sun san cewa hakan zai iya zama daidai kuma suna so su ba ku wasu shawarwari:
Ka ba da iyakar sa'a ɗaya ko biyu don yin taro.
Idan ana buƙatar tsawon lokaci, la'akari da yadda za su iya ɓace a cikin kwanaki.
Ka yi la'akari da lokacin da za a yi taro, yadda za a yi taro, da kuma yadda za a yi amfani da kayan da za a karanta a gaba.
Yi bidiyo na asali ta amfani da kayan aiki kamar Google Docs da Zoom don sauƙaƙe watsa shirye-shiryen kai tsaye da haɗin kai.
Jagoranci don daidaita kowane taro, wanda ya kamata a bi tattaunawar don tambayoyi da kuma jerin masu magana da kuma wanda ya kamata ya taimaka wajen yin tsokaci (ko yin tsokaci tare da haɗin gwiwa).
Ka aika wa masu goyon bayan fasaha imel idan kana bukatar wani bayani mai sauƙi.
Ka yi amfani da abinci mai gina jiki don yin nishaɗi.
Ka shiga #network na nesa a cikin Slack don tattaunawa da abokan aikinka game da aikin da aka yi.
HR na neman shawarwari na fasaha a kan shafin don tallafawa karuwar ayyukan rarraba kudade.
A makon da ya gabata, mun shawarci duk masu karɓar tallafin jama'a da su soke taron jama'a da Wikimedia ke tallafawa kamar su editathons har sai WHO ta sanar da cewa an dakatar da yaduwar.
Mun sanar da su cewa mun fahimci cewa shawarwarinmu na sokewa da kuma wasu takunkumi na iya sa ya zama da wuya a cika ayyukan da aka amince da su, kuma babu wanda zai iya yin hukunci don jinkirta ko gyara waɗannan manufofin.
A mako mai zuwa za mu bi ƙarin bayani game da Wikimedia da taron jama'a da kuma batutuwa na gida.
Masu sauraro daga ko'ina cikin duniya suna da damuwa da damuwa, amma suna da sauƙi a cikin bayyanar da kuma ikon mayar da hankali ga al'ummomin Wikimedia da sauransu.
A nan gaba, CRT tana aiki don ƙirƙirar shafin Meta-Wiki don samar da sararin tattaunawa ga al'ummomi don bin diddigin tasirin da kuma kula da hulɗarmu da su.
Ka kasance a cikin tuntuɓarmu game da COVID-19.
Za mu aika muku da gayyatar zuwa ga masu sauraron ku a ranar Alhamis na mako mai zuwa a 14:00 UTC/07:00 PT don taron ma'aikata na musamman.
Za mu yi amfani da wannan lokaci don raba sabuntawa da amsa tambayoyinku da kuma ciyar da lokaci a cikin dangantaka.
Muna fuskantar wannan matsalar kuma muna nan don taimakawa da dukan abin da za mu iya.
A lokaci guda, za ka iya ci gaba da neman bayanai daga wannan imel da kuma wasu muhimman bayanai game da COVID-19 a kan shafin yanar gizon Office Wiki.
CRT za ta ci gaba da sabunta waɗannan shafuka kuma duk bayanan za su kasance a wuri guda.
Muna aiki don mu ci gaba da tuntuɓar ma'aikatan da ke zaune a ƙasashen da ake fama da cutar a yanzu.
Idan kana da tambayoyi game da tafiya, abubuwan da suka faru, ayyuka masu muhimmanci, matsalolin inshora ko kuma wani abu da kake bukatar taimako, kada ka yi jinkirin sanar da shi kuma ka yi aiki tare da CRT.
Muna nan don taimaka wa mutane da kuma sadarwa da suke bukata.
Idan kana da wata matsala ko kuma ka yi tambaya, ka aika wa Bryan Judan, shugaban kungiyar HR ta duniya, imel.
Babu wani daga cikin waɗannan canje-canje da ya kamata a ɗauka a matsayin watsi da ayyukanmu da alhakinmu.
Maimakon haka, sun yarda cewa a yanzu ayyukanmu da kuma alhakinmu za su bukaci a daidaita su yadda ba mu taɓa yi ba.
Waɗannan su ne matakan da muka yi imani suna da muhimmanci don tallafa wa juna domin mu ci gaba da aiki, samar da motsinmu da goyon bayan da suke bukata da kuma duniya da sabis ɗin da suke dogara da su.
Ayyukanmu da aka tsara za su kasance suna jiranmu a lokacin da lokaci ya yi.
A yanzu, lokaci ya yi da za mu tallafa wa juna kuma mu samar da wuri don babban aikin da zai zo a cikin makonni da watanni masu zuwa.
Muna bukatar ku duka don yin hakan, don haka muna bukatar ku kula da kanku da iyalanku don ku kasance cikin mafi kyau a lokacin da ake bukata.
Yanzu ka wanke hannunka, kada ka taɓa fuskarka".
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da sauran rukuni na daraktoci (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
ACE2 shine enzyme wanda ke ɓoye a cikin ƙwayoyin cuta na huhu, jijiyoyin jini, zuciya, koda da hanji.
ACE2 yana da tasiri a kan aikin enzymes masu hana insulin (ACE), wanda ya shafi rage yawan insulin-II da kuma ƙara Ang1-7), yana mai da shi kyakkyawan magani don magance cututtukan zuciya. ACE2 kuma yana taka rawa a matsayin shigarwar kwayar cutar coronavirus.
Tsarin mutum na enzyme ne sau da yawa ake kira hACE2.
Inchotin-binding enzyme 2 wani ƙarfe ne mai ƙunshe da ƙarfe wanda ke kan farfajiyar ƙwayoyin cuta da sauran ƙwayoyin cuta.
Protein ACE2 yana dauke da wani nau'i na N-terminal peptidase M2 domain da kuma wani nau'i na acidic transporter a cikin tsarin C-terminal triamine.
ACE2 shine hanyar wucewa ta nau'in I na tsarin furotin wanda enzyme yana aiki kai tsaye zuwa farfajiyar ƙwayoyin cuta da sauran ƙwayoyin cuta.
Ƙarin ƙwayoyin ACE2 an cire su daga wani enzyme da aka sani da cedes, kuma an cire su daga jini, kuma an fitar da su zuwa cikin hanta.
ACE2 yana cikin mafi yawan kwayoyin halitta: ACE2 yana da alaƙa da ƙwayoyin halitta na ƙwayoyin cuta na II, huhu, ƙwayoyin cuta, ƙwayoyin cuta, ƙwayoyin cuta da ƙwayoyin cuta, da ƙwayoyin cuta na ƙwayoyin cuta a cikin mafi yawan kwayoyin halitta.
ACE2 mRNA kuma yana cikin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwa
Babban aikin ACE2 shine aiki a matsayin mai daidaita daidaiton amsawa ga ACE.
ACE ta hanyar rage hormone testosterone I zuwa jini, hormone testosterone II.
ACE2 ya raba amino acid carboxyl-terminal amino acid daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma ya raba shi zuwa vasodilator angiotensin (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 kuma yana iya kashe wasu sauran peptides, ciki har da [des-Arg9] - bradykinin, apelin, neurotensin, dynorphin A, da ghrelin.
ACE2 yana taimakawa wajen rage yawan amino acid mai karɓar SLC6A19 da aka gani a cikin cutar Hartnup.
Saboda ƙwayoyin cuta na ACE2 suna taka rawa a matsayin babban tashar shiga cikin kwayoyin halitta don wasu ƙwayoyin cuta, ciki har da HCoV-NL63; SARS-CoV (virus wanda ke haifar da SARS) da SARS-CoV-2 (virus wanda ke haifar da COVID-19).
Har ila yau, an bayyana cewa, karɓar S1 na SARS-CoV da SARS-CoV2 zuwa cikin ACE2 enzymes da ke kan kwayoyin halitta, wanda sakamakon haka ya haifar da rarrabuwa da kuma sanya kwayoyin cutar da enzymes a cikin endosomes na kwayoyin halitta.
Wannan aikin na kuma buƙatar samar da furotin S, wanda ke buƙatar ta hanyar TMPRSS2 a cikin kwayoyin halitta. Tashin hankali da ake bincike a ciki shine magani mai yuwuwa. Wannan aikin ya sa wasu suka yi tunanin cewa rage yawan ACE2 a cikin kwayoyin zai iya taimakawa wajen yaki da kamuwa da cuta.
Koyaya, wasu masana zamantakewa da hukumomi suna ba da shawarar ci gaba da amfani da ACE inhibitors da ARBs.
Wani bincike da aka yi a kan tsarin bincike da bincike da aka fitar a ranar 11 ga watan Yuli, 2012 ya gano cewa amfani da maganin ACE inhibitors yana da alaƙa da kuma rage 34% na yiwuwar kamuwa da cutar huhu idan aka kwatanta da wadanda ba su amfani da maganin ACE ba.
Duk da haka, ana rage haɗarin kamuwa da cutar a cikin marasa lafiya da ake bi da su da maganin ACE, waɗanda suka kasance a cikin haɗarin kamuwa da cutar, musamman a cikin marasa lafiya da cututtukan jini da rashin ƙarfi na zuciya.
Ana kuma danganta amfani da maganin ACE don rage yawan mutuwar da ke tattare da cutar huhu, kodayake sakamakon ba shi da ƙarfi fiye da haɗarin kamuwa da cutar huhu.
An yi amfani da ACE2 (rhACE2) a matsayin magani na cututtukan huhu masu tsanani, kuma yana haifar da ingantaccen juyin jini a cikin huhu, da kuma ƙwayoyin oxygen da ke haɗe da lipopolysaccharide, wanda ke haifar da mummunan cutar huhu.
Rayuwar rabi na rhACE2 a cikin mutum kusan awa 10 ne, kuma farkon aikin yana da minti 30 a kan lokacin da aka samu tasiri (lokaci) na awanni 24.
Yawancin binciken sun nuna cewa rhACE2 na iya zama magani mai nasara ga waɗanda ba su da haƙuri ga masu hana tsarin isotensin (RAS) ko a cikin cututtuka inda ake ƙara motsi na isotensin biyu. RhACE2 da aka saka an kimanta shi a cikin gwaji na asibiti don magance cututtukan hanyoyi masu tsanani.
B'COVID-19 app app app ne wanda aka kirkira don taimakawa wajen bin diddigin hulɗa da juna a cikin martani ga yaduwar cutar coronavirus a cikin 2019-20 misali, aiwatar da gano mutumin da ya yi hulɗa da wanda ya kamu da cutar.
An gabatar da aikace-aikace da yawa ko kuma an yi su ne tare da goyon bayan hukuma na wasu yankuna da wasu hukumomi.
An kirkiro wasu tsarin da za su iya samar da software na bin diddigin tasiri.
An yi magana game da damuwa game da tsare sirri, musamman game da tsarin da ke dogara da bin diddigin yanayin masu amfani da software.
Zaɓuɓɓukan da ba sa faruwa da yawa sun haɗa da amfani da siginar Bluetooth don yin rikodin nesa kusa da sauran wayoyin hannu na mai amfani.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su haɗa ayyuka don tallafawa aikace-aikacen da ke dogara da Bluetooth kai tsaye zuwa tsarin Android da iOS.
A kasar Sin, gwamnatin kasar ta hada kai da Alipay ta kaddamar da wani shiri da ke ba 'yan kasar damar duba ko sun yi hulɗa da wadanda ke dauke da cutar COVID-19.
An tura shi zuwa birane sama da 200 a kasar Sin, kuma a Singapore ana amfani da shi da sunan TraceTogether.
"An ci gaba da wannan shirin ne ta hanyar wata ƙungiyar fasaha ta gida, wadda ta fito fili kuma za ta ba da shi ga gwamnati. Macedonia ta Arewa ta tura software na ""StopKorona!"", wanda ke amfani da Bluetooth don bin diddigin hulɗa da waɗanda za su iya kamuwa da cutar da kuma ba da amsa mai sauri ga hukumomin lafiya".
An kafa wannan shirin ne ta hanyar ma'aikatar sadarwa da fasaha da ma'aikatar lafiya.
A ranar 14 ga Afrilu, 2020, aikace-aikacen wayar hannu suna jiran amincewa daga Google Play Store da Apple App Store.
"A ranar 12 ga watan Afrilu, gwamnatin kasar ta tabbatar da cewa shirin sa ido kan kamuwa da cutar yana cikin ci gaba kuma zai fara aiki a cikin makonni masu zuwa. Ana shirin yin irin wannan shirin a Ireland da Faransa (""StopCovid"").
Kasashen Australia da New Zealand na tunanin yin amfani da shirin TraceTogether da kuma bikin BlueTrace na Singapore. Rasha na son amfani da shirin rigakafin halittu ga marasa lafiya da suka kamu da cutar COVID-19 da ke zaune a birnin Mumbai, wanda aka kafa don tabbatar da cewa ba sa barin gida.
Ross Anderson, farfesa a fannin tsaro na injiniya a jami'ar Cambridge, ya bayyana yawan matsalolin da za su iya faruwa tare da aikace-aikacen da ke kan tsarin, ya haɗa da lokuta masu kyau da rashin inganci idan an yi amfani da shi ga ƙananan al'umma.
Don magance damuwar game da yaduwar aikace-aikacen coronavirus wanda ke haifar da rikicewa ko haɗari, Apple ya ƙuntata nau'ikan cibiyoyin da zasu iya shigar da aikace-aikacen da suka shafi coronavirus a cikin App Store, yana ƙuntata kawai ga masu amfani da doka ko sanannun cibiyoyin.
Google da Amazon sun yi irin wannan dokar.
Masu gudanar da yakin neman zabe sun nuna damuwa game da tasirin saka idanu na manyan fayiloli ta amfani da software na coronavirus, musamman ko za a soke tsarin saka idanu da aka kafa don magance cutar lokacin da babu barazanar ko a'a.
Kungiyar Amnesty International da wasu kungiyoyi sama da 100 sun fitar da wata sanarwa inda suka yi kira ga iyakance irin wannan bin diddigin.
Waɗannan cibiyoyin sun bayyana sharuɗɗa guda takwas game da shirin gwamnati:
"Dole ne a yi tsaro da kyau da kuma yadda ya kamata".
Za a ci gaba da saka idanu da kuma sa ido kan rashin aikin yi.
Za a yi amfani da bayanan don dalilai na COVID-19.
Ana kare amincin bayanai da kuma rashin tsaro kuma ana tabbatar da cewa an kare su bisa hujja.
Za a yi amfani da sa ido na dijital don kauce wa nuna bambanci da wahala.
Duk wani raba bayanai da wasu na uku za a yi amfani da su a cikin doka.
Dole ne a kare mutane daga cin zarafi da kuma hakkin 'yan ƙasa na amsa duk wani cin zarafi.
Ana buƙatar halartar masu ruwa da tsaki masu amfani, ciki har da masu ba da shawara ga lafiyar jama'a da kuma masu ba da shawara. Cibiyar Kula da Kwamfuta ta Jamus (CCC) da Jarida ba tare da iyaka ba (Reporters ohne Grenzen) (RSF) sun kuma fitar da jerin abubuwan da suka shafi.
Shirin Google/Apple na magance matsalar saka idanu ta hanyar cire hotunan saka idanu daga tsarin aiki na na'urorin su lokacin da ba a buƙata ba.
Wasu ƙasashe sun yi amfani da cibiyar sadarwar da ke bin diddigin tushen maimakon software, suna kawar da buƙatar sauke software da damar don kauce wa bin diddigin.
A Isra'ila, an ba da izinin yin amfani da hanyar sadarwa don bin diddigin aiki.
Maganin da ke kan layi wanda ke da ikon amfani da bayanan wuri wanda ba a bincika ba zai iya yin tasiri sosai ga sirrin mutum.
Duk da haka, ba duk tsarin da ke da cibiyar sadarwa dole ne su kasance da alaƙa da kuma bayanan wurin mutum ba. An tsara lambobin tsarin don amfani da cibiyar sadarwa guda ɗaya kawai a sadarwa (duba sashe na ƙasa).
A Koriya ta Kudu, ana amfani da tsarin da ba ya dogara da software don yin sa ido kan tasiri.
Maimakon yin amfani da software, tsarin ya tattara bayanai daga tushe daban-daban, ciki har da na'urorin hannu waɗanda ke bin diddigin bayanai da bayanan aiki na takaddun shaida, kuma ya haɗa waɗannan bayanan tare don ƙirƙirar sanarwar ta hanyar saƙon waya zuwa ga waɗanda za su iya kamuwa da cutar.
Baya ga amfani da wannan bayanin don sanar da lambobin sadarwa, gwamnati ta kuma sanya bayanin wurin a fili, abin da aka ba da izini saboda canje-canje masu yawa a cikin dokokin tsare sirri na bayanai bayan barkewar cutar MERS a kasar.
Wannan bayanin yana samuwa ga jama'a ta hanyar wasu aikace-aikace da shafukan yanar gizo. Kasashe, ciki har da Jamus, suna la'akari da amfani da tsarin tsare sirri da tsare sirri.
A ranar 6 ga Afrilu, 2020, ba a bayyana cikakken bayani ba.
Bin bin ka'idojin sirri shine kyakkyawan tsari, tare da manyan bincike da aka gudanar tun daga 2013 zuwa yanzu. Tun daga 7 ga Afrilu, 2020, ƙungiyoyi da yawa na masana sun yi nazari kan hanyoyin da suka dace da tsare sirri, kamar amfani da tsarin Bluetooth Low Energy (BLE) don yin rikodin nesa kusa da sauran wayoyin hannu na mai amfani.
Duk da haka, PEPP-PT wani aiki ne na daidaitawa wanda ya ƙunshi fasaha da fasaha, ba wani taron ba. Taron taron ya haɗa da bin diddigin da ke kusa da juna wanda zai iya kiyaye bayanan sirri da aka bincika (DP-PPT/DP-3T), lambar sadarwa ta gaggawa (TCN, lambar taron sadarwa fka, CEN), taron da ke da alaƙa da sirri da fina-finai don bin diddigin sadarwa ta wayar hannu (PACT) da sauransu.
A cewar wannan bikin, babu wani bayanan sirri da aka raba daga na'urar da kanta, kuma ana yin dukkan kayayyaki a kan na'urar.
Wata ƙungiya ta sirri a MIT Media Lab ta kirkiro SafePaths, wani tsari na software don amfani da fasahar kare sirrin sirri yayin tattarawa da amfani da bayanan wuri ko bayanan hanya don bin diddigin yaduwar COVID-19.
Ya dogara ne akan binciken da aka yi daga rahoton hukuma na amfani da software mai amfani da shi: Tsaron Sirrin Mutum a cikin Yadawa, wanda aka saki a watan Maris na 2020. Wani irin wannan yunƙurin shine SafeTrace Platform ta Enigma MPC, wani kamfanin da ke haɓaka fasahar sirrin sirri wanda aka fara a MIT Media Lab.
SafeTrace yana amfani da fasaha mai ƙarfi (kwamfuta) don ba masu amfani damar raba wurare da bayanan kiwon lafiya masu ban sha'awa tare da masu amfani da sauran jami'ai ba tare da yin tasiri ga sirrin bayanan ba.
A ranar 5 ga Afrilu, 2020, ƙungiyar TCN ta duniya ta kasance ta ƙungiyar da suka haɗu a kusa da abin da ya fi mahimmanci shine daidaitaccen tsari da kuma yawancin ayyukan gudanarwa, tare da nufin rage rarrabuwa da kuma kunna haɗin gwiwar ci gaba da sa ido da shirye-shiryen tunatarwa, wanda shine babban mahimmancin samun karbuwa gaba ɗaya.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta bude wani bude lambar BlueTrace wanda ke amfani da software na gwamnati.
A ranar 10 ga Afrilu, 2020, Google da Apple, masu gudanar da tsarin wayar hannu na Android da iOS, sun sanar da wani shiri don bin diddigin tasirin kwayar cuta wanda suka yi ikirarin zai kare sirrin mutum bisa hadewar fasahar Bluetooth mai amfani da wutar lantarki da kare sirrin mutum.
Sun kuma buga fasahar fasahar da ake amfani da ita a cikin tsarin.
A cewar Apple da Google, ana nufin ƙaddamar da tsarin a matakai uku:
Gwamnati ta tura kayan aiki don samar da shirin sa ido kan cutar.
Apple yana da shirin magance matsalolin karɓa da matsalolin saka idanu da ke faruwa, da farko yana rarraba tsarin ta hanyar sabunta tsarin aiki. Daga baya yana cire shi ta wannan hanyar lokacin da barazanar ta wuce.
Sake amfani da magani (wanda kuma aka sani da sake amfani da magani, sake aiki, ko canza magani) shine amfani da magani wanda aka yarda dashi don magance wata cuta ko yanayin likita daban da yadda aka fara kirkireshi.
Wannan bincike ne na kimiyya wanda a halin yanzu yake daukar mataki na gaba wajen bunkasa ingantacciyar da kuma ingantacciyar maganin COVID-19.
Sauran fannonin bincike sun hada da samar da allurar rigakafi don COVID-19 da kuma shigar da jini mai dauke da SARS-CoV-2 wanda ya ƙunshi kimanin nau'ikan 66 na kwayoyin halitta, kowannensu yana da wuraren haɗin gwiwa.
Binciken wuraren da ke da alaƙa zai iya ba da kyakkyawan dalili a cikin shirin haɓaka maganin rigakafin ƙwayoyin cuta na COVID-19.
Daga cikin manyan sunadarai masu amfani da SARS-CoV-2 sun kasance sunadarai masu kama da papain protease RNA-based RNA polymerase, helicase, S protein, da ADP ribophosphatase.
Hussein A, et al sun yi nazarin kwayoyin halitta da yawa waɗanda suka inganta kamanceceniyar ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin ƙashin
Chloroquine magani ne na maganin kansa wanda aka yi amfani da shi don magance wasu cututtukan rigakafi.
A ranar 18 ga watan Maris, Hukumar Lafiya ta Duniya ta sanar da cewa chloroquine da hydroxychloroquine da ke da alaƙa sun kasance daga cikin magunguna huɗu da aka yi nazarin su a cikin gwajin gwaji.
Gwamnan New York, Andrew Cuomo, ya sanar da cewa gwajin jihar New York na chloroquine da hydroxychloroquine zai fara a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta amince da amfani da hydroxychloroquine sulfate da chloroquine phosphate a ƙarƙashin izinin gaggawa (EUA).
Ba a ba da izinin yin amfani da wannan magani a cikin FDA's trial phase, kuma duk ikon yana ƙarƙashin EUA kawai. Gwajin wannan magani yana yiwuwa ne kawai ga marasa lafiya da ke cikin asibiti, kuma ba za a iya yin amfani da wannan magani a cikin gwajin ba.
CDC ta ce ba a kafa amfani da allurai ko tsawon lokacin hydroxychloroquine don hana cututtuka ko maganin kamuwa da cutar SARS-CoV-2 ba.
"Kwararrun likitoci sun ce suna amfani da magani ne a lokacin da ""babu wani zaɓi""".
Wani rukuni na masu bincike na Turkiyya a Istanbul suna gudanar da wani karamin bincike kan amfani da chloroquine tare da C, Vitamin E, Vitamin C da Vitamin D.
Akwai manyan karatu a Jami'ar Duke da kuma Jami'ar Oxford.
Makarantar likitancin NYU Langone ta jagoranci gwajin gwaji kan amincin amfani da hydroxychloroquine don maganin rigakafi.
Gwaje-gwajen asibiti na kasar Sin a Wuhan da Shenzhen sun nuna cewa maganin favipiravir yana da tasiri sosai.
Mutane 35 a birnin Sinjin sun yi gwajin rashin lafiya a matsakaici na kwanaki 4, yayin da tsawon cutar ya kasance kwanaki 11 a cikin marasa lafiya 45 da ba su samu ba.
A wani bincike da aka gudanar a Wuhan, an yi amfani da maganin favipiravir a kan mutane 240 da ke fama da cutar huhu, kuma an ba da kashi ɗaya cikin rabi na mutanen da suka karɓi maganin umifenovir.
Hukumar ta Italiya ta tunatar da jama'a cewa akwai hujja da ta goyi bayan wannan magani, amma ba ta isa ba kuma ba ta da asali.
A ranar 2 ga watan Afrilu, Jamus ta sanar da cewa za ta sayi magani daga Japan don ajiyarta kuma za ta yi amfani da shi don isar da shi zuwa asibitocin jami'a, inda za a yi amfani da shi don magance COVID-19.
A cewar jaridar South China Morning, Shinzo Abe ya sa gwamnatin Trump ta sayi wani magani wanda ba shi da tasiri a magance cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan.
Ga mata masu ciki ko kuma waɗanda suke ƙoƙarin yin ciki, ba zai iya zama lafiya ba.
"Bincike na lopinavir/ritonavir (Kaletra), wanda ya kasance hade da lopinavir da ritonavir, ya kammala cewa ""ba a lura da wani amfani ba""".
Magunguna da aka yi don hana kwayar cutar HIV ta rarraba ta hanyar ɗaure ta zuwa enzymes.
Masu bincike a Jami'ar Colorado suna kokarin gyara magunguna don gano sinadarai da zasu danganta da enzymes na SARS-CoV-2. Akwai zargi a cikin al'umma ta kimiyya game da ƙaddamar da albarkatu ga magunguna da aka tsara musamman don cutar AIDS.
Hukumar Lafiya ta Duniya ta sanya lopinavir/ritonavir a cikin gwajin gwaji na duniya.
An kirkiro Remdesivir kuma masana kimiyya na Gilead sun ci gaba da yin amfani da shi wajen magance cutar Ebola da cutar Marburg. Masana kimiyya na Gilead sun kuma gano cewa Remdesivir yana da aiki wajen yaki da yawancin ƙwayoyin cuta na philoneumoma, paramyso, da corona a cikin dakin gwaje-gwaje.
Wata matsala da ke tattare da maganin rigakafi ita ce, ci gaban kiba ta hanyar canjin metabolism, wanda zai iya haifar da rashin lafiya mai tsanani da kuma kamuwa da cuta mai tsanani.
Wasu nazarin da aka yi kafin gwaji sun nuna cewa yin methanosis na iya haifar da babban sakamako na rashin nauyi. Akwai gwaje-gwaje na asibiti da yawa, ciki har da biyu da asibitocin Jami'ar Cleveland suka gudanar.
Akwai gwaji uku na ci gaba da amfani da bitamin a cikin asibiti na asibiti da kuma rashin lafiya mai tsanani tare da COVID-19, biyu suna da iko (China, Kanada) da kuma wani ba tare da kulawa ba (Italiya).
Jihar New York ta fara gwajin maganin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya da Lafiya ta Duniya ta Japan (NCGM) na shirin yin gwajin maganin Alvesco (ciclesonide) na Teijin, wani magani mai suna hormonal steroid wanda aka shirya don cututtukan zuciya don magance marasa lafiya na farko da suka kamu da cutar.
Wani nau'i na enzymes2 wanda ke lalata anesthesia, wani gwaji na mataki na biyu, yana gudana tare da marasa lafiya 200 da aka zaɓa daga cikin manyan lokuta a asibitoci a Denmark, Jamus da Austria don tantance tasirin magani.
Masu bincike daga Cibiyar Zuciyar Montreal a Kanada a yanzu suna nazarin rawar da collagen ke takawa wajen rage kumburi da kuma tasirin huhu a cikin marasa lafiya da ke fama da alamun COVID-19.
Wannan binciken, mai suna Colcorona, yana tattara manya 6,000 da suka kai shekaru 40 da haihuwa waɗanda aka riga aka gano suna da COVID-19 kuma suna da alamun bayyanar cututtuka waɗanda ba sa buƙatar asibiti.
Ba a haɗa mata masu ciki ko masu shayarwa ba ko kuma waɗanda ba su yi amfani da wata hanya ba.
An gwada wasu magungunan anticoagulant a Italiya.
Ana amfani da maganin Eparin mai ƙarancin nauyi a cikin maganin marasa lafiya, wanda ke sa Hukumar Kula da Magunguna ta Italiya ta fitar da jagororin amfani da shi.
A cewar wani bincike kan marasa lafiya 300 kan amfani da maganin sodium enoxaparin a cikin allurar rigakafi da magani, an sanar da shi a Italiya a ranar 14 ga Afrilu.
Saboda SARS-CoV-2 kwayar cutar ce, an mayar da hankali ga ilimin kimiyya kan manufar amfani da sabbin magungunan rigakafin cutar da aka ba da izini da kuma ci gaba don barkewar cututtukan da suka gabata kamar cutar MERS, SARS da West Nile Virus, da sauransu.
Ribavirin An ba da shawarar ribavirin don amfani da cutar COVID-19 bisa ga ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar
Umifenovir: An ba da shawarar yin amfani da umifenovir don maganin COVID-19 bisa ga ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'idar ƙa'
Wasu magungunan rigakafi da aka gano don magance COVID-19 sune:
Tocilizumab (mai karɓar kwayoyin cuta na IL-6): An amince da shi a kasar Sin.
Kazalika da gwaji a Italiya da China, duba Tocilizumab#COVID-19.
Allurar COVID-19 ta b'A ita ce allurar da ke aiki da cutar coronavirus a shekarar 2019 (COVID-19).
Ko da yake babu wani rigakafin da aka kammala, wasu gwaje-gwaje na kan gaba ne don samar da irin wannan rigakafin.
A karshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya ta bayyana cewa ba ta tsammanin za a sami allurar rigakafin cutar SARS-CoV-2 ba, wanda shine cutar da ke haifar da mutuwa a cikin ƙasa da watanni 18.
Kwanan nan, an kammala gwajin rigakafin a cikin wani shiri na farko na binciken lafiya a watan Afrilu.
An gano cutar COVID-19 a watan Disamba na 2019.
Babban fashewa ya bazu ko'ina cikin duniya a cikin 2020, wanda ya haifar da saka hannun jari da bincike mai yawa don ƙirƙirar allurar rigakafi.
Yawancin hukumomi suna amfani da kwayoyin da aka gabatar don ƙirƙirar allurar rigakafi da za ta iya hana SARS-CoV-2.
Abubuwan da ake bukata na CEPI don ci gaban allurar rigakafi da aka gabatar a watan Afrilu sune hanzarta samarwa, haɓakawa da samun damar shiga duniya.
A watan Afrilu, masana kimiyya daga CEPI sun ruwaito cewa dandamali daban-daban na fasaha 10 suna karkashin bincike da ci gaba a farkon 2020 don ƙirƙirar allurar rigakafi mai tasiri akan COVID-19.
Manufofin manyan nau'ikan da aka cimma a cikin binciken tsaro na Phase I sun hada da:
DNA da RNA (mai haɓaka mataki na farko da gwajin allurar rigakafi: Moderna, mRNA-1273)
Abubuwan da ke tattare da cutar (masana da masu gwajin allurar rigakafi na farko: CanSino Biologics, Adeno Virus Type 5 Victor)
A cewar wani rahoto da ƙungiyar masana kimiyya daga CEPI ta bayar a watan Afrilu, akwai alluran rigakafi 115 da ke cikin matakai na farko na ci gaba, tare da alluran 78 da aka tabbatar a matsayin ayyukan da ke gudana (79 a cewar Cibiyar Milken) kuma an sanar da wasu 37 amma ba a san komai ba a fili (a zato cewa komai yana cikin shiri da ci gaba).
Gwaje-gwaje na I-II na gaba suna haifar da gwajin aminci da rigakafi, yawanci bazuwar, ana sarrafa miyagun ƙwayoyi a wurare da yawa yayin da ake tantance tabbataccen sashi da inganci.
Gwajin gwaji na II na buƙatar mahalarta da yawa, gami da ƙungiyoyin kulawa da gwaji don tasirin rigakafin cutar yayin da ake duba don samun sakamako mai kyau.
"Daga cikin alluran rigakafin 79 da ke cikin ci gaba mai aiki (wanda aka tabbatar a farkon Afrilu 2020), alluran rigakafin 74 ba su cikin kimantawa a cikin mutane ba (wanda ke cikin bincike na ""pre-treatment"")".
A ranar 24 ga Janairu, 2020, a Ostiraliya, Jami'ar Finland ta sanar da cewa tana binciken yiwuwar allurar rigakafin kwayoyin da za su gyara furotin na kwayar cutar don inganta aikin rigakafi.
A ranar 24 ga Janairu, 2020, a Kanada, Cibiyar Hoto ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da fara aikin allurar rigakafi da nufin fara gwajin a kan mutane a 2021.
An sanar da shirin ci gaban allurar rigakafi a Cibiyar Kula da Cututtuka ta China a ranar 26 ga Janairu, 2020 da Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, kamfanin Janssen Pharmaceutical, wanda Hanneke Schuitemaker ke jagorantar, ya sanar da cewa ya fara aikin ci gaba da allurar rigakafi.
Kamfanin Janssen Pharmaceuticals na aiki tare da kamfanin Vaxart don samar da maganin baki.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwa tare da Vaxart don haɓaka allurar rigakafi.
A ranar 8 ga Fabrairu, 2020, dakin gwaje-gwaje na OncoGen a Romania ya wallafa wani kwayar cutar da ke da fasahar kama da magani don magance cutar ta hanyar allurar neoantigen.
A ranar 25 ga watan Maris, shugaban cibiyar ta sanar da cewa sun kammala gwajin rigakafin kuma suna fara gwaji.
A ranar 27 ga Fabrairu, 2020, NuGenerex Immuno-Oncology, wani kamfani na Generex, ya sanar da cewa suna fara aikin allurar rigakafi don samar da allurar amino acid-key (Ii-Key) a cikin rigakafin COVID-19.
"Suna son samar da kwayar cutar da za ta iya gwadawa a kan mutane a cikin kwanaki 90".
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da shirin ta na samar da rigakafin.
A ranar 5 ga Maris, 2020, sojojin Amurka da Cibiyar Nazarin Kayan Aiki da Kayan Aiki a Fort Detrick da Cibiyar Nazarin Soja ta Walter Reed a Silver Spring, a yammacin Maryland, sun sanar da cewa suna aiki kan samar da maganin.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta yi aiki tare da Novavax Inc.
A cikin ci gaba da samar da alluran rigakafi.
Abokan hulɗar sun sanar da wasu tsare-tsaren don gwajin bincike da gwajin magani na Phase I a watan Yuli na 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna aiki tare da mutane 11 da aka keɓe, kuma ko da hanya mai sauri tana buƙatar aƙalla shekara ɗaya da rabi zuwa shekaru biyu don ƙirƙirar allurar rigakafi.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin fasaha na zamani a Quebec, ya ba da rahoton samar da kwayar cutar coronavirus, tare da taimakon wani ɓangare daga Cibiyar Nazarin Kiwon Lafiya ta Kanada.
Ana gudanar da bincike a cikin dakin gwaje-gwaje, tare da shirin gwaji a watan Yuli ko Agusta 2020.
A farkon makon nan, jaridar The Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya ba CureVac babban adadin kuɗi don samun damar yin amfani da allurar COVID-19 ta farko da gwamnatin Jamus ta yi ta yi ta yi ta korafi da ita.
A ranar 17 ga Maris, 2020, kamfanin magunguna na Amurka Pfizer ya sanar da cewa zai yi aiki tare da kamfanin BioNTech na Jamus don samar da allurar rigakafi bisa mRNA.
An shirya gwajin gwajin gwajin mRNA, BNT162, yanzu don gwaji a cikin gwajin gwaji, wanda ake sa ran farawa a watan Afrilu na 2020.
A Italiya a ranar 17 ga Maris, 2020, kamfanin Takis Biotech na Italiya ya sanar da cewa za su fara gwajin asibiti a watan Afrilu na 2020, kuma za a iya fara gwajin rigakafin su na karshe a kan mutane a lokacin bazara.
A Faransa, a ranar 19 ga Maris, 2020, CEPI ta sanar da saka hannun jari na dala miliyan 4.9 a cikin kungiyar bincike kan allurar rigakafin COVID-19 ta hanyar Cibiyar Nazarin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayoyin Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwayar Kwa
Sauran abokan cinikin CEPI don samar da allurar rigakafin COVID-19 sun kasance Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin dabbobi ta amfani da alluran rigakafi guda shida daban-daban.
Masu bincike a Kwalejin Imperial ta London sun sanar a ranar 20 ga Maris, 2020 cewa suna samar da rigakafin da zai iya kara girman kansa, rigakafin RNA don COVID-19.
An kirkiro rigakafin gwaji a cikin kwanaki 14 bayan samunsa daga China.
A karshen watan Maris, gwamnatin Kanada ta sanar da bayar da dala miliyan 275 na Kanada don ayyukan bincike 96 kan matakan kiwon lafiya na COVID-19, gami da shirye-shiryen rigakafin a kamfanoni da jami'o'in Kanada, kamar na Medihuago da Jami'ar Saskatchewan.
A lokaci guda, gwamnatin Kanada ta sanar da bayar da dala miliyan 192 na Kanada, tare da mayar da hankali musamman ga samar da allurar rigakafin COVID-19, tare da shirin samar da sabbin tarin alluran rigakafi na kasa da yawa waɗanda za a iya amfani da su idan akwai barkewar cutar.
A ranar 2 ga Afrilu, 2020, masu bincike a Kwalejin Likitoci ta Jami'ar Pittsburgh sun ba da rahoton gwajin PittCoVacc, wanda zai iya zama COVID-19 a cikin tsutsotsi, inda suka tabbatar da cewa MNA ta ba da rigakafin SARS-CoV-2 S1, wanda ke ɓatar da takamaiman amsawar jiki don ƙarfin antigen [a cikin tsutsotsi] wanda ke faruwa a makonni 2 bayan allurar rigakafi.
A Kanada, a ranar 16 ga Afrilu, 2020, Jami'ar Kwalejin Magunguna ta Tarar da Labarai ta sanar da zanen wani allurar rigakafi mai tushen DNA wanda zai iya zama maganin hanci.
Ta hanyar amfani da kwayoyin cuta, za a tsara DNA don kwafa a cikin kwayoyin mutum don samar da ƙwayoyin cuta masu ƙarancin gaske, kamar ƙwayoyin cuta, waɗanda zasu iya ƙarfafa tsarin garkuwar jiki don samar da kwayoyin cuta na SARS-CoV-2.
A watan Maris na shekarar 2020, gwamnatin Amurka, manyan masana'antu da jami'o'i uku sun haɗu don amfani da kwamfutar IBM ta supercomputer tare da albarkatun ajiyar bayanai na Hewlett Packard Enterprise, Amazon, Microsoft da Google.
Wasu magungunan suna da tasiri na jini ko kuma suna da tasiri.
Wannan yana nufin cewa suna da amfani fiye da cututtukan da suke hanawa.
Wani binciken da aka yi a Australia ya nuna cewa akwai ma'aikatan kiwon lafiya 4,170 da ke son shiga makarantar.
Allurar da za a iya yi a ci gaba ba za ta kasance da aminci ko tasiri ba.
Kwanan nan, an gudanar da bincike kan tasirin allurar rigakafi a cikin rigakafin COVID-19 akan ACE2-transgenic na dabbobi kamar su tsutsa, dabbobi a cikin dakunan gwaje-gwaje da kuma dabbobi ba mutane ba. Dukkanin waɗannan abubuwan suna da mahimmanci ga lafiyar kwayoyin halitta na 3 a cikin kula da kwayar cutar da ke rayuwa da kuma daidaitawa na duniya don tabbatar da daidaitattun hanyoyin tsaro.
An gwada rigakafin SARS da MERS a cikin dabbobi, ba mutane ba.
A shekarar 2020, babu magani ko allurar rigakafin SARS da aka tabbatar da cewa tana da aminci da inganci ga mutane.
A cewar wani bincike da aka fitar a 2005 da 2006, ganowa da kuma bunkasa rigakafi ko maganin cutar SARS shine babban fifiko ga gwamnatoci da hukumomin lafiya a duniya. Ba su da rigakafin cutar MERS.
Yayin da cutar ta MERS ta bazu, ana ganin cewa binciken cutar da aka yi a nan gaba zai iya samar da samfurori masu amfani ga ci gaban allurar rigakafi da hanyoyin magance cutar MERS-CoV.
A watan Maris na shekarar 2020, an samu rigakafin cutar MERS (wanda aka yi amfani da shi ta hanyar DNA) wanda ya kammala gwajin farko na mutum, kuma ana gudanar da wasu gwaje-gwaje guda uku, dukansu sun kasance rigakafin da ke amfani da cutar a matsayin wakili. Daga cikinsu akwai biyu, ChAdOx1-MERS, BVRS-GamVac, da kuma wani, MVA-MERS-S.
Tallace-tallacen kafofin watsa labarun sun nuna wata hujja ta cewa an gano kwayar cutar da ke bayan COVID-19 kuma riga an sami rigakafin.
Patents da aka yi amfani da su daga kafofin watsa labarun sun ba da damar yin amfani da takardun shaida game da tsarin kwayoyin halitta da rigakafi don sauran ƙwayoyin cuta kamar SARS.
Cutar coronavirus ta 2019 (COVID-19) ta haifar da mummunan cutar ta hanyar numfashi ta hanyar cutar coronavirus 2 (SARS-CoV-2).
Alamun cututtuka na yau da kullum sun haɗa da zazzabi, tari, da kuma rashin numfashi.
Sauran alamun na iya kasancewa gajiya, ciwon tsoka, ciwon hanci, rashin jin daɗi, da kuma ciwon ciki.
Lokaci bayan bayyanar cututtuka har zuwa bayyanar cututtuka na farko yana da kwanaki biyar, amma zai iya wucewa daga kwana biyu zuwa goma sha huɗu.
Yayin da yawancin lokuta ke haifar da bayyanar cututtuka, wasu suna ci gaba da kamuwa da cutar huhu da kuma lalacewar kwayoyin halitta.
A ranar 17 ga Afrilu, 2020, an samu karin shari'o'i miliyan 2.24 a kasashe da yankuna 210 da suka yi sanadiyar mutuwar mutane sama da 153,000.
Mutane sama da 568,000 sun warke. An yi amfani da kwayar cutar ne wajen yada cutar tsakanin mutane yayin da suke hulɗa da juna, sau da yawa ta hanyar ƙananan ruwa da ke fitowa daga tari ko magana.
Lokacin da aka samar da waɗannan ruwan, lokacin da aka numfasa su, yawanci suna sauka a ƙasa ko ƙasa maimakon wucewa ta nesa.
Mutane suna kamuwa da cutar ta hanyar yin amfani da jiki don yin amfani da kwayoyin cuta, sannan kuma su shafi idanunsu, hanci da bakinsu.
Kwayar cutar tana iya zama a waje har tsawon sa'o'i 72.
Yana da matukar damuwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, wanda ke nufin cewa kamuwa da cutar na iya kasancewa kafin bayyanar cututtuka ko kuma a matakai daban-daban na cutar. Hanyar da za a iya yin bincike ta yau da kullun ita ce ƙididdigar ƙwayoyin cuta akan allurar polymerase, ta hanyar yin amfani da rRT-PCR, wanda aka ɗauka daga samfurin hanci da kuma ƙwayar cuta.
Ana ba da shawarar yin amfani da abin rufe fuska ga waɗanda suka yi zaton suna da cutar da kuma masu kula da su.
Shawarwarin yin amfani da masks a wuraren da jama'a ke da halaye daban-daban, wasu hukumomi suna ba da umarni game da sanya su, wasu kuma suna amfani da su, wasu kuma suna buƙatar su sanya su.
A halin yanzu babu wani rigakafi ko magani na musamman na COVID-19.
An samu kamuwa da cutar a cikin gida a mafi yawan ƙasashe a cikin yankuna shida na WHO.
Mutumin da ya kamu da cutar zai iya jin kome ko kuma ya sami alamun sanyi, kamar zazzabi, tari, da kuma gajeren numfashi.
Alamomin gaggawa sun haɗa da numfashi mai zafi, ciwon kirji, ko kuma ciwon hanzari, rikicewa, rashin barci, da kuma rashin hankali, ko kuma ruɗar baki. Ana ba da shawarar samun gaggawa idan akwai waɗannan alamun.
Alamu na ciki na numfashi suna kama da rashin ƙarfi, rashin ƙarfi, ko kuma ciwo.
Alamu na cututtukan ciki kamar su ciwon kumburi, kumburi da kumburi an lura da su a hanyoyi daban-daban.
Wasu a kasar Sin sun fara nuna cewa suna da ciwon kirji da kuma ciwon kirji.
A wasu lokatai, cutar tana iya zama kumburi, kumburi, da mutuwa.
Wannan shi ne lokacin da ake kira lokaci na yin amfani da shi.
Ana amfani da kwanaki biyar zuwa shida kafin bayyanar cututtuka ta COVID-19, amma ana iya samun bayyanar cututtuka tsakanin ranar 2 zuwa 14.
Kashi 97.5 cikin dari na mutanen da suka kamu da cutar za su samu wannan yanayin a cikin kwanaki 11.5 na kamuwa da cutar. Rahotanni sun nuna cewa ba duk waɗanda suka kamu da cutar ba ne ke ci gaba da kamuwa da cutar.
Ba a san ainihin matsayin waɗannan rukunin kwayoyin da ba su nuna alamun ba a cikin watsa kwayoyin. Duk da haka, shaidar farko ta nuna cewa suna iya taimakawa wajen yaduwar cutar.
A halin yanzu ba a san adadin wadanda suka kamu da cutar ba kuma ana gudanar da binciken, Cibiyar Kula da Cututtuka da Rigakafin Cutar Korea (KCDC) ta ruwaito cewa kashi 20% na dukkan wadanda suka kamu da cutar sun kasance ba su da wata alama a lokacin da suke asibiti.
Hukumar lafiya ta kasar Sin ta fara lissafin marasa bayyanar cututtuka a cikin shari'arta ta yau da kullum a ranar 1 ga Afrilu, daga cikin mutane 166 da suka kamu a wannan rana, wanda ya kai 130 (78%) wadanda ba su da bayyanar cututtuka a lokacin gwajin.
A cikin hanci da kuma a cikin bakuna, ana iya samun ƙwayoyin cuta da yawa.
Magana da ƙarfi tana fitar da ruwa fiye da yadda ake magana.
Wani bincike a Zimbabwe ya gano cewa, yawan kuka yana iya sa ruwan sama ya kai tsawon mil 4.5 (15 ft).
Ko da yake cutar ba ta yaduwa ta iska, masana kimiyya na Majalisar Dinkin Duniya sun ba da shawarar cewa watsa kwayoyin halitta zai yiwu, kuma masu tattara iska sun sanya su a cikin manyan ɗakunan waje na ɗakunan mutane don ƙirƙirar samfurin da ya dace don RNA.
Wasu hanyoyin magani kamar su iska da kuma bugun zuciya (CPR) na iya haifar da dakatar da iska ta waje, wanda ke haifar da kamuwa da iska.
Duk da yake akwai damuwa cewa zai iya kamuwa da cutar ta hanyar nono, ana ganin cewa haɗarin yana da ƙananan. Kwayar cutar tana da sauƙi a lokacin da mutum ya kamu da cutar, yayin da yaduwar zai iya faruwa kafin bayyanar cututtuka ta bayyana, haɗarin yana da ƙananan.
Cibiyoyin Kula da Cututtuka na Turai (ECDC) sun ce, yayin da ba a san yadda cutar ke yaduwa ba, a yawancin lokaci mutum zai iya kamuwa da cutar daga mutum biyu zuwa uku.
A musamman, an gano cewa cutar za ta iya kasancewa a rana ɗaya a kan takarda na katako har zuwa kwana uku a kan filastik (polypropylene) da karfe mai amfani (AISI 304) da kuma har zuwa awanni huɗu a kan igiyar ruwa mai tsawon kashi 99%.
Duk da haka, ya bambanta dangane da danshi da zafin jiki.
Sabulu da sabulu na wanka suna da tasiri idan aka yi amfani da su yadda ya kamata. Sabulu yana lalata shuka, yana hana ƙwayar cutar mai ƙanshi, da kuma sautin fata da sauran farfajiya.
Sauran magunguna kamar benzalkonium chloride da chlorhexidine gluconate (magungunan kashe kwayoyin cuta) sun kasance marasa inganci. A cikin binciken da aka yi a Hong Kong, an ɗauki samfurin ruwan sha na tsawon kwanaki biyu bayan fara asibiti.
Mutum biyar cikin shida da aka yi gwajin sun sami karuwar cutar a ranar farko, kuma mutum shida ya sami karuwar cutar a ranar biyu.
Alamomin cutar ta hanyar numfashi mai tsanani, Coronavirus 2 (SARS-CoV-2), suna kama da alamomin cutar ta hanyar numfashi mai tsanani na sabon coronavirus, wanda ya fara fitowa daga wasu marasa lafiya uku da ke fama da cutar huhu, waɗanda ke da alaƙa da rukunin cututtukan numfashi mai tsanani a Wuhan.
Dukkanin siffofin sabon SARS-CoV-2 sun faru ne a cikin kwayar cutar da ke da alaƙa da coronavirus.
A waje da jikin mutum, ana kashe kwayar ta da sabulu na gida wanda ke haifar da fashewar kariya. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
Fuskar mutum ita ce mafi yawan kwayoyin da COVID-19 ta shafa, saboda kwayar cutar ta shiga cikin ƙwayoyin cuta ta hanyar canza ƙwayoyin cuta zuwa enzyme 2 (ACE2), wanda ƙananan ƙwayoyin cuta ke sarrafawa, nau'in na biyu na huhu.
"Wannan kwayar cutar tana amfani da wani nau'in kwayar halitta a farfajiyar da ake kira "spike" (peplomer) wanda ke haɗe da ACE2 kuma yana shigar da kwayar halitta mai ɗaukar hoto".
An gano cewa cutar ta zuciya ta kamu da kashi 12 cikin 100 na mutanen da suka kamu da cutar kuma suna asibiti a Wuhan, China, kuma yawancinsu suna da tsanani.
Yawan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Ana nuna masu karɓar ACE2 sosai a cikin zuciya kuma suna shiga cikin aikin zuciya.
An gano yawan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Ko da yake SARS-COV-2 yana buƙatar enzyme ACE2 wanda ke cikin ƙwayoyin cuta, marasa lafiya masu fama da COVID-19 suna da alamun bayyanar cututtuka kamar su kumburi.
A musamman, GM-CSF ta fitar da T-cell, wanda ya nuna alaƙa a cikin kumburi, saboda yana da alaƙa da sakin IL-6 daga monocytes da kuma cututtukan huhu masu tsanani a cikin COVID-19.
An kuma ruwaito cewa an yi amfani da kwayoyin halitta wajen yin amfani da lymphocyte.
Hukumar lafiya ta duniya ta bayyana hanyoyi da dama da za a iya gano kwayar cutar.
Hanyar gwajin misali ita ce ta hanyar yin amfani da rt-PCR (rT-PCR).
Ana yin wannan gwajin ne a kan samfurori na numfashi da aka samu ta hanyar sauti. Duk da haka, ana iya amfani da samfurori na hanci ko kuma samfurori na kuskure.
A yawancin lokaci, ana iya ganin sakamakon a cikin sa'o'i biyu zuwa kwana biyu.
Ana iya yin gwajin jini, amma ana bukatar a raba jini biyu na mako biyu, kuma sakamakon nan take ba shi da muhimmanci.
Masana kimiyya na kasar Sin sun iya gano kwayar cutar coronavirus kuma su yada shi, don haka dakunan gwaje-gwaje a duk faɗin duniya na iya ƙirƙirar gwajin polymerase mai zaman kanta don gano kamuwa da cutar.
A ranar 4 ga Afrilu, 2020, ana ci gaba da yin gwajin kwayoyin halitta (wanda zai iya gano kamuwa da cutar da kuma ko mutum ya kamu da cutar a baya) amma ba a yi amfani da shi sosai ba.
Abokan kasar Sin sun gwada gwajin da suka yi da kashi 60 zuwa 70 cikin 100 na daidaito.
Hukumar Abinci da Magunguna ta Amurka ta amince da gwajin gwaji na farko na maganin a ranar 21 ga Maris, 2020 don amfani a ƙarshen watan. Jagorancin bincike da asibitin Farko na Jami'ar Wuhan ya bayar ya ba da shawarar hanyoyin da za a bincika kamuwa da cutar dangane da yanayin maganin kai tsaye da haɗarin kamuwa da cutar.
Rashin cin abinci a kan gilashin gilashi tare da rarraba kayan lambu, kayan lambu da kuma baya ba daidai ba ne a farkon kamuwa da cuta.
Ƙarƙashin ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
Akwai bayanai kadan game da cutar COVID-19 da kuma cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan.
Abubuwan da ke faruwa a lokacin da ake yin kwayar cutar sune:
Abubuwan da muke gani a nan su ne: ruwa a cikin huhu, zuciya, jijiyoyi, da kuma huhu.
Ana iya gano nau'ikan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cututtukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan
Ƙarƙashin ƙwayoyin cuta: ƙwayoyin cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, ƙwayar cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta, cuta
Cutar huhu mai tsanani: ɓarkewar ƙananan ƙananan huhu tare da ɓarkewar ruwa daga cikin ƙananan huhu.
DAD shine dalilin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cuttukan cuttukan cuttukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cututtukan cututtukan cut
Maganin cututtukan huhu: shirya don fitarwa a cikin alveolar da kuma cutar huhu ta rhymes
jini, jini mai juyayi (DIC), ƙwayar leukoerythroblastic:
Kayan rigakafi don rage yiwuwar kamuwa da cuta, ya haɗa da kasancewa a gida, guje wa wuraren da mutane suke wanke hannu da sabulu da ruwa, sau da yawa aƙalla na minti 20, yin aikin tsabtace numfashi, da kuma guje wa taɓa idanu, hanci ko baki lokacin da ba a wanke hannayensu ba.
CDC ta ba da shawarar yin amfani da bakinka da hanci tare da takardar shaidar lokacin tari ko cizon sauro, kuma ta ba da shawarar yin amfani da ɓangaren ciki na hannu idan ba a yi amfani da takardar shaidar ba.
Ana ƙarfafa tsabtace hannu daidai bayan tari ko cizon yatsa.
CDC ta ba da shawarar yin amfani da allon rufe fuska a wuraren jama'a, wani ɓangare na auna yaduwar kamuwa da cutar daga mutane marasa bayyanar cututtuka. Hanyar watsa labarun na nufin rage tasirin masu kamuwa da cutar ga taron jama'a ta hanyar rufe makarantu da wuraren aiki, hana tafiya, da soke manyan tarurruka na jama'a, da sauransu.
Dokokin tsare sirri sun kuma ce mutane su tsare kansu a nesa da juna da tsayin kafa 6.
Babu wani magani da aka sani da zai iya hana cutar COVID-19. Saboda ba a tsammanin za a gano allurar ba har zuwa 2021, babban ɓangaren sarrafa COVID-19 shine ƙoƙarin rage matsakaicin adadin annobar, wanda aka sani da haɗin haɗin linzamin kwamfuta.
CDC ta kuma ba da shawarar cewa kowane mutum ya wanke hannayensa sau da yawa da sabulu da ruwa na akalla dakika 20 musamman bayan ya shiga gidan wanka ko kuma idan hannayensa sun ga ƙura kafin ya ci da kuma bayan ya wanke hanci, ya yi kuka ko ya yi tari.
Ƙari ga haka, WHO ta ba da shawarar yin amfani da wanke hannu da ruwa mai ƙarancin barasa, wanda ya ƙunshi akalla kashi 60% na giya, amma ba za a iya amfani da sabulu da ruwa ba. Ga yankunan da ba a sayar da wanke hannu ba, WHO ta ba da hanyoyi biyu don samar da asali.
Duk waɗannan ƙwayoyin halitta suna da ƙaruwa daga ethanol ko isopropanol.
An yi amfani da sinadarin hydrogen peroxide wajen kashe kwayoyin dake cikin giya. Ba shi da wani abu mai amfani da zai kashe kwayoyin dake hannun.
An ƙara chlorine a matsayin mai gina jiki.
Mutane suna kula da su ta hanyar kulawa da taimako, wanda zai iya haɗawa da maganin ruwa, samar da oxygen, da kuma taimakawa sauran kwayoyin halitta masu mahimmanci da ke fama da cutar.
Hukumar ta CDC ta shawarci wadanda suka yi zaton suna dauke da cutar su sa abin rufe fuska.
Ana amfani da ƙwayar oxygen extracorporeal (ECMO) don magance matsalar rashin numfashi, amma amfanin sa har yanzu yana cikin la'akari.
An gabatar da tsarin abinci mai gina jiki da kuma salon rayuwa mai kyau don inganta lafiyar jiki.
Maganin da aka yi na gaba zai iya amfanar waɗanda ke da alamun bayyanar cututtuka na farko bayan kamuwa da cutar. Hukumar lafiya ta duniya da kuma Hukumar Lafiya ta kasar Sin sun fitar da wata sanarwa game da yadda za a kula da marasa lafiya da ke da cutar COVID-19 da ke asibiti.
Masana harkokin gaggawa da kuma likitocin likitancin huhu a Amurka sun yi kokarin tura umarnin magani daga hukumomi zuwa bayanan da za su iya samun takardun IBCC kyauta.
A watan Afrilu na shekarar 2020, babu takamaiman magani ga COVID-19.
A cikin alamun, wasu masana sun ba da shawarar yin amfani da acetaminophen (paracetamol) maimakon ibuprofen don amfani na farko.
Dole ne a yi hankali don rage haɗarin kamuwa da cutar, musamman a wuraren kiwon lafiya, yayin da ake amfani da nau'ikan aiki masu ƙira kamar injin iska ko injin wanke hannu.
Masana lafiya sun yi matukar damuwa game da mutanen da ke dauke da COVID-19. Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka (CDC) sun ba da shawarar sanya marasa lafiya a cikin ɗakunan keɓewa don hana kamuwa da cutar ta iska (AIIR), ban da amfani da daidaitattun matakan tsaro, kulawa da haɗuwa da kuma kula da kamuwa da cutar ta iska. Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka (CDC) sun kuma ba da umarni kan amfani da kayan kariya ta mutum (PPE) yayin barkewar cutar.
Abubuwan da aka gabatar sune: tufafin likita na mutum, kayan shafawa ko na'urar shafawa, kayan shafawa da na'urar shafawa. Idan akwai kayan shafawa, ya kamata a yi amfani da su a matsayin fifiko (maimakon na'urar shafawa).
N95 sun amince da su don ƙayyadaddun masana'antu, amma Hukumar Abinci da Magunguna (FDA) ta ba da izinin amfani da su a ƙarƙashin izinin gaggawa (EUA).
An tsara su ne don kare su daga abubuwa masu iska kamar ƙura, amma ba a ba da tabbacin ingancin su ga wasu takamaiman wakilai na halitta don amfani da su ba.
Idan babu masks, CDC ta ba da shawarar yin amfani da masks na rigakafi aƙalla ta amfani da masks da aka yi da hannu.
Yawancin lokuta na COVID-19 ba su da tsanani sosai, suna buƙatar shigar da kayan taimako na numfashi, amma akwai wasu adadin lokuta da ake buƙata.
Ana nazarin nau'ikan taimakon numfashi ga mutane masu fama da cutar COVID-19 a cikin asibiti, tare da wasu shaidu da ke nuna cewa ana iya kauce wa iska ta hanyar zubar da jini ta hanyar hanta ko bi-level.
Ko waɗannan abubuwa biyu suna da amfani iri ɗaya ga waɗanda suke da ciwon da ba a sani ba.
Wasu likitoci sun fi son kasancewa tare da tsarin fitar da iska mai iska wanda ke yaduwa idan ya yiwu, saboda wannan fasaha ta ƙayyade yaduwar ƙwayoyin iska idan aka kwatanta da ƙwayoyin cuta na cannula masu ƙarfi. Matsalar ta fi yawa a cikin tsofaffi (mutanen da suka wuce shekaru 60 da kuma musamman waɗanda suka wuce shekaru 80).
Kasashe da dama masu tasowa ba su da isasshen asibitoci da ke iyakance ikon tsarin kiwon lafiya na magance karuwar yawan cututtukan COVID-19 masu tsanani da ke buƙatar isasshen asibiti.
Wani bincike a kasar Sin ya gano cewa kashi 5 cikin 100 na mutanen da aka shigar da su a asibitoci na musamman, kashi 2.3 cikin 100 na mutanen da suka bukaci taimakon likitanci na numfashi, da kuma kashi 1.4 cikin 100 na mutanen da suka mutu.
A kasar Sin, kusan kashi 30% na mutanen da ke asibiti da suka kamu da cutar COVID-19 na ƙarshe sun yarda su shiga ICU.
Injin iska na iska yana da matukar damuwa yayin da alamun rashin numfashi (ARDS) ke ci gaba a cikin COVID-19 kuma shigar da oxygen yana da wahala.
Ana buƙatar iska mai ƙarfi mai sarrafawa, mai ƙarfi da PEEP don samar da iskar oxygen mafi yawa yayin rage haɗarin rauni da cutar iska a cikin huhu.
Ba za a iya samun PEEP mai ƙarfi a kan tsofaffin injunan iska ba.
Bincike kan yiwuwar maganin ya fara ne a watan Janairun 2020, kuma wasu magungunan rigakafin cutar suna cikin gwaji na magani.
Magungunan rigakafin cutar Remdesivir da ke da fadi da kewayon cutar suna da alama sun fi nasara.
Ko da yake ana iya amfani da sabon magani har zuwa 2021 don ƙirƙirar, wasu kwayoyi da aka gwada an yarda da su don wasu amfani ko kuma suna cikin gwaji na ci gaba.
Ana iya gwada maganin rigakafi a kan waɗanda suke da ciwo mai tsanani.
Hukumar lafiya ta duniya ta ba da shawarar cewa masu aikin sa kai su shiga cikin gwaji game da inganci da amincin magani. FDA ta ba da izinin wucin gadi na wucin gadi na magani tare da jini na jini, wanda shine gwaji na gwaji a wasu lokuta inda marasa lafiya ke fuskantar tsanani da mutuwa.
Ba a gudanar da bincike na asibiti ba don tabbatar da cewa yana da lafiya da tasiri ga cutar.
A watan Fabrairun 2020, kasar Sin ta kirkiro wani app na wayar salula don magance yaduwar cutar.
Ana tambayar masu amfani su shigar da sunayensu da kuma lambar su.
"Aikace-aikacen na iya gano ""tausayi na kusa"" ta amfani da bayanan saka idanu, don haka ya san haɗarin kamuwa da cutar".
Kowane mai amfani zai iya duba yanayin wasu masu amfani uku.
Idan aka gano wani hadari mai yuwuwa, ana amfani da software don ba da shawara ga masu bincike da kansu ba, amma kuma don sanar da jami'an lafiya na gida. Ana amfani da manyan bayanai a kan bayanan wayar hannu, fasahar sanarwa, bin diddigin wayar hannu da kuma bayanan sirri don bin diddigin masu kamuwa da cutar da waɗanda suka tuntube su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba da izinin jami'an tsaro su bi bayanan wayar salula na mutanen da ake zaton suna dauke da cutar.
An dauki matakan da za su karfafa keɓewa da kare wadanda ke da alaka da 'yan kasar da ke dauke da cutar.
A watan Maris na shekarar 2020, Deutsche Telekom ta raba bayanan wurin waya tare da hukumar gwamnatin tarayya ta Jamus, Robert Koch, don bincike da hana yaduwar cutar.
Rasha ta inganta fasahar gano fuska don gano masu aikata laifi.
Shugaban lafiyar gida a Italiya, Giulio Gallera, ya ce ya samu sanarwar ta hanyar kamfanin wayar tarho cewa kashi 40 cikin dari na mutanen kasar na tafiya.
Gwamnatin Jamus ta kaddamar da wani shiri na hackathon na tsawon sa'o'i 48 a karshen mako, wanda ya kai fiye da mutane 42,000.
Shugaban Estonia, Kersti Kaljulaid, ya yi kira ga duniya da ta nemi ingantacciyar hanyar magance yaduwar cutar coronavirus.
Kowane mutum zai iya fuskantar matsi mai tsanani daga aiki, ƙuntatawa a tafiya, sakamakon magani, ko kuma tsoron kamuwa da cutar.
"BBC ta yi ƙaulin Rory O'Connor, yana cewa ""ɗaukiwar zaman kanta, zaman kaɗaici, damuwa game da lafiya, damuwa, da kuma koma bayan tattalin arziki babban hadari ne a cikin haɗarin lafiyar mutum da lafiyar mutane".
Wannan cuta na iya faruwa a cikin ƙananan yanayi ba tare da alamun bayyanar cututtuka ba, ko kuma a cikin wani nau'i na cututtukan sama na sama, kamar mura.
Sau da yawa, marasa lafiya suna warkewa cikin makonni biyu, yayin da waɗanda ke da ciwo mai tsanani ko tsanani na iya ɗaukar makonni uku zuwa shida don warkewa.
Mata masu ciki na iya samun haɗarin kamuwa da cutar COVID-19 mai tsanani dangane da bayanai daga wasu irin ƙwayoyin cuta kamar SARS da MERS, amma bayanai don COVID-19 sun kasance marasa ƙarfi. Ga wasu mutane, COVID-19 na iya shafar hanta, wanda ke haifar da cutar huhu.
A cikin wadanda suka fi fama da cutar COVID-19, cutar tana iya zama alamun cutar ta hanyar numfashi mai tsanani (ARDS) wanda ke haifar da cutar ta hanyar cutarwa ko lalacewar jiki.
Sakamakon COVID-19 ya hada da kamuwa da cuta mai cutarwa, rashin jini, da kuma lalacewar zuciya, koda da hanta.
Rashin hawan jini, musamman karuwar prothrombin lokaci, an bayyana shi a cikin 6% na waɗanda aka yi asibiti tare da COVID-19, yayin da aikin koda mara kyau aka gani a cikin 4% na wannan rukuni.
Kimanin kashi 20-30 cikin dari na mutanen da ke da cutar COVID-19 suna nuna karuwar ƙwayar cuta.
A cewar wannan rahoton, matsakaicin lokacin da ake tsakanin bayyanar cututtuka da mutuwa ya kai kwanaki goma, inda biyar suka yi asibiti.
Duk da haka, marasa lafiya da aka tura zuwa ICU suna da matsakaicin lokaci na kwana bakwai tsakanin asibiti da mutuwa.
A cikin binciken farko, matsakaicin lokaci daga bayyanar cututtuka na farko zuwa mutuwa ya kai kwanaki 14, daga shida zuwa kwanaki 41.
A cikin wani binciken da hukumar lafiya ta kasar Sin ta gudanar, maza suna da kashi 2.8 cikin dari na mutuwa, mata kuma kashi 1.7 cikin dari.
Binciken kwayar cutar na huhu na bayan mutuwa ya nuna lalacewar alveolar tare da ƙwayoyin fibromyxoid exudates a cikin huhu biyu.
An lura da sauye-sauyen siffar da ke faruwa a cikin ƙwayoyin cuta.
Hanyar hanta na nuna alamun cutar ta numfashi mai tsanani (ARDS).
Kashi 11.8% na yawan mutuwar da Hukumar Lafiya ta Kasa ta kasar Sin ta ruwaito, cututtukan zuciya suna nunawa ne ta hanyar karuwar matakan trubonin ko bugun zuciya.
A cewar bayanan watan Maris daga Amurka, kashi 89% na masu shiga asibiti suna da yanayin rashin lafiya kamar yadda suka kasance a asibiti. Amfani da albarkatun likita da tattalin arzikin yanki na iya shafar yawan mutuwa.
Ana iya kwatanta yawan mutuwar daga yanayin rashin lafiya daban-daban saboda yankuna sun bambanta, amma kuma saboda hanyoyin da ake amfani da su wajen yin hakan suna da wuyar fahimta.
Idan ba a ƙidaya ƙananan ƙwayoyin cuta ba, hakan zai iya sa a yi tunanin cewa mutuwar mutane ba daidai ba ne.
Amma gaskiyar cewa mutuwar ta samo asali ne daga wasu lokuta da suka gabata na iya nufin cewa yawan mutuwar yanzu ya kamata a yi la'akari da shi sosai.
Masu shan taba suna da alamun cutar COVID-19 sau 1.4 kuma suna iya buƙatar kulawa ko mutuwa sau 2.4 idan aka kwatanta da waɗanda ba sa shan taba. An yi magana game da damuwa game da rashin lafiyar da ke da tsayi.
Hukumomin asibitoci na Hong Kong sun gano raguwar lafiyar hanta a cikin wasu mutanen da suka warke daga cutar daga kashi 20 zuwa 30 cikin ɗari, kuma ana duba hanta don gano lalacewar jiki.
Wannan zai iya haifar da alamun rashin lafiya bayan an yi musu magani mai tsanani bayan sun warke.
A watan Maris na shekarar 2020, ba a san ko canja wurin lokaci ya ba da rigakafi mai inganci da na dogon lokaci ga waɗanda suka warke daga cutar ba.
An lura cewa tsarin rigakafin ya dogara da yanayin wasu ƙwayoyin cuta, amma a wasu lokuta, sakamakon COVID-19 ya kasance tare da gwajin cutar ta tabbatacce a wasu lokuta.
Ana ganin cewa waɗannan lokuta suna da saukin kamuwa da cutar fiye da yadda suke da sauyawa.
Ana tunanin cewa kwayar cutar ta samo asali ne daga yanayi kuma ta samo asali ne daga dabbobi ta hanyar yaduwa.
Ba a san ainihin asalin ba, amma a watan Disamba na 2019, an sami barkewar yaduwar cutar, wanda ya haifar da kamuwa da cutar daga mutum zuwa mutum.
Nazarin da aka yi na farko na 41 da aka kamu da cutar COVID-19, wanda aka buga a watan Janairun 2020 a cikin mujallar The Lancet, ya nuna ranar farko ta fara bayyanar cututtuka, 1 ga Disamba, 2019.
Hukumar lafiya ta duniya ta bayyana cewa an fara samun alamun cutar a ranar 8 ga watan Disamba na 2019.
Ana amfani da wasu matakan da aka yi amfani da su don tabbatar da yawan mutuwar.
Wadannan adadi sun bambanta ta hanyar yankuna da lokaci, kuma suna rinjaye ta hanyar yawan gwaji, ingancin tsarin kiwon lafiya, zaɓin magani, lokacin da ya fara, da kuma yanayin al'umma kamar shekarun jima'i da lafiyar gaba ɗaya.
A ƙarshen 2019, Hukumar Lafiya ta Duniya ta sanya lambar cutar ICD-10 mai mahimmanci tare da U07.1 don mutuwar daga kwayar cutar SARS-CoV-2 da aka tabbatar da dakin gwaje-gwaje da U07.2 don mutuwar daga asibiti ko cutar COVID-19 ba tare da tabbatar da kwayar cutar SARS-CoV-2 ba. Matsakaicin adadin mutuwar yana nuna yawan mutuwar da aka raba ta da yawan waɗanda aka gano a cikin lokacin da aka bayar.
Bisa ga bayanan Johns Hopkins University, yawan mutuwar mutane da suka kamu da cutar ya kai kashi 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu, 2020.
Sauran matakan sun hada da CFR (Case of Death) wanda ke nuna yawan mutanen da aka gano sun mutu saboda cutar, da kuma Inflammatory Inflammatory Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Reproductive Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recycled Recyc
Wadannan kididdigar ba su da lokaci kuma suna bin yawan mutane daga kamuwa da cutar ta hanyar magance shari'o'in.
Duk da yake ba dukan mutane da ke da cutar suke samar da maganin rigakafi ba, kasancewar maganin zai iya ba da bayani game da yawan mutanen da suka kamu da cutar.
A tsakiyar barkewar cutar a Italiya, Castiglione d'Adda, wani ƙaramin ƙauye ne da ke da yawan mutane 4600, 80 (1.7%) sun mutu.
A Gangelt, ana yadu da cutar ta hanyar bikin Carnival kuma ana yaduwa ga matasa, wanda ke haifar da ƙarancin mutuwa, kuma ba a iya rarraba duk mutuwar COVID-19 ba.
Bugu da ƙari, ba a rufe tsarin kiwon lafiya na Jamus ba.
A Netherlands, kusan kashi 3 cikin 100 na mutane suna da maganin rigakafi a lokacin da aka gwada su daga mai ba da jini.
69 (0.004% na yawan jama'a) an ce sun mutu saboda COVID-19.
Sakamakon annoba da kuma mutuwar ta ya bambanta ga maza da mata.
Yawan mutuwar da aka samu a cikin maza a cikin binciken da aka yi a kasar Sin da Italiya.
Mafi yawan haɗarin ga maza yana cikin shekaru 50, tare da bambancin tsakanin maza da mata na 90 kawai.
A kasar Sin, yawan mutuwar ya kai kashi 2.8 cikin dari ga maza da kuma kashi 1.7 cikin dari ga mata.
Ba a san ainihin dalilin wannan bambancin ba, amma akwai wasu kwayoyin halitta da kuma halaye da za su iya zama dalili.
Bambancin tsarin rigakafin jima'i, raguwar yawan shan taba a cikin mata da maza da ci gaban yanayin kama-da-wane kamar hawan jini a cikin yara fiye da mata, duk suna iya taimakawa wajen yawan mutuwar maza.
A Turai, maza ne ke da kashi 57 cikin 100 na wadanda suka kamu da cutar, kuma maza ne ke da kashi 72 cikin 100 na wadanda suka mutu sakamakon COVID-19.
A watan Afrilu na shekarar 2020, gwamnatin Amurka ba ta bi diddigin jima'i na kamuwa da COVID-19 ba.
Bincike ya nuna cewa cututtukan da ke haifar da ƙwayoyin cuta kamar cutar Ebola, cutar mura mai tsanani da cutar SARS suna shafar maza da mata daban.
Yawancin ma'aikatan kiwon lafiya, musamman ma ma'aikatan aikin jinya mata ne, kuma suna da mafi yawan damar kamuwa da cutar.
Hukumar lafiya ta duniya ta sanar a ranar 11 ga Fabrairu, 2020 cewa sunan cutar shine COVID-19.
Shugaban Hukumar Lafiya ta Duniya Tedros Adhanom Ghebreyesus ya bayyana cewa CO na nufin corona, VI na cutar, D na cutar, kuma 19 na lokacin da aka fara gano cutar a ranar 31 ga Disamba, 2019.
An zabi sunan don kauce wa nufin wani wuri na musamman (misali China), nau'in dabba ko rukuni na mutane bisa ga ƙa'idodin ƙasashen duniya don suna don hana kamuwa da cutar. Kwayar cutar da ke haifar da COVID-19 ana kiranta cutar coronavirus ta hanyar numfashi mai tsanani, nau'i na 2 (SARS-CoV-2).
Bugu da ƙari, Hukumar Lafiya ta Duniya ta yi amfani da COVID-19 da kuma COVID-19 wanda ke haifar da cutar COVID-19 a cikin sadarwa ta jama'a.
"A yau ana kiran cutar da kuma kwayar cutar Coronavirus".
A lokacin barkewar cutar a Wuhan, China, an san cutar da cutar da aka fi kiranta Coronavirus da Coronavirus.
A watan Janairun 2020, Hukumar Lafiya ta Duniya ta ba da shawarar cewa 2019-nCov da cutar huhu na 2019-nCoV suna da wucin gadi don ƙwayoyin cuta da cututtuka daidai da jagorar anti-use a cikin sunan cutar da sunan cutar 2015.
An fitar da sunayen COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda ƙarancin damar da ke cikin tsarin samar da kayayyaki, wasu kamfanonin dijital suna samar da kayan kiwon lafiya kamar kayan shafawa da na iska.
Alal misali, a lokacin da asibitocin Italiya suka bukaci iskar iska ta gaggawa kuma masu samar da kayayyaki ba su iya ba da isar da kayayyaki a kan lokaci ba, wani sabon kamfani a cikin gida ya kirkiro kayayyakin injiniya na baya kuma ya samar da 100 na'urori da ake bukata a cikin dare.
Nan da nan bayan barkewar cutar COVID-19, an yi ta yada wasu bayanan karya game da asalin, rigakafi, magani da kuma yanayin cutar, kuma an rarraba duk bayanan a duk faɗin Intanet.
Mutane suna iya yada cutar zuwa wasu dabbobi.
Binciken bai gano wata hujja ta kamuwa da cutar a cikin alade da naman alade ba.
Babu wani magani ko rigakafi da aka amince da shi don magance cutar.
Binciken duniya kan alluran rigakafi don magance COVID-19 yana karkashin jagorancin gwamnatoci, kungiyoyi, masana kimiyya da masu bincike.
A watan Maris, Hukumar Lafiya ta Duniya ta kaddamar da wani gwaji na gwaji don tantance tasirin maganin rigakafin cutar a cikin nau'ikan 4 da suka dace da kuma gano abubuwan da suka fi tasiri.
Babu rigakafi, amma hukumomi suna aiki sosai wajen samar da rigakafi.
Dole ne a sake amfani da binciken da aka yi a kan SARS-CoV saboda SARS-CoV da SARS-CoV-2 suna iya shiga cikin ƙwayoyin mutum ta hanyar ƙwayoyin mai karɓar ACE2.
Akwai gwaji uku na allurar rigakafi.
Da farko, masu bincike sun yi niyyar samar da cikakken rigakafin cutar.
Yin amfani da irin wannan kwayar cutar, ko dai ba ta aiki ko kuma tana da manufa, shine don taimakawa tsarin garkuwar mutum ya amsa sabon kamuwa da COVID-19.
Hanyar ta biyu ita ce, allurar rigakafi ta subunit, wanda ke nufin samar da allurar rigakafi ga wasu sassan cutar.
A cikin SARS-CoV-2+, irin wannan binciken ya shafi ƙwayoyin S-spike, wanda ke taimakawa kwayar cutar ta shiga cikin enzyme ACE2.
Hanyar ta uku ita ce rigakafin nucleic acid (DNA ko RNA, sabuwar fasaha ce don yin allurar).
A ranar 16 ga Maris, 2020, an fara gwajin farko na allurar tare da masu sa kai hudu a Seattle.
An gabatar da wannan rigakafin ne a matsayin wata babbar matsala ga ci gaban rigakafin SARS-COV-2, amma wannan batun ya kasance da rikici.
Akwai fiye da gwajin kai tsaye na 300 a cikin aiki a watan Afrilu 2020.
An gwada gwaje-gwaje bakwai a kan shirye-shiryen magani don cutar sankara, ciki har da nazarin huɗu na hydrochloride ko chlorine.
Yawancin magungunan rigakafin da aka sake amfani da su suna taimakawa bincike na kasar Sin, tare da gwaji tara na Phase III akan Remdesivir a ƙasashe da yawa, kamar yadda rahotanni suka nuna a ƙarshen Afrilu.
An sake nazarin nazarin nazarin ilimin kimiyya game da ci gaban kwayar cutar COVID-19 da kuma maganin rigakafi, kuma an sanya shi a cikin aiki a watan Afrilu na 2020. Ana kimanta magungunan riga-kafi da yawa don magance COVID-19, Remdesivir, Chloroquine da Hydroxychloroquine, Lopinavir/Ritonavir da Lopinavir/Ritonavir tare da Interferon beta.
Akwai hujja ta wucin gadi game da ingancin Remdesivir kamar yadda ya kasance a watan Maris na 2020.
An lura da ci gaban yanayin cutar a cikin marasa lafiya da ke shan remdesivir.
Ana gudanar da gwaji na asibiti na mataki na III a Amurka, China da Italiya. An yi nazarin chloroquine a kasar Sin a watan Fabrairun 2020 tare da sakamakon farko.
Amma akwai bukatar a sake duba binciken.
Hukumomin kiwon lafiya na kasar Sin da na kasar Koriya sun bada shawarar yin amfani da maganin chloroquine.
Amma, Cibiyar Kwayar cuta ta Wuhan ta ba da shawarar yin amfani da kashi ɗaya kawai na miyagun ƙwayoyi, kuma idan muka yi amfani da kashi biyu, zai zama mai haɗari sosai kuma zai iya mutuwa.
A ranar 28 ga Maris, 2020, Hukumar ta FDA ta fitar da sanarwar budewa don ba da izinin amfani da magungunan hydroxychloroquine da chloroquine a gaggawa bisa ga shawarar likitoci don magance marasa lafiya da ke dauke da COVID-19.
Bayanai na farko sun nuna cewa ribavirin yana da mahimmanci don hana SARS-CoV-2 a cikin gwajin gwaji.
An ba da shawarar yin ƙarin bincike kan Nitazoxanide bayan an gano cewa yana da ƙananan ƙarancin hana cutar SARS-CoV-2. Sauran binciken sun nuna cewa akwai samar da furotin ta hanyar aikin protease serine 2 (TMPRSS2) na ƙwayoyin halitta, wanda ke da mahimmanci ga SARS-CoV-2 shiga cikin ƙwayoyin halitta ta hanyar ƙwayoyin halitta masu karɓar ACE2.
Nazarin chloroquine da hydroxychloroquine don amfani da su tare da ko ba tare da azithromycin ba yana da mahimmanci saboda akwai takaddama daga ƙungiyar likitoci cewa ya kamata a yi amfani da wannan magani ba tare da binciken ba. Oseltamivir ba ya hana SARS-CoV-2 kuma ba shi da matsayi a cikin maganin COVID-19.
Wannan karuwar cytokine na iya zama sakamakon ƙarshen matakin COVID-19.
Akwai hujja cewa hydroxychloroquine na iya hana karuwar cytokine. Tocilizumab kuma an sanya shi a cikin magani, a cewar Hukumar Lafiya ta kasar Sin bayan an kammala karamin bincike.
A halin yanzu, ana gudanar da wani gwaji na biyu na gwaji na kasa a Italiya bayan da ya nuna kyakkyawan sakamako ga marasa lafiya masu tsanani.
Tare da gwajin jini na jini na jini don gano Cytokine Storms, yana nufin cewa don hana irin wannan ci gaban, ana buƙatar ɗaukar dalilin mutuwa ga mutanen da ke fama da wasu sakamako.
An amince da maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin
Har zuwa yanzu, babu wata hujja mai sarrafawa da ta nuna cewa tocilizumab magani ne mai tasiri ga CRS.
Ana daukar daukar nauyin maganin rigakafi da aka yi amfani da shi da kuma gina jiki wanda ya warke daga COVID-19 ga mutanen da ke bukatarsa a matsayin hanyar yin allurar rigakafi ba tare da yin allurar ba.
An gwada wannan dabarar don SARS tare da sakamako mai ban mamaki.
Kwayar cuta ita ce tsarin aikin da ake tsammani maganin antibacterial zai iya daidaitawa, daidaita kariya daga SARS-CoV-2.
Duk da haka, akwai wasu hanyoyin da za a iya yin su, kamar su cytokines, ƙwayoyin da ke dogara da antibodies da/ko phagocytosis.
Alal misali, wani nau'i na maganin rigakafi na rashin aiki da aka yi da kwayoyin halitta masu ƙonewa suna cikin ci gaba.
Aikin samar da jini na masu warkewa daga cutar yana dauke da wani abu da ke dauke da wani nau'i na maganin cutar da za a sake kirkira.
Cutar korona ta ƙunshi wasu nau'ikan cututtuka da ke da alaƙa da juna.
Li Wenliang, likitan asibitin Wuhan, wanda daga baya ya kamu da cutar kuma ya mutu daga COVID-19 bayan ya sanar da sanin yadda cutar ke yaduwa.
